Reaction ID,Reaction: Links to Reaxys,Data Count,Number of Reaction Details,Reaction Rank,Record Type,Reactant,Product,Bin,Reaction,Reaction Details: Reaction Classification,Example label,Example title,Fulltext of reaction,Number of Reaction Steps,Multi-step Scheme,Multi-step Details,Number of Stages,Solid Phase,Time (Reaction Details) [h],Temperature (Reaction Details) [C],Pressure (Reaction Details) [Torr],pH-Value (Reaction Details),Other Conditions,Reaction Type,Subject Studied,Prototype Reaction,Named Reaction,Type of reaction description (Reaction Details),Location,Comment (Reaction Details),Product,Yield,Yield (numerical),Yield (optical),Stage Reactant,Reagent,Catalyst,Solvent (Reaction Details),References,Links to Reaxys
4480561,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=4480561&database=RX&origin=ReaxysOutput&ln=,(1 of 3),1,76,full reaction; has preparation,diisopropyl zinc; pyrimidine-5-carbaldehyde,(R)-2-Methyl-1-pyrimidin-5-yl-propan-1-ol; (S)-2-methyl-1-(5-pyrimidyl)-1-propanol,217365; 217365,CC(C)[Zn]C(C)C.O=CC1=CN=CN=C1.O=CC1=CN=CN=C1>>CC(C)[C@@H](O)C1=CN=CN=C1.CC(C)[C@H](O)C1=CN=CN=C1,Preparation,,,,1,,,,,40,0,,,,,,,,,,Yield given. Yields of byproduct given. Title compound not separated from byproducts,,,,,,(S)-2-methyl-1-(5-pyrimidyl)-1-propanol,,toluene,"Article; Shibata, Takanori; Morioka, Hiroshi; Hayase, Tadakatsu; Choji, Kaori; Soai, Kenso; Journal of the American Chemical Society; vol. 118; 2; (1996); p. 471 - 472;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6014533&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
5327685,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=5327685&database=RX&origin=ReaxysOutput&ln=,(2 of 3),1,63,full reaction; has preparation,acetic anhydride; (S)-2-methyl-1-(5-pyrimidyl)-1-propanol,Acetic acid (S)-2-methyl-1-pyrimidin-5-yl-propyl ester,260781,CC(=O)OC(C)=O.CC(C)[C@H](O)C1=CN=CN=C1>>CC(C)[C@H](OC(C)=O)C1=CN=CN=C1,Preparation,,,,1,,,,,,0 - 20,,,,Acetylation,,,,,,,,,,,,,,pyridine,"Article; Tanji, Shigehisa; Kodaka, Yasutaka; Shibata, Takanori; Soai, Kenso; Heterocycles; vol. 52; 1; (2000); p. 151 - 158;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6219411&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8498563,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8498563&database=RX&origin=ReaxysOutput&ln=,(3 of 3),1,12,half reaction,diisopropyl zinc; pyrimidine-5-carbaldehyde; (S)-2-methyl-1-(5-pyrimidyl)-1-propanol,,,CC(C)[Zn]C(C)C.O=CC1=CN=CN=C1.CC(C)[C@H](O)C1=CN=CN=C1>>,Chemical behaviour,,,,1,,,,,66,0,,,other substituted pyrimidine-5-carbaldehyde; automultiplication,,,,,,,,,,,,,,,toluene,"Article; Shibata, Takanori; Morioka, Hiroshi; Hayase, Tadakatsu; Choji, Kaori; Soai, Kenso; Journal of the American Chemical Society; vol. 118; 2; (1996); p. 471 - 472;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6014533&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
1554712,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=1554712&database=RX&origin=ReaxysOutput&ln=,(1 of 327),10,96,full reaction; has preparation,5-bromopyrimidine; formic acid ethyl ester,pyrimidine-5-carbaldehyde,46949,BrC1=CN=CN=C1.CCOC=O>>O=CC1=CN=CN=C1,Preparation,,,,1,,,2,,0.333333; 0.333333,-100; -100,,,,,,,,,,,pyrimidine-5-carbaldehyde,52 percent,52,,5-bromopyrimidine; formic acid ethyl ester,n-butyllithium,,tetrahydrofuran; hexane; tetrahydrofuran; hexane,"Article; Coleman, Paul J; Brashear, Karen M; Askew, Ben C; Hutchinson, John H; McVean, Carol A; Duong; Feuston, Bradley P; Fernandez-Metzler, Carmen; Gentile, Michael A; Hartman, George D; Kimmel, Donald B; Leu, Chih-Tai; Lipfert, Lorraine; Merkle, Kara; Pennypacker, Brenda; Prueksaritanont, Thomayant; Rodan, Gideon A; Wesolowski, Gregg A; Rodan, Sevgi B; Duggan, Mark E; Journal of medicinal chemistry; vol. 47; 20; (2004); p. 4829 - 4837;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6460747&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
1554712,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=1554712&database=RX&origin=ReaxysOutput&ln=,(1 of 327),10,96,full reaction; has preparation,5-bromopyrimidine; formic acid ethyl ester,pyrimidine-5-carbaldehyde,46949,BrC1=CN=CN=C1.CCOC=O>>O=CC1=CN=CN=C1,Preparation,87.A,Pyrimidine-5-carboxaldehyde,"EXAMPLE 87A Pyrimidine-5-carboxaldehyde A modified procedure of Rho and Abuh (Syn. Commun. 1994, 24, 253-256) was followed for the preparation of the titled aldehyde. Under nitrogen, to a solution of 5-bromopyrimidine (1 g, 6.3 mmol) in 60 mL anhydrous THF, was added BuLi (2.5 M, 2.6 mL, 6.5 mmol) at -78 C. The resulting yellow solution was stirred for 20 min, after which ethyl formate (0.55 mL, 6.7 mmol) was added dropwise over 5 min. After 20 min, the reaction was quenched with 1.5 M THF/HCl solution (4.5 mL, 6.7 mmol). The cold bath was removed, and the reaction mixture was stirred for 1 h. THF was removed in vacco, 10 mL of water was then added. The mixture was extracted with CHCl3 (2*10 mL), and the combined organics were dried (MgSO4) and concentrated. The crude product was purified via flash column chromatography (5% MeOH/CHCl3) to give 0.35 g (51%) of the titled pyrimidine-5-carboxaldehydepyrimidine-5-carboxaldehyde.",1,,,3,,0.333333; 0.416667; 1,-78,,,,,,,,,Page/Page column 42,,pyrimidine-5-carbaldehyde,51 percent,51,,5-bromopyrimidine; formic acid ethyl ester,n-butyllithium; hydrogenchloride,,tetrahydrofuran; tetrahydrofuran; tetrahydrofuran,"Patent; Kosogof, Christi; Liu, Bo; Liu, Gang; Liu, Mei; Nelson, Lissa T.J.; Serby, Michael D.; Sham, Hing L.; Szczepankiewicz, Bruce G.; Xin, Zhili; Zhao, Hongyu; US2005/70712; (2005); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8820924&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
1554712,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=1554712&database=RX&origin=ReaxysOutput&ln=,(1 of 327),10,96,full reaction; has preparation,5-bromopyrimidine; formic acid ethyl ester,pyrimidine-5-carbaldehyde,46949,BrC1=CN=CN=C1.CCOC=O>>O=CC1=CN=CN=C1,Preparation,81A,Pyrimidine-5-carboxaldehyde:,"A modified procedure of Rho and Abuh (Syn. Commun. 1994, 24, 253-256) was followed for the preparation of the titled aldehyde. Under nitrogen, to a solution of 5-bromopyrimidine (1 g, 6.3 mmol) in 60 mL anhydrous THF, was added BuLi (2.5 M, 2.6 mL, 6.5 mmol) at -78 C. The resulting yellow solution was stirred for 20 min, after which ethyl formate (0.55 mL, 6.7 mmol) was added dropwise over 5 min. After 20 min, the reaction was quenched with 1.5 M THF/HCl solution (4.5 mL, 6.7 mmol). The cold bathwas removed, and the reaction mixture was stirred for 1 h. THF was removed in vacco, 10 mL of water was then added. The mixture was extracted with CHCl3 (2*10 mL), and the combined organics were dried (MgSO4) and concentrated. The crude product was purified via flash column chromatography (5% MeOH/CHCl3) to give 0.35 g (51%) of the titled pyrimidine-5-carboxaldehydepyrimidine-5-carboxaldehyde.",1,,,2,,0.333333; 0.0833333,-78,,,,,,,,,Page/Page column 41,,pyrimidine-5-carbaldehyde,51 percent,51,,5-bromopyrimidine; formic acid ethyl ester,n-butyllithium,,tetrahydrofuran,"Patent; Kosogof, Christi; Liu, Bo; Liu, Gang; Liu, Mei; Nelson, Lissa T. J.; Serby, Michael D.; Sham, Hing L.; Szczepankiewicz, Bruce G.; Xin, Zhili; Zhao, Hongyu; US2005/171131; (2005); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8821888&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
1554712,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=1554712&database=RX&origin=ReaxysOutput&ln=,(1 of 327),10,96,full reaction; has preparation,5-bromopyrimidine; formic acid ethyl ester,pyrimidine-5-carbaldehyde,46949,BrC1=CN=CN=C1.CCOC=O>>O=CC1=CN=CN=C1,Preparation,15.1,1) Preparation of pyrimidine-5-carbaldehyde,"1) Preparation of pyrimidine-5-carbaldehyde A solution of 5-bromo-pyrimidine (5 g, 31.4 mmol, 1.0 eq.) in anhydrous THF (300 mL) was placed under an argon atmosphere in a three-necked round bottom flask equipped with a low-temperature thermometer. The mixture was cooled to -100 C. in a EtOH/N2(l) bath. To the solution of 5-bromopyridine was added a solution of n-BuLi in hexane (20 mL, 1.6 M, 32.5 mmol, 1.0 eq.). The resulting mixture was stirred for 20 minutes at 100 C. and the organolithium that formed was trapped with a solution of ethyl formate (2.7 mL, 33.5 mmol, 1.1 eq.) in THF (10 mL). The reaction was stirred for another 20 minutes at 100 C. and quenched with a solution of hydrochloric acid in ether (17 mL, 2M, 34 mmol). Then, the cold bath was removed and the mixture stirred at room temperature for 1 hour. The solution was concentrated under reduced pressure, and then treated with water and saturated aqueous sodium carbonate (10 mL). The mixture was extracted with dichloromethane and the organic layer was dried over MgSO4. The solvent was removed under reduced pressure and the residue purified by silica gel flash-column chromatography (eluent: CH2Cl2/AcOEt, 60:40 to 50:50) to afford pyrimidine-5-carbaldehyde as beige crystals (1.2 g, 35%).",1,,,2,,0.333333; 0.333333,-100 - 100; 100,,,Inert atmosphere,,,,,,Page/Page column 42,,pyrimidine-5-carbaldehyde,35 percent,35,,5-bromopyrimidine; formic acid ethyl ester,3-Bromopyridine; n-butyllithium,,tetrahydrofuran; ethanol; hexane; tetrahydrofuran; ethanol; hexane,"Patent; COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; Guillou, Catherine; Kozielski, Frank; Labriere, Christophe; Gueritte, Francoise; Tcherniuk, Sergey; Skoufias, Dimitrios; Thal, Claude; Husson, Henri-Philippe; US9212138; (2015); B2;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=67833191&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
1554712,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=1554712&database=RX&origin=ReaxysOutput&ln=,(1 of 327),10,96,full reaction; has preparation,5-bromopyrimidine; formic acid ethyl ester,pyrimidine-5-carbaldehyde,46949,BrC1=CN=CN=C1.CCOC=O>>O=CC1=CN=CN=C1,Preparation,,,,1,,,2,,0.333333; 0.333333,-100; -100 - -95,,,Inert atmosphere; Inert atmosphere,,,,,Experimental part,supporting information,,pyrimidine-5-carbaldehyde,19 percent,19,,5-bromopyrimidine; formic acid ethyl ester,n-butyllithium,,tetrahydrofuran; hexane; tetrahydrofuran; hexane,"Article; Giroud, Maude; Ivkovic, Jakov; Martignoni, Mara; Fleuti, Marianne; Trapp, Nils; Haap, Wolfgang; Kuglstatter, Andreas; Benz, Joerg; Kuhn, Bernd; Schirmeister, Tanja; Diederich, Francois; ChemMedChem; vol. 12; 3; (2017); p. 257 - 270;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=70586329&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
1554712,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=1554712&database=RX&origin=ReaxysOutput&ln=,(1 of 327),10,96,full reaction; has preparation,5-bromopyrimidine; formic acid ethyl ester,pyrimidine-5-carbaldehyde,46949,BrC1=CN=CN=C1.CCOC=O>>O=CC1=CN=CN=C1,Preparation,,,,1,,,,,,,,,"1.) hexane, -100 deg C, 20 min, 2.) hexane, from -100 deg C to -80 deg C",,,,,,,Yield given. Multistep reaction,,,,,,hydrogenchloride; n-butyllithium,,,Article; Rho; Abuh; Synthetic Communications; vol. 24; 2; (1994); p. 253 - 256;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=5896214&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
1554712,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=1554712&database=RX&origin=ReaxysOutput&ln=,(1 of 327),10,96,full reaction; has preparation,5-bromopyrimidine; formic acid ethyl ester,pyrimidine-5-carbaldehyde,46949,BrC1=CN=CN=C1.CCOC=O>>O=CC1=CN=CN=C1,Preparation,13.2,Step 2. Pynmidine-5-carboxaldehyde.,"To a solution of 5-bromopyrimidine (2 g, 1 2,58 mmol, 1 .00 equiv) in THF (20 mL) placed in a 50-mL 3-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen was added n-butyllithium ( 1 . 1 mL) at -78 C. The reaction mixture was stirred at -78 ""C for another 2 h . Ethyl formate (5.2 mL) was then added and the resulting solution was stirred for 2 h at -78 C. The resulting mixture was warmed to 0  C and washed with 50 mL of brine. The organ ic layer was dried with anhydrous sodium carbonate and concentrated The residue was purified on a silica gel column eluted with ethyl acetate/petroleum ether ( 1 1 ) to give 1 1 g of crude pyrimidine-5-carboxaldehyde as a yellow oil . TLC : ethyl acetate/petroleum ether ( 1 / 1 ), Rf= 0.2.",1,,,2,,2; 2,-78; -78 - 0,,,Inert atmosphere; Inert atmosphere,,,,,,Page/Page column 144,,,,,,5-bromopyrimidine; formic acid ethyl ester,n-butyllithium,,tetrahydrofuran; tetrahydrofuran,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; BUCKMELTER, Alexandre J.; CLODFELTER, Karl H.; DRAGOVICH, Peter; GOSSELIN, Francis; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; LIU, Xiongcai; REYNOLDS, Dominic J.; SMITH, Chase C.; WANG, Zhongguo; ZAK, Mark; ZHANG, Yamin; ZHAO, Guiling; ZHENG, Xiaozhang; YUEN, Po-Wai; WO2013/127266; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727359&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
1554712,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=1554712&database=RX&origin=ReaxysOutput&ln=,(1 of 327),10,96,full reaction; has preparation,5-bromopyrimidine; formic acid ethyl ester,pyrimidine-5-carbaldehyde,46949,BrC1=CN=CN=C1.CCOC=O>>O=CC1=CN=CN=C1,Preparation,13.2,Step 2. Pynmidine-5-carboxaldehyde.,"To a solution of 5-bromopyrimidine (2 g, 1 2,58 mmol, 1 .00 equiv) in THF (20 mL) placed in a 50-mL 3-necked round- bottom flask purged and maintained with an inert atmosphere of n itrogen was added n-butyllithium ( 1 . 1 mL) at -78 C. The jeaction mixture was stirred at -78 ""C for another 2 h . Ethyl formate (5.2 mL) was then added and the resulting solution was stirred for 2 h at -78 C. The resulting mixture was warmed to 0 ""C and washed with 50 mL of brine. The organ ic layer was dried with anhydrous sodium carbonate and concentrated The residue was purified on a silica gel column eluted with ethyl acetate/petroleum ether ( 1 1 ) to give 1 1 g of crude pyrimid ine-5-carboxaldehyde as a yellow oil . TLC : ethyl acetate/petroleum ether ( 1 / 1 ), Rf= 0.2.",1,,,2,,2; 2,-78; -78,,,Inert atmosphere; Inert atmosphere,,,,,,Page/Page column 95; 96,,,,,,5-bromopyrimidine; formic acid ethyl ester,n-butyllithium,,tetrahydrofuran; tetrahydrofuran,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; DRAGOVICH, Peter; GOSSELIN, Francis; YUEN, Po-Wai; ZAK, Mark; ZHENG, Xiaozhang; WO2013/127267; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727360&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
1554712,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=1554712&database=RX&origin=ReaxysOutput&ln=,(1 of 327),10,96,full reaction; has preparation,5-bromopyrimidine; formic acid ethyl ester,pyrimidine-5-carbaldehyde,46949,BrC1=CN=CN=C1.CCOC=O>>O=CC1=CN=CN=C1,Preparation,10.2,Step 2. Pyrimidine-5-carboxaldehyde.,"To a solution of prop-2-yn-1-amine (11.5 g, 208.79 mmol, 1 .00 equiv) and sodium hydroxide (9.1 g, 227.50 mmol, 1 .09 equiv) in water (40 mL) and toluene (1 10 mL) maintained under nitrogen was added ethyl chloroformate (23.9 g, 220.23 mmol, 1 .05 equiv) dropwise in 20 min with stirring at 10C. The resulting solution was stirred overnight at rt then extracted with 3x100 mL of toluene. The combined organic layers were dried over anhydrous sodium sulfate then concentrated under vacuum to give 15 g (57%) of ethyl N-(prop- 2-yn-1-yl)carbamate as a light yellow oil. TLC: ethyl acetate/petroleum ether (1 :2), Rf = 0.5.",1,,,2,,2; 2,-78; -78,,,Inert atmosphere; Inert atmosphere,,,,,,Page/Page column 69; 70,,,,,,5-bromopyrimidine; formic acid ethyl ester,n-butyllithium,,tetrahydrofuran; tetrahydrofuran,"Patent; GENENTECH,INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; BUCKMELTER, Alexandre J.; CLODFELTER, Kanl H.; DRAGOVICH, Peter; HAN, Bingsong; LIN, Jian; LIU, Xiongcai; REYNOLDS, Dominic J.; SMITH, Chase C.; WANG, Zhongguo; YUEN, Po-Wai; ZAK, Mark; ZHANG, Yamin; ZHENG, Xiaozhang; ZHAO, Guiling; WO2013/127268; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727361&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
1554712,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=1554712&database=RX&origin=ReaxysOutput&ln=,(1 of 327),10,96,full reaction; has preparation,5-bromopyrimidine; formic acid ethyl ester,pyrimidine-5-carbaldehyde,46949,BrC1=CN=CN=C1.CCOC=O>>O=CC1=CN=CN=C1,Preparation,13.2,Step 2. Pyrimidine-5-carboxaldehyde.,"[0217] Step 2. Pyrimidine-5-carboxaldehyde. To a solution of 5-bromopyrimidine (2 g, 12.58 mmol, 1.00 equiv) in THF (20 mL) placed in a 50-mL 3-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen was added n-butyllithium (1.1 mL) at -78 C. The reaction mixture was stirred at -78 C for another 2 h. Ethyl formate (5.2 mL) was then added and the resulting solution was stirred for 2 h at -78 C. The resulting mixture was warmed to 0C and washed with 50 mL of brine. The organic layer was dried with anhydrous sodium carbonate and concentrated. The residue was purified on a silica gel column eluted with ethyl acetate/petroleum ether (1:1) to give 11 g of crude pyrimidine-5- carboxaldehyde as a yellow oil. TLC: ethyl acetate/petroleum ether (1/1), Rf = 0.2.",1,,,2,,2; 2,-78; -78,,,Inert atmosphere,,,,,,Paragraph 0217,,,,,,5-bromopyrimidine; formic acid ethyl ester,n-butyllithium,,tetrahydrofuran; tetrahydrofuran,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; GOSSELIN, Francis; ZAK, Mark; ZHENG, Xiaozhang; WO2013/130935; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727676&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
28688007,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=28688007&database=RX&origin=ReaxysOutput&ln=,(2 of 327),3,94,full reaction; has preparation,pyrimidine-5-carbaldehyde; 1-t-Butoxycarbonylpiperazine,tert-butyl 4-(pyrimidin-5-ylmethyl)piperazine-1-carboxylate,,O=CC1=CN=CN=C1.CC(C)(C)OC(=O)N1CCNCC1>>CC(C)(C)OC(=O)N1CCN(CC2=CN=CN=C2)CC1,Preparation,,,,1,,,,,6,20,,,,,,,,Experimental part,supporting information,,tert-butyl 4-(pyrimidin-5-ylmethyl)piperazine-1-carboxylate,92 percent,92,,,sodium triacetoxy borohydride; acetic acid,,dichloromethane,"Article; Bavetsias, Vassilios; Crumpler, Simon; Sun, Chongbo; Avery, Sian; Atrash, Butrus; Faisal, Amir; Moore, Andrew S.; Brown, Nathan; Sheldrake, Peter W.; Bush, Katherine; Henley, Alan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; Raynaud, Florence I.; Workman, Paul; Eccles, Suzanne A.; Linardopoulos, Spiros; Blagg, Julian; Kosmopoulou, Magda; Bayliss, Richard; Journal of Medicinal Chemistry; vol. 55; 20; (2012); p. 8721 - 8734,14;; ; Article; Bavetsias, Vassilios; Crumpler, Simon; Sun, Chongbo; Avery, Sian; Atrash, Butrus; Faisal, Amir; Moore, Andrew S.; Kosmopoulou, Magda; Brown, Nathan; Sheldrake, Peter W.; Bush, Katherine; Henley, Alan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; Raynaud, Florence I.; Workman, Paul; Eccles, Suzanne A.; Bayliss, Richard; Linardopoulos, Spiros; Blagg, Julian; Journal of Medicinal Chemistry; vol. 55; 20; (2012); p. 8721 - 8734;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20212028;35220251&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
28688007,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=28688007&database=RX&origin=ReaxysOutput&ln=,(2 of 327),3,94,full reaction; has preparation,pyrimidine-5-carbaldehyde; 1-t-Butoxycarbonylpiperazine,tert-butyl 4-(pyrimidin-5-ylmethyl)piperazine-1-carboxylate,,O=CC1=CN=CN=C1.CC(C)(C)OC(=O)N1CCNCC1>>CC(C)(C)OC(=O)N1CCN(CC2=CN=CN=C2)CC1,Preparation,121,tert-Butyl 4-(pyrimidin-5-ylmethyl)piperazine-1-carboxylate,"A solution of pyrimidine 5-carboxaldehyde (100 mg, 0.92 mmol) in ethanol (2 mL) and acetic acid (0.2 mL) at room temperature was treated with tert-butyl-1-piperazine carboxylate (2.5 eq, 2.31 mmol, 430 mg) and stirred for 5 minutes. Sodium cyanoborohydride (0.95 eq, 0.88 mmol, 55 mg) was added portionwise and the reaction then stirred for 16 h. Concentration in vacuo and preparative tlc purification (EtOAc) gave the product (141 mg, 55%) as a pale yellow oil; deltaH (500 MHz, CDCl3) 1.47 (s, 9H, C(CH3)3), 1.95 (br, 2H, piperazine NCH2), 2.42 (t, J=4.7 Hz, 2H, piperazine NCH2), 3.45 (t, J=4.9 Hz, 4H, piperazine N(CH2)2), 3.54 (s, 2H, CH2), 8.78 (s, 2H, pyrimidine H-4 & H-6), 9.15 (s, 1H, pyrimidine H-2);LC (Method B)-MS (ESI, m/z): Rt=1.84 min-279 [(M+H)+]. ESI-HRMS: Found: 279.1812, calculated for C14H22N4O2 (M+H)+: 279.1821.",1,,,2,,0.0833333; 16,20,,,,,,,,,Page/Page column 69,,tert-butyl 4-(pyrimidin-5-ylmethyl)piperazine-1-carboxylate,55percent,55,,pyrimidine-5-carbaldehyde; 1-t-Butoxycarbonylpiperazine,acetic acid; sodium cyanoborohydride,,ethanol; ethanol,Patent; THE INSTITUTE OF CANCER RESEARCH; US2009/247507; (2009); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8774745&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
28688007,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=28688007&database=RX&origin=ReaxysOutput&ln=,(2 of 327),3,94,full reaction; has preparation,pyrimidine-5-carbaldehyde; 1-t-Butoxycarbonylpiperazine,tert-butyl 4-(pyrimidin-5-ylmethyl)piperazine-1-carboxylate,,O=CC1=CN=CN=C1.CC(C)(C)OC(=O)N1CCNCC1>>CC(C)(C)OC(=O)N1CCN(CC2=CN=CN=C2)CC1,Preparation,,,,1,,,,,16,20,,,,,,,,,supporting information; experimental part,,tert-butyl 4-(pyrimidin-5-ylmethyl)piperazine-1-carboxylate,55 percent,55,,,sodium cyanoborohydride,,ethanol; acetic acid,"Article; Bavetsias, Vassilios; Large, Jonathan M.; Sun, Chongbo; Bouloc, Nathalie; Kosmopoulou, Magda; Matteucci, Mizio; Wilsher, Nicola E.; Martins, Vanessa; Reynisson, Johannes; Atrash, Butrus; Faisal, Amir; Urban, Frederique; Valenti, Melanie; De Haven Brandon, Alexis; Box, Gary; Raynaud, Florence I.; Workman, Paul; Eccles, Suzanne A.; Bayliss, Richard; Blagg, Julian; Linardopoulos, Spiros; McDonald, Edward; Journal of Medicinal Chemistry; vol. 53; 14; (2010); p. 5213 - 5228;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8914838&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733333,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733333&database=RX&origin=ReaxysOutput&ln=,(3 of 327),2,93,full reaction; has preparation,3?(cyclopentyloxy)aniline; pyrimidine-5-carbaldehyde,[3-(cyclopentyloxy)phenyl]-(pyrimidin-5-ylmethyl)amine,224501,NC1=CC(OC2CCCC2)=CC=C1.O=CC1=CN=CN=C1>>C(NC1=CC(OC2CCCC2)=CC=C1)C1=CN=CN=C1,Preparation,1,,"EXAMPLE l N -[3-(cyclopentyloxy)phenyl]-2,2,2-trifluoro-N -(pyrimidin-5-ylmethyl)ethanesulfonamideDiisopropyl azodicarboxylate (0.45 mL, 2.3 mmol) was added dropwise to a stirred solution of 3-aminophenol (250 mg, 2.3 mmol), cyclopentanol (0.25 mL, 2.8 mmol), and triphenylphosphine (600 mg, 2.3 mmol) in tetrahydrofuran (1.4 mL) at 0 0C. After stirring for an additional 12hr at room temperature, the reaction mixture was rotovapped in vacuo to remove volatile solvents. The residue was directly purified via column chromatography on silica gel (eluting 5-50% EPO <DP n=""19""/>ethyl acetate/hexanes) to give 157 mg (40%) of [3-(cyclopentyloxy)phenyl]amine as red oil. To a solution of [3-(cyclopentyloxy)phenyl]-amine (157 mg, 0.89 mmol), pyrimidine aldehyde (96 mg, 0.89 mmol) and acetic acid (51 uL, 0.89 mmol) in dichloroethane 3.6 mL) was added sodium triacetoxyborohydride (283 mg, 1.3 mmol) at room temperature. The resulting mixture was stirred for an additional 2hr or until TLC indicated complete conversion. The reaction mixture was then rotovapped in vacuo to remove volatile solvents. The residue was directly purified via column chromatography on silica gel (eluting 15-100% ethyl acetate/hexanes) to give 200 mg (83%) of [3-(cyclopentyloxy)phenyl]- (pyrimidin-5-ylmethyl)amine as brown oil.A solution of 2,2,2-trifluoroethanesulfonyl chloride (0.1 ImL, l.Ommol) was added dropwise to a solution of [3-(cyclopentyloxy)phenyl](pyrimidin-5-ylmethyl)amine (200 mg, 0.74 mmol) in dichloroethane (2.8 mL) and pyridine (1.4 mL) at 00C. The reaction mixture was allowed to gradually warm to room temperature and then stirred at room temperature until TLC indicated completion of reaction. The solution was then rotovapped in vacuo to remove volatile solvents. The residue was directly purified via column chromatography on silica gel (eluting with 0-100% ethyl acetate/dichloromethane) to give N -[3-(cyclopentyloxy)phenyl]-2,2,2-trifluoro-N -(pyrimidin-5- ylmethyl)ethanesulfonamide as a solid. 1H NMR(CDCl3, 500MHz), delta 9.14 (s, IH), 8.61 (s, 2H), 7.29- 7.25 (m, IH), 6.87-6.85 (m, IH), 6.81-6.79 (m, IH), 6.72-6.71 (m, IH), 4.89 (s, 2H), 4.67-4.65 (m, IH), 3.88-3.83 (m, 2H), 1.90-1.61 (m, 8H). MS (ESI): 416 (M+ + H).",1,,,,,2,20,,,,,,,,,Page/Page column 17; 18,,[3-(cyclopentyloxy)phenyl]-(pyrimidin-5-ylmethyl)amine,83 percent,83,,,sodium tris(acetoxy)borohydride; acetic acid,,"1,2-dichloro-ethane","Patent; MERCK &amp; CO., INC.; WO2006/49968; (2006); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=7167088&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733333,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733333&database=RX&origin=ReaxysOutput&ln=,(3 of 327),2,93,full reaction; has preparation,3?(cyclopentyloxy)aniline; pyrimidine-5-carbaldehyde,[3-(cyclopentyloxy)phenyl]-(pyrimidin-5-ylmethyl)amine,224501,NC1=CC(OC2CCCC2)=CC=C1.O=CC1=CN=CN=C1>>C(NC1=CC(OC2CCCC2)=CC=C1)C1=CN=CN=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563182,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563182&database=RX&origin=ReaxysOutput&ln=,(4 of 327),4,93,full reaction; has preparation,2-aminopyridine; pyrimidine-5-carbaldehyde,N-(5-pyrimidinylmethylene)-2-pyridinamine,152561,NC1=NC=CC=C1.O=CC1=CN=CN=C1>>C(=NC1=NC=CC=C1)C1=CN=CN=C1,Preparation,1.A,,"Step A: Preparation of N-(5-pyrimidinylmethylene)-2-pyridinamineA solution of 2-aminopyridine (11.314 g, 120.3 mmole) and pyrimidine-5- carboxaldehyde (14.0 g, 129.6 mmole) in chloroform (300 mL) was stirred at room temperature for 15 minutes. The volatiles were then removed under reduced pressure (1 hour at 75 C) to yield a yellow solid. The crude solid was dissolved in chloroform (300 mL), and the solution was stirred for 15 minutes. The volatiles were then removed under reduced pressure (1 hour at 75 C) to yield a yellow solid. The crude solid was again dissolved in chloroform (300 mL), the solution was stirred for 15 minutes, and the volatiles were removed under reduced pressure (1 hour at 85 C) to yield a yellow solid. This solid was dried in a vacuum oven overnight at 80 C to yield 22.090 g (99.8%) of the title compound. lU NMR (CDC13) delta 9.26-9.32 (m, 4Eta), 8.52 (d, 1Eta), 7.82 (t, 1Eta), 7.42 (d, 1Eta), 7.26 (t, 1Eta).",1,,,,,0.25,20,,,,,,,,,Page/Page column 54,,N-(5-pyrimidinylmethylene)-2-pyridinamine,99.8 percent,99.8,,,,,chloroform,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; PAHUTSKI, Thomas, Francis., Jr.; WO2012/92115; (2012); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20156312&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563182,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563182&database=RX&origin=ReaxysOutput&ln=,(4 of 327),4,93,full reaction; has preparation,2-aminopyridine; pyrimidine-5-carbaldehyde,N-(5-pyrimidinylmethylene)-2-pyridinamine,152561,NC1=NC=CC=C1.O=CC1=CN=CN=C1>>C(=NC1=NC=CC=C1)C1=CN=CN=C1,Preparation,3.A,Step A: Preparation of N-( 5 -pyrimidinylmethylene)-2-pyridinamine,"A solution of 2-aminopyridine ( 11.314 g, 120.3 mmol) and pyrimidine-5- carboxaldehyde (14.0 g, 129.6 mmol) in chloroform (300 mL) was stirred at room temperature for 15 min. The volatiles were then removed under reduced pressure (1 h at 75 C) to yield a yellow solid. The crude solid was dissolved in chloroform (300 mL) and the solution was stirred for 15 min. The volatiles were then removed under reduced pressure (1 h at 75 C) to yield a yellow solid. The crude solid was again dissolved in chloroform (300 mL), the solution was stirred for 15 min, and the volatiles were removed under reduced pressure ( 1 h at 85 C) to yield a yellow solid. This solid was dried in a vacuum oven overnight at 80 C to yield 22.090 g (99.8%) of the title compound. NMR (CDC13) delta 9.26-9.32 (m, 4H), 8.52 (d, 1H), 7.82 (t, 1H), 7.42 (d, 1H), 7.26 (t, 1H).",1,,,,,0.25,20,,,,,,,,,Page/Page column 38; 39,,N-(5-pyrimidinylmethylene)-2-pyridinamine,99.8 percent,99.8,,,,,chloroform,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; ZHANG, Wenming; ANNIS, Gary David; WO2013/90547; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=35495458&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563182,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563182&database=RX&origin=ReaxysOutput&ln=,(4 of 327),4,93,full reaction; has preparation,2-aminopyridine; pyrimidine-5-carbaldehyde,N-(5-pyrimidinylmethylene)-2-pyridinamine,152561,NC1=NC=CC=C1.O=CC1=CN=CN=C1>>C(=NC1=NC=CC=C1)C1=CN=CN=C1,Preparation,,,,1,,,,,,25,,,,,,,,Scheme or table,,,N-(5-pyrimidinylmethylene)-2-pyridinamine,99 percent,99,,,,,chloroform,"Article; Zhang, Wenming; Holyoke, Caleb W.; Pahutski, Thomas F.; Lahm, George P.; Barry, James D.; Cordova, Daniel; Leighty, Robert M.; Singh, Vineet; Vicent, Daniel R.; Tong, My-Hanh T.; Hughes, Kenneth A.; McCann, Stephen F.; Henry, Yewande T.; Xu, Ming; Briddell, Twyla A.; Bioorganic and Medicinal Chemistry Letters; vol. 27; 1; (2017); p. 16 - 20;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=70183534&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563182,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563182&database=RX&origin=ReaxysOutput&ln=,(4 of 327),4,93,full reaction; has preparation,2-aminopyridine; pyrimidine-5-carbaldehyde,N-(5-pyrimidinylmethylene)-2-pyridinamine,152561,NC1=NC=CC=C1.O=CC1=CN=CN=C1>>C(=NC1=NC=CC=C1)C1=CN=CN=C1,Preparation,1.A,Step A: Preparation of N-(5-pyrimidinylmethylene)-2-pyridinamine,"To a 1L 3-neck round bottomed flask equipped with an overhead stirrer, a thermocouple, a Dean-Stark trap (about 25 mL total volume), and a condenser with a nitrogen inlet was added 400.0 g of a 2.1 weight % solution of pyrimidine-5-carboxaldehyde in dichloromethane (8.4 g, 77.7 mmole contained pyrimidine-5-carboxaldehyde) and 7.39 g of 99.0 weight % 2-aminopyridine (77.7 mmole). The reaction mixture was heated to reflux under a nitrogen blanket and 349 g of dichloromethane were removed via the Dean-Stark trap at 39-48 C and atmospheric pressure. Toluene (126 mL) was added to the reaction mixture at about 48 C, followed by 31 mg of 98.5 weight % /?ara-toluenesulfonic acid monohydrate (0.16 mmol). The resulting reaction mixture was heated to reflux and distillate removed via the Dean-Stark trap until the temperature of the reaction mixture reached 110 C, at which point an additional 40 g of distillate had been removed. 50 mL of toluene was added to the reactor and the reaction mixture was refluxed at 112-1 14 C under atmospheric pressure for about 3.75 hours with removal of water via the Dean-Stark trap. HPLC analysis of the reaction mixture indicated 94.1 area % N-(5-pyrimidinylmethylene)-2-pyridinamine.",1,,,,,3.75,112 - 114,760.051,,Inert atmosphere; Dean-Stark,,,Temperature,,,Page/Page column 16; 17,,,,,,,toluene-4-sulfonic acid,,toluene,"Patent; E I DU PONT DE NEMOURS AND COMPANY; DUMAS, Donald J.; TRAN, Loc Thanh; (24 pag.)WO2017/189339; (2017); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=72745592&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
52133460,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=52133460&database=RX&origin=ReaxysOutput&ln=,(5 of 327),1,93,full reaction; has preparation,pyrimidine-5-carbaldehyde,"5-pyrimidinecarboxaldehyde, sodium bisulfite",220072,O=CC1=CN=CN=C1>>[Na+].OC(C1=CN=CN=C1)S([O-])(=O)=O,Preparation,2.A,Step A: Preparation of 5-pyrimidinecarboxaldehyde - sodium bisulfite adduct,"To a 500 mL round bottom flask were added 150 g of a 3.4 wt% solution of 5- pyrimidinecarboxaldehyde in methanol (5.1 g, 0.047 mole contained 5-pyrimidine carboxaldehyde) and 20.9 g of a 28.2 wt% solution of sodium bisulfite in water (5.9 g, 0.057 mol contained sodium bisulfite). The resulting solution was then stirred for 30 min at ambient temperature. Most of the methanol was distilled off using a rotary evaporator at 50 C to give a light slurry, to which 40 mL of isopropyl alcohol was added. The resulting slurry was cooled down to ambient temperature and stirred overnight after which time the product was collected by filtration, washed with 15 mL of mixture of water and isopropyl alcohol (5 and 10 mL), and suction-dried at ambient temperature for 4 hours to give 16.6 g of white solid. Analysis of the product by NMR indicated 61 wt% of 5-pyrimidinecarboxaldehyde - sodium bisulfite adducts (quantitative yield from 5-pyrimidinecarboxaldehyde). ' H NMR (500 MHz, DMSO- d6) d 9.04 (s, 1H), 8.78 (s, 2H), 6.48 (b, 1H), 5.09 (d, J = 5.6 Hz, 1H).",1,,,,,0.5,18 - 28,,,,,,,,,Page/Page column 39,,"5-pyrimidinecarboxaldehyde, sodium bisulfite",100 percent,100,,,sodium hydrogensulfite,,methanol; water,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; DUMAS, Donald J.; HONG, Junbae; (65 pag.)WO2019/173173; (2019); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=77794972&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Preparation,12,Synthesis of 4-(1-propionylindolin-5-yl)-N-(pyrimidin-5-ylmethyl)benzamide (Compound I-51),"To a solution of pyrimidine-5-carbaldehyde (500 mg, 4.6 mmol) in MeOH (10 mL) at 0, was added NaBH4 (262 mg, 6.9 mmol) in one portion. The mixture was stirred at RT for 4 h. It was then washed with brine and extracted with EA. The combined organic layers were washed with brine, dried over Na2SO4, and concentrated to give pyrimidin-5- ylmethanol as a white solid (456 mg, 89%). LC-MS (ESI): m/z (M+H) =111.13",1,,,,,4,0 - 20,,,,,,,,,Paragraph 0331; 0391-0392,,5-(hydroxymethyl)pyrimidine,89 percent,89,,,sodium tetrahydroborate,,methanol,"Patent; REMEDY PLAN, INC.; CRIMMINS, Gregory, Thomas; DE JESUS DIAZ, Dennise, Alexandra; BHURRUTH-ALCOR, Yushma; (483 pag.)WO2019/213570; (2019); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78332759&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Preparation,13.3,Step 3. Pyrimidin-5-ylmethanol.,"[0218] Step 3. Pyrimidin-5-ylmethanol. A mixture of pyrimidine-5-carboxaldehyde (2 g, 18.50 mmol, 1.00 equiv) and sodium borohydride (2 g) in methanol (100 mL) was stirred at 0- 10C for 30 mm. The reaction mixture was concentrated under vacuum and the residue was purified on a silica gel column eluted with dichloromethane/methanol (50:1) to yield 1.2 g (59%) of pyrimidin-5-ylmethanol as a light yellow solid. MS: m/z = 111.0 [M+H].",1,,,,,0.5,0 - 10,,,,,,,,,Paragraph 0218,,5-(hydroxymethyl)pyrimidine,59 percent,59,,,methanol; sodium tetrahydroborate,,,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; GOSSELIN, Francis; ZAK, Mark; ZHENG, Xiaozhang; WO2013/130935; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727676&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Preparation,5.a,(a) Pyrimidin-5-ylmethanol,"To a solution of pyrimidine-5-carbaldehyde (0.300 g, 2.77 mmol) in methanol (6 mL), sodium borohydride (0.158g, 4.16 mmol) was added at 0 C over 10 minutes and the reaction mixture was stirred at the same temperature for 30 min. After completion of the reaction, the solvent was removed under vacuum. The residue obtained was poured into water (30 mL), extracted with ethyl acetate (150 mL), The organic layer was dried over sodium sulfate and concentrated to provide the title compound (0.160 g, 52.4%), 1H NMR (400 MHz, DMSO-d6) delta ppm 9.18-9.20 (s, 1H), 8.74 (s, 2H), 5.49-5.67 (b, 1H), 4.60 (s, 2H).",1,,,,,0.666667,0,,,,,,,,,Page/Page column 41,,5-(hydroxymethyl)pyrimidine,52.4 percent,52.4,,,sodium tetrahydroborate,,methanol,"Patent; TEMPERO PHARMACEUTICALS, INC.; BALOGLU, Erkan; GHOSH, Shomir; LOBERA, Mercedes; SCHMIDT, Darby, R.; WO2013/19621; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=35461613&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,lithium aluminium tetrahydride,,,Article; Sard; Gonzalez; Mahadevan; McKew; Journal of Organic Chemistry; vol. 65; 26; (2000); p. 9261 - 9264;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6262661&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Preparation,1.1,,"Step 1 : Pyrimidin-5-ylmethanolPyrimidine-5-carboxaldehyde (14.97 g, 138 mmol) in methanol (80 mL) at 0 0C was treated portionwise with sodium borohydride (5.24 g, 138 mmol). When the addition of sodium <n=""31""/>borohydride was complete the mixture was stirred for 1 hour at 0 0C. The mixture was quenched carefully with acetone and the solvent was evaporated under reduced pressure. The residue was purified by column chromatography on silica gel Biotage 4OM, eluting with 5% methanol in dichloromethane to give pyrimidin-5-ylmethanol as a white crystalline solid.1H NMR (CDCl3): delta 9.18 (s, 1 H), 8.78 (s, 2 H), 4.81 (s, 2 H) MS: m/e 111.04 (M + H)+",1,,,2,,1,0; 18 - 25,,,,,,,,,Page/Page column 29-30,,,,,,pyrimidine-5-carbaldehyde,sodium tetrahydroborate; methanol; acetone,,methanol,"Patent; MERCK &amp; CO., INC.; WO2009/45381; (2009); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8733179&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Preparation,1.1,,"Step 1 : Preparation of pyrimidin-5-ylmethanol <n=""34""/>Pyrimidine-5-carboxaldehyde (14.97 g, 138.0 mmol) in methanol (80 mL) at 0 0C was treated portionwise with sodium borohydride (5.24 g, 138 mmol). The resulting mixture was stirred at 0 0C for 1 hour. The mixture was quenched carefully with acetone, then concentrated under reduced pressure. The residue was purified by column chromatography on silica gel Biotage 4OM, eluting with 5% methanol/dichloromethane, to give pyrimidin-5-ylmethanol as a white crystalline solid.1H NMR (CDCl3): delta 9.18 (s, 1 H), 8.78 (s, 2 H), 4.81 (s, 2 H) MS: m/e 1 1 1.04 (M + H)+",1,,,2,,1,0,,,,,,,,,Page/Page column 32-33,,,,,,pyrimidine-5-carbaldehyde,sodium tetrahydroborate; methanol; acetone,,methanol,"Patent; MERCK &amp; CO., INC.; WO2009/45386; (2009); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8733183&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Preparation,1.1,,"Pyrimidine-5-carboxaldehyde (14.97 g, 138 mraol) in methanol (80 mL) at 0 0C was treated portionwise with sodium borohydride (5.24 g, 138 mrnol). When the addition of sodium borohydride was complete the mixture was stirred for 1 hour at 0 0C. The mixture was quenched carefully with acetone and the solvent was evaporated under reduced pressure. The residue was purified by column chromatography on silica gel Biotage 4OM, eluting with 5% methanol in dichloromethane to give pyrimidin-5-ylmethanol as a white crystalline solid. 1H NMR (CDCl3): delta 9.18 (s, 1 H), 8.78 (s, 2 H), 4.81 (s, 2 H)MS: m/e 111.04 (M + H)+",1,,,,,,0,,,,,,,,,Page/Page column 32-33,,,,,,,methanol; sodium tetrahydroborate,,,"Patent; MERCK &amp; CO., INC.; DUFFY, Joseph, L.; HOYT, Scott, B.; LONDON, Clare; STEVENSON, Christian, P.; ULLMAN, Andrew, M.; WO2010/17048; (2010); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8844236&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Preparation,13.3,Step 3. Pyrimidin-5-ylmethanol,"A mixture of pyrimidine-5-carboxaldehyde (2 g. 1 8.50 mmol, 1 .00 equiv) and sodium borohydnde (2 g) in methanol ( 100 mL) was stirred at 0-10C for 30 min. The reaction mixture was concentrated under vacuum and the residue was purified on a silica gel column eluted with dichloromethane/methanol (50:1) to yield 1.2 g (59%) of pyrimidin-5-ylmethanol (commercially available, C AS 251 93-95-7) as a light yellow solid. LC/MS (Method N ESI): RT= 0.74 min, m/z = 111.0 [M+H]+",1,,,,,0.5,0 - 10,,,,,,,,,Page/Page column 144; 145,,5-(hydroxymethyl)pyrimidine,1.2 g,,,,methanol; sodium tetrahydroborate,,,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; BUCKMELTER, Alexandre J.; CLODFELTER, Karl H.; DRAGOVICH, Peter; GOSSELIN, Francis; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; LIU, Xiongcai; REYNOLDS, Dominic J.; SMITH, Chase C.; WANG, Zhongguo; ZAK, Mark; ZHANG, Yamin; ZHAO, Guiling; ZHENG, Xiaozhang; YUEN, Po-Wai; WO2013/127266; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727359&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Preparation,13.3,Step 3. Pyrimidin-5-ylmethanol,"A mixture of pyrimidine-5-carboxaldehyde (2 g. 1 8.50 mmol, 1 .00 equiv) and sodium borohydnde (2 g) in methanol ( 1 00 m L ) was stirred at 0 - 1 0C for 30 min. The reaction mixture was concentrated under vacuum and the residue was purified on a silica gel column eluted with dichloromethane/methanol (50: 1 ) to yield 1 .2 g (59%) of pyrimidin-5-ymethanol (commercially available, C AS 251 93-95-7) as a light yellow solid. LC MS (Method N ESI): RT= 0.74 min, m/z = 111.0 [M+H]+",1,,,,,0.5,0 - 10,,,,,,,,,Page/Page column 95; 96,,5-(hydroxymethyl)pyrimidine,1.2 g,,,,methanol; sodium tetrahydroborate,,,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; DRAGOVICH, Peter; GOSSELIN, Francis; YUEN, Po-Wai; ZAK, Mark; ZHENG, Xiaozhang; WO2013/127267; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727360&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Preparation,10.3,Step 3. Pyrimidin-5-ylmethanol.,"A mixture of pyrimidine-5-carboxaldehyde (2 g, 1 8.50 mmol, 1 .00 equiv) and sodium borohydride (2 g) in MeOH (100 mL) was stirred at 0 - 10C for 30 min. The reaction mixture was concentrated under vacuum and the residue was purified on a silica gel column eluted with DCM/MeOH (50: 1 ) to yield 1 .2 g (59%) of pyrimidin-5-ylmethanol as a light yellow solid. LC/MS (Method K, ESI): RT= 0.74 min, m z = 1 1 1 0 [M+H]+.",1,,,,,0.5,0 - 10,,,,,,,,,Page/Page column 69; 70,,5-(hydroxymethyl)pyrimidine,1.2 g,,,,methanol; sodium tetrahydroborate,,,"Patent; GENENTECH,INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; BUCKMELTER, Alexandre J.; CLODFELTER, Kanl H.; DRAGOVICH, Peter; HAN, Bingsong; LIN, Jian; LIU, Xiongcai; REYNOLDS, Dominic J.; SMITH, Chase C.; WANG, Zhongguo; YUEN, Po-Wai; ZAK, Mark; ZHANG, Yamin; ZHENG, Xiaozhang; ZHAO, Guiling; WO2013/127268; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727361&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Preparation,,Step 3. Pyrimidin-5-ylmethanol,"0226] Step 3. Pyrimidin-5-ylmethanol. A mixture of pyrimidine-5-carboxaldehyde (2 g, 18.50 mmol, 1.00 equiv) and sodium borohydride (2 g) in methanol (100 mL) was stirred at 0 - 10C for 30 min. The reaction mixture was concentrated under vacuum and the residue was purified on a silica gel column eluted with dichloromethane/methanol (50: 1) to yield 1.2 g (59%) of pyrimidin-5-ylmethanol as a light yellow solid. MS: m/z = 111.0 [M+H]+.",1,,,,,0.5,0 - 10,,,,,,,,,Paragraph 0226,,5-(hydroxymethyl)pyrimidine,1.2 g,,,,sodium tetrahydroborate,,methanol,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; BUCKMELTER, Alexandre, J.; CLODFELTER, Karl, H.; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; REYNOLDS, Dominic, J.; SMITH, Chase, C.; WANG, Zhongguo; ZAK, Mark; ZHENG, Xiaozhang; ZHAO, Guiling; WO2013/130943; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727677&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695846,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695846&database=RX&origin=ReaxysOutput&ln=,(6 of 327),12,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,5-(hydroxymethyl)pyrimidine,328456,O=CC1=CN=CN=C1>>OCC1=CN=CN=C1,Chemical behaviour,,,,1,,,,,,25,,7.1,Enzymatic reaction,,Kinetics,Reagent/catalyst,,Body text,,,,,,,,"equine liver alcohol dehydrogenase; N-benzyl-1,4-dihydronicotinamide",,acetone,"Article; Sunderland, James R.; Tao, Xingjian; Butrick, Elizabeth E.; Keilich, Lauren C.; Villa, Christine E.; Miecznikowski, John R.; Jain, Swapan S.; Polyhedron; vol. 114; (2016); p. 145 - 151;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=69043192&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
38711691,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=38711691&database=RX&origin=ReaxysOutput&ln=,(7 of 327),1,91,full reaction; has preparation,"N3-(3,5-dichlorophenyl)-1H-[1,2,4]-triazole-3,5-diamine; pyrimidine-5-carbaldehyde","N3-(3,5-dichlorophenyl)-N5-((pyrimidin-5-yl)methyl)-1H-[1,2,4]triazole-3,5-diamine",228693,NC1=NC(NC2=CC(Cl)=CC(Cl)=C2)=NN1.O=CC1=CN=CN=C1>>ClC1=CC(NC2=NNC(NCC3=CN=CN=C3)=N2)=CC(Cl)=C1,Preparation,2,"N3-(3,5-dichlorophenyl)-N5-(pyrimidin-5-ylmethyl)-1H-[1,2,4]triazole-3,5-diamine (Compound 31)","A solution of pyrimidine-5-carbaldehyde(54 mg, 0.5 mmol) and N3-(3,5-dichlorophenyl)-1H-1,2,4-triazole-3,5-diamine Intermediate 2 (122 mg, 0.50 mmol) and picolineborane (54 mg, 0.5 mmol) was stirred at rt for 4 hours. The mixture was poured into water (20 mL) and extracted with EtOAc (3x10 mL). The extract was dried with sodium sulfate and the solvent was reduced to 2 mL. The remaining residue was loaded on a 25 g silica gel column and eluted with 5% MeOH in ethyl acetate to give 128 mg (76.2%) of desired product as a white solid. MS +m/z 335.90 (M+H)+",1,,,,,4,20,760.051,,,,,,,,Page/Page column 58,,"N3-(3,5-dichlorophenyl)-N5-((pyrimidin-5-yl)methyl)-1H-[1,2,4]triazole-3,5-diamine",76.2 percent,76.2,,,2-picoline borane complex,,,"Patent; F. HOFFMANN-LA ROCHE AG; HOFFMANN-LA ROCHE INC.; DING, Qingjie; JIANG, Nan; WEIKERT, Robert James; WO2014/135422; (2014); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=64121176&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
40045742,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=40045742&database=RX&origin=ReaxysOutput&ln=,(8 of 327),1,91,full reaction; has preparation,pyrimidine-5-carbaldehyde,pyrimidine-5-carbaldehyde oxime,272864,O=CC1=CN=CN=C1>>ON=CC1=CN=CN=C1,Preparation,126B,Example 126B - pyrimidine-5-carbaldehyde oxime (B-228),"To a mixture of pyrimidine-5-carbaldehyde (0.50 g, 4.6 mmol) and hydroxylamine hydrochloride (0.97 g, 14 mmol) in ethanol (10 mL) was added sodium hydroxide (0.56 g, 14 mmol). The mixture was stirred at room temperature overnight. On completion, the mixture was filtered, and the filtrate was concentrated in vacuo and purified by silica gel chromatography (Petroleum ether: Ethyl acetate = 1 : 1 ) to give compound B-228 (0.40 g, 70% yield) as a white solid.",1,,,,,,20,,,,,,,,,Paragraph 00452-00453,,pyrimidine-5-carbaldehyde oxime,70 percent,70,,,hydroxylamine hydrochloride; sodium hydroxide,,ethanol,"Patent; FORUM PHARMACEUTICALS, INC.; BURNETT, Duane, A.; BURSAVICH, Matthew, Gregory; MCRINER, Andrew, J.; WO2015/66371; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=66155944&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
40245168,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=40245168&database=RX&origin=ReaxysOutput&ln=,(9 of 327),1,91,full reaction; has preparation,ethyl 3-amino-4-(1-adamantylamino)benzoate; pyrimidine-5-carbaldehyde,(Z)-ethyl 4-(adamantylamino)-3-(pyrimidin-5-ylmethyleneamino)benzoate,152561,CCOC(=O)C1=CC(N)=C(NC23CC4CC(CC(C4)C2)C3)C=C1.O=CC1=CN=CN=C1>>CCOC(=O)C1=CC(\N=C/C2=CN=CN=C2)=C(NC23CC4CC(CC(C4)C2)C3)C=C1,Preparation,2,"Synthesis of ethyl 4-(adamantylamino)-3-(pyrimidin-5-ylmethyleneamino)benzoate (SRS15-72, Scheme 2).","General procedure: General procedure E (Imine formation) [0220] A representative example is the condensation reaction between SRS15-67 and pyrimidine-5-carbaldehyde in ethanol in the presence of a catalytic amount of HCl (Scheme 3). To the ethyl 3-amino-4-(adamantylamino)benzoate (SRS15-67; 100 mg, 0.318 mmol) in ethanol (4 mL), drops of HCl (10 PL) were added. The mixture was stirred at 80C for 4 hours. The solvent was evaporated. The residue was purified by flash-column chromatography on silica gel to provide the desired (Z)-ethyl 4-(adamantylamino)-3-(pyrimidin-5-ylmethyleneamino)benzoate (SRS15-72). 0231] Following the above general procedure E, the reaction was purified by flash-column chromatography on silica gel to provide the desired ethyl 4- (adamantylamino)-3-(pyrimidin-5-ylmethyleneamino)benzoate (SRS15-72, Scheme 3) (99 mg, 0.245 mmol, 77%).1H NMR (400 MHz, CDCl3)delta 9.31 (s, 1H), 9.22 (s, 2H), 8.68 (s, 1H), 7.89- 7.78 (m, 2H), 7.00 (d, J = 8.7 Hz, 1H), 5.62 (s, 1H), 4.37 (q, J = 7.1 Hz, 2H), 2.20 (s, 3H), 2.09 (d, J = 2.5 Hz, 6H), 1.77 (s, 6H), 1.40 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) delta 166.72, 159.78, 156.48, 150.74, 146.56, 134.47, 130.69, 129.70, 117.92, 117.03, 112.46, 60.38, 51.89, 42.52, 36.38, 29.60, 14.49; LC/MS (APCI+, M+1) 405.57.",1,,,,,4,80,,,,,,,,,Paragraph 0220; 0231,,(Z)-ethyl 4-(adamantylamino)-3-(pyrimidin-5-ylmethyleneamino)benzoate,77 percent,77,,,hydrogenchloride,,ethanol; water,"Patent; THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK; STOCKWELL, Brent R.; SKOUTA, Rachid; DIXON, Scott; WO2015/84749; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=66409027&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
40245169,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=40245169&database=RX&origin=ReaxysOutput&ln=,(10 of 327),1,91,full reaction; has preparation,ethyl 3-amino-4-(1-adamantylamino)benzoate; pyrimidine-5-carbaldehyde,ethyl 4-(adamantylamino)-3-(pyrimidin-5-ylmethylamino)benzoate,224501,CCOC(=O)C1=CC(N)=C(NC23CC4CC(CC(C4)C2)C3)C=C1.O=CC1=CN=CN=C1>>CCOC(=O)C1=CC(NCC2=CN=CN=C2)=C(NC23CC4CC(CC(C4)C2)C3)C=C1,Preparation,2,"Synthesis of ethyl 4-(adamantylamino)-3-(pyrimidin-5-ylmethylamino)benzoate (SRS16-41, Scheme 2).","General procedure C (reductive amination reaction) (Abdel-Magid et al., 1996) [0217] Method I: ethyl 3-amino-4-(cyclohexylamino)benzoate (Fer-1 ) (100 mg, 0.382 mmol, 1 equiv) and benzaldehyde (39 PL, 0.382 mmol, 1 equiv) were heated in DCE for 1 hour at 80C in the presence of molecular sieve (4A) then the mixture was cooled down to room temperature before addition of the NaBH(OAc)3 in small portions over 3 hours. The reaction mixture was stirred at room temperature under a nitrogen atmosphere for 17 hours. The reaction mixture was quenched with aqueous saturated NaHCO3, and the product was extracted with EtOAc. The EtOAc extract was dried (MgSO4), and the solvent was evaporated. The residue was purified by flash-column chromatography on silica gel to provide the desired ethyl 3- (benzylamino)-4-(cyclohexylamino)benzoate (SRS15-23, Scheme 3). [0218] Method II: To ethyl 3-amino-4-(cyclohexylamino)benzoate (Fer-1 ) (100 mg, 0.382 mmol, 1 equiv) and benzaldehyde (39 PL, 0.382 mmol, 1 equiv) in DCE was added NaBH(OAc)3 (129.5 mg, 0.611 mmol, 1.6 equiv). The reaction mixture was treated in the same way as in method I. Synthesis of ethyl 4-(adamantylamino)-3-(pyrimidin-5-ylmethylamino)benzoate (SRS16-41, Scheme 2). [0232] Following the above general procedure C, the reaction was purified by flash-column chromatography on silica gel to provide the desired ethyl 4- (adamantylamino)-3-(pyrimidin-5-ylmethylamino)benzoate (SRS16-41, Scheme 3) (80 mg, 0.197 mmol, 80%).1H NMR (400 MHz, CDCl3)delta 1H NMR (400 MHz, CDCl3) delta 9.17(s,1H),8.77(s,2H), 7.55 (d,J = 8.3 Hz, 1H), 7.40 (s, 1H), 6.96 (d, J = 8.3 Hz, 1H), 4.37- 4.29 (m, 4H), 3.76 (s, 1H), 2.14 (s, 3H), 1.94 (s, 6H), 1.72 (d, J = 12.3 Hz, 6H), 1.35 (dd, J = 9.3, 4.9 Hz, 3H); 13C NMR (101 MHz, CDCl3) delta 166.93, 157.98, 156.52 , 140.64, 136.71, 132.54, 123.24, 120.65, 116.53, 115.76, 60.37, 52.51, 44.83, 42.88, 36.40, 29.63, 14.43; LC/MS (APCI+, M+1) 407.27.",1,,,,,17,20,,,Inert atmosphere,,,Reagent/catalyst; Temperature,,,Paragraph 0217-0218; 0227,,ethyl 4-(adamantylamino)-3-(pyrimidin-5-ylmethylamino)benzoate,80 percent,80,,,sodium tris(acetoxy)borohydride,,"1,2-dichloro-ethane","Patent; THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK; STOCKWELL, Brent R.; SKOUTA, Rachid; DIXON, Scott; WO2015/84749; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=66409027&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53299788,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53299788&database=RX&origin=ReaxysOutput&ln=,(11 of 327),1,91,full reaction; has preparation,"3-(5-(((1S,2S)-2-aminocyclohexyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione; pyrimidine-5-carbaldehyde","3-(1-oxo-5-(((1S,2S)-2-((pyrimidin-5-ylmethyl)amino)cyclohexyl)oxy)isoindolin-2-yl)piperidine-2,6-dione",228701,N[C@H]1CCCC[C@@H]1OC1=CC=C2C(=O)N(CC2=C1)C1CCC(=O)NC1=O.O=CC1=CN=CN=C1>>O=C1N(CC2=CC(O[C@H]3CCCC[C@@H]3NCC3=CN=CN=C3)=CC=C12)C1CCC(=O)NC1=O,Preparation,85,Example 85,"Example 85 3-(1-oxo-5-(((1S,2S)-2-((pyrimidin-5-ylmethyl)amino)cyclohexyl)oxy)isoindolin-2-yl)piperidine-2,6-dione (I-103) To a solution of 3-(5-(((1S,2S)-2-aminocyclohexyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione (I-15, 0.16 g, 0.184 mmol) in DMF (2 mL) was added pyrimidine-5-carbaldehyde (85-1, 0.02 mL, 0.26 mmol) and the resulting mixture was stirred at rt for 15 minutes. Sodium triacetoxyborohydride (58 mg, 0.28 mmol) was added and stirring was continued at rt for 24 h. Additional pyrimidine-5-carbaldehyde (85-1, 12 mg, 0.11 mmol) was added and the reaction mixture was stirred at rt for 15 min. Additional sodium triacetoxyborohydride (25 mg, 0.12 mmol) was added stirring was continued at rt for 1 h. Additional pyrimidine-5-carbaldehyde (85-1, 12 mg, 0.11 mmol) was added and the reaction mixture was stirred at rt for 15 minutes. Sodium triacetoxyborohydride (25 mg, 0.12 mmol) was the again added and stirring was continued at rt for 1 h. The reaction mixture was then quenched with saturated aqueous sodium bicarbonate and extracted with 20% i-PrOH in DCM (*3). The combined organic phases were passed through a phase separating column and concentrated onto Celite. The crude material was purified by silica gel chromatography eluting with 0-100% EtOAc:EtOH (v/v=3:1, with 1% Et3N as a modifier) in heptane to afford I-103 (67 mg, 0.14 mmol, 79% yield) as a white solid. MS [M+H]+=450.3. 1H NMR (400 MHz, DMSO-d6) delta 10.96 (s, 1H), 9.04 (s, 1H), 8.74 (s, 2H), 7.61 (d, J=8.3 Hz, 1H), 7.20 (s, 1H), 7.08 (d, J 8.5 Hz, 1H), 5.07 (dd, J=13.3, 5.1 Hz, 1H), 4.43-4.18 (m, 3H), 3.92-3.76 (m, 1H), 3.14-3.03 (m, 1H), 2.91 (ddd, J=17.9, 13.5, 5.3 Hz, 1H), 2.64-2.55 (m, 1H), 2.44-2.31 (m, 1H), 2.29 (s, 1H), 2.13-1.93 (m, 3H), 1.73-1.59 (m, 2H), 1.42-1.13 (m, 4H).",1,,,2,,0.25; 26.5,20; 20,,,,,,,,,Paragraph 1623-1624,,"3-(1-oxo-5-(((1S,2S)-2-((pyrimidin-5-ylmethyl)amino)cyclohexyl)oxy)isoindolin-2-yl)piperidine-2,6-dione",79 percent,79,,"3-(5-(((1S,2S)-2-aminocyclohexyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione; pyrimidine-5-carbaldehyde",sodium tris(acetoxy)borohydride,,"N,N-dimethyl-formamide; N,N-dimethyl-formamide","Patent; Novartis AG; ADCOCK, Claire; BONAZZI, Simone; CERNIJENKO, Artiom; LAM, Philip; LINKENS, Kathryn Taylor; MALIK, Hasnain Ahmed; THOMSEN, Noel Marie-France; VISSER, Michael Scott; US2020/17461; (2020); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78977517&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
38769509,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=38769509&database=RX&origin=ReaxysOutput&ln=,(12 of 327),1,90,full reaction; has preparation,methyl (4-pyridyl) ketone; pyrimidine-5-carbaldehyde,"4?-(pyrimidin-5-yl)-4,2?:6?,4?-terpyridine",13537,CC(=O)C1=CC=NC=C1.O=CC1=CN=CN=C1.CC(=O)C1=CC=NC=C1>>C1=CC(=CC=N1)C1=CC(=CC(=N1)C1=CC=NC=C1)C1=CN=CN=C1,Preparation,,Ligand 3,"Pyrimidine-5-carbaldehyde (0.28 g, 2.5 mmol) was dissolved in EtOH (40 mL) and 4-acetylpyridine (0.57 mL, 0.62 g, 5 mmol) was added, followed by crushed KOH (0.28 g, 5 mmol). The initially colourless solution changed to yellow and then red. Aqueous NH3 (25% in water, 12.3 mL, 80 mmol) was added dropwise and the reaction mixture stirred at room temperature overnight. A yellow precipitate formed which was collected by filtration, washed with water (3 * 5 mL) and EtOH (3 * 5 mL) and recrystallized from CHCl3/MeOH. Compound 3 was obtained as a yellow solid (0.34 g, 1.28 mmol, 51%). Decomp. >260 C. 1H NMR (500 MHz, CDCl3) ?/ppm 9.39 (s, 1H, HC2) 9.13 (s, 2H, HC4), 8.83 (m, 4H, HA2), 8.09 (m, 4H, HA3), 8.04 (s, 2H, HB3). 1H NMR (500 MHz, d-TFA) ?/ppm 9.97 (s, 2H, HC4) 9.80 (s, 1H, HC2), 9.06-8.90 (m, 8H, HA2/HA3), 8.83 (s, 2H, HB3); 13C{1H} NMR (126 MHz, d-TFA) ?/ppm 158.4 (CC3), 157.0 (CA4), 155.2 (CB2), 154.5 (CC2), 145.0 (CB4), 144.1 (CA2), 135.8 (CC5), 127.3 (CA3), 125.5 (CB3); IR (solid, nu/cm-1) 4696 (m), 3033 (w), 2925 (w), 1652 (w), 1613 (w), 1596 (s), 1569 (s), 1553 (s), 1544 (m), 1539 (m), 1533 (m), 1506 (w), 1436 (s), 1416 (m), 1393 (s), 1356 (m), 1327 (w), 1318 (w), 1274 (w), 1189 (m), 1133 (w), 1059 (w), 1029 (w), 995 (m), 897 (w), 890 (w), 841 (m), 823 (s), 804 (w), 722 (s), 701 (m), 642 (m), 638 (s), 625 (s), 619 (s), 616 (s), 609 (m), 514 (m), 508 (s), 502 (s). UV-Vis (CH2Cl2, 2.5 * 10-5 M) lambda/nm (epsilon/dm3 mol-1 cm-1) 242 (47 359), 312 (9184). ESI MS m/z 312.2 [M+H]+ (calc. 312.1). Satisfactory elemental analysis could not be obtained (see text).",1,,,,,,20,,,,,,,,Experimental part,,,"4?-(pyrimidin-5-yl)-4,2?:6?,4?-terpyridine",51 percent,51,,,ammonium hydroxide; potassium hydroxide,,ethanol,"Article; Maximilian Klein; Constable, Edwin C.; Housecroft, Catherine E.; Zampese, Jennifer A.; Polyhedron; vol. 81; (2014); p. 98 - 104;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=63781079&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
41064879,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=41064879&database=RX&origin=ReaxysOutput&ln=,(13 of 327),1,90,full reaction; has preparation,trimethyl 2-(tert-butoxycarbonylamino)phosphonoacetate; pyrimidine-5-carbaldehyde,methyl (Z)-2-((tert-butoxycarbonyl)amino)-3-(pyrimidin-5-yl)acrylate,169114,COC(=O)C(NC(=O)OC(C)(C)C)P(=O)(OC)OC.O=CC1=CN=CN=C1>>COC(=O)C(\NC(=O)OC(C)(C)C)=C\C1=CN=CN=C1,Preparation,39,[0003971 Synthesis of methyl (Z)-2-((tert-butoxycarbonyl) amino)-3-(pyrimidin-5-yl)acrylate (507),"[000397] Synthesis of methyl (Z)-2-((tert-butoxycarbonyl) amino)-3-(pyrimidin-5-yl) acrylate (507): To a stirred solution of methyl 2-(Qert-butoxycarbonyl) amino)-2- (dimethoxyphosphoryl) acetate 506 (3.3 g, 11.11 mmol) in CH2C12 (15 mL) under inert atmosphere was added potassium t-butoxide (13.8 mL, 13.88 mmol, 1M solution in THF), portion wise for 15 mm at -30 C. To this was added pyrimidine-5-carbaldehyde 505 (1 g, 9.25 mmol) in CH2C12 (5 mL) drop wise for 10 mm at -30 C, stirred for 2 h; warmed to 0 C and stirred for 2 h. The reaction was monitored by TLC; after completion of the reaction, the reaction mixture was diluted with water (50 mL) and extracted with CH2C12 (2 x 100 mL). The combined organic extracts were washed with water (100 mL), dried over sodium sulfate, filtered and concentrated in vacuo to obtain the crude. The crude was purified through silica gel column chromatography using 50% EtOAc/ hexanes to afford compound 507 (1.8 g, 72%) as an off- white solid. TLC: 70% EtOAc/ hexanes (R 0.8); 1H NMR (500MHz, DMSO-d6): oe 9.11 (s, 1H), 9.02 (brs, 1H), 8.98 (s, 2H), 6.46 (s, 1H), 3.76 (s, 3H), 1.42-1.38 (m, 9H).",1,,,2,,0.25; 4.16,-30; -30 - 0,,,Inert atmosphere,,,,,,Paragraph 000397,,methyl (Z)-2-((tert-butoxycarbonyl)amino)-3-(pyrimidin-5-yl)acrylate,72percent,72,,trimethyl 2-(tert-butoxycarbonylamino)phosphonoacetate; pyrimidine-5-carbaldehyde,potassium tert-butylate,,tetrahydrofuran; dichloromethane; tetrahydrofuran; dichloromethane,"Patent; INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION; ASSEMBLY BIOSCIENCES, INC.; TURNER, William W.; ARNOLD, Lee Daniel; MAAG, Hans; ZLOTNICK, Adam; WO2015/138895; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=67157386&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
41580949,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=41580949&database=RX&origin=ReaxysOutput&ln=,(14 of 327),1,90,full reaction; has preparation,diphenyl ((5-bromopyridin-2-yl)(phenylamino)methyl)phosphonate; pyrimidine-5-carbaldehyde,1-(5-bromopyridin-2-yl)-2-(pyrimidin-5-yl)ethanone,172823,BrC1=CN=C(C=C1)C(NC1=CC=CC=C1)P(=O)(OC1=CC=CC=C1)OC1=CC=CC=C1.O=CC1=CN=CN=C1>>BrC1=CN=C(C=C1)C(=O)CC1=CN=CN=C1,Preparation,6.B,Step B: Preparation of l-(5-bromopyridin-2-yl)-2-(pyrimidin-5-yl)ethanone.,"Step B: Preparation of l-(5-bromopyridin-2-yl)-2-(pyrimidin-5-yl)ethanone. [00129] To a magnetically stirred mixture of diphenyl ((5-bromopyridin-2-yl)(phenylamino)- methyl)phosphonate (400 mg, 0.808 mmol), and pyrimidine-5-carbaldehyde (96 mg, 0.888 mmol) in a mixture of THF (1615 mu) and IPA (404 mu) was added Cs2C03 (342 mg, 1.050 mmol) under an inert atmosphere (N2). The reaction mixture was stirred at 25 C for 16.5 h and then treated dropwise with 3 N HCl (0.81 mL, 2.42 mmol), which produced a gentle evolution of gas. After 2 h, the pH of the reaction mixture was adjusted to 9 by the addition of 5% w/v aqueous NaOH solution and extracted with EtOAc (3x). The combined organic extracts were dried by passing through a phase separator cartridge and the volatile components were evaporated under a gentle stream of N2. The resulting residue was triturated with ice cold EtOAc to give the title compound (149 mg, 66.3%) as a light brown solid: 1H NMR (400 MHz, CDC13) delta 9.14 (s, 1H), 8.79 (d, J= 1.7 Hz, 1H), 8.72 (s, 2H), 8.02 (dd, J= 8.4, 2.2 Hz, 1H), 7.96 (d, J= 8.2 Hz, 1H), 4.52 (s, 2H); 13C NMR (101 MHz, CDC13) delta 196.19, 157.96, 157.40, 150.47, 150.37, 139.98, 128.33, 126.16, 123.66, 38.86; ESIMS m/z 278 [M+H]+, m/z 276 ([M-H] ).",1,,,2,,16.5; 2,25,,,Inert atmosphere,,,,,,Paragraph 00128,,1-(5-bromopyridin-2-yl)-2-(pyrimidin-5-yl)ethanone,66.3 percent,66.3,,diphenyl ((5-bromopyridin-2-yl)(phenylamino)methyl)phosphonate; pyrimidine-5-carbaldehyde,caesium carbonate; hydrogenchloride; water,,tetrahydrofuran; isopropyl alcohol; tetrahydrofuran; isopropyl alcohol,"Patent; DOW AGROSCIENCES LLC; LOSO, Michael R.; GUSTAFSON, Gary D.; KUBOTA, Asako; YAP, Maurice C.; BUCHAN, Zachary A.; STEWARD, Kimberly M.; SULLENBERGER, Michael T.; HOEKSTRA, William J.; YATES, Christopher M.; WO2015/160665; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=67430535&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
45004166,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=45004166&database=RX&origin=ReaxysOutput&ln=,(15 of 327),1,90,full reaction; has preparation,"6-fluoro-1,2,3,4-tetrahydrobenzo[4,5]thieno[2,3-c]pyridine; pyrimidine-5-carbaldehyde","6-fluoro-2-(pyrimidin-5-ylmethyl)-1,2,3,4-tetrahydrobenzo[4,5]thieno[2,3-c]pyridine",228603,FC1=CC=C2SC3=C(CCNC3)C2=C1.O=CC1=CN=CN=C1>>FC1=CC=C2SC3=C(CCN(CC4=CN=CN=C4)C3)C2=C1,Preparation,,4.1.1.1. General method a for reductive amination.,"General procedure: To a solution of amine (1.0 equiv) in 1,2-dichloroethane (0.1 M) were added aldehyde (1.2 equiv) and acetic acid (0.5 mL), the reaction mixture stirred at rt for 10 min, followed the addition of sodium triacetoxyborohydride (2.0 equiv). The reaction was stirred at rt under nitrogen for 18 h and concentrated. Sat. NaHCO3 (30 mL) was added and extracted with dichloromethane (20 mL x 3) and the combined organic layers were dried over anhydrous Na2SO4, filtered and evaporated under reduced pressure. The crude residue was purified by flash chromatography on silica gel eluting with 0-10% methanol/dichloromethane to give the desired product.",1,,,2,,0.166667,23; 23,,,Inert atmosphere,,,,,Experimental part,,,"6-fluoro-2-(pyrimidin-5-ylmethyl)-1,2,3,4-tetrahydrobenzo[4,5]thieno[2,3-c]pyridine",71.5 percent,71.5,,"6-fluoro-1,2,3,4-tetrahydrobenzo[4,5]thieno[2,3-c]pyridine; pyrimidine-5-carbaldehyde",acetic acid; sodium tris(acetoxy)borohydride,,"1,2-dichloro-ethane; 1,2-dichloro-ethane","Article; Wang, Mingliang; Fang, Yanjia; Gu, Shoulai; Chen, Fangfang; Zhu, Zhengjiang; Sun, Xun; Zhu, Jidong; European Journal of Medicinal Chemistry; vol. 132; (2017); p. 157 - 172;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=70902829&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
37592281,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=37592281&database=RX&origin=ReaxysOutput&ln=,(16 of 327),1,89,full reaction; has preparation,morpholine; trimethylsilyl cyanide; pyrimidine-5-carbaldehyde,2-morpholino-2-(pyrimidin-5-yl)acetonitrile,222936,C1COCCN1.C[Si](C)(C)C#N.O=CC1=CN=CN=C1>>N#CC(N1CCOCC1)C1=CN=CN=C1,Preparation,,2-Morpholino-2-(pyrimidin-5-yl)acetonitrile,"2-Morpholino-2-(pyrimidin-5-yl)acetonitrile To a mixture of pyrimidine-5-carbaldehyde (2 g, 18.52 mmol) and TMSCN (3.67 g, 37.0 mmol) in HOAc (50 mL) was added morpholine (2.42 g, 27.8 mmol) at room temperature and NaOAc (3.34 g, 40.7 mmol) was followed. The resulting mixture was stirred at room temperature overnight. Saturated aqueous Na2CO3 solution was added to quench the reaction mixture, the pH was adjusted to about 7 and extracted with EtOAc (3*100 mL). The combined organic layer was washed with brine, dried over Na2SO4 and concentrated to give crude 2-morpholino-2-(pyrimidin-5-yl)acetonitrile (2.5 g, yield: 66%). 1H NMR (CDCl3 400 MHz): delta9.25 (s, 1H), 8.92 (d, J=10.0 Hz, 2H), 4.87 (s, 1H), 3.79-3.70 (m, 4H), 2.67-2.56 (m, 4H).",1,,,,,,20,,,,,,,,,Paragraph 0160; 0161,,2-morpholino-2-(pyrimidin-5-yl)acetonitrile,66percent,66,,,sodium acetate,,acetic acid,"Patent; H. Lundbeck A/S; Kilburn, John Paul; Rasmussen, Lars Kyhn; Jessing, Mikkel; Eldemenky, Eman Mohammed; Chen, Bin; Jiang, Yu; US2014/107335; (2014); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=63369829&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48149449,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48149449&database=RX&origin=ReaxysOutput&ln=,(17 of 327),1,89,full reaction; has preparation,(x)C2HF3O2*C15H17F3N4S; pyrimidine-5-carbaldehyde,C20H21F3N6S,228605,OC(=O)C(F)(F)F.[H][C@@]12CN(C[C@]1([H])CNCC2)C1=C2C=C(CC(F)(F)F)SC2=NC=N1.O=CC1=CN=CN=C1>>[H][C@@]12CN(C[C@]1([H])CN(CC1=CN=CN=C1)CC2)C1=C2C=C(CC(F)(F)F)SC2=NC=N1,Preparation,B26,PREPARATION OF COMPOUND 104,"To a solution of Intermediate 47 (200 mg, 0.292 mmol) in DCM (8 mL) was added pyrimidine-5-carbaldehyde (37.9 mg, 0.350 mmol) and NaBH(OAc)3 (155 mg, 0.73 mmol). After stirring at room temperature overnight, the mixture was concentrated to give a residue which was purified by prep-HPLC (Waters 2767/Qda, Column: (0980) Waters Xbridge 19* 150mm lOum, Mobile Phase A: H20 (0.1%NH4OH), B: ACN) to yield compound 104 (74 mg, 58.3% yield) as a light yellow solid. (0981) NMR CD3OD (400 MHz): delta 9.06 (s, 1H), 8.78 (s, 2H), 8.27 (s, 1H), 7.62 (s, 1H), 3.95-3.78 (m, 6H), 3.60 (s, 2H), 2.63-2.35 (m, 6H), 1.83-1.65 (m, 2H)",1,,,,,,20,,,,,,,,,Page/Page column 114,,C20H21F3N6S,58.3 percent,58.3,,,sodium tris(acetoxy)borohydride,,dichloromethane,"Patent; JANSSEN PHARMACEUTICA NV; ANGIBAUD, Patrick, Rene; PANDE, Vineet; HERKERT, Barbara; KROSKY, Daniel, Jason; QUEROLLE, Olivier, Alexis, Georges; PATRICK, Aaron Nathaniel; (161 pag.)WO2018/50684; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73566514&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49027816,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49027816&database=RX&origin=ReaxysOutput&ln=,(18 of 327),1,89,full reaction; has preparation,"7-(1,1-dioxo-4-thiomorpholin)-2-((trans)-4-isobutylpyrrolidine-3-yl)pyrrolo[2,1-f][1,2,4]triazine-4(3H)-one; pyrimidine-5-carbaldehyde","7-(1,1-dioxo-4-thiomorpholin)-2-((3S,4S)-4-isobutyl-1-(pyrimidin-5-ylmethyl)pyrrolidin-3-yl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one",228605,CC(C)C[C@@H]1CNC[C@H]1C1=NN2C(=CC=C2C(=O)N1)N1CCS(=O)(=O)CC1.O=CC1=CN=CN=C1>>CC(C)C[C@@H]1CN(CC2=CN=CN=C2)C[C@H]1C1=NN2C(=CC=C2C(=O)N1)N1CCS(=O)(=O)CC1,Preparation,6.4,"Step 4: synthesis of 7-(1,1-dioxythiomorpholinyl)-2-((3S,4S)-4-isobutyl-1-(pyrimidin-5-ylmethyl)pyrrolidin-3-yl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one","7-(1,1-Dioxythiomorpholinyl)-2-((3S,4S)-4-isobutylpyrrol-3-yl)pyrrolo[2,1-f][1,2,4]triazine-4(3H)-one (188.76 mg)Dissolved in DCM (4 mL),Add pyrimidine-5-formaldehyde (62.27 mg, 0.576 mmol)And sodium triacetoxyborohydride (254.3 mg, 1.2 mmol), stirred at room temperature overnight.TLC monitors the reaction completely,Add saturated aqueous sodium bicarbonate (5 mL),Extracted with DCM (3 x 10 mL),Organic phase merger,Washed (2 × 5mL),Dry over anhydrous sodium sulfate,filter,concentrate,The crude product was purified by silica gel column chromatography (DCM: MeOH = 100: 1-20: 1) gave a white solid 7-(1,1-dioxythiomorpholinyl)-2-((3S,4S)-4-isobutyl-1-(pyrimidin-5-ylmethyl)pyrrolidin-3-yl)pyrrole[2,1-f][1,2,4]triazin-4(3H)-one (130.0 mg, yield: 56.03%).",1,,,,,,20,,,,,,,,,Paragraph 0238-0240,,"7-(1,1-dioxo-4-thiomorpholin)-2-((3S,4S)-4-isobutyl-1-(pyrimidin-5-ylmethyl)pyrrolidin-3-yl)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one",56.03percent,56.03,,,sodium tris(acetoxy)borohydride,,dichloromethane,"Patent; Nanjing Yaojie Good Health Biological Technology Co., Ltd.; Wu Yongqian; Wang Lin; Yang Xiaoju; Tian Yuwei; (46 pag.)CN108341819; (2018); A;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74746236&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
28135446,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=28135446&database=RX&origin=ReaxysOutput&ln=,(19 of 327),1,88,full reaction; has preparation,diethylaluminium cyanide; pyrimidine-5-carbaldehyde; 1-t-Butoxycarbonylpiperazine,"(+/-)-1,1-dimethylethyl 4-[cyano(5-pyrimidinyl)methyl]-1-piperazinecarboxylate",222937,CC[Al](CC)C#N.O=CC1=CN=CN=C1.CC(C)(C)OC(=O)N1CCNCC1>>CC(C)(C)OC(=O)N1CCN(CC1)C(C#N)C1=CN=CN=C1,Preparation,,,"Intermediate 109: (+/-)-1 ,1-Dimethylethyl 4-rcvano(5-pyrimidinyl)methyll-1- piperazinecarboxylate; To a solution of 1 g of 5-pyrimidinecarbaldehyde (9.2 mmole, Aldrich) in 10 mL of dichloroethane in a dry flask under nitrogen were added 1.7 g of 1 ,1-dimethylethyl 1- piperazinecarboxylate (9.2 mmole, Fluka) followed by 3.8 mL of Ti(iOPr)4 (12.8 mmole, <n=""130""/>Aldrich). The solution was then stirred at RT overnight. 11 mL of a solution of Et2AICN 1 M in toluene (11 mmole, Aldrich) were added dropwise at RT and the mixture was stirred at RT for 4 h. Then 3x10 mL of a saturated solution of NaHCO3 in water was added dropwise and the mixture was stirred at RT overnight. The resulting precipitate was filtered on celite and the cake was washed with AcOEt. The organic phase was washed with a saturated solution of NaHCO3 in water and the layers were separated on a phase separator cartridge. Solvents were removed under reduced pressure and the resulting crude compound was purified by flash chromatography on a 25 g silica gel cartridge with AcOEt/CH 1 :1 as an eluent to give the title compound as a sand color solid (1.72 g). 1H- NMR (400 MHz, CDCI3): delta 1.46 (9H, s), 2.56 (4H, m), 3.41 (4H, m), 5.11 (1 H, s), 8.81 (2H, s), 8.94 (1 H, s); UPLC-MS [Acquity UPLC BEH C18, 50x21 mm, 1.7 mum, gradient: A: H2O +0.1 % HCOOH/B: MeCN+0.075% HCOOH: 1 % to 6%B in 0.2 min., 6% to 60%B in 1.05 min, 60% to 100%B in 0.5 min., 100%B for 0.2 min, flow rate: 1 mL/min]: R1 = 0.64 min. m/z (ES): 326 [M+Na]+, 248 [M-CN]+.",1,,,2,,4,20; 20,,,,,,,,,Page/Page column 127-128,,"(+/-)-1,1-dimethylethyl 4-[cyano(5-pyrimidinyl)methyl]-1-piperazinecarboxylate",62 percent,62,,pyrimidine-5-carbaldehyde; 1-t-Butoxycarbonylpiperazine; diethylaluminium cyanide,titanium(IV) isopropylate,,"1,1-dichloroethane; 1,1-dichloroethane; toluene",Patent; GLAXO GROUP LIMITED; WO2008/148853; (2008); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8669005&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
29864558,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=29864558&database=RX&origin=ReaxysOutput&ln=,(20 of 327),2,88,full reaction; has preparation,"5-bromopyrimidine; N,N-dimethyl-formamide",pyrimidine-5-carbaldehyde,137263,BrC1=CN=CN=C1.CN(C)C=O>>O=CC1=CN=CN=C1,Preparation,44.1,,"Step 1. Pyrimidine-5-carbaldehyde 2: To a solution of 5-bromopyrimidine (1Og, 56.96 mmol) in THF (500 mL) under the an inert atmosphere of nitrogen was added butyllithium (20 ml, 3.6 M) dropwise with stirring while cooling to a temperature of -100 C. The resulting solution was allowed to stir for an additional 1 hour at -100 C, followed by adding HCl (5 ml) dropwise with stirring while keeping the temperature at - 80 C and then warmed up to room temperature. The reaction progress was monitored by TLC (EtOAc/PE = 1:1). The resulting solution was extracted with ethyl ether (3 x 500 ml) and the organic layer was combined and dried over Na2SO4 and concentrated by evaporation under vacuum using a rotatory evaportator yield 2 g (29%) of pyrmidine-5-cabaldehyde as an colorless oil.",1,,,3,,1,-100,,,,,,,,,Page/Page column 48,,pyrimidine-5-carbaldehyde,29 percent,29,,"5-bromopyrimidine; N,N-dimethyl-formamide",n-butyllithium; hydrogenchloride,,tetrahydrofuran; tetrahydrofuran; tetrahydrofuran; water,"Patent; KALYPSYS, INC.; WO2007/101213; (2007); A2;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8938922&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
29864558,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=29864558&database=RX&origin=ReaxysOutput&ln=,(20 of 327),2,88,full reaction; has preparation,"5-bromopyrimidine; N,N-dimethyl-formamide",pyrimidine-5-carbaldehyde,137263,BrC1=CN=CN=C1.CN(C)C=O>>O=CC1=CN=CN=C1,Preparation,A.xxxxvii,Synthesis of pyrimidine-5-carbaldehyde:,"[0745] Synthesis of pyrimidine-5-carbaldehyde: [0746] To a stirred solution of 5-bromopyrimidine (5 g, 31.66 mmol) in THF (50 mL) under argon atmosphere was added n-butyl lithium (2.2 g, 34.83 mmol) drop wise for 10 min at -78 C and stirred for 20 min. To this was added DMF (2.3 g, 31.66 mmol) at -78 C and stirred for 30 min. The reaction was monitored by TLC; after completion of the reaction, the reaction mixture was quenched with saturated ammonium chloride solution (40 mL) and extracted with EtOAc (3 x 40 mL). The combined organic extracts were washed with water (30 mL), brine (30 mL), dried over sodium sulfate, filtered and concentrated in vacuo to obtain the crude. The crude was purified through silica gel column chromatography using 25% EtOAc/ Hexanes to afford pyrimidine-5-carbaldehyde (200 mg, 3%) as colorless thick syrup. TLC: 30% EtOAc/ Hexanes (R 0.2).",1,,,2,,0.5; 0.5,-78; -78,,,Inert atmosphere; Inert atmosphere,,,,,,Paragraph 0745; 0746,,pyrimidine-5-carbaldehyde,3 percent,3,,"5-bromopyrimidine; N,N-dimethyl-formamide",n-butyllithium,,tetrahydrofuran; tetrahydrofuran,"Patent; ENVIVO PHARMACEUTICALS, INC.; RIPKA, Amy; SHAPIRO, Gideon; MCRINER, Andrew, J.; BURSAVICH, Matthew, Gregory; WO2013/142269; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=61423979&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
47816296,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=47816296&database=RX&origin=ReaxysOutput&ln=,(21 of 327),1,88,full reaction; has preparation,"pyrimidine-5-carbaldehyde; 3-acetyl-4-phenyl-1,2-dihydroquinolin-2-one","4-phenyl-3-[(2E)-3-(pyrimidin-5-yl)prop-2-enoyl]-1,2-dihydroquinolin-2-one",163593,O=CC1=CN=CN=C1.CC(=O)C1=C(C2=CC=CC=C2)C2=CC=CC=C2NC1=O>>O=C(\C=C\C1=CN=CN=C1)C1=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC=C2,Preparation,3.1,"[00180] 4-phenyl-3-[(2E)-3-(pyrimidin-5-yl)prop-2-enoyl]-1,2-dihydroquinolin-2-one (I-122) (EV-AR9068-002) - Step 1","[00181] To Ba(OH)2 (95%, 137 mg, 0.76 mmol) was added Water (120 _) and pyrimidine-5-carbaldehyde (164.23 mg, 1.52 mmol) in Methanol (2 ml). To the resultant mixture was added 3- acetyl-4-phenyl-1,2-dihydroquinolin-2-one (EV-AR9030-002, 200 mg, 0.76 mmol) in Methanol (6 ml) dropwise over lOmin and the reaction was stirred at room temperature for 30min. The reaction was quenched with Acetic acid (6 ml), diluted with DCM (60 ml) and washed with water (30 ml). The aqueous was extracted with DCM (2 x 60 ml). The organics were combined, dried over MgSC""4 and concentrated in vacuo to afford a yellow oil. The crude material was purified by Basic preparative HPLC method A and the relevant fractions were lyophilized to afford 120mg (45%) of 4-phenyl-3-[(2E)-3-(pyrimidin-5-yl)prop-2-enoyl]-1,2-dihydroquinolin-2-one (1-122) (EV-AR9068-002) as a yellow powder. LCMS (method A): retention time 3.96min, M/z = 354.2 (M + 1). [00182]",1,,,,,0.666667,20,,,,,,,,,Paragraph 00180-00181,,"4-phenyl-3-[(2E)-3-(pyrimidin-5-yl)prop-2-enoyl]-1,2-dihydroquinolin-2-one",45 percent,45,,,water; barium(II) hydroxide,,methanol,"Patent; PADLOCK THERAPEUTICS, INC.; DEVRAJ, Rajesh; KUMARAVEL, Gnanasambandam; LECCI, Cristina; LOKE, Pui; MENICONI, Mirco; MONCK, Nat; NORTH, Carl; RIDGILL, Mark; TYE, Heather; (205 pag.)WO2018/49296; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73439980&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48463787,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48463787&database=RX&origin=ReaxysOutput&ln=,(22 of 327),1,88,full reaction; has preparation,4-amino-3-(cyclopropylamino)benzonitrile; pyrimidine-5-carbaldehyde,1-cyclopropyl-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole-6-carbonitrile,150523,NC1=CC=C(C=C1NC1CC1)C#N.O=CC1=CN=CN=C1>>N#CC1=CC=C2N=C(N(C3CC3)C2=C1)C1=CN=CN=C1,Preparation,3,1-Cyclopropyl-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole-6-carbonitrile (Ex. 3),"To a stirred solution of 4-amino-3-(cyclopropylamino)benzonitrile Int-4 (100 mg, 0.58 mmol) in DMF (3 mL) under an inert atmosphere was added pyrimidine-5-carbaldehyde (62 mg, 0.58 mmol), oxone (108 mg, 0.69 mmol), and water (0.2 mL) at room temperature. The reaction mixture was stirred at room temperature for 4 h. After consumption of starting material (by TLC), the reaction mixture was diluted with saturated potassium carbonate solution (20 mL) and extracted with EtOAc (2*20 mL). The combined organic extracts were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude material was purified by silica gel column chromatography (eluent: 100% EtOAc) to afford 1-cyclopropyl-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole-6-carbonitrile Ex. 3 (70 mg, 0.27 mmol, 47%) as an off white solid. ?H NMR (400 MHz, DMSO-d5): oe 9.45 (s, 2H),9.38 (s, 1H), 8.3 1-8.29 (m, 1H), 7.92 (dd, J=8.3, 0.4 Hz, 1H),7.70 (dd, J=8.3, 1.6 Hz, 1H), 3.96-3.90 (m, 1H), 1.21-1.15(m, 2H), 0.82-0.77 (m, 2H). LC-MS: mlz 262.0 [M+H] at 2.46 RT (99.46%purity). HPLC: 99.61%.",1,,,,,4,20,,,Inert atmosphere,,,,,,Paragraph 0428; 0429; 0430; 0431; 0432,,1-cyclopropyl-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole-6-carbonitrile,47 percent,47,,,Oxone,,"water; N,N-dimethyl-formamide","Patent; Viamet Pharmaceuticals (NC), Inc.; Sparks, Steven; Yates, Christopher M.; Shaver, Sammy R.; (93 pag.)US2018/186773; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74451393&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8826438,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8826438&database=RX&origin=ReaxysOutput&ln=,(23 of 327),2,87,full reaction; has preparation,methylmagnesium bromide; pyrimidine-5-carbaldehyde,5-(alpha-hydroxyethyl)pyrimidine,215503,C[Mg]Br.O=CC1=CN=CN=C1>>CC(O)C1=CN=CN=C1,Preparation,,Preparation of A49,"To a solution of 44 (100 mg, 0.9 rnmol) in THF (2 mL) is added MgMeBr (1 M, 1.1 mL, 1.1 mmoi) dropwise at --70 C. After stirring for 1 hour, EtOH (1 rnL) is added at 0 C and then the mixture is acidified with 2 M HC1 to pH 6. The mixture is then extracted with EA(i0 mL >c 2). The combined organic layers are dried over anhydrous sodium sulfate, filtered, concentrated, and purified by silica gel column chromatography (MeOH:DCM = 1:50) to give A49 as a colorless oil (80 mg, 70% yield). (MS: [M+Hj 125.1)",1,,,,,1,-70,,,,,,,,,Paragraph 0275,,5-(alpha-hydroxyethyl)pyrimidine,70 percent,70,,,,,tetrahydrofuran,"Patent; IMMUNE SENSOR, LLC; THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM; ZHONG, Boyu; SUN, Lijun; SHI, Heping; LI, Jing; CHEN, Chuo; CHEN, Zhijian; (270 pag.)WO2017/176812; (2017); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=72481988&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8826438,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8826438&database=RX&origin=ReaxysOutput&ln=,(23 of 327),2,87,full reaction; has preparation,methylmagnesium bromide; pyrimidine-5-carbaldehyde,5-(alpha-hydroxyethyl)pyrimidine,215503,C[Mg]Br.O=CC1=CN=CN=C1>>CC(O)C1=CN=CN=C1,Preparation,,,,1,,,,,1,20,,,,Grignard reaction,,,,,,,5-(alpha-hydroxyethyl)pyrimidine,67 percent,67,,,,,diethyl ether,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
29545067,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=29545067&database=RX&origin=ReaxysOutput&ln=,(24 of 327),1,87,full reaction; has preparation,2-amino-N-(4-sec-butylphenyl)benzamide; pyrimidine-5-carbaldehyde,3-(4-sec-butylphenyl)-2-(pyrimidin-5-yl)quinazolin-4(3H)-one,,CCC(C)C1=CC=C(NC(=O)C2=CC=CC=C2N)C=C1.O=CC1=CN=CN=C1>>CCC(C)C1=CC=C(C=C1)N1C(=O)C2=C(C=CC=C2)N=C1C1=CN=CN=C1,Preparation,45,,"Example 45. Preparation of 3-(4-sec-butylphenyl)-2-(pyrimidin-5-yl)quinazolin-4(3H)- one; [0232] 2-amino-Lambda/-(4-sec-butylphenyl)benzamide (0.544 g, 2.03 mmol) and pyrimidine-5-carbaldehyde (0.241 g, 2.23 mmol), NaHSO3 (0.253 g, 2.44 mmol) and p-TsOH (0.039 g, 0.20 mmol) were dissolved in DMA (20 ml_) and heated at 150C for 18 hours. The mixture was cooled to room temperature, diluted with ethyl acetate (100 ml_), washed with water (2 x 200 mL), dried (Na2SO4), filtered, and concentrated. Flash chromatograph on silica gel, eluting with 20% ethyl acetate/heptane to 70% ethyl acetate/heptane, afforded the title compound as a white solid (0.280 g, 39%). 1H-NMR (300 MHz, DMSO-d6): delta 9.05 (s, 1 H), 8.77 (s, 2H), 8.22-8.25 (m, 1 H), 7.92-7.98 (m, 1 H), 7.83 (d, J = 7.7 Hz, 1 H), 7.64-7.69 (m, 1 H), 7.31-7.35 (m, 2H), 7.18-7.23 (m, 2H), 2.54-2.61 (m, 1 H), 1.37-1.58 (m, 2H), 1.15 (d, J = 6.9 Hz, 3H), 0.64 (t, J = 7.3 Hz, 3H).MS (APCI) m/z: 357 (M+H)+.",1,,,,,18,150,,,,,,,,,Page/Page column 93,,3-(4-sec-butylphenyl)-2-(pyrimidin-5-yl)quinazolin-4(3H)-one,39 percent,39,,,toluene-4-sulfonic acid; sodium hydrogensulfite,,"N,N-dimethyl acetamide","Patent; RESVERLOGIX CORP.; HANSEN, C., Henrik; WO2010/79431; (2010); A2;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8890227&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
44296148,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=44296148&database=RX&origin=ReaxysOutput&ln=,(25 of 327),1,87,full reaction; has preparation,"pyrimidine-5-carbaldehyde; 2-oxo-6-(5,6,7,8-tetrahydro-[1,8]-naphthyridin-2-yl)-hexyl-phosphonic acid dimethyl ester","1-(pyrimidin-5-yl)-7-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)-hept-1-en-3-one",169252,O=CC1=CN=CN=C1.COP(=O)(CC(=O)CCCCC1=NC2=C(CCCN2)C=C1)OC>>O=C(CCCCC1=CC=C2CCCNC2=N1)C=CC1=CN=CN=C1,Preparation,3.A,"Step A: 1 -(Pyrimidin-5-yl)-7-(5,6,7,8-tetrahydro-[1 ,8lnaphthyridin-2-yl)-hept- 1 -en-3-one (3-2)","To a stirred suspension of anhydrous lithium chloride (3.54 g, 83.3 mmol) in acetonitrile (350 mL) at room temperature was added a solution of ketophosphonate 3-1 (for preparation of 3-1, see U.S. Patent No. 6,048,861) (28.3 g, 83.1 mmol) in acetonitrile (128 mL). After stirring for 15 mm, a solution of DBU (9.52 mL, 64.1 mmol) in acetonitrile (32 mL) was added to produce a mostly fine white precipitate with some larger masses. The reaction mixturewas briefly sonicated to break up the larger masses and stirred for 30 mm. A solution of pyrimidine-5-carboxaldehyde (6.92 g, 64.1 mmol) in acetonitrile (128 mL) was added over 15 mm. After 2 h, the reaction mixture was filtered and the filtrate concentrated. The residue was purified by flash chromatography (8% MeOHIEtOAc) to give 18.5 g (90%) of enone as a yellow crystalline solid; m.p. 10 1-102C.?HNIVIR (399.87 IVIHz, CDC13): oe 9.19 (s, 1H), 8.89 (s, 2 H), 7.45 (d, J= 16.3 Hz, 1H), 7.05 (d, J 7.3 Hz, 1H), 6.85 (d, J 16.3 Hz, 1H), 6.35 (d, J= 7.3 Hz, 1H) 4.78 (br s, 1H), 3.39 (m, 2H), 2.72-2.67 (om, 4H), 2.58 (m, 2H), 1.89 (m, 2H), 1.79-1.72 (om, 4H) ppm.?3C NIVIR (100.55 IVIHz, CDC13): 199.3, 159.40, 159.36, 158.0, 155.9, 136.8, 134.7, 129.4, 128.8, 113.5, 111.5, 41.8, 41.6, 37.7, 29.5, 26.5, 23.9, 21.7 ppm.",1,,,3,,0.25; 0.5; 2.25,,,,Sonication,,,,,,Page/Page column 39,,"1-(pyrimidin-5-yl)-7-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)-hept-1-en-3-one",90 percent,90,,"2-oxo-6-(5,6,7,8-tetrahydro-[1,8]-naphthyridin-2-yl)-hexyl-phosphonic acid dimethyl ester; pyrimidine-5-carbaldehyde","lithium chloride; 1,8-diazabicyclo[5.4.0]undec-7-ene",,acetonitrile; acetonitrile; acetonitrile,"Patent; MERCK SHARP &amp; DOHME CORP.; COX, Jason, M.; MA, Lijun; ZHOU, Xiaoyan; HAIMBACH, Robin, E.; COLEMAN, Paul, J.; ZHOU, Haihong; KELLEY, David, E.; STOCH, Selwyn Aubrey; DUONG, Le, T.; HOEK, Maarten; (68 pag.)WO2016/154369; (2016); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=69699432&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48463789,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48463789&database=RX&origin=ReaxysOutput&ln=,(26 of 327),1,87,full reaction; has preparation,"5-chloro-N1-cyclopropyl-4-fluorobenzene-1,2-diamine; pyrimidine-5-carbaldehyde",6-chloro-1-cyclopropyl-5-fluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole,150523,NC1=CC(F)=C(Cl)C=C1NC1CC1.O=CC1=CN=CN=C1>>FC1=C(Cl)C=C2N(C3CC3)C(=NC2=C1)C1=CN=CN=C1,Preparation,38,6-Chloro-1-cyclopropyl-5-fluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole (Ex. 38),"To a stirred solution of 5-chloro-N1-cyclopropyl-4-fluorobenzene-1,2-diamine Int-14 (150 mg, 0.75 mmol) in DMF (3 mL) under an inert atmosphere was added pyrimidine-5-carbaldehyde (81 mg, 0.75 mmol) and oxone (253 mg, 0.82 mmol) followed by water (1.04 mL) at room temperature. The reaction mixture was stirred at room temperature for 6 h. After consumption of starting material (by TLC), the reaction mixture was diluted with water (20 mL) and extracted with EtOAc (2*20 mL). The combined organic extracts were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude material was purified by silica gel column chromatography (eluent: 40% EtOAc/hexane) to afford 6-chloro-1-cyclopropyl-5-fluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole Ex. 38 (80 mg, 0.27 mmol, 37%) as a brown solid. ?H NMR (400 MHz, DMSO-d5): oe 9.41 (s, 2H),9.36 (s, 1H), 7.94 (d, J=6.7 Hz, 1H), 7.82 (d, J=9.8 Hz, 1H),3.90-3.86 (m, 1H), 1.21-1.11 (m, 2H), 0.80-0.63 (m, 2H). EC-MS: m/z 288.9 [M+H] at 2.49 RT (94.97% purity). HPEC: 98.24%.",1,,,,,6,20,,,Inert atmosphere,,,,,,Paragraph 0668; 0669; 0670; 0671; 0672,,6-chloro-1-cyclopropyl-5-fluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole,37 percent,37,,,Oxone,,"water; N,N-dimethyl-formamide","Patent; Viamet Pharmaceuticals (NC), Inc.; Sparks, Steven; Yates, Christopher M.; Shaver, Sammy R.; (93 pag.)US2018/186773; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74451393&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48778024,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48778024&database=RX&origin=ReaxysOutput&ln=,(27 of 327),1,87,full reaction; has preparation,"N,N-dimethyl-formamide; uracil",pyrimidine-5-carbaldehyde,,CN(C)C=O.O=C1NC=CC(=O)N1>>O=CC1=CN=CN=C1,Preparation,2,,"In the reaction bottle,Add solvent DMF (560 mL),Cool down to 5  C,Slowly add phosphorus oxychloride (230g),Control the reaction temperature of the mixed system to not exceed 5  C,After the addition of phosphorus oxychloride,Add aluminum trichloride (133g),Stir for 30min,Then, 112 g (1 mol) of uracil in a solid form was added in portions to the above mixed system.Control the reaction temperature not to exceed 5  C,After stirring for 2 hours,Slowly warm to room temperature and continue to stir the reaction until the raw materials disappear.After the reaction is over,Adding the reactants to the rapidly stirred ice-water mixture,Precipitating pyrimidine-5-formaldehyde solid 133g,Yield 95%,The purity is 99.5%.",1,,,2,,0.5; 2,5; 5,,,,,,Temperature; Reagent/catalyst,,,Paragraph 0008; 0009; 0010; 0011; 0012; 0013,,pyrimidine-5-carbaldehyde,95 percent,95,,"N,N-dimethyl-formamide; uracil",aluminum (III) chloride; trichlorophosphate,,,"Patent; Chongqing Aoshe Biochemical Co., Ltd.; Cui Zhenwei; Li Ling; Zhang Fuqing; (5 pag.)CN108276345; (2018); A;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74455332&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
50248450,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=50248450&database=RX&origin=ReaxysOutput&ln=,(28 of 327),1,87,full reaction; has preparation,3-thiophene carboxaldehyde; pyrimidine-5-carbaldehyde,pyrimidin-5-yl(thiophen-3-yl)methanol,217168,O=CC1=CSC=C1.O=CC1=CN=CN=C1>>OC(C1=CSC=C1)C1=CN=CN=C1,Preparation,19.A,"Example 19 - Preparation of 3-((2-chlorophenyl)thio)-6-(pyrimidin-5-yl)-6- (thiophen-3-yl)dihydro-2H-pyran-2,4(3H)-dione Step A","To a solution of pyrimidine-5-carbaldehyde (1.0 g, 6.3 mmol) in THF (63 mL) at -78 C was added tetramethylethylenediamine (1.4 mL, 9.5 mmol) and n- butyllithium (2.8 mL, 6.9 mmol) in hexanes. After 30 min at -78 C, thiophene-3- carbaldehyde (830 muL, 9.5 mmol) was added and the mixture was allowed to warm to -40 C over a period of 1.5 h and stirred for another 30 min at -40 C. The reaction was stopped by the addition of aqueous saturated NH4C1 and diluted with ethyl acetate. The organic phase was washed with brine, dried over Na2S04 and concentrated under reduced pressure. The crude product was purified by flash column chromatography (silica gel, eluent: heptane/ethyl acetate = 30 % to 50 to 70) to give pyrimidin-5-yl(thiophen-3-yl)methanol in 41% yield.",1,,,2,,0.5; 2,-78; -78 - -40,,,,,,,,,Page/Page column 67,,pyrimidin-5-yl(thiophen-3-yl)methanol,41 percent,41,,pyrimidine-5-carbaldehyde; 3-thiophene carboxaldehyde,"n-butyllithium; N,N,N,N,-tetramethylethylenediamine",,tetrahydrofuran; hexane; tetrahydrofuran; hexane,"Patent; ARCTIC PHARMA AS; GOLDING, Louise; KLAVENESS, Jo; SIENG, Bora; LUNDVALL, Steffi; BØEN, Claudia Alejandra; HNIDA, Kathrin; (128 pag.)WO2018/211277; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=75535132&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
51816814,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=51816814&database=RX&origin=ReaxysOutput&ln=,(29 of 327),1,87,full reaction; has preparation,4-phenyl-5H-furan-2-one; pyrimidine-5-carbaldehyde,5-(pyrimidin-5-methylene)-4-phenylfuran-2(5H)-one,163467,O=C1OCC(=C1)C1=CC=CC=C1.O=CC1=CN=CN=C1>>O=C1OC(=CC2=CN=CN=C2)C(=C1)C1=CC=CC=C1,Preparation,19.3,,"(3) Add 4.1 g (37.5 mmol) of pyrimidine-5-formaldehyde, 5.0 g (31.2 mmol) of intermediate 2 and 30 ml of methanol to a 150 ml single-mouth bottle, stir and mix well, and add 0.4 g of ethylenediamine to the mixture, and heat. The reaction 12 was refluxed and the reaction was completed. After the reaction product is cooled to room temperature, it is extracted with dichloromethane, washed with water, dried over anhydrous sodium sulfate, filtered, and then evaporated to remove the methylene chloride under vacuum distillation to obtain a crude product, using a chromatography column (eluting solvent is petroleum ether). The product 5-pyrimidine-5-methylene-4-phenylfuran-2(5H)-one 8.4 g was obtained in a yield of 89.5%.",1,,,,,,,,,Reflux,,,,,,Paragraph 0140-0141; 0144,,5-(pyrimidin-5-methylene)-4-phenylfuran-2(5H)-one,89.5 percent,89.5,,,ethylenediamine,,methanol,Patent; Yangtze University; Wu Qinglai; Cai Jinlong; (28 pag.)CN109761939; (2019); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=76958408&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
10753386,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=10753386&database=RX&origin=ReaxysOutput&ln=,(30 of 327),1,86,full reaction; has preparation,4-Chlorobenzenesulfonamide; pyrimidine-5-carbaldehyde,(E)-4-chloro-N-(pyrimidin-5-ylmethylene)benzenesulfonamide,,NS(=O)(=O)C1=CC=C(Cl)C=C1.O=CC1=CN=CN=C1>>ClC1=CC=C(C=C1)S(=O)(=O)\N=C\C1=CN=CN=C1,Preparation,4,,"Synthesis of (E)-4-chloro-N-(pyrimidin-5-ylmethylene)benzenesulfonamide (69). To a solution of 5-formyl pyrimidine (68, 1.0 g, 9.3 mmol) and 4-chlorobenzene sulfonamide (1.95 g, 10.2 mmol) in toluene (20 mL) was added 4 A molecular sieves (1.0 g) and MP-TsOH (1.0 g). Dean-stark apparatus with reflux condenser was affixed to reaction vessel and reaction was heated at reflux for 18 hours. The reaction mixture was cooled to room temperature and concentrated in vacuo. The residue was taken up in EtOAc and filtered through Celite. The filtrate was concentrated in vacuo to yield 2.12 g (81%) 69 as a light brown solid. 1H NMR (CDCI3) delta 9.42 (s, 1 H), 9.25 (s, 2H), 9.15 (s, 1H)1 7.98 (d, 2H)1 7.57 (d, 2H).",1,,,,,18,,,,Heating / reflux,,,,,,Page/Page column 112,,(E)-4-chloro-N-(pyrimidin-5-ylmethylene)benzenesulfonamide,81 percent,81,,,4 A molecular sieves; MP-TsOH,,toluene,"Patent; ELAN PHARMACEUTICALS, INC.; WO2007/64914; (2007); A2;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8938376&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
25899975,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=25899975&database=RX&origin=ReaxysOutput&ln=,(31 of 327),1,86,full reaction; has preparation,C12H9BrN4; pyrimidine-5-carbaldehyde,C17H13BrN6,228693,NC1=NC(=CN2C(Br)=CN=C12)C1=CC=CC=C1.O=CC1=CN=CN=C1>>BrC1=CN=C2N1C=C(N=C2NCC1=CN=CN=C1)C1=CC=CC=C1,Preparation,49,,"A mixture of the product from Preparative Example 28 (1.16 g, 4.00 mmol), pyrimidine-5-carboxaldehyde (540 mg, 5.00 mmol), and Ti(OiPr)4 (4.54 g, 16.0 mmol) in anhydrous THF (20 mL) was stirred under N2 at 50 C. for 3 hr. The mixture was cooled to 25 C., NaBH3CN (1.26 g, 20.0 mmol) was added, and the mixture was stirred at 25 C. for 30 min. The mixture was poured into 5% aqueous NaOH (500 mL), saturated aqueous NaCl (50 mL) was added, and the mixture was extracted with CH2Cl2 (3×100 mL). The combined extracts were dried over Na2SO4, filtered, and the solvent was evaporated. The residue was purified by column chromatography on silica gel with CH2Cl2/MeOH/conc. aqueous NH4OH (20:1:0.1). Pale yellow solid (410 mg, 27%) was obtained. M. P. 201-203 C., LCMS: MH+=383.",1,,,3,,3; 0.5,50; 25,,,,,,,,,Page/Page column 32,,C17H13BrN6,27 percent,27,,C12H9BrN4; pyrimidine-5-carbaldehyde,titanium(IV) isopropylate; sodium cyanoborohydride; sodium hydroxide,,tetrahydrofuran; tetrahydrofuran; tetrahydrofuran; water,Patent; SCHERING CORPORATION; US2004/63715; (2004); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=7160033&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48463788,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48463788&database=RX&origin=ReaxysOutput&ln=,(32 of 327),1,86,full reaction; has preparation,"N1-cyclopropyl-5-(methylsulfonyl) benzene-1,2-diamine; pyrimidine-5-carbaldehyde",1-cyclopropyl-6-(methylsulfonyl)-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole,150523,CS(=O)(=O)C1=CC=C(N)C(NC2CC2)=C1.O=CC1=CN=CN=C1>>CS(=O)(=O)C1=CC=C2N=C(N(C3CC3)C2=C1)C1=CN=CN=C1,Preparation,26,1-Cyclopropyl-6-(methylsulfonyl)-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole (Ex. 26),"To a stirred solution of N1-cyclopropyl-5-(methylsulfonyl) benzene-1,2-diamine Int-12 (100 mg, 0.44 mmol) in DMF (2 mL) and water (2 mL) under an inert atmosphere was added pyrimidine-5-carbaldehyde (48 mg, 0.44 mmol) and oxone (149 mg, 0.48 mmol) at room temperature. The reaction mixture was stirred at room temperature for 6 h. After consumption of starting material (by TLC), the reaction mixture was diluted with water (20 mL) and extracted with EtOAc (2*20 mL). The combined organic extracts were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude material was purified by preparative HPLC to afford 1-cyclopropyl-6-(methylsulfonyl)-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole Ex. 26 (40 mg, 0.12 mmol, 29%) as an off white solid. ?H NMR (400 MHz, DMSO-d5): oe 9.46 (s, 2H),9.39 (s, 1H), 8.23 (s, 1H), 7.98 (d, J=8.5 Hz, 1H), 7.85 (dd, J=8.5, 1.6 Hz, 1H), 4.00-3.97 (m, 1H), 3.29 (s, 3H), 1.27- 1.12 (m, 2H), 0.88-0.78 (m, 2H) EC-MS: m/z 314.9 [M+H] at 1.71 RT (96.70% purity). HPEC: 97.88%.",1,,,,,6,20,,,Inert atmosphere,,,,,,Paragraph 0586; 0587; 0588; 0589; 0590,,1-cyclopropyl-6-(methylsulfonyl)-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole,29 percent,29,,,Oxone,,"water; N,N-dimethyl-formamide","Patent; Viamet Pharmaceuticals (NC), Inc.; Sparks, Steven; Yates, Christopher M.; Shaver, Sammy R.; (93 pag.)US2018/186773; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74451393&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48805962,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48805962&database=RX&origin=ReaxysOutput&ln=,(33 of 327),1,86,full reaction; has preparation,"N1-cyclopropyl-5-methoxybenzene-1,2-diamine; pyrimidine-5-carbaldehyde",1-cyclopropyl-6-methoxy-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole,150523,COC1=CC=C(N)C(NC2CC2)=C1.O=CC1=CN=CN=C1>>COC1=CC=C2N=C(N(C3CC3)C2=C1)C1=CN=CN=C1,Preparation,25,1-Cyclopropyl-6-methoxy-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole (Ex. 25),"To a stirred solution of N-cyclopropyl-5-methoxy-2-methylaniline Int-11 (200 mg, 1.12 mmol) in DMF (4 mL) and water (0.4 mL) under an inert atmosphere was added pyrimidine-5-carbaldehyde (182 mg, 1.68 mmol) and oxone (690 mg, 2.24 mmol) at room temperature. The reaction mixture was stirred at room temperature for 2 h. After consumption of starting material (by TLC), the reaction mixture was diluted with water (20 mL) and extracted with EtOAc (2*20 mL). The combined organic extracts were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude material was purified by silica gel column chromatography (eluent: 2% MeOH/CH2Cl2) to afford 1-cyclopropyl-6-methoxy-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole Ex. 25 (95 mg, 0.35 mmol, 32%) as an off white solid. ?H NMR (400 MHz, CD3OD): oe 9.36 (s, 2H), 9.28(s, 1H), 7.60 (d, J=8.8 Hz, 1H), 7.20 (d, J=2.3 Hz, 1H), 6.98(dd, J=8.8, 2.4 Hz, 1H), 3.92 (s, 3H), 3.78-3.76 (m, 1H),1.25-1.22 (m, 2H), 0.84-0.72 (m, 2H) EC-MS: mlz 267 [M+H] at 1.70 RT (98.22% purity). HPEC: 99.94%.",1,,,,,2,20,,,Inert atmosphere,,,,,,Paragraph 0581; 0582; 0583; 0584; 0585,,1-cyclopropyl-6-methoxy-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole,32 percent,32,,,Oxone,,"water; N,N-dimethyl-formamide","Patent; Viamet Pharmaceuticals (NC), Inc.; Sparks, Steven; Yates, Christopher M.; Shaver, Sammy R.; (93 pag.)US2018/186773; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74451393&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100033,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100033&database=RX&origin=ReaxysOutput&ln=,(34 of 327),1,86,full reaction; has preparation,3-acetylindole; pyrimidine-5-carbaldehyde,(2E)-1-(1H-indol-3-yl)-3-(pyrimidine-5-yl)prop-2-en-1-one,163593,CC(=O)C1=CNC2=CC=CC=C12.O=CC1=CN=CN=C1>>O=C(\C=C\C1=CN=CN=C1)C1=CNC2=C1C=CC=C2,Preparation,,General method for the preparation of (2E)-1-(1H-indol-3-yl)-3-(pyrimidine-5-yl)prop-2-en-1-one (1),"A mixture of equimolar pyrimidine-5-carbaldehyde and 3-acetylindole in ethanol (50 mL) was refluxed for 3 h following up the drop by drop addition of 20% sodium hydroxide solution yielded(2E)-1-(1H-indol-3-yl)-3-(pyrimidine-5-yl)prop-2-en-1-one (1). On completion of the reaction, the product was achieved by pouring the reaction mixture on to the ice cooled water to yield the precipitate [53]. Yield 81%; yellow-colored crystals; m. p: 125-127 C; Anal. calc. for C15H11N3O:C 72.28%,H 4.45%, N 16.86%; found: C 72.32%, H 4.40%, N 16.91%;IR numax(cm-1): 1535 (C=N), 1610 (C=N), 1734 (C=O), 3190(NH), 2985 (CH-Ar); 1H NMR (CDCl3)delta(ppm): 7.083 (s, 1H,Ar-H), 7.142 (s, 1H, Ar-H), 7.310 (s, 1H, Ar-H), 7.371 (s,1H, Ar-H), 7.410-7.489 (d, 1H, -HC=CH-), 8.198-8.257(m, 4H, Ar-H), 8.294-8.310 (d, 1H, -HC=CH-), 10.805 (s,1H, NH); 13C NMR (CDCl3)deltappm: 121.41, 121.89, 122.33,123.10, 124.21, 124.93, 125.09, 125.48, 125.88, 126.22,126.95, 127.37, 131.47, 132.51, 174.29 (C=O); ESI-MS(m/z): [M++1] 250.25 (250.09).",1,,,,,3,,,,Reflux,,,,,Experimental part,,,(2E)-1-(1H-indol-3-yl)-3-(pyrimidine-5-yl)prop-2-en-1-one,81 percent,81,,,sodium hydroxide,,ethanol; water,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100034,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100034&database=RX&origin=ReaxysOutput&ln=,(35 of 327),1,86,full reaction; has preparation,"6?(1H?indol?3?yl)?4,5??bipyrimidine?2?amine; pyrimidine-5-carbaldehyde","(E)?N?[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]?1?(pyrimidine?5?yl)methanimine",152561,NC1=NC(=CC(=N1)C1=CNC2=CC=CC=C12)C1=CN=CN=C1.O=CC1=CN=CN=C1>>N1C=C(C2=CC=CC=C12)C1=NC(\N=C\C2=CN=CN=C2)=NC(=C1)C1=CN=CN=C1,Preparation,,General method for the preparation of compounds(3-12),"General procedure: The equimolar amount 6-(1H-indol-3-yl)-4,5?-bipyrimidine-2-amine and substituted aldehydes were mixed in a round bottom flask containing 50 mL of ethanol, some droplets of glacial acetic acid were added to the mixture, and it was set on refluxing for 18 h. Solid product was observed on the completion of reaction that was filtered and dried under vacuum and recrystallized using proper solvent [50].",1,,,,,18,,,,Reflux,,,,,Experimental part,,,"(E)?N?[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]?1?(pyrimidine?5?yl)methanimine",76 percent,76,,,acetic acid,,ethanol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
10905835,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=10905835&database=RX&origin=ReaxysOutput&ln=,(36 of 327),1,85,full reaction; has preparation,"N4-((1R,4R)-4-(tert-Butyldiphenylsilyloxy)-1,2,3,4-tetrahydronaphthalen-1-yl)-2-(6-fluoro-1H-benzo[d]imidazol-1-yl)pyrimidine-4,5-diamine; pyrimidine-5-carbaldehyde","9-((1R,4R)-4-(tert-Butyldiphenylsilyloxy)-1,2,3,4-tetrahydronaphthalen-1-yl)-2-(6-fluoro-1H-benzo[d]imidazol-1-yl)-8-(pyrimidin-5-yl)-9H-purine",150523,CC(C)(C)[Si](O[C@@H]1CC[C@@H](NC2=NC(=NC=C2N)N2C=NC3=C2C=C(F)C=C3)C2=C1C=CC=C2)(C1=CC=CC=C1)C1=CC=CC=C1.O=CC1=CN=CN=C1>>CC(C)(C)[Si](O[C@@H]1CC[C@@H](N2C(=NC3=C2N=C(N=C3)N2C=NC3=C2C=C(F)C=C3)C2=CN=CN=C2)C2=C1C=CC=C2)(C1=CC=CC=C1)C1=CC=CC=C1,Preparation,O; 112,,"9-((1R,4R)-4-(tert-Butyldiphenylsilyloxy)-1,2,3,4-tetrahydronaphthalen-1-yl)-2-(6-fluoro-1H-benzo[d]imidazol-1-yl)-8-(pyrimidin-5-yl)-9H-purine. In a microwave vial, to the solution of 50 mg (0.080 mmol) the above diamine in 1 mL anhydrous DMF was added 10 mg (0.096 mmol) pyrimidine-5-carboxaldehyde (Matrix) and 100 mg FeCl3 on silica gel (15% wt). The vial was capped and the mixture was heated in an Emrys Optimizer microwave at 150 C. for 3 hrs. Water was then added to the mixture, and this aqueous phase was extracted with EtOAc three times. The combined organic layer was concentrated in vacuo, and purified on 1000 micron silica gel plate developing with 0.8% MeOH in 1:1 DCM:EtOAc to yield 13 mg (23%) the titled compound as a yellow solid. MS (ESI), m/z 717 ([M+H]+).",1,,,,,3,150,,,Microwave irradiation,,,,,,Page/Page column 30,,"9-((1R,4R)-4-(tert-Butyldiphenylsilyloxy)-1,2,3,4-tetrahydronaphthalen-1-yl)-2-(6-fluoro-1H-benzo[d]imidazol-1-yl)-8-(pyrimidin-5-yl)-9H-purine",23 percent,23,,,15% FeCl3 on silica gel,,"N,N-dimethyl-formamide","Patent; PHARMACOPEIA, INC.; US2008/85898; (2008); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=460163&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
41710675,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=41710675&database=RX&origin=ReaxysOutput&ln=,(37 of 327),1,85,full reaction; has preparation,5-methoxyindole-3-acetonitrile; pyrimidine-5-carbaldehyde,(Z)-2-(5-methoxy-1H-indol-3-yl)-3-pyrimidin-5-yl-acrylonitrile,163467,COC1=CC=C2NC=C(CC#N)C2=C1.O=CC1=CN=CN=C1>>COC1=CC2=C(NC=C2\C(=C\C2=CN=CN=C2)C#N)C=C1,Preparation,16,(Z)-2-(5-methoxy-1H-indol-3-yl)-3-pyrimidin-5-yl-acrylonitrile,"EXAMPLE 16 (Z)-2-(5-methoxy-1H-indol-3-yl)-3-pyrimidin-5-yl-acrylonitrile To a solution of sodium ethanolate [prepared from sodium (44 mg, 1.9 mmol, 1.8 eq.) and anhydrous ethanol (10 mL)] were added, under an argon atmosphere, (5-methoxy-1H-indol-3-yl)-acetonitrile 8a (200 mg, 1.1 mmol, 1.0 eq.) and, after 10 minutes stirring, pyrimidine-5-carbaldehyde (207 mg, 1.9 mmol, 1.5 eq.). The reaction apparatus was protected from light and the mixture stirred at room temperature for 40 hours. The solvent was removed under reduced pressure, and the crude purified by silica gel flash-column chromatography (eluent: CH2Cl2/MeOH, 2:98 to 3:97). The residue was triturated with diethyl ether to afford the compound (16) as a yellow powder (60 mg, 20%). 1H NMR (DMSO, 500 MHz): delta (ppm): 3.84 (3H, s, 5'-methoxy), 6.92 (1H, dd, J6'-7'=8.5 Hz, J6'-4'=1.8 Hz, H6'), 7.42 (1H, d, J7'-6'=8.5 Hz, H7'), 7.52 (1H, d, J4'-6'=1.8 Hz, H4'), 7.74 (1H, s, H3), 7.83 (1H, s, H2'), 9.18 (1H, s, H2'), 9.24 (1H, s, H4"" and H6""), 11.74 (1H, s, indolic H); 13C NMR (DMSO, 75.5 MHz): delta (ppm): 59.6 (5'-methoxy), 106.1 (C4'), 114.0 and 114.1 (C2 and C3'), 116.4 (C6'), 117.2 (C7'), 121.6 (C1), 127.8 (C3a'), 131.9 (C3), 132.3 (C2'), 133.4 (C5""), 136.3 (C7a'), 158.6 (C5'), 159.8 (C4"" and C6""), 161.4 (C2""); TLC: Rf=0.24 (CH2Cl2 96/MeOH, 4); MS: ESI: m/z: 275.1 ([M-H]-); HRMS (ESI): calcd for C16H11N4O: m/z=275.0933. found: 275.0922. IR numax (cm-1): 2217 (nuCN); Mp 214 C.",1,,,2,,0.166667; 40,20,,,Inert atmosphere; Darkness,,,,,,Page/Page column 43,,(Z)-2-(5-methoxy-1H-indol-3-yl)-3-pyrimidin-5-yl-acrylonitrile,20 percent,20,,5-methoxyindole-3-acetonitrile; pyrimidine-5-carbaldehyde,sodium methylate,,ethanol; ethanol,"Patent; COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; Guillou, Catherine; Kozielski, Frank; Labriere, Christophe; Gueritte, Francoise; Tcherniuk, Sergey; Skoufias, Dimitrios; Thal, Claude; Husson, Henri-Philippe; US9212138; (2015); B2;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=67833191&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
41710712,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=41710712&database=RX&origin=ReaxysOutput&ln=,(38 of 327),1,85,full reaction; has preparation,indole-3-acetonitrile; pyrimidine-5-carbaldehyde,(Z)-2-(1H-indol-3-yl)-3-pyrimidin-5-yl-acrylonitrile,163467,N#CCC1=CNC2=C1C=CC=C2.O=CC1=CN=CN=C1>>N#CC(=C/C1=CN=CN=C1)\C1=CNC2=C1C=CC=C2,Preparation,15.2,2) Preparation of (Z)-2-(1H-indol-3-yl)-3-pyrimidin-5-yl-acrylonitrile ),"2) Preparation of (Z)-2-(1H-indol-3-yl)-3-pyrimidin-5-yl-acrylonitrile To a solution of sodium ethanolate [prepared from sodium (53 mg, 2.3 mmol, 1.8 eq.) and anhydrous ethanol (10 mL)] were added, under an argon atmosphere, (1H-indol-3-yl)-acetonitrile (200 mg, 1.3 mmol, 1.0 eq.) and, after 10 minutes stirring, pyrimidine-5-carbaldehyde (207 mg, 1.9 mmol, 1.5 eq.). The reaction apparatus was protected from light and the mixture stirred at room temperature for 40 hours. The solvent was removed under reduced pressure, and the crude purified by silica gel flash-column chromatography (eluent: CH2Cl2/MeOH, 1:99 to 2:98). The residue was triturated with diethyl ether to afford the compound (15) as a yellow powder (65 mg, 21%). 1H NMR (DMSO, 500 MHz): delta (ppm): 7.22 (1H, t, J5'-6'=J5'-4'=7.9 Hz, H5'), 7.27 (1H, t, J6'-5'=J6'-7'=7.9 Hz, H6'), 7.53 (1H, d, J7'-6'=7.9 Hz, H7'), 7.81 (1H, s, H3), 7.88 (1H, s, H2'), 8.13 (1H, d, J4'-5'=7.9 Hz, H4'), 9.19 (1H, s, H2""), 9.25 (1H, s, H4"" and H6""), 11.87 (1H, s, indolic H); 13C NMR (DMSO, 75.5 MHz): delta (ppm): 113.9 and 114.3 (C2 and C3'), 116.5 (C7'), 121.6 (C1), 123.6 (C4'), 124.8 (C5'), 126.7 (C6'), 127.3 (C3a'), 131.9 (C2'), 132.3 (C3), 133.3 (C5""), 141.2 (C7a'), 159.8 (C4"" and C6""), 161.4 (C2""); TLC: Rf=0.47 (CH2Cl2 96/MeOH, 4); MS: ESI: m/z: 245.0 ([M-H]-); HRMS (ESI): calcd for C15H9N4: m/z=245.0827. found: 245.0818. IR numax (cm-1): 2219 (nuCN); Mp 231 C.",1,,,2,,0.166667; 40,20,,,Inert atmosphere; Darkness,,,,,,Page/Page column 42; 43,,(Z)-2-(1H-indol-3-yl)-3-pyrimidin-5-yl-acrylonitrile,21 percent,21,,indole-3-acetonitrile; pyrimidine-5-carbaldehyde,sodium methylate,,ethanol; ethanol,"Patent; COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; Guillou, Catherine; Kozielski, Frank; Labriere, Christophe; Gueritte, Francoise; Tcherniuk, Sergey; Skoufias, Dimitrios; Thal, Claude; Husson, Henri-Philippe; US9212138; (2015); B2;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=67833191&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
52725047,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=52725047&database=RX&origin=ReaxysOutput&ln=,(39 of 327),1,85,full reaction; has preparation,C15H21N5O3S*C2HF3O; pyrimidine-5-carbaldehyde,"1-(1,1-dioxotetrahydro-2H-thiopyran-4-yl)-6-((trans)-4-methyl-1-(pyrimidin-5-ylmethyl)pyrrolidin-3-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one",228604,FC(F)(F)C=O.C[C@@H]1CNC[C@H]1C1=NC2=C(C=NN2C2CCS(=O)(=O)CC2)C(=O)N1.O=CC1=CN=CN=C1>>C[C@@H]1CN(CC2=CN=CN=C2)C[C@H]1C1=NC2=C(C=NN2C2CCS(=O)(=O)CC2)C(=O)N1,Preparation,3,"Example 3: Synthesis of 1-(1,1-dioxotetrahydro-2H-thiopyran-4-yl) -6-((trans)-4-methyl-1-(pyrimidin-5-ylmethyl) pyrrolidin-3-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one","1-(1,1-dioxotetrahydro-2H-thian-4-yl) -6-((trans) -4-methylpyrrolidin-3-yl) -1,5-dihydro -4H-pyrazolo [3,4-d] pyrimidin-4-one trifluoroacetate (65mg, 0.140mmol, 1.0eq),Pyrimidine-5-carbaldehyde (37.6mg, 0.349mmol, 2.5eq)And acetic acid (16.7mg, 0.279mmol, 2.0eq) in methanol (5mL),Heated to 50 for 2h,The temperature was lowered to 0  C, sodium cyanoborohydride (26.3 mg, 0.419 mmol, 3.0 eq) was added, and the temperature was raised to 50  C and stirred for 1 h.Add pyrimidine-5-formaldehyde (37.6mg, 0.349mmol, 2.5eq), stir at 50  C for 1h, add sodium cyanoborohydride (26.3mg, 0.419mmol, 3.0eq) and stir at room temperature for 12h.TLC monitoring showed complete reaction,Concentrated under reduced pressure, added saturated aqueous sodium carbonate (10 mL) and saturated brine (10 mL), and extracted with dichloromethane (50 mL x 4). The organic phases were combined, dried, filtered, and concentrated.The crude product was subjected to preparative thin layer chromatography (MeOH: DCM = 1: 20)Purification afforded the product as an off-white solid (29 mg, yield: 24.2%).",1,,,2,,2; 1,50; 0 - 50,,,,,,,,,Paragraph 0209-0213,Further stages,"1-(1,1-dioxotetrahydro-2H-thiopyran-4-yl)-6-((trans)-4-methyl-1-(pyrimidin-5-ylmethyl)pyrrolidin-3-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one",24.2 percent,24.2,,C15H21N5O3S*C2HF3O; pyrimidine-5-carbaldehyde,acetic acid; sodium cyanoborohydride,,methanol; methanol,"Patent; Nanjing Yaojie Good Health Biological Technology Co., Ltd.; Wu Yongqian; Peng Peng; Li Lin; (59 pag.)CN110357888; (2019); A;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78134006&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733332,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733332&database=RX&origin=ReaxysOutput&ln=,(40 of 327),2,84,full reaction; has preparation,3-(2-methoxy-phenoxy)-aniline; pyrimidine-5-carbaldehyde,[3-(2-methoxyphenoxy)phenyl](pyrimidin-5-ylmethyl)amine,224501,COC1=C(OC2=CC=CC(N)=C2)C=CC=C1.O=CC1=CN=CN=C1>>COC1=CC=CC=C1OC1=CC(NCC2=CN=CN=C2)=CC=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733332,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733332&database=RX&origin=ReaxysOutput&ln=,(40 of 327),2,84,full reaction; has preparation,3-(2-methoxy-phenoxy)-aniline; pyrimidine-5-carbaldehyde,[3-(2-methoxyphenoxy)phenyl](pyrimidin-5-ylmethyl)amine,224501,COC1=C(OC2=CC=CC(N)=C2)C=CC=C1.O=CC1=CN=CN=C1>>COC1=CC=CC=C1OC1=CC(NCC2=CN=CN=C2)=CC=C1,Preparation,3,,"EXAMPLE 3 2,2,2-trifluoro-N -[3-(2-methoxyphenoxy)phenyl]-N -(pyrimidin-5-ylmethyl)ethane-sulfonamide To a solution of [3-(2-methoxyphenoxy)phenyl]amine (0.30 g,l .39 mmol), pyrimidine-5- carbaldehyde (0.16 g, 1.5 mmol) in dichloroethane (3 ml) was added acetic acid (0.08, 1.4 mmol) and sodiumtriacetoxyborohydride (0.50 g, 2.1 mmol) at ambient temperature. After stirring for 2h, the reaction was quenched with EtOAc (100 mL), washed with saturated sodium hydrogencarbonate solution (50 ml), H2O (50 mL), then brine (5OmL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by silica gel chromatography eluting with EtOAc to afford [3-(2-methoxyphenoxy)phenyl](pyrimidin-5-ylmethyl)amine as a yellow solid. 1H NMR (CDCl3, 300 MHz) 9.12(s, IH), 8.67 (s, 2H), 5.97-7.11 (m,2H), 6.95-6.98 (m, 2H), 6.89-6.91 (m, IH), 6.28-6.31 (m, 2H), 5.19 (s, IH), 4.29-4.31 (m, 2H), 4.23 (s, IH), 3.79 (s, 3H). [3-(2- methoxyphenoxy)phenyl](pyrimidin-5-ylmethyl)amine (0.05 g, 0.16 mmol) was dissolved in dichloroethane (4 mL) and pyridine (2 ml) and cooled to -5C under argon. A neat solution of 2,2,2- triflouroethylsulfonyl chloride (0.04 g, 0.21 mmol) was added dropwise due to exotherm. After 30 min stirring at 00C, the reaction mixture was stirred at ambient temperature for an additional 16h before quenching with potassium carbonate (0.10 g, 0.69 mmol). The mixture was diluted with EtOAc (50 mL), washed with H2O (50 mL), then brine (50 mL). The organic layer was dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by Prep TLC eluting with hexane:EtOAc (1 :9) to afford 2,2,2-trifluoro-N-[3-(2-methoxyphenoxy)phenyl]-N-(pyrimidin-5-ylmethyl)ethanesulfonamide. 1H NMR (CDCl3, 300 MHz) delta 9.13(s, IH), 8.57(s, 2H), 7.27(t, IH), 7.19(m, IHO, 7.00(d, IH), 6.95(m,2H), 6.90(d, 2H), 6.79(s, IH), 4.85(s, 2H), 3.82(m, 5H). MS 454.2 (M++H).",1,,,,,2,20,,,,,,,,,Page/Page column 20,,,,,,,sodium tris(acetoxy)borohydride; acetic acid,,"1,2-dichloro-ethane","Patent; MERCK &amp; CO., INC.; WO2006/49968; (2006); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=7167088&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48463682,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48463682&database=RX&origin=ReaxysOutput&ln=,(41 of 327),1,84,full reaction; has preparation,"4-amino-3-((2,2,2-trifluoroethyl)amino)benzonitrile; pyrimidine-5-carbaldehyde","2-(pyrimidin-5-yl)-1-(2,2,2-trifluoroethyl)-1H-benzo[d]imidazole-6-carbonitrile",150523,NC1=CC=C(C=C1NCC(F)(F)F)C#N.O=CC1=CN=CN=C1>>FC(F)(F)CN1C2=CC(=CC=C2N=C1C1=CN=CN=C1)C#N,Preparation,43,"2-(Pyrimidin-5-yl)-1-(2,2,2-trifluoroethyl)-1H-benzo[d]imidazole-6-carbonitrile (Ex. 43)","To a stirred solution of 4-amino-3-((2,2,2-trifluoroethyl)amino)benzonitrile Int-16 (195 mg, 0.90 mmol) in DMF (2 mL) and water (0.2 mL) under an inert atmosphere was added pyrimidine-5-carbaldehyde (117 mg, 1.08 mmol) and oxone (552.6 mg, 1.80 mmol) at room temperature. The reaction mixture was stirred at room temperature for 2 h. After consumption of starting material (by TLC), the reaction mixture was diluted with water (20 mL) and extracted with EtOAc (2*20 mL). The combined organic extracts were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude material was purified by preparative HPLC to afford 2-(pyrimidin-5-yl)-1-(2,2,2-trifluoroethyl)-1H-benzo[d]imidazole-6-carbonitrile Ex. 43 (26 mg, 0.08 mmol, 9.4%) as an off white solid. ?H NMR (400 MHz, CD3OD): oe 9.42 (s, 1H), 9.22(s, 2H), 8.29 (s, 1H), 7.96 (d, J=8.4 Hz, 1H), 7.75 (dd, J=8.4,1.4, Hz, 1H), 5.38-5.31 (m, 2H). EC-MS: m/z 344.9 [M+H] at 2.19 RT (99.49% purity). HPEC: 99.20%.",1,,,,,2,20,,,Inert atmosphere,,,,,,Paragraph 0701; 0702; 0703; 0704; 0705,,"2-(pyrimidin-5-yl)-1-(2,2,2-trifluoroethyl)-1H-benzo[d]imidazole-6-carbonitrile",9.4 percent,9.4,,,Oxone,,"water; N,N-dimethyl-formamide","Patent; Viamet Pharmaceuticals (NC), Inc.; Sparks, Steven; Yates, Christopher M.; Shaver, Sammy R.; (93 pag.)US2018/186773; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74451393&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
50395402,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=50395402&database=RX&origin=ReaxysOutput&ln=,(42 of 327),1,84,full reaction; has preparation,"(2,4-dimethylphenyl)hydrazine hydrochloride; pyrimidine-5-carbaldehyde","(E)-5-((2-(2,4-dimethylphenyl)hydrazono)methyl)pyrimidine",272887,Cl[H].CC1=CC=C(NN)C(C)=C1.O=CC1=CN=CN=C1>>CC1=CC(C)=C(N\N=C\C2=CN=CN=C2)C=C1,Preparation,1.1,"Step 1) Synthesis of (E)-5-((2-(2,4-dimethylphenyl)fluorenylene)methyl)pyrimidine","Pyrimidine-5-formaldehyde (1.00 g, 9.25 mmol),2,4-Dimethylphenylhydrazine hydrochloride (1.60 g, 9.30 mmol)And DMF (16 mL) was added to a 100 mL single-neck round bottom flask in turn.Reaction at room temperature for 1 h,Neutralize the hydrochloride with 8 mL of saturated sodium bicarbonate solution, then add water (80 mL).A yellow solid precipitated, and the solid was filtered, washed with water (50 mL×2).Dissolve in dichloromethane (20 mL), separate the layers, and collect the organic phase.The title compound was obtained as a yellow solid (1.20 g, 57.0%).",1,,,,,1,20,,,,,,,,,Paragraph 0172-0176,,"(E)-5-((2-(2,4-dimethylphenyl)hydrazono)methyl)pyrimidine",57 percent,57,,,,,"N,N-dimethyl-formamide","Patent; Guangdong Dongyangguang Pharmaceutical Co., Ltd.; Chen Kangzhi; Jin Chuanfei; Luo Ming; Zhang Yingjun; (28 pag.)CN108863948; (2018); A;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=75575788&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
23229252,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=23229252&database=RX&origin=ReaxysOutput&ln=,(43 of 327),1,83,full reaction; has preparation,formic acid ethyl ester,pyrimidine-5-carbaldehyde,75296,CCOC=O>>O=CC1=CN=CN=C1,Preparation,23.A,5-pyrimidinecarbaldehyde,"A solution of 5-bromopyrimidine (12 g, 0.075 mol) in THF (500 mL) at -100 C. was treated with 2.5M n-butyllithium in hexanes (30.2 mL, 79 mmol) over 35 minutes, stirred for 15 minutes at -100 C., treated with ethyl formate (6.7 mL, 0.0825 mol) over 15 minutes, stirred for 15 minutes at -95 C., treated with 1M HCl in ether (79 mL, 0.0787 mol) over 10 minutes, warmed to room temperature over 1 hour, and concentrated. The concentrate was treated with dichloromethane, and the resulting solution was washed with water and brine, dried (MgSO4), filtered, and concentrated to provide the desired product.",1,,,3,,0.833333; 0.5; 1.16667,-100; -95; -95 - 20,,,,,,,,,Page/Page column 28,,,,,,5-bromopyrimidine; formic acid ethyl ester,n-butyllithium; hydrogenchloride,,tetrahydrofuran; tetrahydrofuran; tetrahydrofuran; diethyl ether,"Patent; Ma, Zhenkun; Phan, Ly Tam; Clark, Richard F.; Zhang, Suoming; Djuric, Stevan; US2006/166906; (2006); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=406185&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
47816244,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=47816244&database=RX&origin=ReaxysOutput&ln=,(44 of 327),1,83,full reaction; has preparation,"6-fluoro-3-methanesulfonyl-4-phenyl-1,2-dihydroquinolin-2-one; pyrimidine-5-carbaldehyde","6-fluoro-4-phenyl-3-[(E)-2-(pyrimidin-5-yl)ethenesulfonyl]-1,2-dihydroquinolin-2-one",163593,CS(=O)(=O)C1=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(F)=C2.O=CC1=CN=CN=C1>>FC1=CC2=C(NC(=O)C(=C2C2=CC=CC=C2)S(=O)(=O)\C=C\C2=CN=CN=C2)C=C1,Preparation,34.3,"[00367] 6-fluoro-4-phenyl-3-[(E)-2-(pyrimidin-5-yl)ethenesulfonyl]-1,2-dihydroquinolin-2-one (EV-AT8379-001) - Step 3","[00368] A cold (0C) solution of 6-fluoro-3-methanesulfonyl-4-phenyl-1,2-dihydroquinolin-2-one (EV-AT8375-001, 200 mg, 0.63 mmol) in dry THF (5 ml) under a nitrogen atmosphere was treated dropwise with 1.6M n-butyllithium (1260.5 _). Once the addition was complete the deep red was stirred at 0C for lOmin before diethyl phosphorochloridate (109 ul, 0.76 mmol) was added. The solution was stirred at 0C for lOmin before it was cooled to - 78C and treated with pyrimidine-5-carbaldehyde (68.1mg, 0.63 mmol) as a solid and the mixture was allowed to slowly warm to room temperature overnight. The solution was quenched by the addition of NH4CI and extracted twice with EtOAc. The organics were washed with brine, dried (MgS04) and evaporated under vacuum. The crude was passed through an SCX-II column (product eluted in ammonia methanol) and the residue was purified by acidic preparative HPLC. The fractions were concentrated in vacuo and the solid was triturated with EtOAc and dried in a vacuum oven to obtain 11.2 mg (4.4%) of 6-fluoro-4-phenyl-3-[(E)-2-(pyrimidin-5-yl)ethenesulfonyl]-1,2-dihydroquinolin-2-one (I-62)(EV-AT8379-001) as a pale yellow solid. LCMS (method A): retention time 2.65min, M/z = 408 (M + 1).",1,,,3,,0.166667; 0.166667,0; 0; -78 - 20,,,Inert atmosphere; Inert atmosphere; Inert atmosphere,,,,,,Paragraph 00367-00368,,"6-fluoro-4-phenyl-3-[(E)-2-(pyrimidin-5-yl)ethenesulfonyl]-1,2-dihydroquinolin-2-one",4.4 percent,4.4,,"6-fluoro-3-methanesulfonyl-4-phenyl-1,2-dihydroquinolin-2-one; pyrimidine-5-carbaldehyde",n-butyllithium; diethyl chlorophosphate,,tetrahydrofuran; tetrahydrofuran; tetrahydrofuran,"Patent; PADLOCK THERAPEUTICS, INC.; DEVRAJ, Rajesh; KUMARAVEL, Gnanasambandam; LECCI, Cristina; LOKE, Pui; MENICONI, Mirco; MONCK, Nat; NORTH, Carl; RIDGILL, Mark; TYE, Heather; (205 pag.)WO2018/49296; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73439980&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306587,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306587&database=RX&origin=ReaxysOutput&ln=,(45 of 327),3,82,full reaction; has preparation; has multi-step,pyrimidine-5-carbaldehyde,amino(pyrimidin-5-yl)acetonitrile,226386,O=CC1=CN=CN=C1>>NC(C#N)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:14306587-Steps:8570487;8583586,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,ammonium hydroxide; ammonium chloride,,water; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306587,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306587&database=RX&origin=ReaxysOutput&ln=,(45 of 327),3,82,full reaction; has preparation; has multi-step,pyrimidine-5-carbaldehyde,amino(pyrimidin-5-yl)acetonitrile,226386,O=CC1=CN=CN=C1>>NC(C#N)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:14306587-Steps:8570487;8583586,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating,,,,,,,,,,,,,,1: Addition / 2: Substitution,,,,,,ammonium hydroxide; ammonium chloride,,water; acetic acid; acetonitrile,"Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306587,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306587&database=RX&origin=ReaxysOutput&ln=,(45 of 327),3,82,full reaction; has preparation; has multi-step,pyrimidine-5-carbaldehyde,amino(pyrimidin-5-yl)acetonitrile,226386,O=CC1=CN=CN=C1>>NC(C#N)C1=CN=CN=C1,Preparation,22,Amino(pyrimidin-5-yl)acetonitrile,"Example 22 Amino(pyrimidin-5-yl)acetonitrile Potassium cyanide (651 mg, 10 mmol) and ammonium chloride (588 mg, 11 mmol) are dissolved in water (2.6 mL) with stirring. Pyrimidine-5-carboxaldehyde (1.08 g, 10 mmol) in methanol (2.6 mL) is added to the clear solution rapidly, giving first a yellow, then a dark red solution, and mildly exothermic reaction. The water is evaporated after three hours stirring, and the reddish residue is chromatographed (silica, chloroform/methanol) to give a yellow solid 1.1 g (82%) identified as product ms m/z=134.",1,,,,,,,,,,,,,,,,,,,,,,ammonium chloride,,methanol; water,Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
23313211,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=23313211&database=RX&origin=ReaxysOutput&ln=,(46 of 327),1,82,full reaction; has preparation,ethylmagnesium bromide; pyrimidine-5-carbaldehyde,C7H10N2O,217553,CC[Mg]Br.O=CC1=CN=CN=C1>>CCC(O)C1=CN=CN=C1,Preparation,P-5 A,,"Example P-5 A: Preparation of 5-propionyl-pyrimidine; 5.6 g of pyrimidine-5-carboxaldehyde in 100 ml of ether are slowly added dropwise, at 0-5C, to 18 ml of 3M ethylmagnesium bromide solution in ether. The yellowish suspension is stirred for 1 hour at 5C and then 30 ml of saturated NH4CI are added, with cooling. The phases are separated and the reaction solution is extracted 3 times with diethyl ether. The combined organic phases are washed with brine, filtered and concentrated. 3.14 g of a yellow oil are obtained, which-as the crude product-is reacted further. The intermediate is dissolved in 100 ml of methylene chloride and, after adding 10.26 g (1.2 eq. ) of pyridinium dichromate, is stirred for 20 hours at room temperature. The reaction mixture is filtered over Hyflo. The organic phase is washed with H2O/brine, dried and concentrated. After chromatography of the crude product on silica gel using ethyl acetate/hexane (1: 2), 0.95 g of the title product is obtained in the form of a colourless oil.",1,,,2,,1,0 - 5,,,,,,,,,Page/Page column 30,,,,,,ethylmagnesium bromide; pyrimidine-5-carbaldehyde,water; ammonium chloride,,diethyl ether; diethyl ether,Patent; SYNGENTA PARTICIPATIONS AG; WO2005/47281; (2005); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8821345&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
27781671,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=27781671&database=RX&origin=ReaxysOutput&ln=,(47 of 327),1,82,full reaction; has preparation,l-cysteine hydrochloride; pyrimidine-5-carbaldehyde,(R)-2-pyrimidin-5-yl-thiazolidine-4-carboxylic acid,227254,Cl[H].[H][C@](N)(CS)C(O)=O.O=CC1=CN=CN=C1>>OC(=O)[C@@H]1CSC(N1)C1=CN=CN=C1,Preparation,22,,"R)-2-Pyrimidin-5-yl-thiazolidine-4-carboxylic acidTo a solution of L-cysteine hydrochloride (400 mg, 2.54 mmol) in distilled water (4 mL), potassium acetate (275 mg, 2.80 mmol) was added. Once the solids went into solution, methanol (4 mL) was added followed by pyrimidine-5-carbaldehyde (328.3 mg, 3.04 mmol). The reaction was allowed to stir at ambient temperature for one hour. The solvent was removed, and no further purification steps were taken.",1,,,,,1,20,,,,,,,,,Page/Page column 84,,,,,,,potassium acetate,,methanol; water,"Patent; GENELABS TECHNOLOGIES, INC.; WO2008/64218; (2008); A2;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8638134&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
27885630,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=27885630&database=RX&origin=ReaxysOutput&ln=,(48 of 327),1,82,full reaction; has preparation,[2-(4-fluoro-3-methyl-phenyl)-2-oxo-ethyl]-phosphonic acid dimethyl ester; pyrimidine-5-carbaldehyde,(E)-1-(4-fluoro-3-methyl-phenyl)-3-pyrimidin-5-yl-propenone,169252,COP(=O)(CC(=O)C1=CC(C)=C(F)C=C1)OC.O=CC1=CN=CN=C1>>CC1=CC(=CC=C1F)C(=O)\C=C\C1=CN=CN=C1,Preparation,66.a,,"To a mixture of 19.2 g (155 mmol) dimethyl methylphosphonate in 150 mL THF at -70 C. was added 97 mL (155 mmol) 1.6M n-BuLi in hexane. The mixture was stirred for 45 min and a solution of 11.8 g (70 mmol) 4-fluoro-3-methyl-benzoic acid methyl ester in 15 mL THF was added. After 15 min at -70 C. the mixture was allowed to warm to 0 C. and neutralized with 4N HCl in dioxane. The mixture was diluted with 500 mL THF to obtain [2-(4-fluoro-3-methyl-phenyl)-2-oxo-ethyl]-phosphonic acid dimethyl ester. 6 mmol [2-(4-fluoro-3-methyl-phenyl)-2-oxo-ethyl]-phosphonic acid dimethyl ester in THF was stirred together with 0.5 g (4.6 mmol) pyrimidine-5-carboxaldehyde and 1.65 g Cs2CO3 for 16 h at room temperature. The mixture was diluted with NH4Cl aq. and ethyl acetate. The organic layer was separated, dried with MgSO4 and evaporated to dryness. The residue was used crude in the consecutive step.",1,,,,,16,20,,,,,,,,,Page/Page column 35,,,,,,,caesium carbonate,,tetrahydrofuran,"Patent; Gobbi, Luca; Knust, Henner; Malherbe, Parichehr; Nettekoven, Matthias; Pinard, Emmanuel; Roche, Olivier; Rogers-Evans, Mark; US2008/221166; (2008); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8647049&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
29181010,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=29181010&database=RX&origin=ReaxysOutput&ln=,(49 of 327),1,82,full reaction; has preparation,tert-butyl 4-aminobenzoate; pyrimidine-5-carbaldehyde,4-[(pyrimidin-5-ylmethyl)-amino]-benzoic acid tert-butyl ester,224501,CC(C)(C)OC(=O)C1=CC=C(N)C=C1.O=CC1=CN=CN=C1>>CC(C)(C)OC(=O)C1=CC=C(NCC2=CN=CN=C2)C=C1,Preparation,6,Synthesis of 4-[(Pyrimidin-5-ylmethyl)-amino]-benzoic acid tert-butyl ester,"Example 6 Synthesis of 4-[(Pyrimidin-5-ylmethyl)-amino]-benzoic acid tert-butyl ester A mixture of 4-amino-benzoic acid tert-butyl ester (3.93 g, 20.4 mmol), pyrimidine-5-carboxaldehyde (2.00 g, 18.5 mmol), Na(OAc)3BH (5.88 g, 27.8 mmol) and methanol (3 drops) in dichloroethane (75 mL) was stirred at room temperature for 16 hr. The reaction mixture was then diluted with dichloromethane, washed with an aqueous saturated solution of sodium bicarbonate and brine, dried over sodium sulfate, filtered and evaporated. The resulting crude material was purified via flash chromatography (hexane/ethyl acetate), to afford 4.02 g of 4-[(pyrimidin-5-ylmethyl)-amino]-benzoic acid tert-butyl ester.",1,,,2,,16,20,,,,,,,,,Page/Page column 41,,,,,,tert-butyl 4-aminobenzoate; pyrimidine-5-carbaldehyde,sodium tris(acetoxy)borohydride; sodium hydrogencarbonate,,"methanol; 1,1-dichloroethane; dichloromethane; water",Patent; MEMORY PHARMACEUTICALS CORPORATION; ROCHE PALO ALTO LLC; US2010/29689; (2010); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8830411&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
31459542,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=31459542&database=RX&origin=ReaxysOutput&ln=,(50 of 327),1,82,full reaction; has preparation,3-methylpyridin-2-ylamine; pyrimidine-5-carbaldehyde,N-(5-pyrimidinylmethyl)-3-methyl-2-pyridinamine,228693,CC1=CC=CN=C1N.O=CC1=CN=CN=C1>>CC1=CC=CN=C1NCC1=CN=CN=C1,Preparation,5.A,,"Step A: Preparation of N-(5-pyrimidinylmethyl)-3-methyl-2-pyridinamine To a solution of 5-pyrimidinecarboxaldehyde (5.0 g, 46 mmol) in toluene (100 rnL) was added 2-amino-3-picoline (5.0 g, 46 mmol). The reaction mixture was heated to 80 0C on a rotary evaporator while under reduced pressure. After 10 min an additional 200 mL of toluene was added. Continued heating under reduced pressure resulted in a white solid which was dissolved in methanol (200 mL). This solution was stirred vigorously under a nitrogen atmosphere, and granular sodium borohydride (10.0 g, 265 mmol) was added portionwise, resulting in vigorous bubbling. The reaction was allowed to stir for 1 h at room temperature after completion of the sodium borohydride addition. Acetic acid (1 mL) was then added, and the reaction mixture was stirred for 5 min, followed by the addition of water (100 mL). The volatiles were removed under reduced pressure, and the aqueous suspension was extracted with dichloromethane (2 x 100 mL). The organic layers were combined and dried over MgSO4, filtered, and the solvent was removed under reduced pressure to yield an off-white solid. The crude solid was adsorbed onto Celite and purified by column chromatography (gradient of 100% hexanes to 100% ethyl acetate over 30 minutes) to yield 8.848 g of a white solid.1H NMR (CDCl3) delta 9.11 (s, IH), 8.77 (s, 2H), 8.00 (d, IH), 7.26 (s, IH), 6.60 (dd, IH), 4.73 (d, 2H), 4.59 (br s, NH), 2.12 (s, 3H).",1,,,2,,1,80; 20,,,Inert atmosphere,,,,,,Page/Page column 123,,,,,,3-methylpyridin-2-ylamine; pyrimidine-5-carbaldehyde,methanol; sodium tetrahydroborate,,toluene; toluene,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; ZHANG, Wenming; HOLYOKE JR, Caleb, William; HUGHES, Kenneth Andrew; LAHM, George, P.; PAHUTSKI JR, Thomas, Francis; TONG, My-Hanh, Thi; XU, Ming; WO2011/17342; (2011); A2;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8981661&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
32836261,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=32836261&database=RX&origin=ReaxysOutput&ln=,(51 of 327),1,82,full reaction; has preparation,"1'-(5-amino-6-(methylamino)pyrimidin-4-yl)spiro[indoline-3,4'-piperidin]-2-one; pyrimidine-5-carbaldehyde","1'-(9-methyl-8-pyrimidin-5-yl-9H-purin-6-yl)spiro[indole-3,4'-piperidin]-2(1H)-one",150523,CNC1=NC=NC(N2CCC3(CC2)C(=O)NC2=CC=CC=C32)=C1N.O=CC1=CN=CN=C1>>CN1C(=NC2=C(N=CN=C12)N1CCC2(CC1)C(=O)NC1=CC=CC=C21)C1=CN=CN=C1,Preparation,24,,"-(9-Methyl-8-pyrimidin-5-yl-9H-purin-6^[00228] To a solution of 1 '-[5-amino-6-(methylamino)pyrimidin-4-yl]spiro[indole-3,4'- piperidin]-2(lH)-one (100 mg, 0.30 mmol) in anhydrous ethanol (12 mL) were added pyrimidine-5-carbaldehyde (38 mg, 0.35 mmol, Apollo Scientific Ltd.) and catalytic amount of hydrochloric acid (0.05 mL, 4N, Dioxane, Aldrich). The reaction mixture was heated to 80 C for 18 hours. The reaction mixture was cooled to room temperature and concentrated under reduced pressure. The product was purified by preparatory HPLC (reverse-phase, acetonitrile/water with 0.1 % formic acid) to give 35.0 mg (28% yield) of the title compound. NMR (400 MHz, DMSO-d6) 610.49 (s, 1H), 9.35 (s, 1H), 9.32 (s, 2H), 8.36 (s, 1H), 7.49 (d, 1H), 7.20 (td, 1H), 6.99 - 6.92 (m, 1H), 6.87 (t, 1H), 3.91 (s, 3H), 1.80 (d, 4H). MS (EI) for C22H20N8O: 413.6 (MH+).",1,,,,,18,80,,,,,,,,,Page/Page column 177-178,,,,,,,,hydrogenchloride,ethanol; water,"Patent; EXELIXIS, INC.; PATRICK, Kearney; WO2012/37226; (2012); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20098523&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36597226,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36597226&database=RX&origin=ReaxysOutput&ln=,(52 of 327),1,82,full reaction; has preparation,5-bromopyrimidine; chloroformic acid ethyl ester,pyrimidine-5-carbaldehyde,47022,BrC1=CN=CN=C1.CCOC(Cl)=O>>O=CC1=CN=CN=C1,Preparation,,Step 2. Pyrimidine-5-carboxaldehvde,"0225] Step 2. Pyrimidine-5-carboxaldehvde. To a solution of 5-bromopyrimidine (2 g, 12.58 mmol, 1.00 equiv) in THF (20 mL) placed in a 50-mL 3-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen was added n-butyllithium (1.1 mL) at -78 C. The reaction mixture was stirred at -78 C for another 2 h. Ethyl formate (5.2 mL) was then added and the resulting solution was stirred for 2 h at -78 C. The resulting mixture was warmed to 0 C and washed with 50 mL of brine. The organic layer was dried with anhydrous sodium carbonate and concentrated. The residue was purified on a silica gel column eluted with ethyl acetate/petroleum ether (1 : 1) to give 11 g of crude pyrimidine-5- carboxaldehyde as a yellow oil. TLC: ethyl acetate/petroleum ether (1/1), Rf = 0.2.",1,,,2,,2; 2,-78; -78,,,Inert atmosphere,,,,,,Paragraph 0225,,,,,,5-bromopyrimidine; chloroformic acid ethyl ester,n-butyllithium,,tetrahydrofuran; tetrahydrofuran,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; BUCKMELTER, Alexandre, J.; CLODFELTER, Karl, H.; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; REYNOLDS, Dominic, J.; SMITH, Chase, C.; WANG, Zhongguo; ZAK, Mark; ZHENG, Xiaozhang; ZHAO, Guiling; WO2013/130943; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727677&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48463674,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48463674&database=RX&origin=ReaxysOutput&ln=,(53 of 327),1,82,full reaction; has preparation,"N1-cyclopropyl-5-(trifluoromethoxy)benzene-1,2-diamine; pyrimidine-5-carbaldehyde",1-cyclopropyl-2-(pyrimidin-5-yl)-6-(trifluoromethoxy)-1H-benzo[d]imidazole,150523,NC1=CC=C(OC(F)(F)F)C=C1NC1CC1.O=CC1=CN=CN=C1>>FC(F)(F)OC1=CC=C2N=C(N(C3CC3)C2=C1)C1=CN=CN=C1,Preparation,42,1-Cyclopropyl-2-(pyrimidin-5-yl)-6-(trifluoromethoxy)-1H-benzo[d]imidazole (Ex. 42),"To a stirred solution of N1-cyclopropyl-5-(trifluoromethoxy)benzene-1,2-diamine Int-15 (100 mg, 0.44 mmol) in DMF (2 mL) under an inert atmosphere was added pyrimidine-5-carbaldehyde (46 mg, 0.44 mmol) and oxone (198 mg, 0.64 mmol) followed by water (1 mmol) at room temperature. The reaction mixture was stirred at room temperature for 6 h. After consumption of starting material (by TLC), the reaction mixture was diluted with water (20 mL) and extracted with EtOAc (2*20 mL). The combined organic extracts were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude material was purified by silica gel column chromatography (eluent: 40% EtOAc/hexane) to afford 1-cyclopropyl-2-(pyrimidin-5-yl)-6-(trifluoromethoxy)-1H-benzo[d]imidazole Ex. 42 (50 mg, 0.15 mmol, 37%) as an off-white solid. ?H NMR (500 MHz, DMSO-d5): oe 9.40 (s, 2H), 9.35 (s, 1H), 7.84 (d, J=8.7 Hz, 1H), 7.69 (s, 1H), 7.28 (d, J=8.7 Hz, 1H), 3.91-3.88 (m, 1H), 1.20-1.09 (m, 2H), 0.79-0.66 (m, 2H). EC-MS: m/z 320.9 [M+H] at 2.69 RT (97.87% purity). HPEC: 97.48%.",1,,,,,6,20,,,Inert atmosphere,,,,,,Paragraph 0696; 0697; 0698; 0699; 0700,,1-cyclopropyl-2-(pyrimidin-5-yl)-6-(trifluoromethoxy)-1H-benzo[d]imidazole,50 mg,,,,Oxone,,"water; N,N-dimethyl-formamide","Patent; Viamet Pharmaceuticals (NC), Inc.; Sparks, Steven; Yates, Christopher M.; Shaver, Sammy R.; (93 pag.)US2018/186773; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74451393&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48463691,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48463691&database=RX&origin=ReaxysOutput&ln=,(54 of 327),1,82,full reaction; has preparation,"N1?cyclopropyl?4,5?difluorobenzene?1,2?diamine; pyrimidine-5-carbaldehyde","1-cyclopropyl-5,6-difluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole",150523,NC1=CC(F)=C(F)C=C1NC1CC1.O=CC1=CN=CN=C1>>FC1=C(F)C=C2N(C3CC3)C(=NC2=C1)C1=CN=CN=C1,Preparation,7,"1-Cyclopropyl-5,6-difluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole (Ex. 7)","To a stirred solution of N1-cyclopropyl-4,5-difluorobenzene-1,2-diamine Int-6 (200 mg, crude) in DMF (2 mL) under an inert atmosphere was added oxone (198 mg, 1.3 mmol), pyrimidine-5-carbaldehyde (129 mg, 1.19 mmol) and water (0.2 mL) at room temperature. The reaction mixture was stirred at room temperature for 24 h. After consumption of starting material (by TLC), the reaction mixture was diluted with ice cold water (20 mL) and extracted with EtOAc (2*20 mL). The combined organic extracts were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude material was purified by silica gel column chromatography (eluent: 50% EtOAc/hexane) to afford 1-cyclopropyl-5,6-difluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole Ex. 7 (25 mg, 0.09 mmol, 5%) as an off white solid. ?H NMR (400 MHz, CD3OD): oe 9.38 (s, 2H), 9.31 (s, 1H), 7.69 (dd, J=10.2, 7.2 Hz, 1H), 7.59 (dd, J=10.4, 7.3 Hz, 1H), 3.84-3.78 (m, 1H), 1.26-1.20 (m, 2H), 0.84-0.79 (m, 2H). EC-MS: m/z 273.3 [M+H] at 3.63 RT (98.80%purity). HPEC: 98.42%.",1,,,,,24,20,,,Inert atmosphere,,,,,,Paragraph 0455; 0456; 0457; 0458; 0459,,"1-cyclopropyl-5,6-difluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole",25 mg,,,,Oxone,,"water; N,N-dimethyl-formamide","Patent; Viamet Pharmaceuticals (NC), Inc.; Sparks, Steven; Yates, Christopher M.; Shaver, Sammy R.; (93 pag.)US2018/186773; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74451393&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48463782,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48463782&database=RX&origin=ReaxysOutput&ln=,(55 of 327),1,82,full reaction; has preparation,"N1-cyclopropyl-5,6-difluorobenzene-1,2-diamine; pyrimidine-5-carbaldehyde","1-cyclopropyl-6,7-difluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole",150523,NC1=CC=C(F)C(F)=C1NC1CC1.O=CC1=CN=CN=C1>>FC1=CC=C2N=C(N(C3CC3)C2=C1F)C1=CN=CN=C1,Preparation,2,"1-Cyclopropyl-6,7-difluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole (Ex. 2)","To a stirred solution of N1-cyclopropyl-5,6-difluorobenzene-1,2-diamine Int-2 (200 mg, 1.09 mmol) in DMF (2 mL) under an inert atmosphere was added pyrimidine-5-carbaldehyde (129 mg, 1.19 mmol), oxone (198 mg, 1.3 mmol), and water (0.2 mL) at room temperature. The reaction mixture was stirred at room temperature for 3 h. After consumption of starting material (by TLC), the reaction mixture was quenched with water (20 mL) and stirred for 10 min. The precipitated solid was filtered, washed with n-hexane (2*7 mL) and dried under vacuum to afford 1-cyclopropyl-6,7-difluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole Ex. 2 (90 mg, 0.33 mmol, 30%) as a white solid. ?H NMR (400 MHz, DMSO-d5): oe 9.38 (s, 2H),9.36 (s, 1H), 7.60-7.55 (m, 1H), 7.39-7.30 (m, 1H), 4.11-4.03 (m, 1H), 1.13-1.06 (m, 2H), 0.85-0.79 (m, 2H). EC-MS: m/z 272.9 [M+H] at 2.75 RT (97.90%purity). HPEC: 99.01%.",1,,,,,3,20,,,Inert atmosphere,,,,,,Paragraph 0423; 0424; 0425; 0426; 0427,,"1-cyclopropyl-6,7-difluoro-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole",90 mg,,,,Oxone,,"water; N,N-dimethyl-formamide","Patent; Viamet Pharmaceuticals (NC), Inc.; Sparks, Steven; Yates, Christopher M.; Shaver, Sammy R.; (93 pag.)US2018/186773; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74451393&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48463785,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48463785&database=RX&origin=ReaxysOutput&ln=,(56 of 327),1,82,full reaction; has preparation,"5-Chloro-N1-cyclopropylbenzene-1,2-diamine; pyrimidine-5-carbaldehyde",6-chloro-1-cyclopropyl-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole,150523,NC1=C(NC2CC2)C=C(Cl)C=C1.O=CC1=CN=CN=C1>>ClC1=CC=C2N=C(N(C3CC3)C2=C1)C1=CN=CN=C1,Preparation,23,6-Chloro-1-cyclopropyl-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole (Ex. 23),"To a stirred solution of 5-chloro-N1-cyclopropylbenzene-1,2-diamine Int-7 (100 mg, 0.54 mmol) in DMF (3 mL) and water (0.3 mL) under an inert atmosphere was added pyrimidine-5-carbaldehyde (72 mg, 0.66 mmol) and oxone (167 mg, 1.09 mmol) at room temperature. The reaction mixture was stirred at room temperature for 2 h. After consumption of starting material (by TLC), the reaction mixture was diluted with water (20 mL) which afforded a solid that was filtered and dried under reduced pressure. The crude material was purified by silica gel column chromatography (eluent: 2% MeOH/CH2Cl2) to afford 6-chloro-1-cyclopropyl-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole Ex. 23 (50 mg, 0.18 mmol, 38%) as brown solid. ?H NMR (400 MHz, DMSO-d5): oe 9.41 (s, 2H),9.35 (s, 1H), 7.78-7.76 (m, 1H), 7.75 (s, 1H), 7.32 (dd, J=8.5, 2.0 Hz, 1H), 3.90-3.85 (m, 1H), 1.20-1.11 (m, 2H), 0.78-0.71 (m, 2H) EC-MS: mlz 271.2 [M+H] at 3.85 RT (99.76% purity). HPEC: 99.61%",1,,,,,2,20,,,Inert atmosphere,,,,,,Paragraph 0569; 0570; 0571; 0572; 0573,,6-chloro-1-cyclopropyl-2-(pyrimidin-5-yl)-1H-benzo[d]imidazole,50 mg,,,,Oxone,,"water; N,N-dimethyl-formamide","Patent; Viamet Pharmaceuticals (NC), Inc.; Sparks, Steven; Yates, Christopher M.; Shaver, Sammy R.; (93 pag.)US2018/186773; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74451393&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
50304600,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=50304600&database=RX&origin=ReaxysOutput&ln=,(57 of 327),1,82,full reaction; has preparation,C16H15N3OS; pyrimidine-5-carbaldehyde,C26H23N7OS,207073,COC1=CC=C(C=C1)C1=CN=C(S1)C1=NC(CN)=CC=C1.O=CC1=CN=CN=C1.O=CC1=CN=CN=C1>>COC1=CC=C(C=C1)C1=CN=C(S1)C1=NC(CN(CC2=CN=CN=C2)CC2=CN=CN=C2)=CC=C1,Preparation,2,Chromis-2-ctrl (4a).,"To a 10-mL round-bottom flask containing crude amine 21 (1 eq., 0.834 mmol, 248 mg) was added 5-formylpyrimidine (2.1 eq., 1.75 mmol, 189 mg), Na(OAc)3BH (2.5 eq., 2.09 mmol, 442 mg) and a stir bar. The flask was sealed with a rubber septum, evacuated under high vacuum, and backfilled with argon. The contents were suspended in anhydrous 1 ,2-dichloroethane (5 mL), and the reaction was stirred vigorously at room temperature overnight. The reaction mixture was quenched with 1 M disodium citrate (1 mL) for ~ 15 minutes, followed by extraction with dichloromethane (3 x 10 mL). The combined organic layers were dried over Na2S04, filtered, and concentrated to an amber-colored oil. The oily residue was purified by column chromatography (silica gel) using 7:3 acetone:DCM as the eluent. The pure column product (pale yellow oil) was crystallized by the addition of MTBE, followed by recrystallization from boiling MTBExyclohexane to afford 4a as an off-white solid. Yield: 54 mg (0.112 mmol, 13%).  FontWeight=""Bold"" FontSize=""10"" H NMR (CDCb, 400 MHz) delta 3.82 (s, 4H), 3.84 (s, 2H), 3.86 (s, 3H), 6.97 (d, J= 8.8 Hz, 2H), 7.30 (dd, J= 7.7, 0.8 Hz, 1H), 7.60 (d, J= 8.8 Hz, 2H), 7.79 (t, J = 7.8 Hz, 1H), 7.99 (s, 1H), 8.09 (dd, J= 7.8, 0.8 Hz, 1H), 8.82 (s, 4H), 9.17 (s, 2H). 13C NMR (CDCb, 100 MHz) delta 53.1, 55.4, 58.1, 114.6, 118.1, 123.5, 124.0, 128.1, 131.7, 137.7, 138.7, 141.8, 151.3, 157.6, 158.1, 160.0, 166.8. EI-MS m/z 481 ([M]+, 3%), 282 (100%,). EI- HRMS m/z calc'd for C26H23N7OS 481.1685, found 481.1676.",1,,,,,,20,,,Sealed tube; Inert atmosphere,,,,,,Paragraph 0129,,C26H23N7OS,54 mg,,,,sodium tris(acetoxy)borohydride,,"1,2-dichloro-ethane","Patent; GEORGIA TECH RESEARCH CORPORATION; FAHRNI, Christoph J.; MCCALLUM, Adam M.; MORGAN, Michael Thomas; (109 pag.)WO2018/231843; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=75711774&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
51505618,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=51505618&database=RX&origin=ReaxysOutput&ln=,(58 of 327),1,82,full reaction; has preparation,"pyrimidine-5-carbaldehyde; N,N'-Dibenzylethylenediamine","1,3-dibenzyl-2-(5-pyrimidinyl)imidazolidine",227615,O=CC1=CN=CN=C1.C(CNCC1=CC=CC=C1)NCC1=CC=CC=C1>>C(N1CCN(CC2=CC=CC=C2)C1C1=CN=CN=C1)C1=CC=CC=C1,Preparation,,"3.5.2. General Procedure for the Preparation of 1,3-Dibenzyl-2-aryl Imidazolidine 4c-4r","General procedure: The corresponding aldehydes (1.0 mmol) were added to a solution of N,N'-dibenzyl ethylenediamine (480 mg, 2.0 mmol) in aqueous ethanol (50%, 3 mL). The reaction mixture was stirred at room temperature until the complete consumption of aldehydes, as determined by thin layer chromatography (TLC). The mixture was ltered and the lter cake was washed with a small amount of water and cold ethanol to aord the pure product.",1,,,,,,20,,,,,,,,Experimental part,supporting information,,"1,3-dibenzyl-2-(5-pyrimidinyl)imidazolidine",7 percent,7,,,,,ethanol; water,"Article; Liu, Yajun; Liu, Xiaoxia; Li, Lihong; Dai, Rui; Shi, Meiyun; Xue, Hongyu; Liu, Yong; Wang, Hecheng; Molecules; vol. 24; 11; (2019);",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=76942247&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
52047802,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=52047802&database=RX&origin=ReaxysOutput&ln=,(59 of 327),1,82,full reaction; has preparation,"pyrimidine-5-carbaldehyde; 2-[(4-methoxyphenyl)methyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane",2-(4-methoxyphenyl)-1-(pyrimidin-5-yl)ethan-1-ol,215473,O=CC1=CN=CN=C1.COC1=CC=C(CB2OC(C)(C)C(C)(C)O2)C=C1>>COC1=CC=C(CC(O)C2=CN=CN=C2)C=C1,Preparation,,,,1,,,,,8,30 - 35,,,Inert atmosphere; Irradiation,,,,,Experimental part,supporting information,,2-(4-methoxyphenyl)-1-(pyrimidin-5-yl)ethan-1-ol,76 percent,76,,,"3-hydroxyquinuclidine; [4,4?-bis(1,1-dimethylethyl)-2,2?-bipyridine-N1,N1?]bis [3,5-difluoro-2-[5-(trifluoromethyl)-2-pyridinyl-N]phenyl-C]iridium(III) hexafluorophosphate",,methanol; acetone,"Article; Chen, Yiding; May, Oliver; Blakemore, David C.; Ley, Steven V.; Organic Letters; vol. 21; 15; (2019); p. 6140 - 6144;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=77552498&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
52133462,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=52133462&database=RX&origin=ReaxysOutput&ln=,(60 of 327),1,82,full reaction; has preparation,2-aminopyridine; pyrimidine-5-carbaldehyde,sodium (2-pyridylamino)pyrimidin-5-ylmethanesulfonate,225423,NC1=NC=CC=C1.O=CC1=CN=CN=C1>>[Na+].[O-]S(=O)(=O)C(NC1=NC=CC=C1)C1=CN=CN=C1,Preparation,1.A,Step A: Preparation of sodium (2-pyridylamino)-pyrimidin-5-yl-methanesulfonate,"To a 2 L round bottomed flask were added 687.7 g of a 2.52 wt% solution of 5- pyrimidinecarboxaldehyde in methanol (17.3 g, 0.16 mole contained 5-pyrimidine- carboxaldehyde), 108.4 g of a 17 wt% solution of sodium bisulfite in water (18.4 g, 0.176 mol contained sodium bisulfite), and 18.1 g of a 99 wt% of 2-aminopyridine (0.192 mole). The reaction mixture was then concentrated under the reduced pressure (110-200 mmHg) via rotary evaporator at 50 C bath temperature until most of methanol was distilled off. The resulting suspension was transferred to a 200 mL jacketed resin kettle equipped with an overhead stirrer, a thermocouple, and a recirculating heating. The flask was rinsed with 30 mL of water, which was then combined with the reaction mixture. The resulting suspension was heated to 60 C for 2 hours. HPLC analysis of the reaction mixture indicated 70-75 area % sodium (2-pyridylamino)-pyrimidin-5-yl-methanesulfonate. The product separated as a gum. A small sample of this was removed and analyzed by NMR. ' H NMR (400 MHz, DMSO-ifc) d 9.02 (s, 1H), 8.87 (s, 2H), 7.92 (m, 1H), 7.52 (b, 1H), 7.44 (m, 1H), 6.87 (d, J = 8.5 Hz, 1H), 6.54 (m, 1H), 5.92 (d, / = 9.2 Hz, 1H).",1,,,,,2,60,,,,,,Temperature,,,Page/Page column 37-38; 40-41,,,,,,,sodium hydrogensulfite,,methanol; water,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; DUMAS, Donald J.; HONG, Junbae; (65 pag.)WO2019/173173; (2019); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=77794972&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36360505,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36360505&database=RX&origin=ReaxysOutput&ln=,(61 of 327),1,81,full reaction; has preparation,"(-)-2-((3,4-trans)-4-methylpyrrolidin-3-yl)-7-(tetrahydro-2H-pyran-4-yl)imidazo[5,1-f][1,2,4]triazin-4(3H)-one; pyrimidine-5-carbaldehyde","(+)-2-((3,4-trans)-4-methyl-1-(pyrimidin-5-ylmethyl)pyrrolidin-3-yl)-7-(tetrahydro-2H-pyran-4-yl)imidazo[5,1-f][1,2,4]triazin-4(3H)-one",228605,C[C@@H]1CNC[C@H]1C1=NN2C(=NC=C2C(=O)N1)C1CCOCC1.O=CC1=CN=CN=C1>>C[C@@H]1CN(CC2=CN=CN=C2)C[C@H]1C1=NN2C(=CN=C2C2CCOCC2)C(=O)N1,Preparation,B.110,"110. f+)-2-f(3.,4-trans)-4-methyl-l-fpyrimi(iin-5-ylmethyl)pyrroli(iin-3-yl)- 7-ftetrahvdro-2H-pyran-4-yl)imidazo[5,l- 1 [l,2,41triazin-4f3H -one","110. f+)-2-f(3.,4-trans)-4-methyl-l-fpyrimi(iin-5-ylmethyl)pyrroli(iin-3-yl)- 7-ftetrahvdro-2H-pyran-4-yl)imidazo[5,l- 1 [l,2,41triazin-4f3H -one [1069] To a stirred solution of (-)-2-((3,4-trans)-4-methylpyrrolidin-3-yl)-7- (tetrahydro-2H-pyran-4-yl)imidazo[5,l- J[l,2,4]triazin-4(3H)-one (100 mg, 0.33 mmol) in MeOH (10 mL) was added pyrimidine-5-carbaldehyde (46.3 mg, 0.42 mmol) at RT under argon atmosphere. After being stirred for 2 h, NaCNBH3 (62.3 mg, 0.99 mmol) was added to the reaction mixture and stirring was continued for another 5 h at RT. The volatiles were evaporated under reduced pressure. The residue was diluted with ice-cold water and extracted with DCM (2 x 20 mL). Combined organic layer was dried over sodium sulphate, filtered and concentrated in vacuo to obtain the crude product. The crude material was purified by silica gel column chromatography to afford (+)-2-((3,4-trans)-4-methyl-l-(pyrimidin-5- ylmethyl)pyrrolidin-3 -yl)-7-(tetrahydro-2H-pyran-4-yl)imidazo [5 , 1 -f [ 1 ,2,4]triazin- 4(3H)-one (35 mg, 27%) as an off-white solid. 1H-NMR (DMSO d6, 500 MHz): delta 9.15 (s, 1H), 8.72 (s, 2H), 7.63 (s, 1H), 3.96-3.95 (m, 2H), 3.78-3.76 (m, 1H), 3.67- 3.62 (m, 2H), 3.57-3.54 (m, 2H), 3.51-3.47 (m, 1H), 2.97-2.92 (m, 2H), 2.85-2.80 (m, 1H), 2.68-2.64 (m, 1H), 2.31-2.24 (m, 1H), 1.89-1.81 (m, 4H), 1.08 (d, 3H); Mass (ESI): 396.5 [M++l] LC-MS: 98.58%; 396.4 (M++l); (column; X-bridge C-18, (50x3.0 mm, 3.5mu); RT 3.21 min. 0.05% TFA in water: ACN; 0.8 ml/min); UPLC (purity): 95%; (column; Acquity HSS T3, (2.1 100 mm, 1.8mu); RT 2.80 min. 0.025% TFA (Aq): ACN; 0.3 ml/min; Chiral HPLC: 98.27%, R,= 9.35 min (Chiralpak IA, 250 x 4.6mm, 5mu; mobile phase (A) 0.1% DEA in n-Hexane (B) Ethanol (A: B : 60:40); flow Rate: 1.00 mL/min); Optical rotation [a]D2: +5.15 (c = 0.25, DCM). TLC: 5% MeOH/DCM (Rf: 0.4).",1,,,2,,2; 5,20; 20,,,Inert atmosphere; Inert atmosphere,,,,,,Paragraph 1069,,"(+)-2-((3,4-trans)-4-methyl-1-(pyrimidin-5-ylmethyl)pyrrolidin-3-yl)-7-(tetrahydro-2H-pyran-4-yl)imidazo[5,1-f][1,2,4]triazin-4(3H)-one",27 percent,27,,"(-)-2-((3,4-trans)-4-methylpyrrolidin-3-yl)-7-(tetrahydro-2H-pyran-4-yl)imidazo[5,1-f][1,2,4]triazin-4(3H)-one; pyrimidine-5-carbaldehyde",methanol; sodium cyanoborohydride,,,"Patent; ENVIVO PHARMACEUTICALS, INC.; RIPKA, Amy; SHAPIRO, Gideon; MCRINER, Andrew, J.; BURSAVICH, Matthew, Gregory; WO2013/142269; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=61423979&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
29980584,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=29980584&database=RX&origin=ReaxysOutput&ln=,(62 of 327),1,80,full reaction; has preparation,3-Bromopyridine; 5-bromopyrimidine; sodium carbonate; formic acid ethyl ester,pyrimidine-5-carbaldehyde,46949,BrC1=CN=CC=C1.BrC1=CN=CN=C1.[Na+].[O-]C([O-])=O.CCOC=O>>O=CC1=CN=CN=C1,Preparation,15.1,1),"1) Preparation of pyrimidine-5-carbaldehyde A solution of 5-bromo-pyrimidine (5 g, 31.4 mmol, 1.0 eq.) in anhydrous THF (300 mL) was placed under an argon atmosphere in a three-necked round bottom flask equipped with a low-temperature thermometer. The mixture was cooled to -100C in a EtOH/N2(1) bath. To the solution of 5-bromopyridine was added a solution of n-BuLi in hexane (20 mL, 1.6 M, 32.5 mmol, 1.0 eq.). The resulting mixture was stirred for 20 minutes at 100C and the organolithium that formed was trapped with a solution of ethyl formate (2.7 mL, 33.5 mmol, 1.1 eq.) in THF (10 mL). The reaction was stirred for another 20 minutes at 100C and quenched with a solution of hydrochloric acid in ether (17 mL, 2M, 34 mmol). Then, the cold bath was removed and the mixture stirred at room temperature for 1 hour. The solution was concentrated under reduced pressure, and then treated with water and saturated aqueous sodium carbonate (10 mL). The mixture was extracted with dichloromethane and the organic layer was dried over MgSO4. The solvent was removed under reduced pressure and the residue purified by silica gel flash-column chromatography (eluent: CH2Cl2/AcOEt, 60:40 to 50:50) to afford pyrimidine-5-carbaldehyde as beige crystals (1.2 g, 35%).",1,,,,,,,,,,,,,,,,,pyrimidine-5-carbaldehyde,35percent,35,,,hydrogenchloride; n-butyllithium,,tetrahydrofuran; hexane; water,Patent; Centre National de la Recherche Scientifique; EP2266562; (2010); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8966582&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
37750166,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=37750166&database=RX&origin=ReaxysOutput&ln=,(63 of 327),1,80,full reaction; has preparation,pyrimidine-5-carbaldehyde; MFCD 03791187,C12H8N4O,152561,O=CC1=CN=CN=C1.NC1=CC2=C(C=C1)N=CO2>>O1C=NC2=CC=C(C=C12)N=CC1=CN=CN=C1,Preparation,,,"General procedure: A mixture of the appropriate amine (1M-3M, 2 mmol) and the appropriate aldehyde (2.2 mmol) in ethanol (10 mL) was stirred at room temperature for 8 h.",1,,,,,8,20,,,,,,,,Experimental part,,,,,,,,,,ethanol,"Article; Zhang, Da-Jun; Sun, Wen-Fang; Zhong, Zhao-Jin; Gao, Rong-Mei; Yi, Hong; Li, Yu-Huan; Peng, Zong-Gen; Li, Zhuo-Rong; Molecules; vol. 19; 1; (2014); p. 925 - 939;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=62544191&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
37750233,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=37750233&database=RX&origin=ReaxysOutput&ln=,(64 of 327),1,80,full reaction; has preparation,"1,3-benzothiazol-6-amine; pyrimidine-5-carbaldehyde",C12H8N4S,152561,NC1=CC2=C(C=C1)N=CS2.O=CC1=CN=CN=C1>>S1C=NC2=CC=C(C=C12)N=CC1=CN=CN=C1,Preparation,,,"General procedure: A mixture of the appropriate amine (1M-3M, 2 mmol) and the appropriate aldehyde (2.2 mmol) in ethanol (10 mL) was stirred at room temperature for 8 h.",1,,,,,8,20,,,,,,,,Experimental part,,,,,,,,,,ethanol,"Article; Zhang, Da-Jun; Sun, Wen-Fang; Zhong, Zhao-Jin; Gao, Rong-Mei; Yi, Hong; Li, Yu-Huan; Peng, Zong-Gen; Li, Zhuo-Rong; Molecules; vol. 19; 1; (2014); p. 925 - 939;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=62544191&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8570487,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8570487&database=RX&origin=ReaxysOutput&ln=,(65 of 327),2,79,full reaction; has preparation,potassium cyanide; pyrimidine-5-carbaldehyde,hydroxy(pyrimidin-5-yl)acetonitrile,214940,[K]C#N.O=CC1=CN=CN=C1>>OC(C#N)C1=CN=CN=C1,Preparation,,,,1,,,,,,5 - 20,,,,Addition,,,,,,,hydroxy(pyrimidin-5-yl)acetonitrile,67 percent,67,,,,,water; acetic acid,"Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8570487,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8570487&database=RX&origin=ReaxysOutput&ln=,(65 of 327),2,79,full reaction; has preparation,potassium cyanide; pyrimidine-5-carbaldehyde,hydroxy(pyrimidin-5-yl)acetonitrile,214940,[K]C#N.O=CC1=CN=CN=C1>>OC(C#N)C1=CN=CN=C1,Preparation,,,,1,,,2,,2,5 - 10; 20,,,,,,,,,,,hydroxy(pyrimidin-5-yl)acetonitrile,67 percent,67,,potassium cyanide; pyrimidine-5-carbaldehyde,acetic acid,,water; water,"Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
28925695,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=28925695&database=RX&origin=ReaxysOutput&ln=,(66 of 327),1,79,full reaction; has preparation,3-Hydroxy-3-methyl-2-butanone; pyrimidine-5-carbaldehyde,(E)-4-hydroxy-4-methyl-1-(pyrimidin-5-yl)pent-1-en-3-one,163593,CC(=O)C(C)(C)O.O=CC1=CN=CN=C1>>CC(C)(O)C(=O)\C=C\C1=CN=CN=C1,Preparation,,,,1,,,,,,20,,,,Aldol condensation,,,,,supporting information; experimental part,,(E)-4-hydroxy-4-methyl-1-(pyrimidin-5-yl)pent-1-en-3-one,12 percent,12,,,water,,tetrahydrofuran; water,"Article; Chiang, Pei-Chen; Rommel, Michael; Bode, Jeffrey W.; Journal of the American Chemical Society; vol. 131; (2009); p. 8714 - 8718;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8780996&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
29980595,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=29980595&database=RX&origin=ReaxysOutput&ln=,(67 of 327),1,79,full reaction; has preparation,indole-3-acetonitrile; sodium ethanolate; pyrimidine-5-carbaldehyde,(Z)-2-(1H-indol-3-yl)-3-pyrimidin-5-yl-acrylonitrile,163467,N#CCC1=CNC2=C1C=CC=C2.[Na+].CC[O-].O=CC1=CN=CN=C1>>N#CC(=C/C1=CN=CN=C1)\C1=CNC2=C1C=CC=C2,Preparation,15.2,2),"2) Preparation of (Z)-2-(1H-indol-3-yl)-3-pyrimidin-5-yl-acrylonitrile To a solution of sodium ethanolate [prepared from sodium (53 mg, 2.3 mmol, 1.8 eq.) and anhydrous ethanol (10 mL)] were added, under an argon atmosphere, (1H-indol-3-yl)-acetonitrile (200 mg, 1.3 mmol, 1.0 eq.) and, after 10 minutes stirring, pyrimidine-5-carbaldehyde (207 mg, 1.9 mmol, 1.5 eq.). The reaction apparatus was protected from light and the mixture stirred at room temperature for 40 hours. The solvent was removed under reduced pressure, and the crude purified by silica gel flash-column chromatography (eluent: CH2Cl2/MeOH, 1:99 to 2:98). The residue was triturated with diethyl ether to afford the compound (15) as a yellow powder (65 mg, 21%). 1H NMR (DMSO, 500 MHz): delta (ppm): 7.22 (1H, t, J5'-6' = J5'-4' = 7.9 Hz, H5'), 7.27 (1H, t, J6'-5' = J6'-7' = 7.9 Hz, H6'), 7.53 (1H, d, J7'-6'= 7.9 Hz, H7'), 7.81 (1H, s, H3), 7.88 (1H, s, H2'), 8.13 (1H, d, J4'-5' = 7.9 Hz, H4'), 9.19 (1H, s, H2'), 9.25 (1H, s, H4' and H6'), 11.87 (1H, s, indolic H); 13C NMR (DMSO, 75.5 MHz): delta (ppm): 113.9 and 114.3 (C2 and C3'), 116.5 (C7'), 121.6 (C1), 123.6 (C4'), 124.8 (C5'), 126.7 (C6'), 127.3 (C3a'), 131.9 (C2'), 132.3 (C3), 133.3 (C5''), 141.2 (C7a'), 159.8 (C4' and C6'), 161.4 (C2'); TLC: Rf= 0.47 (CH2Cl2 96/MeOH 4); MS: ESI: m/z: 245.0 ([M-H]-); HRMS (ESI): calcd for C15H9N4: m/z = 245.0827, found: 245.0818; IR numax (cm-1): 2219 (nu CN); Mp 231 C.",1,,,,,,,,,,,,,,,,,(Z)-2-(1H-indol-3-yl)-3-pyrimidin-5-yl-acrylonitrile,21percent,21,,,sodium,,ethanol,Patent; Centre National de la Recherche Scientifique; EP2266562; (2010); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8966582&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
40032707,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=40032707&database=RX&origin=ReaxysOutput&ln=,(68 of 327),2,79,full reaction; has preparation,6-bromo-4-hydroxyquinoline-2(1H)-one; pyrimidine-5-carbaldehyde,6-bromo-4-hydroxy-3-(pyrimidin-5-ylmethyl)quinolin-2(1H)-one,228858,OC1=CC(=O)NC2=C1C=C(Br)C=C2.O=CC1=CN=CN=C1>>OC1=C(CC2=CN=CN=C2)C(=O)NC2=C1C=C(Br)C=C2,Preparation,49.a,6-Bromo-4-hydroxy-3-(pyrimidin-5-ylmethyl)quinolin-2(1H)-one,"To a dark solution of 6-bromo-4-hydroxyquinolin-2(1H)-one (3.92 g, 16.31 mmol, Intermediate 45: step a) and pyrimidine-5-carbaldehyde (1.94 g, 17.95 mmol) in pyridine (29 mL) was added diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate (4.13 g, 16.31 mol). The resulting mixture was warmed with stirring in a 100 C. oil bath for a period of 5 hours. After cooling to room temperature, the mixture was diluted with ethanol. The tan precipitate was isolated by filtration, rinsing further with EtOH then acetonitrile and dried to provide the title compound that was carried to the next step without further purification.",1,,,,,5,100,,,,,,,,,Paragraph 0435; 0436,,,,,,,"pyridine; diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate",,,"Patent; Janssen Pharmaceutica NV; Leonard, Kristi A.; Barbay, Kent; Edwards, James P.; Kreutter, Kevin D.; Kummer, David A.; Maharoof, Umar; Nishimura, Rachel; Urbanski, Maud; Venkatesan, Hariharan; Wang, Aihua; Wolin, Ronald L.; Woods, Craig R.; Fourie, Anne; Xue, Xiaohua; Cummings, Maxwell D.; Jones, William Moore; Goldberg, Steven; US2015/105366; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=65935854&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
40032707,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=40032707&database=RX&origin=ReaxysOutput&ln=,(68 of 327),2,79,full reaction; has preparation,6-bromo-4-hydroxyquinoline-2(1H)-one; pyrimidine-5-carbaldehyde,6-bromo-4-hydroxy-3-(pyrimidin-5-ylmethyl)quinolin-2(1H)-one,228858,OC1=CC(=O)NC2=C1C=C(Br)C=C2.O=CC1=CN=CN=C1>>OC1=C(CC2=CN=CN=C2)C(=O)NC2=C1C=C(Br)C=C2,Preparation,49.a,Intermediate 49: step a 6-bromo-4-hydroxy-3-(pyrimidin-5-ylmethyl)quinolin-2(1H)-one,"Intermediate 49: step a 6-bromo-4-hydroxy-3-(pyrimidin-5-ylmethyl)quinolin-2(1H)-one To a dark solution of 6-brom.o-4-hydroxyqumolin-2(l H)-one (3,92 g, 16,31 mmol, Intermediate 45: step a) and pyrimidine-5-carbaldehyde (1.94 g, 17.95 mmol) in pyridine (29 mL) was added diethyl 2,6-dimethyl-l ,4-dihydropyridine-3,5-dicarboxylate (4.13 g, 16.31 mol). The resulting mixture was warmed with stirring in a 100 C oil bath for a period of 5 hours. After cooling to room temperature, the mixture was diluted with ethanol. The tan precipitate was isolated by filtration, rinsing further with EtOH then acetonitrile and dried to provide the title compound that was carried to the next step without further purification.",1,,,,,5,,,,,,,,,,Page/Page column 121,,,,,,,"diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate",,pyridine,"Patent; JANSSEN PHARMACEUTICA NV; LEONARD, Kristi A.; BARBAY, Kent; EDWARDS, James P.; KREUTTER, Kevin D.; KUMMER, David A.; MAHAROOF, Umar; NISHIMURA, Rachel; URBANSKI, Maud; VENKATESAN, Hariharan; WANG, Aihua; WOLIN, Ronald L.; WOODS, Craig R.; FOURIE, Anne; XUE, Xiaohua; CUMMINGS, Maxwell D.; JONES, William Moore; GOLDBERG, Steven; WO2015/57205; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=66108177&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
25043147,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=25043147&database=RX&origin=ReaxysOutput&ln=,(69 of 327),1,78,full reaction; has preparation,pyrimidine-5-carbaldehyde,N-(5-pyrimidinylmethyl)ethylenediamine,228706,O=CC1=CN=CN=C1>>NCCNCC1=CN=CN=C1,Preparation,42,Example 42,"STR676 Ethylenediamine (60 g) was dissolved in benzene (200 ml), and 5-formylpyrimidine (21.6 g) was added at room temperature. Subsequently, the mixture was heated, and refluxed for 3 hours while removing water as an azeotrope. After the reaction, benzene and the excess of ethylenediamine were distilled off under reduced pressure. The residue was dissolved in ethanol (200 ml). Sodium borohydride (8.4 g) was added portionwise to this solution at room temperature, and subsequently the mixture was stirred at room temperature for 5 hours. Ethanol was distilled off under reduced pressure. Dichloromethane (100 ml) was added to the residue, and a dichloromethane-soluble portion was separated. Dichloromethane was distilled off from the dichloromethane layer under reduced pressure to give N-(5-pyrimidinylmethyl)ethylenediamine (25.8 g) as a colorless oil. nD25 =1.5532.",1,,,,,,,,,,,,,,,,,,,,,,sodium borohydrid; ethylenediamine,,ethanol; dichloromethane; benzene,Patent; Nihon Tokushu Noyaku Seizo K. K.; US4742060; (1988); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=417504&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9666689,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9666689&database=RX&origin=ReaxysOutput&ln=,(70 of 327),1,77,full reaction; has preparation,"pyrimidine-5-carbaldehyde; 2-oxo-6-(5,6,7,8-tetrahydro-[1,8]-naphthyridin-2-yl)-hexyl-phosphonic acid dimethyl ester","1-pyrimidin-5-yl-7-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)hept-1-en-3-one",169252,O=CC1=CN=CN=C1.COP(=O)(CC(=O)CCCCC1=NC2=C(CCCN2)C=C1)OC>>O=C(CCCCC1=NC2=C(CCCN2)C=C1)\C=C\C1=CN=CN=C1,Preparation,,,,1,,,,,1,,,,Heating,Horner-Wadsworth-Emmons reaction,,,,,,,"1-pyrimidin-5-yl-7-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)hept-1-en-3-one",78 percent,78,,,potassium carbonate,,tetrahydrofuran,"Article; Coleman, Paul J; Brashear, Karen M; Askew, Ben C; Hutchinson, John H; McVean, Carol A; Duong; Feuston, Bradley P; Fernandez-Metzler, Carmen; Gentile, Michael A; Hartman, George D; Kimmel, Donald B; Leu, Chih-Tai; Lipfert, Lorraine; Merkle, Kara; Pennypacker, Brenda; Prueksaritanont, Thomayant; Rodan, Gideon A; Wesolowski, Gregg A; Rodan, Sevgi B; Duggan, Mark E; Journal of medicinal chemistry; vol. 47; 20; (2004); p. 4829 - 4837;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6460747&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
24714931,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=24714931&database=RX&origin=ReaxysOutput&ln=,(71 of 327),1,77,full reaction; has preparation,toluene-4-sulfonic acid; pyrimidine-5-carbaldehyde,"5-(1,3-dioxolan-2-yl)pyrimidine",227439,CC1=CC=C(C=C1)S(O)(=O)=O.O=CC1=CN=CN=C1>>C1COC(O1)C1=CN=CN=C1,Preparation,12,"5-(1,3-dioxolan-2-yl)pyrimidine","Example 12 5-(1,3-dioxolan-2-yl)pyrimidine Pyrimidine-5-carboxaldehyde (1.017 g, 9.41 mmol) was dissolved in benzene (25 ml) with heat in a 100 ml round bottomed flask fitted with a condenser, drying tube and a Dean-stark trap. p-Toluene sulfonic acid (0.179 g, 0.941 mmol) and ethylene glycol (1.1 ml, 18.82 mmol) were added and the mixture refluxed overnight. After cooling to room temperature the excess benzene was evaporated in vacuo. Saturated sodium carbonate (10 ml) was added and extracted with chloroform (7*10 ml). The chloroform extract was dried over magnesium sulfate, filtered and the solvent evaporated in vacuo to give 1.1611 g (81%) yellow oil. TLC on silica gel using chloroform/methanol (9:1) indicated the product and some starting material. Column chromatographic separation on silica gel and the same solvent system gave 0.911 g (64%) yellow oil rf=0.78 which was freeze-dried in a lyophilizer to obtain crystals. 300 MHz nmr indicated product. Microanalysis calc.: C 55.25, H 5 30, N 18.42; found: C 55.12, H 5.22, N 18.24.",1,,,,,,,,,,,,,,,,,"5-(1,3-dioxolan-2-yl)pyrimidine",0.911 g (64percent),,,,sodium carbonate,,methanol; chloroform; ethylene glycol; benzene,Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
24717674,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=24717674&database=RX&origin=ReaxysOutput&ln=,(72 of 327),1,77,full reaction; has preparation,pyrimidine-5-carbaldehyde; 2-hydroxyethanethiol,"5-(1,3-oxathiolan-2-yl)pyrimidine",227294,O=CC1=CN=CN=C1.OCCS>>C1CSC(O1)C1=CN=CN=C1,Preparation,13,"5-(1,3-oxathiolan-2-yl)pyrimidine","Example 13 5-(1,3-oxathiolan-2-yl)pyrimidine Pyrimidine-5-carboxaldehyde (1 g, 9.25 mmol), p-toluene sulfonic acid (0.176 g, 0.95 mmol) and 2-mercaptoethanol (0.65 ml, 9.25 mmol) were all put in a 50 ml round bottomed flask, fitted with a condenser, drying tube and a Dean-stark trap. Toluene (30 ml) was added and the mixture refluxed with stirring overnight, cooled to room temperature and excess toluene evaporated in vacuo. Saturated sodium carbonate 10 ml was added and extracted with chloroform (7*10 ml). The extract was dried over MgSO4, filtered and the solvent evaporated in vacuo to 1.73 g (115%) crude yellow oil. TLC (silica; chloroform/methanol 9.8:0.2) indicated the product and some impurities. Column chromatographic separation on silica gel using the same solvent system gave 0.780 g (52%) yellow oil. 300 MHz nmr indicated pure compound. Microanalysis calc.: C 49.98, H 4.79, N 16.66, S 19.06; found: C 50.02, H 5.04, N 16.48, S 18.91.",1,,,,,,,,,,,,,,,,,"5-(1,3-oxathiolan-2-yl)pyrimidine",0.780 g (52percent),,,,sodium carbonate; toluene-4-sulfonic acid,,toluene,Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
29880421,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=29880421&database=RX&origin=ReaxysOutput&ln=,(73 of 327),1,77,full reaction; has preparation,pyrimidine-5-carbaldehyde; p-aminoethylbenzoate,4-[(pyrimidin-5-ylmethyl)-amino]-benzoic acid ethyl ester,,O=CC1=CN=CN=C1.CCOC(=O)C1=CC=C(N)C=C1>>CCOC(=O)C1=CC=C(NCC2=CN=CN=C2)C=C1,Preparation,26,,"Intermediate 26[00331] Pyrimidine-5-carboxaldehyde (lOOmg, 0.6053mmol, leq.) was dissolved in DCE (2ml) and stirred for lOmin. Ethyl 4-aminobenzoate (130mg, 1.21mmol, 2eq.) and acetic acid (70mul, 1.21mmol, 2eq.) were added and the reaction mixture stirred for Ih. STAB (192mg, 0.9079mmol, 1.5eq.) was added and the reaction stirred for 2h. The reaction was partitioned between saturated aqueous NaHCtheta3 and DCM. The organic layer was dried over a hydrophobic frit, concentrated in vacuo and the residue taken up into heptane/EtOAc (9:1). The resulting bright yellow precipitate was filtered and washed with heptane/EtOAc (9:1) (20ml) to yield the title compound Intermediate 26 (164mg, quantitative). The crude product was taken directly to the next step without purification.",1,,,3,,1; 2,,,,,,,,,,Page/Page column 72,,,,,,pyrimidine-5-carbaldehyde; p-aminoethylbenzoate,acetic acid; sodium tris(acetoxy)borohydride; sodium hydrogencarbonate,,"1,2-dichloro-ethane; 1,2-dichloro-ethane; water; 1,2-dichloro-ethane","Patent; EVOTEC AG; TAYLOR, Steven; HALLETT, David James; TOWNSEND, Robert James; WO2010/130638; (2010); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8940438&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
35624523,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=35624523&database=RX&origin=ReaxysOutput&ln=,(74 of 327),1,77,full reaction; has preparation,"2-(benzo[d][1,3]dioxol-5-yl)pyrimidin-4-amine; pyrimidine-5-carbaldehyde","2-(benzo[d][1,3]dioxol-5-yl)-N-(pyrimidin-5-ylmethyl)pyrimidin-4-amine",228693,NC1=CC=NC(=N1)C1=CC2=C(OCO2)C=C1.O=CC1=CN=CN=C1>>C(NC1=CC=NC(=N1)C1=CC2=C(OCO2)C=C1)C1=CN=CN=C1,Preparation,,,"General procedure: To each reaction tube in a 24-position Bohdan MiniBlock XT was added the appropriate aldehyde (5.0 equiv, 1.15 mmol), which was dissolved in MeCN (1 mL). A solution of 2-(benzo[d][1,3]dioxol-5- yl)pyrimidin-4-amine (8) in MeCN (0.13 M, 1.8 mL, 0.23 mmol, 1.0 equiv) was then dispensed into each tube. ClTi(Oi-Pr)3 (95%, 0.35 mL, 1.38 mmol, 6.0 equiv) was added to each tube, followed by AcOH (3 drops). The reactions were shaken at 450 rpm for 5 minutes, and then solid NaBH(OAc)3 (95%, 257 mg, 1.15 mmol, 5.0 equiv) was added to each tube. The reactions were shaken at 450 rpm for an additional 1.5 hours, and then a solution of 15% aqueous NH4OH (2 mL) and CH2Cl2 (2 mL) were added to each tube causing white solids to precipitate. Shaking was continued for 30 minutes at 450 rpm. Using stackable 24-position Bohdan MiniBlock XTs, the liquid portions of the crude reaction mixtures were passed into phase separators, to which H2O (2 mL) was added. The biphasic mixtures were mixed by hand using pipettes, and then the heavier organic layers were passed from the phase separators into new reaction tubes. The white solids in the original reaction tubes were washed with CH2Cl2 (2 mL) and the washings were passed into the closed phase separators. The biphasic mixtures were again mixed by hand using pipettes and the heavier organic layers were passed into the reaction tubes containing the organic layers from the first separation. The crude reaction mixtures were then placed on a sample concentrator to remove the solvents. TFA/MeOH (1:19, 3 mL) was added to each crude reaction mixture, and the samples were then shaken at 450 rpm for 1 hour. The solutions were then passed onto columns of Dowex 50WX4-400 ion exchange resin (2.0 g, pre-washed with TFA/MeOH (1:99, 5 mL)). Each reaction tube was washed with MeOH (2 mL) and the washings were allowed to pass onto the Dowex columns. The columns were washed with MeOH (3 mL) and the washings discarded. The products were then eluted into collection tubes using a mixture of Et3N/MeOH (1:9, 10 mL). Solvents were removed using a sample concentrator and the products were subjected to reverse-phase preparative HPLC purification.",1,,,2,,0.0833333; 1.5,,,,Combinatorial reaction / High throughput screening (HTS); Combinatorial reaction / High throughput screening (HTS),,,,,Experimental part,supporting information,,,,,,"2-(benzo[d][1,3]dioxol-5-yl)pyrimidin-4-amine; pyrimidine-5-carbaldehyde",triisopropoxytitanium(IV) chloride; acetic acid; sodium tris(acetoxy)borohydride,,acetonitrile; acetonitrile,"Article; Coombs, Thomas C.; Tanega, Cordelle; Shen, Min; Wang, Jenna L.; Auld, Douglas S.; Gerritz, Samuel W.; Schoenen, Frank J.; Thomas, Craig J.; Aube, Jeffrey; Bioorganic and Medicinal Chemistry Letters; vol. 23; 12; (2013); p. 3654 - 3661;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=35496459&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
50275024,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=50275024&database=RX&origin=ReaxysOutput&ln=,(75 of 327),1,77,full reaction; has preparation,diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate; pyrimidine-5-carbaldehyde,(E)-5-(2-((4'-methoxyphenyl)sulfonyl)vinyl)pyrimidine,169252,CCOP(=O)(CS(=O)(=O)C1=CC=C(OC)C=C1)OCC.O=CC1=CN=CN=C1>>COC1=CC=C(C=C1)S(=O)(=O)\C=C\C1=CN=CN=C1,Preparation,,,,1,,,2,,1; 1,-78; -78 - 20,,,,Horner-Wadsworth-Emmons Olefination; Horner-Wadsworth-Emmons Olefination,,,,Experimental part,,,(E)-5-(2-((4'-methoxyphenyl)sulfonyl)vinyl)pyrimidine,86 percent,86,,diethyl (((4-methoxyphenyl)sulfonyl)methyl)phosphonate; pyrimidine-5-carbaldehyde,n-butyllithium,,tetrahydrofuran; cyclohexane; tetrahydrofuran; cyclohexane,"Article; Choi, Ji Won; Kim, Siwon; Park, Jong-Hyun; Kim, Hyeon Jeong; Shin, Su Jeong; Kim, Jin Woo; Woo, Seo Yeon; Lee, Changho; Han, Sang Moon; Lee, Jaeick; Pae, Ae Nim; Han, Gyoonhee; Park, Ki Duk; Journal of Medicinal Chemistry; vol. 62; 2; (2019); p. 811 - 830;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=75723766&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
4480561,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=4480561&database=RX&origin=ReaxysOutput&ln=,(76 of 327),1,76,full reaction; has preparation,diisopropyl zinc; pyrimidine-5-carbaldehyde,(R)-2-Methyl-1-pyrimidin-5-yl-propan-1-ol; (S)-2-methyl-1-(5-pyrimidyl)-1-propanol,217365; 217365,CC(C)[Zn]C(C)C.O=CC1=CN=CN=C1.O=CC1=CN=CN=C1>>CC(C)[C@@H](O)C1=CN=CN=C1.CC(C)[C@H](O)C1=CN=CN=C1,Preparation,,,,1,,,,,40,0,,,,,,,,,,Yield given. Yields of byproduct given. Title compound not separated from byproducts,,,,,,(S)-2-methyl-1-(5-pyrimidyl)-1-propanol,,toluene,"Article; Shibata, Takanori; Morioka, Hiroshi; Hayase, Tadakatsu; Choji, Kaori; Soai, Kenso; Journal of the American Chemical Society; vol. 118; 2; (1996); p. 471 - 472;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6014533&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
24198958,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=24198958&database=RX&origin=ReaxysOutput&ln=,(77 of 327),1,76,full reaction; has preparation,"1-chloro-2,4-pyrrolidinedione; pyrimidine-5-carbaldehyde; N-(4-benzoylphenyl)acrylamide","(+/-)-N-(4-benzoylphenyl)-4,5-dihydro-3-(5-pyrimidinyl)-5-isoxazolecarboxamide",208868,ClN1CC(=O)CC1=O.O=CC1=CN=CN=C1.C=CC(=O)NC1=CC=C(C=C1)C(=O)C1=CC=CC=C1>>O=C(NC1=CC=C(C=C1)C(=O)C1=CC=CC=C1)C1CC(=NO1)C1=CN=CN=C1,Preparation,B.29,EXAMPLE B.29,"EXAMPLE B.29 1-Chloro-2,4-pyrrolidinedione (0.011 mol; 98%) was added portionwise to a solution of 5-pyrimidinecarboxaldehyde, oxime (0.036 mol) in DMF (50 ml) and this mixture was heated to 50 C. to start the reaction. The mixture was cooled to RT. Pyridine (0.28 ml) was added. The rest of 1-chloro-2,4-pyrrolidinedione (0.043 mol) was added portionwise and the mixture was stirred for 3 hours at RT. N-(4-benzoylphenyl)propenamide (0.025 mol) was added. Triethylamine (0.053 mol) was added dropwise and the resulting reaction mixture was stirred overnight at RT. The crude mixture was washed with water, then extracted with EtOAc. The organic layer was separated, and the solvent was evaporated. The residue was washed with water and extracted with CH2Cl2. The separated organic layer was dried (Na2SO4), filtered and the solvent was evaporated. The residue was crystallized from CH3OH, washed with diethyl ether and hot CH2Cl2, dried and repurified by HPLC over silica gel (eluent: CH2Cl2/CH3OH 97/3). The pure fractions were collected and the solvent was evaporated, yielding 3.5 g of (+-)-N-(4-benzoylphenyl)-4,5-dihydro-3-(5-pyrimidinyl)-5-isoxazolecarboxamide (compound 349)",1,,,,,,,,,,,,,,,,,,,,,,pyridine; triethylamine,,"N,N-dimethyl-formamide","Patent; Janssen Pharmaceutica, N.V.; US6583141; (2003); B1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=224649&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33625734,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33625734&database=RX&origin=ReaxysOutput&ln=,(78 of 327),1,75,full reaction; has preparation,"1-piperidin-4-yl-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-b]-pyridine; pyrimidine-5-carbaldehyde","1-(1-pyrimidin-5-ylmethyl-piperidin-4-yl)-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-b]pyridine",228605,C1CC(CCN1)N1C=NC2=C1C1=C(NC=C1)N=C2.O=CC1=CN=CN=C1>>C(N1CCC(CC1)N1C=NC2=C1C1=C(NC=C1)N=C2)C1=CN=CN=C1,Preparation,,,,1,,,2,,2; 60,20; 20,,,Molecular sieve; Inert atmosphere; Molecular sieve; Inert atmosphere,,,,,,supporting information; experimental part,,"1-(1-pyrimidin-5-ylmethyl-piperidin-4-yl)-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-b]pyridine",65 percent,65,,"1-piperidin-4-yl-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-b]-pyridine; pyrimidine-5-carbaldehyde",acetic acid; sodium tris(acetoxy)borohydride,,"1,2-dichloro-ethane; 1,2-dichloro-ethane","Article; Kulagowski, Janusz J.; Blair, Wade; Bull, Richard J.; Chang, Christine; Deshmukh, Gauri; Dyke, Hazel J.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Harrison, Trevor K.; Hewitt, Peter R.; Liimatta, Marya; Hurley, Christopher A.; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Bir Kohli, Pawan; Maxey, Robert J.; Mendonca, Rohan; Mortara, Kyle; Murray, Jeremy; Narukulla, Raman; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; Van Abbema, Anne; Ward, Stuart I.; Waszkowycz, Bohdan; Zak, Mark; Journal of Medicinal Chemistry; vol. 55; 12; (2012); p. 5901 - 5921;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20171982&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
37024670,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=37024670&database=RX&origin=ReaxysOutput&ln=,(79 of 327),1,75,full reaction; has preparation,diethoxyphosphoryl-acetic acid ethyl ester; pyrimidine-5-carbaldehyde,(E)-ethyl 3-(pyrimidin-5-yl)acrylate,169252,CCOC(=O)CP(=O)(OCC)OCC.O=CC1=CN=CN=C1>>CCOC(=O)\C=C\C1=CN=CN=C1,Preparation,,,,1,,,2,,1; 17,0; 20,,,Inert atmosphere; Inert atmosphere,,,,,Experimental part,supporting information,,(E)-ethyl 3-(pyrimidin-5-yl)acrylate,68 percent,68,,diethoxyphosphoryl-acetic acid ethyl ester; pyrimidine-5-carbaldehyde,sodium hydride,,tetrahydrofuran; tetrahydrofuran,"Article; Buerli, Roland W.; Luckhurst, Christopher A.; Aziz, Omar; Matthews, Kim L.; Yates, Dawn; Lyons, Kathy. A.; Beconi, Maria; McAllister, George; Breccia, Perla; Stott, Andrew J.; Penrose, Stephen D.; Wall, Michael; Lamers, Marieke; Leonard, Philip; Mueller, Ilka; Richardson, Christine M.; Jarvis, Rebecca; Stones, Liz; Hughes, Samantha; Wishart, Grant; Haughan, Alan F.; O'Connell, Catherine; Mead, Tania; McNeil, Hannah; Vann, Julie; Mangette, John; Maillard, Michel; Beaumont, Vahri; Munoz-Sanjuan, Ignacio; Dominguez, Celia; Journal of Medicinal Chemistry; vol. 56; 24; (2013); p. 9934 - 9954;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=62375602&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
50275022,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=50275022&database=RX&origin=ReaxysOutput&ln=,(80 of 327),1,75,full reaction; has preparation,diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate; pyrimidine-5-carbaldehyde,(E)-5-(2-((2'-methoxyphenyl)sulfonyl)vinyl)pyrimidine,169252,CCOP(=O)(CS(=O)(=O)C1=CC=CC=C1OC)OCC.O=CC1=CN=CN=C1>>COC1=C(C=CC=C1)S(=O)(=O)\C=C\C1=CN=CN=C1,Preparation,,,,1,,,2,,1; 1,-78; -78 - 20,,,,Horner-Wadsworth-Emmons Olefination; Horner-Wadsworth-Emmons Olefination,,,,Experimental part,,,(E)-5-(2-((2'-methoxyphenyl)sulfonyl)vinyl)pyrimidine,72 percent,72,,diethyl (((2-methoxyphenyl)sulfonyl)methyl)phosphonate; pyrimidine-5-carbaldehyde,n-butyllithium,,tetrahydrofuran; cyclohexane; tetrahydrofuran; cyclohexane,"Article; Choi, Ji Won; Kim, Siwon; Park, Jong-Hyun; Kim, Hyeon Jeong; Shin, Su Jeong; Kim, Jin Woo; Woo, Seo Yeon; Lee, Changho; Han, Sang Moon; Lee, Jaeick; Pae, Ae Nim; Han, Gyoonhee; Park, Ki Duk; Journal of Medicinal Chemistry; vol. 62; 2; (2019); p. 811 - 830;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=75723766&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13478806,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13478806&database=RX&origin=ReaxysOutput&ln=,(81 of 327),1,74,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-[1,8]-naphthyridin-2-yl)-nonanoic acid",,O=CC1=CN=CN=C1>>OC(=O)C[C@H](CCCCCCC1=NC2=C(CCCN2)C=C1)C1=CN=CN=C1,Multi-step reaction,,,,5,Reaction-ID:13478806-Steps:9666689;9698273;9665750;9701480;9702041,"1: 78 percent / K2CO3 / tetrahydrofuran / 1 h / Heating; 2: 45 percent / NaBH4 / methanol / 0.25 h; 3: 98 percent / propionic acid / 2 h / 145 C; 4: 77 percent / 1,4-cyclohexadiene / Pd/C / acetic acid / 1 h / 80 C; 5: 69 percent / aq. NaOH / methanol; tetrahydrofuran / 16 h / 20 C",,,,,,,,,,,,,,1: Horner-Wadsworth-Emmons reaction / 3: Claisen rearrangement,,,,,,"sodium hydroxide; sodium tetrahydroborate; cyclohexa-1,4-diene; potassium carbonate; propionic acid",palladium on activated charcoal,tetrahydrofuran; methanol; acetic acid,"Article; Coleman, Paul J; Brashear, Karen M; Askew, Ben C; Hutchinson, John H; McVean, Carol A; Duong; Feuston, Bradley P; Fernandez-Metzler, Carmen; Gentile, Michael A; Hartman, George D; Kimmel, Donald B; Leu, Chih-Tai; Lipfert, Lorraine; Merkle, Kara; Pennypacker, Brenda; Prueksaritanont, Thomayant; Rodan, Gideon A; Wesolowski, Gregg A; Rodan, Sevgi B; Duggan, Mark E; Journal of medicinal chemistry; vol. 47; 20; (2004); p. 4829 - 4837;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6460747&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13478807,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13478807&database=RX&origin=ReaxysOutput&ln=,(82 of 327),1,74,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-pyrimidin-5-yl-9-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)nonanoic acid ethyl ester",,O=CC1=CN=CN=C1>>CCOC(=O)C[C@H](CCCCCCC1=NC2=C(CCCN2)C=C1)C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:13478807-Steps:9666689;9698273;9665750;9701480,"1: 78 percent / K2CO3 / tetrahydrofuran / 1 h / Heating; 2: 45 percent / NaBH4 / methanol / 0.25 h; 3: 98 percent / propionic acid / 2 h / 145 C; 4: 77 percent / 1,4-cyclohexadiene / Pd/C / acetic acid / 1 h / 80 C",,,,,,,,,,,,,,1: Horner-Wadsworth-Emmons reaction / 3: Claisen rearrangement,,,,,,"sodium tetrahydroborate; cyclohexa-1,4-diene; potassium carbonate; propionic acid",palladium on activated charcoal,tetrahydrofuran; methanol; acetic acid,"Article; Coleman, Paul J; Brashear, Karen M; Askew, Ben C; Hutchinson, John H; McVean, Carol A; Duong; Feuston, Bradley P; Fernandez-Metzler, Carmen; Gentile, Michael A; Hartman, George D; Kimmel, Donald B; Leu, Chih-Tai; Lipfert, Lorraine; Merkle, Kara; Pennypacker, Brenda; Prueksaritanont, Thomayant; Rodan, Gideon A; Wesolowski, Gregg A; Rodan, Sevgi B; Duggan, Mark E; Journal of medicinal chemistry; vol. 47; 20; (2004); p. 4829 - 4837;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6460747&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
35518817,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=35518817&database=RX&origin=ReaxysOutput&ln=,(83 of 327),2,74,full reaction; has preparation,m-Anisidine; pyrimidine-5-carbaldehyde,3-methoxy-N-(pyrimidin-5-ylmethylene)aniline,152561,COC1=CC(N)=CC=C1.O=CC1=CN=CN=C1>>COC1=CC(=CC=C1)N=CC1=CN=CN=C1,Preparation,29.1,General procedure I:,General procedure: A mixture of an aldehyde (1.0 eq) and an amine (1.0 eq) was heated in a sealed tube at 60 C for 6 h. The crude material was dried under vacuum over phosphorus(V) oxide to give quantitatively the imine which was used in the next step without further purification.,1,,,,,6,60,,,Sealed tube,,,,,,Page/Page column 130; 142,,,,,,,,,,"Patent; KATHOLIEKE UNIVERSITEIT LEUVEN; BARDIOT, Dorothee; CARLENS, Gunter; DALLMEIER, Kai; KAPTEIN, Suzanne; McNAUGHTON, Michael; MARCHAND, Arnaud; NEYTS, Johan; SMETS, Wim; WO2013/45516; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=35472108&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
35518817,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=35518817&database=RX&origin=ReaxysOutput&ln=,(83 of 327),2,74,full reaction; has preparation,m-Anisidine; pyrimidine-5-carbaldehyde,3-methoxy-N-(pyrimidin-5-ylmethylene)aniline,152561,COC1=CC(N)=CC=C1.O=CC1=CN=CN=C1>>COC1=CC(=CC=C1)N=CC1=CN=CN=C1,Preparation,,,,1,,,,,6,60,,,,,,,,Experimental part,,,,,,,,,,ethanol,"Article; Bardiot, Dorothee; Koukni, Mohamed; Smets, Wim; Carlens, Gunter; McNaughton, Michael; Kaptein, Suzanne; Dallmeier, Kai; Chaltin, Patrick; Neyts, Johan; Marchand, Arnaud; Journal of Medicinal Chemistry; vol. 61; 18; (2018); p. 8390 - 8401;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74910400&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
45244453,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=45244453&database=RX&origin=ReaxysOutput&ln=,(84 of 327),1,74,full reaction; has preparation,4-vinylpyridine; pyrimidine-5-carbaldehyde,3-(pyridin-4-yl)-1-(pyrimidin-5-yl)propan-1-ol,224216,C=CC1=CC=NC=C1.O=CC1=CN=CN=C1>>OC(CCC1=CC=NC=C1)C1=CN=CN=C1,Preparation,,,,1,,,,,18,23,,,Inert atmosphere; Sealed tube; Irradiation,,,,,Experimental part,supporting information,regioselective reaction,3-(pyridin-4-yl)-1-(pyrimidin-5-yl)propan-1-ol,62 percent,62,,,"[2,2]bipyridinyl; tris(2,2-bipyridine)ruthenium(II) hexafluorophosphate; diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; lanthanum(lll) triflate",,acetonitrile,"Article; Lee, Katarzyna N.; Lei, Zhen; Ngai, Ming-Yu; Journal of the American Chemical Society; vol. 139; 14; (2017); p. 5003 - 5006;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=71113921&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48578749,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48578749&database=RX&origin=ReaxysOutput&ln=,(85 of 327),1,74,full reaction; has preparation,"(1R,2R,3R,5S)-(-)-Isopinocampheylamine; pyrimidine-5-carbaldehyde","(1R,2R,3R,5S)-2,6,6-trimethyl-N-(pyrimidin-5ylmethyl)bicyclo[3.1.1]heptan-3-amine hydrochloride",228701,C[C@@H]1[C@H]2C[C@@H](C[C@H]1N)C2(C)C.O=CC1=CN=CN=C1>>Cl.[H][C@]12C[C@]([H])([C@@H](C)[C@@H](C1)NCC1=CN=CN=C1)C2(C)C,Preparation,,,,1,,,2,,1; 10,20; 20,,,,,,,,Experimental part,supporting information,,"(1R,2R,3R,5S)-2,6,6-trimethyl-N-(pyrimidin-5ylmethyl)bicyclo[3.1.1]heptan-3-amine hydrochloride",60 percent,60,,"(1R,2R,3R,5S)-(-)-Isopinocampheylamine; pyrimidine-5-carbaldehyde",sodium tris(acetoxy)borohydride,,dichloromethane; dichloromethane,"Article; Zhao, Xin; Li, Runfeng; Zhou, Yang; Xiao, Mengjie; Ma, Chunlong; Yang, Zhongjin; Zeng, Shaogao; Du, Qiuling; Yang, Chunguang; Jiang, Haiming; Hu, Yanmei; Wang, Kefeng; Mok, Chris Ka Pun; Sun, Ping; Dong, Jianghong; Cui, Wei; Wang, Jun; Tu, Yaoquan; Yang, Zifeng; Hu, Wenhui; Journal of Medicinal Chemistry; vol. 61; 12; (2018); p. 5187 - 5198;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73926164&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
2938419,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=2938419&database=RX&origin=ReaxysOutput&ln=,(86 of 327),1,73,full reaction; has preparation,"pyrimidine-5-carbaldehyde; 2-(6-methoxy-1,2,3,4-tetrahydro-2-naphthyl)propane-1,3-diol","5-[5-(6-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-[1,3]dioxan-2-yl]-pyrimidine",227437,O=CC1=CN=CN=C1.COC1=CC=C2CC(CCC2=C1)C(CO)CO>>COC1=CC=C2CC(CCC2=C1)[C@H]1CO[C@@H](OC1)C1=CN=CN=C1,Preparation,,,,1,,,,,1,,,,Heating,,,,,,,,"5-[5-(6-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-[1,3]dioxan-2-yl]-pyrimidine",93.9 percent,93.9,,,toluene-4-sulfonic acid,,benzene,Article; Eriguchi; Takegoshi; Chemical and Pharmaceutical Bulletin; vol. 30; 2; (1982); p. 428 - 439;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=5683947&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
29075402,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=29075402&database=RX&origin=ReaxysOutput&ln=,(87 of 327),1,73,full reaction; has preparation,C19H27NO2; pyrimidine-5-carbaldehyde,C24H29N3O2,163112,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])N(C)C(=O)C=C[C@]12C.O=CC1=CN=CN=C1>>[H][C@@]12C\C(=C/C3=CN=CN=C3)C(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])N(C)C(=O)C=C[C@]12C,Preparation,,,,1,,,,,1,0 - 20,,,Inert atmosphere,,,,,,supporting information; experimental part,,,,,,,potassium hydroxide,,ethanol; water,"Article; Mitchell, Helen J.; Dankulich, William P.; Hartman, George D.; Prueksaritanont, Thomayant; Schmidt, Azriel; Vogel, Robert L.; Bai, Chang; McElwee-Witmer, Sheila; Zhang, Hai Z.; Chen, Fang; Leu, Chih-Tai; Kimmel, Donald B.; Ray, William J.; Nantermet, Pascale; Gentile, Michael A.; Duggan, Mark E.; Meissner, Robert S.; Journal of Medicinal Chemistry; vol. 52; 15; (2009); p. 4578 - 4581;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8831095&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33625876,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33625876&database=RX&origin=ReaxysOutput&ln=,(88 of 327),1,73,full reaction; has preparation,"1-(4-methyl-piperidin-4-yl)-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-b]pyridine; pyrimidine-5-carbaldehyde","1-(4-methyl-1-(pyrimidin-5-ylmethyl)-piperidin-4-yl)-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-b]pyridine",228605,CC1(CCNCC1)N1C=NC2=C1C1=C(NC=C1)N=C2.O=CC1=CN=CN=C1>>CC1(CCN(CC2=CN=CN=C2)CC1)N1C=NC2=C1C1=C(NC=C1)N=C2,Preparation,,,,1,,,2,,2; 60,20,,,Molecular sieve; Inert atmosphere; Molecular sieve; Inert atmosphere,,,,,,supporting information; experimental part,,"1-(4-methyl-1-(pyrimidin-5-ylmethyl)-piperidin-4-yl)-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-b]pyridine",47 percent,47,,"1-(4-methyl-piperidin-4-yl)-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-b]pyridine; pyrimidine-5-carbaldehyde",acetic acid; sodium tris(acetoxy)borohydride,,"1,2-dichloro-ethane; 1,2-dichloro-ethane","Article; Kulagowski, Janusz J.; Blair, Wade; Bull, Richard J.; Chang, Christine; Deshmukh, Gauri; Dyke, Hazel J.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Harrison, Trevor K.; Hewitt, Peter R.; Liimatta, Marya; Hurley, Christopher A.; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Bir Kohli, Pawan; Maxey, Robert J.; Mendonca, Rohan; Mortara, Kyle; Murray, Jeremy; Narukulla, Raman; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; Van Abbema, Anne; Ward, Stuart I.; Waszkowycz, Bohdan; Zak, Mark; Journal of Medicinal Chemistry; vol. 55; 12; (2012); p. 5901 - 5921;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20171982&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
44765885,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=44765885&database=RX&origin=ReaxysOutput&ln=,(89 of 327),1,73,full reaction; has preparation,"5-bromopyrimidine; 2,2-diethoxy acetic acid",pyrimidine-5-carbaldehyde,137263,BrC1=CN=CN=C1.CCOC(OCC)C(O)=O>>O=CC1=CN=CN=C1,Preparation,,,,1,,,,,24,20,,,Schlenk technique; Inert atmosphere; Irradiation,,,,,Experimental part,supporting information,,pyrimidine-5-carbaldehyde,51 percent,51,,,"nickel(II) chloride hexahydrate; (4s,6s)-2,4,5,6-tetra(9H-carbazol-9-yl)isophthalonitrile; caesium carbonate; 4,4'-di-tert-butyl-2,2'-bipyridine",,"N,N-dimethyl-formamide","Article; Huang, He; Li, Xiangmin; Yu, Chenguang; Zhang, Yueteng; Mariano, Patrick S.; Wang, Wei; Angewandte Chemie - International Edition; vol. 56; 6; (2017); p. 1500 - 1505; Angew. Chem.; vol. 129; 6; (2017); p. 1522 - 1527,6;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=70513494&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
24793811,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=24793811&database=RX&origin=ReaxysOutput&ln=,(90 of 327),1,72,full reaction; has preparation,pyrimidine-5-carbaldehyde; 3-[2-(trifluoromethyl)benzyl]aniline,C19H14F3N3,152561,O=CC1=CN=CN=C1.NC1=CC=CC(CC2=CC=CC=C2C(F)(F)F)=C1>>FC(F)(F)C1=CC=CC=C1CC1=CC=CC(=C1)N=CC1=CN=CN=C1,Preparation,2,,"EXAMPLE 2 2,2,2-trifluoro-N-(pyrimidin-5-ylmethyl)-N-{3-[2- (trifluoromethyl)benzyl]phenyl} ethanesulfonamideA heterogeneous solution of l-(bromomethyl)-2-(trifluoromethyl)benzene (1.0 g, 4.2 mmol) and 3-nitrophenyl boronic acid (1.1 g, 6.3 mmol) in dimethoxyethane (38 mL) and 2M solution of sodium carbonate (12.7 mL, 25.5 mmol) was purged with nitrogen for 5 min. Palladium triphenylphosphine (155 mg, 0.13 mmol) was then added to the biphasic mixture. The reaction mixture was heated to 50 0C for 16hr, cooled to room temperature, and quenched by addition of water and ethyl acetate. The organic layer was separated, dried over Na2SO4 and concentrated in vacuo. The residue was purified via column chromatography on silica gel (eluting 15-80% ethyl acetate/hexanes) to give 1.16 g (98%) of l-(3-nitrobenzyl)-2-(trifluoromethyl)benzene as a clear, colorless oil. Hydrazine monohydrate (2 mL, 41.2 mmol) and a catalytic amount of palladium on carbon was added to a solution of l-(3-nitrobenzyl)-2-(trifluoromethyl)benzene (1.16 g, 4.1 mmol) in ethyl alcohol (200 mL) at ambient temperature. The resulting mixture was heated to reflux for 16 hr. The reaction was cooled to room EPO <DP n=""20""/>temperature and filtered over Celite. The filtrate was concentrated in vacuo to give 0.95 g (92%) of 3-[2- (trifluoromethyl)benzyl]aniline.A solution of pyrimidine aldehyde (230 mg, 2.1 mmol) and 3-[2-(trifluoromethyl)benzyl]aniline (450 mg, 1.8 mmol) in methanol (4.5 mL) was refluxed for 2 hr. The resulting mixture was cooled to 00C and then allowed to warm back to room temperature after the addition of sodium borohydride (170 mg, 4.5 mmol). After stirring for an additional 16h at room temperature, the mixture was rotovapped in vacuo to remove volatile solvents. The residue was directly purifed by silica gel chromatography (eluting first with 20-100% ethyl acetate/hexanes followed by 0- 20% MeOH/dichloromethane) to give 141 mg of N-(pyrimidin-5-ylmethyl)-3-[2-(trifluoromethyl)- benzyl] aniline. A neat solution of 2,2,2-trifluoroethanesulfonyl chloride (64 uL, 0.58 mmol) was added dropwise to a solution of N-(pyrimidin-5-ylmethyl)-3-[2-(trifluoromethyl)benzyl]aniline (141 mg, 0.41 mmol) in dichloroethane (1.6 mL) and pyridine (0.8 mL) at 00C. The reaction mixture was allowed to gradually warm to room temperature and stirred at room temperature until TLC indicated completion of reaction. Volatile solvents were removed using a rotary evaporator. The residue was directly purified via column chromatography on silica gel (eluting with 0-100% ethyl acetate/dichloromethane) to give 2,2,2- trifluoro-N-(pyrimidin-5-ylmethyl)-N- {3-[2-(trifluoromethyl)benzyl]phenyl} ethanesulfonamide as solid. 1H NMR (CDCl3, 500MHz), delta 9.12 (s, IH), 8.55 (s, 2H), 7.70-7.68 (d, IH), 7.48-7.47 (m, IH), 7.39-7.29 (m, 3H), 7.18-7.17(d, IH), 7.12-7.09 (m, IH), 6.94 (s, IH), 4.85 (s, 2H), 4.16 (s, 2H), 3.82-3.77 (m, 2H). MS (ESI): 490 (M+ + H).",1,,,,,2,,,,Heating / reflux,,,,,,Page/Page column 18; 19,,,,,,,,,methanol,"Patent; MERCK &amp; CO., INC.; WO2006/49968; (2006); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=7167088&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
29455574,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=29455574&database=RX&origin=ReaxysOutput&ln=,(91 of 327),2,72,full reaction; has preparation,4-Chlorobenzenesulfonamide; pyrimidine-5-carbaldehyde,C11H8ClN3O2S,,NS(=O)(=O)C1=CC=C(Cl)C=C1.O=CC1=CN=CN=C1>>ClC1=CC=C(C=C1)S(=O)(=O)N=CC1=CN=CN=C1,Preparation,,,,1,,,,,,,,,Molecular sieve; Reflux,,,,,,scheme or table,,,,,,,MP-TsOH,,toluene,"Article; Ye, Xiaocong M.; Konradi, Andrei W.; Smith, Jenifer; Xu, Ying-Zi; Dressen, Darren; Garofalo, Albert W.; Marugg, Jennifer; Sham, Hing L.; Truong, Anh P.; Jagodzinski, Jacek; Pleiss, Michael; Zhang, Hongbin; Goldbach, Erich; Sauer, John-Michael; Brigham, Elizabeth; Bova, Michael; Basi, Guriqbal S.; Bioorganic and Medicinal Chemistry Letters; vol. 20; 7; (2010); p. 2195 - 2199;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8882248&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
29455574,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=29455574&database=RX&origin=ReaxysOutput&ln=,(91 of 327),2,72,full reaction; has preparation,4-Chlorobenzenesulfonamide; pyrimidine-5-carbaldehyde,C11H8ClN3O2S,,NS(=O)(=O)C1=CC=C(Cl)C=C1.O=CC1=CN=CN=C1>>ClC1=CC=C(C=C1)S(=O)(=O)N=CC1=CN=CN=C1,Preparation,,,,1,,,,,24,50,,,Inert atmosphere,,,,,Experimental part,supporting information,,,,,,,[bis(acetoxy)iodo]benzene; iodine,,chloroform,"Article; Hopkins, Megan D.; Abebe, Felagot A.; Scott, Kristina A.; Ozmer, Garett L.; Sheir, Alec A.; Schroeder, Lucas J.; Sheaff, Robert J.; Lamar, Angus A.; Organic and Biomolecular Chemistry; vol. 17; 36; (2019); p. 8391 - 8402;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=77773467&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
47680952,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=47680952&database=RX&origin=ReaxysOutput&ln=,(92 of 327),1,72,full reaction; has preparation,pyrimidine-5-carbaldehyde; 4-(diethoxyphosphoryl)-but-2-enoic acid ethyl ester,C11H12N2O2,168971,O=CC1=CN=CN=C1.CCOC(=O)C=CCP(=O)(OCC)OCC>>CCOC(=O)C=CC=CC1=CN=CN=C1,Preparation,,,,1,,,2,,1; 3,-78; -78 - 20,,,Inert atmosphere; Inert atmosphere,Horner-Wadsworth-Emmons Olefination; Horner-Wadsworth-Emmons Olefination,,,,Experimental part,supporting information,,C11H12N2O2,41 percent,41,,4-(diethoxyphosphoryl)-but-2-enoic acid ethyl ester; pyrimidine-5-carbaldehyde,lithium diisopropyl amide,,tetrahydrofuran; tetrahydrofuran,"Article; Dada, Raphael; Wei, Zhongyu; Gui, Ruohua; Lundgren, Rylan J.; Angewandte Chemie - International Edition; vol. 57; 15; (2018); p. 3981 - 3984; Angew. Chem.; vol. 130; (2018); p. 4045 - 4048,4;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73370059&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
50275023,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=50275023&database=RX&origin=ReaxysOutput&ln=,(93 of 327),1,72,full reaction; has preparation,diethyl (((3-methoxyphenyl)sulfonyl)methyl)phosphonate; pyrimidine-5-carbaldehyde,(E)-5-(2-((3'-methoxyphenyl)sulfonyl)vinyl)pyrimidine,169252,CCOP(=O)(CS(=O)(=O)C1=CC=CC(OC)=C1)OCC.O=CC1=CN=CN=C1>>COC1=CC=CC(=C1)S(=O)(=O)\C=C\C1=CN=CN=C1,Preparation,,,,1,,,2,,1; 1,-78; -78 - 20,,,,Horner-Wadsworth-Emmons Olefination; Horner-Wadsworth-Emmons Olefination,,,,Experimental part,,,(E)-5-(2-((3'-methoxyphenyl)sulfonyl)vinyl)pyrimidine,37 percent,37,,diethyl (((3-methoxyphenyl)sulfonyl)methyl)phosphonate; pyrimidine-5-carbaldehyde,n-butyllithium,,tetrahydrofuran; cyclohexane; tetrahydrofuran; cyclohexane,"Article; Choi, Ji Won; Kim, Siwon; Park, Jong-Hyun; Kim, Hyeon Jeong; Shin, Su Jeong; Kim, Jin Woo; Woo, Seo Yeon; Lee, Changho; Han, Sang Moon; Lee, Jaeick; Pae, Ae Nim; Han, Gyoonhee; Park, Ki Duk; Journal of Medicinal Chemistry; vol. 62; 2; (2019); p. 811 - 830;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=75723766&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
50308001,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=50308001&database=RX&origin=ReaxysOutput&ln=,(94 of 327),1,72,full reaction; has preparation,5-bromopyrimidine; carbon monoxide,pyrimidine-5-carbaldehyde,185317,BrC1=CN=CN=C1.[C]=O>>O=CC1=CN=CN=C1,Preparation,,,,1,,,,,,120,9000.9,,Flow reactor; Green chemistry,,,,,Experimental part,,,pyrimidine-5-carbaldehyde,13 percentChromat.,,,,"N,N,N,N,-tetramethylethylenediamine; hydrogen; palladium diacetate; catacxium A",,toluene,"Article; Hone, Christopher A.; Lopatka, Pavol; Munday, Rachel; O'Kearney-McMullan, Anne; Kappe, C. Oliver; ChemSusChem; vol. 12; 1; (2019); p. 326 - 337;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=75387468&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13478804,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13478804&database=RX&origin=ReaxysOutput&ln=,(95 of 327),2,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(R)-1-(pyrimidin-5-yl)-7-(5,6,7,8-tetrahydro-[1,8]-naphthyridin-2-yl)-(E)-hept-1-en-3-ol",,O=CC1=CN=CN=C1>>O[C@H](CCCCC1=NC2=C(CCCN2)C=C1)\C=C\C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:13478804-Steps:9666689;9698273,1: 78 percent / K2CO3 / tetrahydrofuran / 1 h / Heating; 2: 45 percent / NaBH4 / methanol / 0.25 h,,,,,,,,,,,,,,1: Horner-Wadsworth-Emmons reaction,,,,,,sodium tetrahydroborate; potassium carbonate,,tetrahydrofuran; methanol,"Article; Coleman, Paul J; Brashear, Karen M; Askew, Ben C; Hutchinson, John H; McVean, Carol A; Duong; Feuston, Bradley P; Fernandez-Metzler, Carmen; Gentile, Michael A; Hartman, George D; Kimmel, Donald B; Leu, Chih-Tai; Lipfert, Lorraine; Merkle, Kara; Pennypacker, Brenda; Prueksaritanont, Thomayant; Rodan, Gideon A; Wesolowski, Gregg A; Rodan, Sevgi B; Duggan, Mark E; Journal of medicinal chemistry; vol. 47; 20; (2004); p. 4829 - 4837;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6460747&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13478804,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13478804&database=RX&origin=ReaxysOutput&ln=,(95 of 327),2,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(R)-1-(pyrimidin-5-yl)-7-(5,6,7,8-tetrahydro-[1,8]-naphthyridin-2-yl)-(E)-hept-1-en-3-ol",,O=CC1=CN=CN=C1>>O[C@H](CCCCC1=NC2=C(CCCN2)C=C1)\C=C\C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:13478804-Steps:44296148;44296383,"1.1: lithium chloride / acetonitrile / 0.25 h; 1.2: 0.5 h / Sonication; 1.3: 2.25 h; 2.1: 1,1-bi-2,2?-naphthol-lithium aluminum hydride complex / tetrahydrofuran; dichloromethane; toluene / 1.42 h / -75 - -69 C / Inert atmosphere",,,,,,,,,,,,,,,,,,,,"1,1-bi-2,2?-naphthol-lithium aluminum hydride complex; lithium chloride",,tetrahydrofuran; dichloromethane; toluene; acetonitrile,"Patent; MERCK SHARP &amp; DOHME CORP.; COX, Jason, M.; MA, Lijun; ZHOU, Xiaoyan; HAIMBACH, Robin, E.; COLEMAN, Paul, J.; ZHOU, Haihong; KELLEY, David, E.; STOCH, Selwyn Aubrey; DUONG, Le, T.; HOEK, Maarten; (68 pag.)WO2016/154369; (2016); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=69699432&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
24714460,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=24714460&database=RX&origin=ReaxysOutput&ln=,(96 of 327),1,71,full reaction; has preparation,p-Methoxybenzyl 7beta-[(Z)-2-(2-tritylaminothiazol-4-yl)-2-trityloxyiminoacetamido]-3-[(triphenylphosphoranylidene)methyl]-3-cephem-4-carboxylate; di-isopropyl ether; pyrimidine-5-carbaldehyde,p-Methoxybenzyl 7beta-[(Z)-2-(2-tritylaminothiazol-4-yl)-2-trityloxyiminoacetamido]-3-[(Z)-(pyrimidin-5-yl)vinyl]-3-cephem-4-carboxylate,13226,,Preparation,P.13,p-Methoxybenzyl 7beta-[(Z)-2-(2-tritylaminothiazol-4-yl)-2-trityloxyiminoacetamido]-3-[(Z)-(pyrimidin-5-yl)vinyl]-3-cephem-4-carboxylate STR59,"PREPARATION EXAMPLE 13 p-Methoxybenzyl 7beta-[(Z)-2-(2-tritylaminothiazol-4-yl)-2-trityloxyiminoacetamido]-3-[(Z)-(pyrimidin-5-yl)vinyl]-3-cephem-4-carboxylate STR59 p-Methoxybenzyl 7beta-[(Z)-2-(2-tritylaminothiazol-4-yl)-2-trityloxyiminoacetamido]-3-[(triphenylphosphoranylidene)methyl]-3-cephem-4-carboxylate (4 g) and 5-pyrimidinaldehyde (0.8 g) were stirred for 12 hours in dichloromethane (40 ml). The reaction mixture was concentrated to about 15 ml and then subjected to chromatography on a silica gel column. Relevant fractions were combined and concentrated, whereby an oily matter was obtained. It was added dropwise to a mixed solvent of isopropyl ether (20 ml) and n-hexane (80 ml). The resulting precipitate was collected by filtration, whereby the title compound (1.5 g) was obtained. NMR (CDCl3) delta: 3.00, 3.40(2 H,ABq,J=18 Hz), 3.82(3 H,s), 5.08(1 H,d,J=5 Hz), 5.10(2 H,s), 6.05(1 H,dd,J=5 Hz,9 Hz), 6.35, 6.52(2 H,ABq,J=14 Hz), 6.70(1 H,s), 6.85(2 H,ABq,J=8 Hz), 7.22-7.55(32 H,m), 8.50(2 H,s), 8.91(1 H,s).",1,,,,,,,,,,,,,,,,,,,,,,,,hexane; dichloromethane,"Patent; Eisai Co., Ltd.; US5151417; (1992); A;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=7120869&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563181,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563181&database=RX&origin=ReaxysOutput&ln=,(97 of 327),6,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,N-[(5-pyrimidinyl)methyl]-2-pyridinamine,228701,O=CC1=CN=CN=C1>>C(NC1=NC=CC=C1)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:33563181-Steps:33563182;33563201,1: chloroform / 0.25 h / 20 C; 2: sodium tetrahydroborate; methanol / tetrahydrofuran,,,,,,,,,,,,,,,,,,,,methanol; sodium tetrahydroborate,,tetrahydrofuran; chloroform,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; PAHUTSKI, Thomas, Francis., Jr.; WO2012/92115; (2012); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20156312&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563181,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563181&database=RX&origin=ReaxysOutput&ln=,(97 of 327),6,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,N-[(5-pyrimidinyl)methyl]-2-pyridinamine,228701,O=CC1=CN=CN=C1>>C(NC1=NC=CC=C1)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:33563181-Steps:33563182;33563201,1: chloroform / 0.25 h / 20 C; 2: methanol; sodium tetrahydroborate / tetrahydrofuran,,,,,,,,,,,,,,,,,,,,methanol; sodium tetrahydroborate,,tetrahydrofuran; chloroform,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; ZHANG, Wenming; ANNIS, Gary David; WO2013/90547; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=35495458&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563181,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563181&database=RX&origin=ReaxysOutput&ln=,(97 of 327),6,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,N-[(5-pyrimidinyl)methyl]-2-pyridinamine,228701,O=CC1=CN=CN=C1>>C(NC1=NC=CC=C1)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:33563181-Steps:33563182;33563201,1: chloroform / 25 C; 2: sodium tetrahydroborate / methanol; tetrahydrofuran / 20 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate,,tetrahydrofuran; methanol; chloroform,"Article; Zhang, Wenming; Holyoke, Caleb W.; Pahutski, Thomas F.; Lahm, George P.; Barry, James D.; Cordova, Daniel; Leighty, Robert M.; Singh, Vineet; Vicent, Daniel R.; Tong, My-Hanh T.; Hughes, Kenneth A.; McCann, Stephen F.; Henry, Yewande T.; Xu, Ming; Briddell, Twyla A.; Bioorganic and Medicinal Chemistry Letters; vol. 27; 1; (2017); p. 16 - 20;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=70183534&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563181,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563181&database=RX&origin=ReaxysOutput&ln=,(97 of 327),6,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,N-[(5-pyrimidinyl)methyl]-2-pyridinamine,228701,O=CC1=CN=CN=C1>>C(NC1=NC=CC=C1)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:33563181-Steps:33563182;46782305;46782306,1: toluene-4-sulfonic acid / toluene / 3.75 h / 112 - 114 C / 760.05 Torr / Inert atmosphere; Dean-Stark; 2: 16 - 24 C; 3: sodium tetrahydroborate / toluene / 3 h / 9 - 12 C / Inert atmosphere,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; toluene-4-sulfonic acid,,toluene,"Patent; E I DU PONT DE NEMOURS AND COMPANY; DUMAS, Donald J.; TRAN, Loc Thanh; (24 pag.)WO2017/189339; (2017); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=72745592&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563181,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563181&database=RX&origin=ReaxysOutput&ln=,(97 of 327),6,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,N-[(5-pyrimidinyl)methyl]-2-pyridinamine,228701,O=CC1=CN=CN=C1>>C(NC1=NC=CC=C1)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:33563181-Steps:52133462;52133459;52133464,1.1: sodium hydrogensulfite / methanol; water / 2 h / 60 C; 2.1: hydrogenchloride / water / 1 h / 10 - 15 C / pH 4; 3.1: sodium methylate / methanol / 15 C; 3.2: 3.17 h / 10 - 15 C,,,,,,,,,,,,,,,,,,,,hydrogenchloride; sodium methylate; sodium hydrogensulfite,,methanol; water,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; DUMAS, Donald J.; HONG, Junbae; (65 pag.)WO2019/173173; (2019); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=77794972&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563181,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563181&database=RX&origin=ReaxysOutput&ln=,(97 of 327),6,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,N-[(5-pyrimidinyl)methyl]-2-pyridinamine,228701,O=CC1=CN=CN=C1>>C(NC1=NC=CC=C1)C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:33563181-Steps:52133460;52133457;52133459;52133464,1.1: sodium hydrogensulfite / methanol; water / 0.5 h / 18 - 28 C; 2.1: water / 5 h / 60 C; 3.1: hydrogenchloride / water / 1 h / 10 - 15 C / pH 4; 4.1: sodium methylate / methanol / 15 C; 4.2: 3.17 h / 10 - 15 C,,,,,,,,,,,,,,,,,,,,hydrogenchloride; sodium methylate; sodium hydrogensulfite,,methanol; water,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; DUMAS, Donald J.; HONG, Junbae; (65 pag.)WO2019/173173; (2019); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=77794972&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181137,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181137&database=RX&origin=ReaxysOutput&ln=,(98 of 327),5,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-pyrimidinylmethyl chloride,228263,O=CC1=CN=CN=C1>>ClCC1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:36181137-Steps:8695846;36181142,1: methanol; sodium tetrahydroborate / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C,,,,,,,,,,,,,,,,,,,,methanol; sodium tetrahydroborate; thionyl chloride,,dichloromethane,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; BUCKMELTER, Alexandre J.; CLODFELTER, Karl H.; DRAGOVICH, Peter; GOSSELIN, Francis; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; LIU, Xiongcai; REYNOLDS, Dominic J.; SMITH, Chase C.; WANG, Zhongguo; ZAK, Mark; ZHANG, Yamin; ZHAO, Guiling; ZHENG, Xiaozhang; YUEN, Po-Wai; WO2013/127266; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727359&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181137,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181137&database=RX&origin=ReaxysOutput&ln=,(98 of 327),5,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-pyrimidinylmethyl chloride,228263,O=CC1=CN=CN=C1>>ClCC1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:36181137-Steps:8695846;36181142,1: sodium tetrahydroborate; methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C,,,,,,,,,,,,,,,,,,,,methanol; sodium tetrahydroborate; thionyl chloride,,dichloromethane,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; DRAGOVICH, Peter; GOSSELIN, Francis; YUEN, Po-Wai; ZAK, Mark; ZHENG, Xiaozhang; WO2013/127267; (2013); A1;; ; Patent; GENENTECH,INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; BUCKMELTER, Alexandre J.; CLODFELTER, Kanl H.; DRAGOVICH, Peter; HAN, Bingsong; LIN, Jian; LIU, Xiongcai; REYNOLDS, Dominic J.; SMITH, Chase C.; WANG, Zhongguo; YUEN, Po-Wai; ZAK, Mark; ZHANG, Yamin; ZHENG, Xiaozhang; ZHAO, Guiling; WO2013/127268; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727360;48727361&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181137,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181137&database=RX&origin=ReaxysOutput&ln=,(98 of 327),5,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-pyrimidinylmethyl chloride,228263,O=CC1=CN=CN=C1>>ClCC1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:36181137-Steps:8695846;36181142,1: sodium tetrahydroborate; methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C,,,,,,,,,,,,,,,,,,,,methanol; sodium tetrahydroborate; thionyl chloride,,dichloromethane,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; GOSSELIN, Francis; ZAK, Mark; ZHENG, Xiaozhang; WO2013/130935; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727676&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181137,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181137&database=RX&origin=ReaxysOutput&ln=,(98 of 327),5,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-pyrimidinylmethyl chloride,228263,O=CC1=CN=CN=C1>>ClCC1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:36181137-Steps:8695846;36181142,1: sodium tetrahydroborate / methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; thionyl chloride,,methanol; dichloromethane,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; BUCKMELTER, Alexandre, J.; CLODFELTER, Karl, H.; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; REYNOLDS, Dominic, J.; SMITH, Chase, C.; WANG, Zhongguo; ZAK, Mark; ZHENG, Xiaozhang; ZHAO, Guiling; WO2013/130943; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727677&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181137,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181137&database=RX&origin=ReaxysOutput&ln=,(98 of 327),5,71,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-pyrimidinylmethyl chloride,228263,O=CC1=CN=CN=C1>>ClCC1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:36181137-Steps:8695846;36181142,1: sodium tetrahydroborate / methanol / 4 h / 0 - 20 C; 2: thionyl chloride / tetrahydrofuran / 4 h / 0 - 20 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; thionyl chloride,,tetrahydrofuran; methanol,"Patent; REMEDY PLAN, INC.; CRIMMINS, Gregory, Thomas; DE JESUS DIAZ, Dennise, Alexandra; BHURRUTH-ALCOR, Yushma; (483 pag.)WO2019/213570; (2019); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78332759&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
38543104,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=38543104&database=RX&origin=ReaxysOutput&ln=,(99 of 327),1,71,full reaction; has preparation,tert-butylisonitrile; pyrimidine-5-carbaldehyde; benzoic acid; Propargylamine,N-(2-(tert-butylamino)-2-oxo-1-(pyrimidin-5-yl)ethyl)-N-(prop-2-yn-1-yl)benzamide,185791,CC(C)(C)N=[C].O=CC1=CN=CN=C1.OC(=O)C1=CC=CC=C1.NCC#C>>CC(C)(C)NC(=O)C(N(CC#C)C(=O)C1=CC=CC=C1)C1=CN=CN=C1,Preparation,,,,1,,,,,2,50,,,Microwave irradiation,Ugi Condensation,,,,Experimental part,,,N-(2-(tert-butylamino)-2-oxo-1-(pyrimidin-5-yl)ethyl)-N-(prop-2-yn-1-yl)benzamide,17 percent,17,,,indium(III) chloride,,methanol,"Article; Polindara-Garcia, Luis A.; Vazquez, Alfredo; Organic and Biomolecular Chemistry; vol. 12; 36; (2014); p. 7068 - 7082;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=64129322&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48388494,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48388494&database=RX&origin=ReaxysOutput&ln=,(100 of 327),1,71,full reaction; has preparation,"2-phenyl-1,2,3,4-tetrahydroisoquinoline; pyrimidine-5-carbaldehyde","(2-phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)(pyrimidin-5-yl)methanol",222141,C1CC2=CC=CC=C2CN1C1=CC=CC=C1.O=CC1=CN=CN=C1>>OC(C1N(CCC2=C1C=CC=C2)C1=CC=CC=C1)C1=CN=CN=C1,Preparation,,,,1,,,,,12,,,,Inert atmosphere; Irradiation,,,,,Experimental part,supporting information,,"(2-phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)(pyrimidin-5-yl)methanol",83 percent,83,,,"1,4-diaza-bicyclo[2.2.2]octane; lithium tetrafluoroborate; tris(bipyridine)ruthenium(II) dichloride hexahydrate; oxalic acid",,acetonitrile,"Article; Xia, Qing; Tian, Hao; Dong, Jianyang; Qu, Yi; Li, Lili; Song, Hongjian; Liu, Yuxiu; Wang, Qingmin; Chemistry - A European Journal; vol. 24; 37; (2018); p. 9269 - 9273;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73924341&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
2938418,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=2938418&database=RX&origin=ReaxysOutput&ln=,(101 of 327),1,70,full reaction; has preparation,"pyrimidine-5-carbaldehyde; 2-(6-methoxy-2-naphthyl)propane-1,3-diol","trans-5-(6-methoxy-2-naphthyl)-2-(3-pyrimidinyl)-1,3-dioxane",227437,O=CC1=CN=CN=C1.COC1=CC=C2C=C(C=CC2=C1)C(CO)CO>>COC1=CC=C2C=C(C=CC2=C1)[C@H]1CO[C@@H](OC1)C1=CN=CN=C1,Preparation,,,,1,,,,,,,,,Heating,,,,,,,,"trans-5-(6-methoxy-2-naphthyl)-2-(3-pyrimidinyl)-1,3-dioxane",57.2 percent,57.2,,,toluene-4-sulfonic acid,,benzene,Article; Eriguchi; Takegoshi; Chemical and Pharmaceutical Bulletin; vol. 30; 2; (1982); p. 428 - 439;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=5683947&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
34273355,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=34273355&database=RX&origin=ReaxysOutput&ln=,(102 of 327),1,70,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-(piperazin-1-ylmethyl)pyrimidine,228607,O=CC1=CN=CN=C1>>C(N1CCNCC1)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:34273355-Steps:28688007;34273359,1: sodium triacetoxy borohydride; acetic acid / dichloromethane / 6 h / 20 C; 2: trifluoroacetic acid / dichloromethane / 2.25 h / 20 C,,,,,,,,,,,,,,,,,,,,sodium triacetoxy borohydride; acetic acid; trifluoroacetic acid,,dichloromethane,"Article; Bavetsias, Vassilios; Crumpler, Simon; Sun, Chongbo; Avery, Sian; Atrash, Butrus; Faisal, Amir; Moore, Andrew S.; Brown, Nathan; Sheldrake, Peter W.; Bush, Katherine; Henley, Alan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; Raynaud, Florence I.; Workman, Paul; Eccles, Suzanne A.; Linardopoulos, Spiros; Blagg, Julian; Kosmopoulou, Magda; Bayliss, Richard; Journal of Medicinal Chemistry; vol. 55; 20; (2012); p. 8721 - 8734,14;; ; Article; Bavetsias, Vassilios; Crumpler, Simon; Sun, Chongbo; Avery, Sian; Atrash, Butrus; Faisal, Amir; Moore, Andrew S.; Kosmopoulou, Magda; Brown, Nathan; Sheldrake, Peter W.; Bush, Katherine; Henley, Alan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; Raynaud, Florence I.; Workman, Paul; Eccles, Suzanne A.; Bayliss, Richard; Linardopoulos, Spiros; Blagg, Julian; Journal of Medicinal Chemistry; vol. 55; 20; (2012); p. 8721 - 8734;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20212028;35220251&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
34273357,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=34273357&database=RX&origin=ReaxysOutput&ln=,(103 of 327),1,70,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-chloro-3-nitro-4-(4-(pyrimidin-5-ylmethyl)piperazin-1-yl)pyridin-2-amine,228607,O=CC1=CN=CN=C1>>NC1=C(C(N2CCN(CC3=CN=CN=C3)CC2)=C(Cl)C=N1)N(=O)=O,Multi-step reaction,,,,3,Reaction-ID:34273357-Steps:28688007;34273359;34273308,"1: sodium triacetoxy borohydride; acetic acid / dichloromethane / 6 h / 20 C; 2: trifluoroacetic acid / dichloromethane / 2.25 h / 20 C; 3: N-ethyl-N,N-diisopropylamine / isopropyl alcohol / 18 h / 45 C",,,,,,,,,,,,,,,,,,,,"sodium triacetoxy borohydride; acetic acid; N-ethyl-N,N-diisopropylamine; trifluoroacetic acid",,dichloromethane; isopropyl alcohol,"Article; Bavetsias, Vassilios; Crumpler, Simon; Sun, Chongbo; Avery, Sian; Atrash, Butrus; Faisal, Amir; Moore, Andrew S.; Brown, Nathan; Sheldrake, Peter W.; Bush, Katherine; Henley, Alan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; Raynaud, Florence I.; Workman, Paul; Eccles, Suzanne A.; Linardopoulos, Spiros; Blagg, Julian; Kosmopoulou, Magda; Bayliss, Richard; Journal of Medicinal Chemistry; vol. 55; 20; (2012); p. 8721 - 8734,14;; ; Article; Bavetsias, Vassilios; Crumpler, Simon; Sun, Chongbo; Avery, Sian; Atrash, Butrus; Faisal, Amir; Moore, Andrew S.; Kosmopoulou, Magda; Brown, Nathan; Sheldrake, Peter W.; Bush, Katherine; Henley, Alan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; Raynaud, Florence I.; Workman, Paul; Eccles, Suzanne A.; Bayliss, Richard; Linardopoulos, Spiros; Blagg, Julian; Journal of Medicinal Chemistry; vol. 55; 20; (2012); p. 8721 - 8734;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20212028;35220251&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
34273358,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=34273358&database=RX&origin=ReaxysOutput&ln=,(104 of 327),1,70,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"6-chloro-2-(1,3-dimethyl-1H-pyrazol-4-yl)-7-(4-(pyrimidin-5-ylmethyl)piperazin-1-yl)-3H-imidazo[4,5-b]pyridine",228607,O=CC1=CN=CN=C1>>CN1C=C(C(C)=N1)C1=NC2=C(N3CCN(CC4=CN=CN=C4)CC3)C(Cl)=CN=C2N1,Multi-step reaction,,,,4,Reaction-ID:34273358-Steps:28688007;34273359;34273308;34273383,"1: sodium triacetoxy borohydride; acetic acid / dichloromethane / 6 h / 20 C; 2: trifluoroacetic acid / dichloromethane / 2.25 h / 20 C; 3: N-ethyl-N,N-diisopropylamine / isopropyl alcohol / 18 h / 45 C; 4: sodium dithionite / water; ethanol / 18 h / 80 C",,,,,,,,,,,,,,,,,,,,"sodium triacetoxy borohydride; sodium dithionite; acetic acid; N-ethyl-N,N-diisopropylamine; trifluoroacetic acid",,ethanol; dichloromethane; water; isopropyl alcohol,"Article; Bavetsias, Vassilios; Crumpler, Simon; Sun, Chongbo; Avery, Sian; Atrash, Butrus; Faisal, Amir; Moore, Andrew S.; Brown, Nathan; Sheldrake, Peter W.; Bush, Katherine; Henley, Alan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; Raynaud, Florence I.; Workman, Paul; Eccles, Suzanne A.; Linardopoulos, Spiros; Blagg, Julian; Kosmopoulou, Magda; Bayliss, Richard; Journal of Medicinal Chemistry; vol. 55; 20; (2012); p. 8721 - 8734,14;; ; Article; Bavetsias, Vassilios; Crumpler, Simon; Sun, Chongbo; Avery, Sian; Atrash, Butrus; Faisal, Amir; Moore, Andrew S.; Kosmopoulou, Magda; Brown, Nathan; Sheldrake, Peter W.; Bush, Katherine; Henley, Alan; Box, Gary; Valenti, Melanie; De Haven Brandon, Alexis; Raynaud, Florence I.; Workman, Paul; Eccles, Suzanne A.; Bayliss, Richard; Linardopoulos, Spiros; Blagg, Julian; Journal of Medicinal Chemistry; vol. 55; 20; (2012); p. 8721 - 8734;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20212028;35220251&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
40399149,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=40399149&database=RX&origin=ReaxysOutput&ln=,(105 of 327),1,70,full reaction; has preparation,"7-(benzo[b]thiophen-3-yl)-9-methoxy-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine; pyrimidine-5-carbaldehyde","7-(benzo[b]thiophen-3-yl)-9-methoxy-4-(pyrimidin-5-ylmethyl)-2,3,4,5-tetrahydrobenzo[f ][1,4]oxazepine",228603,COC1=CC(=CC2=C1OCCNC2)C1=CSC2=C1C=CC=C2.O=CC1=CN=CN=C1>>COC1=CC(=CC2=C1OCCN(CC1=CN=CN=C1)C2)C1=CSC2=CC=CC=C12,Preparation,,,,1,,,,,,20,,,,Suzuki Coupling,,,,Experimental part,,,"7-(benzo[b]thiophen-3-yl)-9-methoxy-4-(pyrimidin-5-ylmethyl)-2,3,4,5-tetrahydrobenzo[f ][1,4]oxazepine",24 percent,24,,,sodium tris(acetoxy)borohydride,,"1,2-dichloro-ethane","Article; Fox, Brian M.; Beck, Hilary P.; Roveto, Philip M.; Kayser, Frank; Cheng, Qingwen; Dou, Hannah; Williamson, Toni; Treanor, James; Liu, Hantao; Jin, Lixia; Xu, Guifen; Ma, Ji; Wang, Songli; Olson, Steven H.; Journal of Medicinal Chemistry; vol. 58; 13; (2015); p. 5256 - 5273;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=66671735&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8826440,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8826440&database=RX&origin=ReaxysOutput&ln=,(106 of 327),1,69,full reaction; has preparation,pyrimidine-5-carbaldehyde,(Z)-pyrimidine-5-carbaldehyde oxime; (E)-pyrimidine-5-carbaldehyde oxime,272864; 272864,O=CC1=CN=CN=C1>>O\N=C/C1=CN=CN=C1.O\N=C\C1=CN=CN=C1,Preparation,,,,1,,,,,1,,,,Heating,,,,,,,,(E)-pyrimidine-5-carbaldehyde oxime,40 percent,40,,,hydroxylamine hydrochloride,,toluene,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9969092,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9969092&database=RX&origin=ReaxysOutput&ln=,(107 of 327),1,69,full reaction; has preparation,"2-amino-N-(1-benzo[1,3]dioxol-5-ylmethyl-piperidin-4-yl)-5-methoxy-benzamide; pyrimidine-5-carbaldehyde","N-(1-benzo[1,3]dioxol-5-ylmethyl-piperidin-4-yl)-5-methoxy-2-[(pyrimidin-5-ylmethyl)-amino]-benzamide",224501,COC1=CC(C(=O)NC2CCN(CC3=CC=C4OCOC4=C3)CC2)=C(N)C=C1.O=CC1=CN=CN=C1>>COC1=CC(C(=O)NC2CCN(CC3=CC=C4OCOC4=C3)CC2)=C(NCC2=CN=CN=C2)C=C1,Preparation,,,,1,,,,,12,50,,,,,,,,,,,,,,,,sodium tris(acetoxy)borohydride,,"N,N-dimethyl-formamide","Article; Vasudevan, Anil; LaMarche, Matthew J.; Blackburn, Christopher; Che, Jennifer Lee; Luchaco-Cullis, Courtney A.; Lai, Sujen; Marsilje, Thomas H.; Patane, Michael A.; Souers, Andrew J.; Wodka, Derek; Geddes, Bradley; Chen, Sumiao; Brodjian, Seven; Falls, Doug H.; Dayton, Brian D.; Bush, Eugene; Brune, Michael; Shapiro, Robin D.; Marsh, Kennan C.; Hernandez, Lisa E.; Sham, Hing L.; Collins, Christine A.; Kym, Philip R.; Bioorganic and Medicinal Chemistry Letters; vol. 15; 19; (2005); p. 4174 - 4179;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6511716&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
10730462,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=10730462&database=RX&origin=ReaxysOutput&ln=,(108 of 327),2,69,full reaction; has preparation,"6-chloro-N-(piperidin-4-yl)thieno[2,3-d]pyrimidin-4-amine; pyrimidine-5-carbaldehyde","6-Chloro-N-(1-((pyrimidin-5-yl)methyl)piperidin-4-yl)thieno[2,3-d]pyrimidin-4-amine, Monomaleate",228605,ClC1=CC2=C(NC3CCNCC3)N=CN=C2S1.O=CC1=CN=CN=C1>>OC(=O)\C=C/C(O)=O.ClC1=CC2=C(NC3CCN(CC4=CN=CN=C4)CC3)N=CN=C2S1,Preparation,62,"6-Chloro-N-(1-((pyrimidin-5-yl)methyl)piperidin-4-yl)thieno[2,3-d]pyrimidin-4-amine","EXAMPLE 62 6-Chloro-N-(1-((pyrimidin-5-yl)methyl)piperidin-4-yl)thieno[2,3-d]pyrimidin-4-amine The title compound was prepared (119 mg, 45%) from 6-chloro-N-(piperidin-4-yl)thieno[2,3-d]pyrimidin-4-amine (200 mg, 0.74 mmol) and pyrimidine-5-carbaldehyde (80 mg, 0.74 mmol) by following the general procedure described for Preparation 11. 1H NMR (400 MHz, CDCl3): d 9.05 (s, 1H), 8.65 (s, 2H), 8.35 (s, 1H), 7.00 (s, 1H), 5.50 (bs, 1H), 4.10 (m, 1H), 3.45 (s, 2H), 2.80 (m, 2H), 2.20 (m, 2H), 2.00 (m, 2H), 1.50 (m, 2H). MS (ESI) m/z: Calculated: 360.09. Observed: 361.1 (M++1).",1,,,,,,,,,,,,,,,,,,,,,,,,,"Patent; Dhanoa, Dale S.; Becker, Oren; Noiman, Silvia; Reddy, Sekar A.; Cheruku, Srinivasa Rao; Mele'ndez, Rosa E.; Sharadendu, Anurag; Chen, Dongli; Marantz, Yael; Shacham, Sharon; Heifetz, Alexander; Inbal, Boaz; Kesavan, Venkitasamy; Bar-Haim, Shay; US2005/222175; (2005); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=381490&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
10730462,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=10730462&database=RX&origin=ReaxysOutput&ln=,(108 of 327),2,69,full reaction; has preparation,"6-chloro-N-(piperidin-4-yl)thieno[2,3-d]pyrimidin-4-amine; pyrimidine-5-carbaldehyde","6-Chloro-N-(1-((pyrimidin-5-yl)methyl)piperidin-4-yl)thieno[2,3-d]pyrimidin-4-amine, Monomaleate",228605,ClC1=CC2=C(NC3CCNCC3)N=CN=C2S1.O=CC1=CN=CN=C1>>OC(=O)\C=C/C(O)=O.ClC1=CC2=C(NC3CCN(CC4=CN=CN=C4)CC3)N=CN=C2S1,Preparation,62,"6-Chloro-N-(1-((pyrimidin-5-yl)methyl)piperidin-4-yl)thieno[2,3-d]pyrimidin-4-amine","EXAMPLE 62 6-Chloro-N-(1-((pyrimidin-5-yl)methyl)piperidin-4-yl)thieno[2,3-d]pyrimidin-4-amine The title compound was prepared (119 mg, 45%) from 6-chloro-N-(piperidin-4-yl)thieno[2,3-d]pyrimidin-4-amine (200 mg, 0.74 mmol) and pyrimidine-5-carbaldehyde (80 mg, 0.74 mmol) by following the general procedure described for Preparation 11. 1H NMR (400 MHz, CDCl3): delta 9.05 (s, 1H), 8.65 (s, 2H), 8.35 (s, 1H), 7.00 (s, 1H), 5.50 (bs, 1H), 4.10 (m, 1H), 3.45 (s, 2H), 2.80 (m, 2H), 2.20 (m, 2H), 2.00 (m, 2H), 1.50 (m, 2H). MS (ESI) m/z: Calculated: 360.09; Observed: 361.1 (M++1).",1,,,,,,,,,,,,,,,,,,,,,,,,,"Patent; Dhanoa, Dale S.; Becker, Oren; Noiman, Silvia; Alla, Sekar Reddy; Cheruku, Srinivasa Rao; Mele'ndez, Rosa E.; Sharadendu, Anurag; Chen, Dongli; Marantz, Yael; Shacham, Sharon; Heifetz, Alexander; Inbal, Boaz; Kesavan, Venkitasamy; Bar-Haim, Shay; US2005/222176; (2005); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=381491&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13478803,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13478803&database=RX&origin=ReaxysOutput&ln=,(109 of 327),1,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(S)-1-pyrimidin-5-yl-7-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)hept-1-en-3-ol",,O=CC1=CN=CN=C1>>O[C@@H](CCCCC1=NC2=C(CCCN2)C=C1)\C=C\C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:13478803-Steps:9666689;9698273,1: 78 percent / K2CO3 / tetrahydrofuran / 1 h / Heating; 2: 52 percent / NaBH4 / methanol / 0.25 h,,,,,,,,,,,,,,1: Horner-Wadsworth-Emmons reaction,,,,,,sodium tetrahydroborate; potassium carbonate,,tetrahydrofuran; methanol,"Article; Coleman, Paul J; Brashear, Karen M; Askew, Ben C; Hutchinson, John H; McVean, Carol A; Duong; Feuston, Bradley P; Fernandez-Metzler, Carmen; Gentile, Michael A; Hartman, George D; Kimmel, Donald B; Leu, Chih-Tai; Lipfert, Lorraine; Merkle, Kara; Pennypacker, Brenda; Prueksaritanont, Thomayant; Rodan, Gideon A; Wesolowski, Gregg A; Rodan, Sevgi B; Duggan, Mark E; Journal of medicinal chemistry; vol. 47; 20; (2004); p. 4829 - 4837;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6460747&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13478805,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13478805&database=RX&origin=ReaxysOutput&ln=,(110 of 327),1,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(S)-3-pyrimidin-5-yl-9-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl)non-4-enoic acid ethyl ester",,O=CC1=CN=CN=C1>>CCOC(=O)C[C@H](\C=C\CCCCC1=NC2=C(CCCN2)C=C1)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:13478805-Steps:9666689;9698273;9665750,1: 78 percent / K2CO3 / tetrahydrofuran / 1 h / Heating; 2: 45 percent / NaBH4 / methanol / 0.25 h; 3: 98 percent / propionic acid / 2 h / 145 C,,,,,,,,,,,,,,1: Horner-Wadsworth-Emmons reaction / 3: Claisen rearrangement,,,,,,sodium tetrahydroborate; potassium carbonate; propionic acid,,tetrahydrofuran; methanol,"Article; Coleman, Paul J; Brashear, Karen M; Askew, Ben C; Hutchinson, John H; McVean, Carol A; Duong; Feuston, Bradley P; Fernandez-Metzler, Carmen; Gentile, Michael A; Hartman, George D; Kimmel, Donald B; Leu, Chih-Tai; Lipfert, Lorraine; Merkle, Kara; Pennypacker, Brenda; Prueksaritanont, Thomayant; Rodan, Gideon A; Wesolowski, Gregg A; Rodan, Sevgi B; Duggan, Mark E; Journal of medicinal chemistry; vol. 47; 20; (2004); p. 4829 - 4837;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6460747&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
25923004,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=25923004&database=RX&origin=ReaxysOutput&ln=,(111 of 327),1,69,full reaction; has preparation,C25H39ClN4O; pyrimidine-5-carbaldehyde,C30H43ClN6O,228705,CC(C)N1C[C@H]([C@@H](C1)C1=CC=C(Cl)C=C1)C(=O)N1CCN(CC1)C1(CN)CCCCC1.O=CC1=CN=CN=C1>>CC(C)N1C[C@H]([C@@H](C1)C1=CC=C(Cl)C=C1)C(=O)N1CCN(CC1)C1(CNCC2=CN=CN=C2)CCCCC1,Preparation,,,,1,,,,,16,20,,,,,,,,,,,,,,,,sodium tris(acetoxy)borohydride,,"1,2-dichloro-ethane","Article; Chen, Caroline W.; Tran, Joe A.; Fleck, Beth A.; Tucci, Fabio C.; Jiang, Wanlong; Chen, Chen; Bioorganic and Medicinal Chemistry Letters; vol. 17; 24; (2007); p. 6825 - 6831;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=7168811&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181138,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181138&database=RX&origin=ReaxysOutput&ln=,(112 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,ethyl N-(prop-2-yn-1-yl)-N-(pyrimidin-5-ylmethyl)carbamate,214869,O=CC1=CN=CN=C1>>CCOC(=O)N(CC#C)CC1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:36181138-Steps:8695846;36181142;36181135,"1: methanol; sodium tetrahydroborate / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: potassium hydroxide; N-benzyl-N,N,N-triethylammonium chloride / toluene / 20 C / Inert atmosphere",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; thionyl chloride; N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide",,dichloromethane; toluene,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; BUCKMELTER, Alexandre J.; CLODFELTER, Karl H.; DRAGOVICH, Peter; GOSSELIN, Francis; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; LIU, Xiongcai; REYNOLDS, Dominic J.; SMITH, Chase C.; WANG, Zhongguo; ZAK, Mark; ZHANG, Yamin; ZHAO, Guiling; ZHENG, Xiaozhang; YUEN, Po-Wai; WO2013/127266; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727359&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181138,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181138&database=RX&origin=ReaxysOutput&ln=,(112 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,ethyl N-(prop-2-yn-1-yl)-N-(pyrimidin-5-ylmethyl)carbamate,214869,O=CC1=CN=CN=C1>>CCOC(=O)N(CC#C)CC1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:36181138-Steps:8695846;36181142;36181135,"1: sodium tetrahydroborate; methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide / toluene / 20 C / Inert atmosphere",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; thionyl chloride; N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide",,dichloromethane; toluene,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; DRAGOVICH, Peter; GOSSELIN, Francis; YUEN, Po-Wai; ZAK, Mark; ZHENG, Xiaozhang; WO2013/127267; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727360&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181138,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181138&database=RX&origin=ReaxysOutput&ln=,(112 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,ethyl N-(prop-2-yn-1-yl)-N-(pyrimidin-5-ylmethyl)carbamate,214869,O=CC1=CN=CN=C1>>CCOC(=O)N(CC#C)CC1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:36181138-Steps:8695846;36181142;36181135,"1: sodium tetrahydroborate; methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide / toluene / 20 C / Inert atmosphere",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; thionyl chloride; N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide",,dichloromethane; toluene,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; GOSSELIN, Francis; ZAK, Mark; ZHENG, Xiaozhang; WO2013/130935; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727676&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181138,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181138&database=RX&origin=ReaxysOutput&ln=,(112 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,ethyl N-(prop-2-yn-1-yl)-N-(pyrimidin-5-ylmethyl)carbamate,214869,O=CC1=CN=CN=C1>>CCOC(=O)N(CC#C)CC1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:36181138-Steps:8695846;36181142;36181135,"1: sodium tetrahydroborate / methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide / toluene / 20 C / Inert atmosphere",,,,,,,,,,,,,,,,,,,,"sodium tetrahydroborate; thionyl chloride; N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide",,methanol; dichloromethane; toluene,"Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; BUCKMELTER, Alexandre, J.; CLODFELTER, Karl, H.; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; REYNOLDS, Dominic, J.; SMITH, Chase, C.; WANG, Zhongguo; ZAK, Mark; ZHENG, Xiaozhang; ZHAO, Guiling; WO2013/130943; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727677&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181139,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181139&database=RX&origin=ReaxysOutput&ln=,(113 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"ethyl 1H,2H,3H-pyrrolo[3,4-c]pyridine-2-carboxylate",198006,O=CC1=CN=CN=C1>>CCOC(=O)N1CC2=CC=NC=C2C1,Multi-step reaction,,,,4,Reaction-ID:36181139-Steps:8695846;36181142;36181135;36181150,"1: methanol; sodium tetrahydroborate / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: potassium hydroxide; N-benzyl-N,N,N-triethylammonium chloride / toluene / 20 C / Inert atmosphere; 4: 5,5-dimethyl-1,3-cyclohexadiene / 48 h / 150 C / Inert atmosphere",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; thionyl chloride; N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide",,"5,5-dimethyl-1,3-cyclohexadiene; dichloromethane; toluene","Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; BUCKMELTER, Alexandre J.; CLODFELTER, Karl H.; DRAGOVICH, Peter; GOSSELIN, Francis; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; LIU, Xiongcai; REYNOLDS, Dominic J.; SMITH, Chase C.; WANG, Zhongguo; ZAK, Mark; ZHANG, Yamin; ZHAO, Guiling; ZHENG, Xiaozhang; YUEN, Po-Wai; WO2013/127266; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727359&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181139,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181139&database=RX&origin=ReaxysOutput&ln=,(113 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"ethyl 1H,2H,3H-pyrrolo[3,4-c]pyridine-2-carboxylate",198006,O=CC1=CN=CN=C1>>CCOC(=O)N1CC2=CC=NC=C2C1,Multi-step reaction,,,,4,Reaction-ID:36181139-Steps:8695846;36181142;36181135;36181150,"1: sodium tetrahydroborate; methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide / toluene / 20 C / Inert atmosphere; 4: 5,5-dimethyl-1,3-cyclohexadiene / 48 h / 150 C / Inert atmosphere",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; thionyl chloride; N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide",,"5,5-dimethyl-1,3-cyclohexadiene; dichloromethane; toluene","Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; DRAGOVICH, Peter; GOSSELIN, Francis; YUEN, Po-Wai; ZAK, Mark; ZHENG, Xiaozhang; WO2013/127267; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727360&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181139,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181139&database=RX&origin=ReaxysOutput&ln=,(113 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"ethyl 1H,2H,3H-pyrrolo[3,4-c]pyridine-2-carboxylate",198006,O=CC1=CN=CN=C1>>CCOC(=O)N1CC2=CC=NC=C2C1,Multi-step reaction,,,,4,Reaction-ID:36181139-Steps:8695846;36181142;36181135;36181150,"1: sodium tetrahydroborate; methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide / toluene / 20 C / Inert atmosphere; 4: 5,5-dimethyl-1,3-cyclohexadiene / 48 h / 150 C / Inert atmosphere",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; thionyl chloride; N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide",,"5,5-dimethyl-1,3-cyclohexadiene; dichloromethane; toluene","Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; GOSSELIN, Francis; ZAK, Mark; ZHENG, Xiaozhang; WO2013/130935; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727676&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181139,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181139&database=RX&origin=ReaxysOutput&ln=,(113 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"ethyl 1H,2H,3H-pyrrolo[3,4-c]pyridine-2-carboxylate",198006,O=CC1=CN=CN=C1>>CCOC(=O)N1CC2=CC=NC=C2C1,Multi-step reaction,,,,4,Reaction-ID:36181139-Steps:8695846;36181142;36181135;36181150,"1: sodium tetrahydroborate / methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide / toluene / 20 C / Inert atmosphere; 4: 5,5-dimethyl-1,3-cyclohexadiene / 48 h / 150 C / Inert atmosphere",,,,,,,,,,,,,,,,,,,,"sodium tetrahydroborate; thionyl chloride; N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide",,"methanol; 5,5-dimethyl-1,3-cyclohexadiene; dichloromethane; toluene","Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; BUCKMELTER, Alexandre, J.; CLODFELTER, Karl, H.; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; REYNOLDS, Dominic, J.; SMITH, Chase, C.; WANG, Zhongguo; ZAK, Mark; ZHENG, Xiaozhang; ZHAO, Guiling; WO2013/130943; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727677&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181140,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181140&database=RX&origin=ReaxysOutput&ln=,(114 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,3-dihydro-1H-pyrrolo[3,4-c]pyridine",39159,O=CC1=CN=CN=C1>>C1NCC2=C1C=CN=C2,Multi-step reaction,,,,5,Reaction-ID:36181140-Steps:8695846;36181142;36181135;36181150;36181153,"1: methanol; sodium tetrahydroborate / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: potassium hydroxide; N-benzyl-N,N,N-triethylammonium chloride / toluene / 20 C / Inert atmosphere; 4: 5,5-dimethyl-1,3-cyclohexadiene / 48 h / 150 C / Inert atmosphere; 5: water; barium hydroxide / 120 C",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; thionyl chloride; barium hydroxide; N-benzyl-N,N,N-triethylammonium chloride; water; potassium hydroxide",,"5,5-dimethyl-1,3-cyclohexadiene; dichloromethane; toluene","Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; BUCKMELTER, Alexandre J.; CLODFELTER, Karl H.; DRAGOVICH, Peter; GOSSELIN, Francis; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; LIU, Xiongcai; REYNOLDS, Dominic J.; SMITH, Chase C.; WANG, Zhongguo; ZAK, Mark; ZHANG, Yamin; ZHAO, Guiling; ZHENG, Xiaozhang; YUEN, Po-Wai; WO2013/127266; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727359&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181140,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181140&database=RX&origin=ReaxysOutput&ln=,(114 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,3-dihydro-1H-pyrrolo[3,4-c]pyridine",39159,O=CC1=CN=CN=C1>>C1NCC2=C1C=CN=C2,Multi-step reaction,,,,5,Reaction-ID:36181140-Steps:8695846;36181142;36181135;36181150;36181153,"1: sodium tetrahydroborate; methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide / toluene / 20 C / Inert atmosphere; 4: 5,5-dimethyl-1,3-cyclohexadiene / 48 h / 150 C / Inert atmosphere; 5: barium hydroxide; water / 120 C",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; thionyl chloride; barium hydroxide; N-benzyl-N,N,N-triethylammonium chloride; water; potassium hydroxide",,"5,5-dimethyl-1,3-cyclohexadiene; dichloromethane; toluene","Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; DRAGOVICH, Peter; GOSSELIN, Francis; YUEN, Po-Wai; ZAK, Mark; ZHENG, Xiaozhang; WO2013/127267; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727360&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181140,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181140&database=RX&origin=ReaxysOutput&ln=,(114 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,3-dihydro-1H-pyrrolo[3,4-c]pyridine",39159,O=CC1=CN=CN=C1>>C1NCC2=C1C=CN=C2,Multi-step reaction,,,,5,Reaction-ID:36181140-Steps:8695846;36181142;36181135;36181150;36181153,"1: sodium tetrahydroborate; methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide / toluene / 20 C / Inert atmosphere; 4: 5,5-dimethyl-1,3-cyclohexadiene / 48 h / 150 C / Inert atmosphere; 5: barium(II) hydroxide / water / 120 C",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; thionyl chloride; N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide; barium(II) hydroxide",,"5,5-dimethyl-1,3-cyclohexadiene; dichloromethane; water; toluene","Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; GOSSELIN, Francis; ZAK, Mark; ZHENG, Xiaozhang; WO2013/130935; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727676&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181140,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181140&database=RX&origin=ReaxysOutput&ln=,(114 of 327),4,69,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,3-dihydro-1H-pyrrolo[3,4-c]pyridine",39159,O=CC1=CN=CN=C1>>C1NCC2=C1C=CN=C2,Multi-step reaction,,,,5,Reaction-ID:36181140-Steps:8695846;36181142;36181135;36181150;36181153,"1: sodium tetrahydroborate / methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide / toluene / 20 C / Inert atmosphere; 4: 5,5-dimethyl-1,3-cyclohexadiene / 48 h / 150 C / Inert atmosphere; 5: barium(II) hydroxide; water / 120 C",,,,,,,,,,,,,,,,,,,,"sodium tetrahydroborate; thionyl chloride; N-benzyl-N,N,N-triethylammonium chloride; water; potassium hydroxide; barium(II) hydroxide",,"methanol; 5,5-dimethyl-1,3-cyclohexadiene; dichloromethane; toluene","Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth, W.; BAUMEISTER, Timm, R.; BUCKMELTER, Alexandre, J.; CLODFELTER, Karl, H.; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; REYNOLDS, Dominic, J.; SMITH, Chase, C.; WANG, Zhongguo; ZAK, Mark; ZHENG, Xiaozhang; ZHAO, Guiling; WO2013/130943; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727677&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9448537,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9448537&database=RX&origin=ReaxysOutput&ln=,(115 of 327),1,68,full reaction; has preparation,pyrrole; pyrimidine-5-carbaldehyde,"5,10,15,20-tetrakis(3',5'-pyrimidyl)porphyrin",4134,N1C=CC=C1.O=CC1=CN=CN=C1>>N1C2=CC=C1\C(C1=CN=CN=C1)=C1\C=CC(=N\1)/C(C1=CN=CN=C1)=C1NC(/C=C\1)=C(\C1=N\C(\C=C1)=C/2C1=CN=CN=C1)C1=CN=CN=C1,Preparation,,,,1,,,,,1,,,,Heating,,,,,,,,"5,10,15,20-tetrakis(3',5'-pyrimidyl)porphyrin",1 percent,1,,,propionic acid,,,"Article; Zimmerman, Steven C.; Zharov, Ilya; Wendland, Michael S.; Rakow, Neal A.; Suslick, Kenneth S.; Journal of the American Chemical Society; vol. 125; 44; (2003); p. 13504 - 13518;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6423402&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49213619,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49213619&database=RX&origin=ReaxysOutput&ln=,(116 of 327),1,68,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-Triphenylmethyl-5(3-hydroxy-1,2,5-thiadiazol-4-yl)-1,4,5,6-tetrahydropyrimidine",87484,O=CC1=CN=CN=C1>>OC1=NSN=C1C1CN=CN(C1)C(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1,Multi-step reaction,,,,5,Reaction-ID:49213619-Steps:14306587;24727791;24727792;24719877;24727793,"1: ammonium chloride / methanol; water; 2: sodium carbonate / hydrogenchloride; 3: hydrogenchloride / Pd-on-carbon / water; 4: diaza-bicyclo-undecene / N,N-dimethyl-formamide; 5: ammonium hydroxide / pyridine",,,,,,,,,,,,,,,,,,,,hydrogenchloride; ammonium hydroxide; diaza-bicyclo-undecene; ammonium chloride; sodium carbonate,Pd-on-carbon,"pyridine; hydrogenchloride; methanol; water; N,N-dimethyl-formamide",Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49213620,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49213620&database=RX&origin=ReaxysOutput&ln=,(117 of 327),1,68,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"amino(1-triphenylmethyl-1,4,5,6-tetrahydropyrimidin-5-yl)acetamide",87167,O=CC1=CN=CN=C1>>NC(C1CN=CN(C1)C(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)C(N)=O,Multi-step reaction,,,,4,Reaction-ID:49213620-Steps:14306587;24727791;24727792;24719877,"1: ammonium chloride / methanol; water; 2: sodium carbonate / hydrogenchloride; 3: hydrogenchloride / Pd-on-carbon / water; 4: diaza-bicyclo-undecene / N,N-dimethyl-formamide",,,,,,,,,,,,,,,,,,,,hydrogenchloride; diaza-bicyclo-undecene; ammonium chloride; sodium carbonate,Pd-on-carbon,"hydrogenchloride; methanol; water; N,N-dimethyl-formamide",Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49213623,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49213623&database=RX&origin=ReaxysOutput&ln=,(118 of 327),1,68,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"Amino(1,4,5,6-tetrahydropyrimidine-5-yl)acetamide dihydrochloride",226387,O=CC1=CN=CN=C1>>Cl.NC(C1CNC=NC1)C(N)=O,Multi-step reaction,,,,3,Reaction-ID:49213623-Steps:14306587;24727791;24727792,1: ammonium chloride / methanol; water; 2: sodium carbonate / hydrogenchloride; 3: hydrogenchloride / Pd-on-carbon / water,,,,,,,,,,,,,,,,,,,,hydrogenchloride; ammonium chloride; sodium carbonate,Pd-on-carbon,hydrogenchloride; methanol; water,Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49213624,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49213624&database=RX&origin=ReaxysOutput&ln=,(119 of 327),1,68,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-Triphenylmethyl-5(3(1-n-heptanoxy)-1,2,5-thiadiazol-4-yl)-1,4,5,6-tetrahydropyrimidine HCl",87484,O=CC1=CN=CN=C1>>Cl[H].CCCCCCCOC1=NSN=C1C1CN=CN(C1)C(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1,Multi-step reaction,,,,6,Reaction-ID:49213624-Steps:14306587;24727791;24727792;24719877;24727793;24726080,"1: ammonium chloride / methanol; water; 2: sodium carbonate / hydrogenchloride; 3: hydrogenchloride / Pd-on-carbon / water; 4: diaza-bicyclo-undecene / N,N-dimethyl-formamide; 5: ammonium hydroxide / pyridine; 6: NaH / chloroform; N,N-dimethyl-formamide",,,,,,,,,,,,,,,,,,,,hydrogenchloride; ammonium hydroxide; NaH; diaza-bicyclo-undecene; ammonium chloride; sodium carbonate,Pd-on-carbon,"pyridine; hydrogenchloride; methanol; chloroform; water; N,N-dimethyl-formamide",Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
4885508,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=4885508&database=RX&origin=ReaxysOutput&ln=,(120 of 327),1,67,full reaction; has preparation,di-n-butylzinc; pyrimidine-5-carbaldehyde,(R)-1-Pyrimidin-5-yl-pentan-1-ol; (S)-1-Pyrimidin-5-yl-pentan-1-ol,217456; 217456,CCCC[Zn]CCCC.O=CC1=CN=CN=C1>>CCCC[C@@H](O)C1=CN=CN=C1.CCCC[C@H](O)C1=CN=CN=C1,Preparation,,,,1,,,,,32,0,,,,,,,,,,Yield given. Yields of byproduct given,,,,,,"(1S,2R)-(-)-2-(N,N-di-n-butylamino)-1-phenylpropan-1-ol",,toluene,"Article; Shibata, Takanori; Hayase, Tadakatsu; Aiba, Yasuyuki; Tabira, Hayami; Soai, Kenso; Heterocycles; vol. 46; 1; (1997); p. 235 - 240;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6086317&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
4885509,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=4885509&database=RX&origin=ReaxysOutput&ln=,(121 of 327),1,67,full reaction; has preparation,diethylzinc; pyrimidine-5-carbaldehyde,(R)-1-Pyrimidin-5-yl-propan-1-ol; (S)-1-Pyrimidin-5-yl-propan-1-ol,217456; 217456,CC[Zn]CC.O=CC1=CN=CN=C1.O=CC1=CN=CN=C1>>CC[C@@H](O)C1=CN=CN=C1.CC[C@H](O)C1=CN=CN=C1,Preparation,,,,1,,,,,3,0,,,,,,,,,,Yield given. Yields of byproduct given,,,,,,"(1S,2R)-(-)-2-(N,N-di-n-butylamino)-1-phenylpropan-1-ol",,toluene,"Article; Shibata, Takanori; Hayase, Tadakatsu; Aiba, Yasuyuki; Tabira, Hayami; Soai, Kenso; Heterocycles; vol. 46; 1; (1997); p. 235 - 240;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6086317&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9889372,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9889372&database=RX&origin=ReaxysOutput&ln=,(122 of 327),1,67,full reaction; has preparation,(5-fluoro-indan-1-yl)-triphenyl-phosphonium; bromide; pyrimidine-5-carbaldehyde,5-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyrimidine; 5-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyrimidine,170793; 170793,[Br-].FC1=CC=C2C(CCC2=C1)[P+](C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1.O=CC1=CN=CN=C1>>FC1=CC=C2\C(CCC2=C1)=C/C1=CN=CN=C1.FC1=CC=C2\C(CCC2=C1)=C\C1=CN=CN=C1,Preparation,,,,1,,,,,12,,,,Heating,Wittig reaction,,,,,,,,,,,,18-crown-6 ether; potassium carbonate,,dichloromethane,"Article; Ulmschneider, Sarah; Mueller-Vieira, Ursula; Klein, Christian D.; Antes, Iris; Lengauer, Thomas; Hartmann, Rolf W.; Journal of Medicinal Chemistry; vol. 48; 5; (2005); p. 1563 - 1575;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6498043&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15641714,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15641714&database=RX&origin=ReaxysOutput&ln=,(123 of 327),1,67,full reaction; has multi-step,pyrimidine-5-carbaldehyde,pyrimidin-5-ylmethyl methanesulfonate,197740,O=CC1=CN=CN=C1>>CS(=O)(=O)OCC1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:15641714-Steps:8695846;8695206,1: LiAlH4; 2: Et3N / CH2Cl2 / 1 h / -45 - -35 C,,,,,,,,,,,,,,,,,,,,lithium aluminium tetrahydride; triethylamine,,dichloromethane,Article; Sard; Gonzalez; Mahadevan; McKew; Journal of Organic Chemistry; vol. 65; 26; (2000); p. 9261 - 9264;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6262661&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15641715,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15641715&database=RX&origin=ReaxysOutput&ln=,(124 of 327),1,67,full reaction; has multi-step,pyrimidine-5-carbaldehyde,1-(5-methylpyrimidin-4-yl)-1H-indole,119779,O=CC1=CN=CN=C1>>CC1=CN=CN=C1N1C=CC2=C1C=CC=C2,Multi-step reaction,,,,3,Reaction-ID:15641715-Steps:8695846;8695206;8666717,1.1: LiAlH4; 2.1: Et3N / CH2Cl2 / 1 h / -45 - -35 C; 3.1: NaH / dimethylformamide / 1 h / 5 - 10 C; 3.2: 26 percent / dimethylformamide; CH2Cl2 / 18 h / 25 C,,,,,,,,,,,,,,,,,,,,lithium aluminium tetrahydride; sodium hydride; triethylamine,,"dichloromethane; N,N-dimethyl-formamide",Article; Sard; Gonzalez; Mahadevan; McKew; Journal of Organic Chemistry; vol. 65; 26; (2000); p. 9261 - 9264;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6262661&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15641716,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15641716&database=RX&origin=ReaxysOutput&ln=,(125 of 327),1,67,full reaction; has multi-step,pyrimidine-5-carbaldehyde,1-pyrimidin-5-ylmethyl-1H-indole,228604,O=CC1=CN=CN=C1>>C(N1C=CC2=C1C=CC=C2)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:15641716-Steps:8695846;8695206;8666717,1.1: LiAlH4; 2.1: Et3N / CH2Cl2 / 1 h / -45 - -35 C; 3.1: NaH / dimethylformamide / 1 h / 5 - 10 C; 3.2: 24 percent / dimethylformamide; CH2Cl2 / 18 h / 25 C,,,,,,,,,,,,,,,,,,,,lithium aluminium tetrahydride; sodium hydride; triethylamine,,"dichloromethane; N,N-dimethyl-formamide",Article; Sard; Gonzalez; Mahadevan; McKew; Journal of Organic Chemistry; vol. 65; 26; (2000); p. 9261 - 9264;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6262661&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563179,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563179&database=RX&origin=ReaxysOutput&ln=,(126 of 327),3,67,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3,4-dihydro-2,4-dioxo-1-(pyrimidin-5-ylmethyl)-3-(alpha,alpha,alpha-trifluoro-m-tolyl)-2H-pyrido[1,2-a]pyrimidin-1-ium-3-ide",203152,O=CC1=CN=CN=C1>>[O-]C1=C(C(=O)N2C=CC=CC2=[N+]1CC1=CN=CN=C1)C1=CC(=CC=C1)C(F)(F)F,Multi-step reaction,,,,3,Reaction-ID:33563179-Steps:33563182;33563201;33563193,1: chloroform / 0.25 h / 20 C; 2: sodium tetrahydroborate; methanol / tetrahydrofuran; 3: toluene / 6 h / 110 C,,,,,,,,,,,,,,,,,,,,methanol; sodium tetrahydroborate,,tetrahydrofuran; chloroform; toluene,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; PAHUTSKI, Thomas, Francis., Jr.; WO2012/92115; (2012); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20156312&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563179,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563179&database=RX&origin=ReaxysOutput&ln=,(126 of 327),3,67,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3,4-dihydro-2,4-dioxo-1-(pyrimidin-5-ylmethyl)-3-(alpha,alpha,alpha-trifluoro-m-tolyl)-2H-pyrido[1,2-a]pyrimidin-1-ium-3-ide",203152,O=CC1=CN=CN=C1>>[O-]C1=C(C(=O)N2C=CC=CC2=[N+]1CC1=CN=CN=C1)C1=CC(=CC=C1)C(F)(F)F,Multi-step reaction,,,,3,Reaction-ID:33563179-Steps:33563182;33563201;35776138,1: chloroform / 0.25 h / 20 C; 2: methanol; sodium tetrahydroborate / tetrahydrofuran; 3: triethylamine / hexane / 0.5 h / 3 - 20 C,,,,,,,,,,,,,,,,,,,,methanol; sodium tetrahydroborate; triethylamine,,tetrahydrofuran; hexane; chloroform,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; ZHANG, Wenming; ANNIS, Gary David; WO2013/90547; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=35495458&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563179,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563179&database=RX&origin=ReaxysOutput&ln=,(126 of 327),3,67,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3,4-dihydro-2,4-dioxo-1-(pyrimidin-5-ylmethyl)-3-(alpha,alpha,alpha-trifluoro-m-tolyl)-2H-pyrido[1,2-a]pyrimidin-1-ium-3-ide",203152,O=CC1=CN=CN=C1>>[O-]C1=C(C(=O)N2C=CC=CC2=[N+]1CC1=CN=CN=C1)C1=CC(=CC=C1)C(F)(F)F,Multi-step reaction,,,,3,Reaction-ID:33563179-Steps:33563182;33563201;35776138,1: chloroform / 25 C; 2: sodium tetrahydroborate / methanol; tetrahydrofuran / 20 C; 3: triethylamine / toluene / 3 - 25 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; triethylamine,,tetrahydrofuran; methanol; chloroform; toluene,"Article; Zhang, Wenming; Holyoke, Caleb W.; Pahutski, Thomas F.; Lahm, George P.; Barry, James D.; Cordova, Daniel; Leighty, Robert M.; Singh, Vineet; Vicent, Daniel R.; Tong, My-Hanh T.; Hughes, Kenneth A.; McCann, Stephen F.; Henry, Yewande T.; Xu, Ming; Briddell, Twyla A.; Bioorganic and Medicinal Chemistry Letters; vol. 27; 1; (2017); p. 16 - 20;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=70183534&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
39009941,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=39009941&database=RX&origin=ReaxysOutput&ln=,(127 of 327),1,67,full reaction; has preparation,C11H11ClO3S; pyrimidine-5-carbaldehyde,C16H15ClN2O4S,229180,COC(=O)C(SC1=C(Cl)C=CC=C1)=C(C)O.O=CC1=CN=CN=C1>>COC(=O)C(SC1=C(Cl)C=CC=C1)=C(O)CC(O)C1=CN=CN=C1,Preparation,,,,1,,,2,,,0,,,,,,,,Scheme or table,,,,,,,C11H11ClO3S; pyrimidine-5-carbaldehyde,lithium diisopropyl amide,,tetrahydrofuran,"Article; Fauber, Benjamin P.; Dragovich, Peter S.; Chen, Jinhua; Corson, Laura B.; Ding, Charles Z.; Eigenbrot, Charles; Labadie, Sharada; Malek, Shiva; Peterson, David; Purkey, Hans E.; Robarge, Kirk; Sideris, Steve; Ultsch, Mark; Wei, Binqing; Yen, Ivana; Yue, Qin; Zhou, Aihe; Bioorganic and Medicinal Chemistry Letters; vol. 24; 24; (2014); p. 5683 - 5687;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=64347593&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
41046214,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=41046214&database=RX&origin=ReaxysOutput&ln=,(128 of 327),1,67,full reaction; has preparation,tert-butyl (2-((2-amino-4-carbamoylphenyl)amino)ethyl)carbamate; pyrimidine-5-carbaldehyde,C19H22N6O3,150523,CC(C)(C)OC(=O)NCCNC1=C(N)C=C(C=C1)C(N)=O.O=CC1=CN=CN=C1>>CC(C)(C)OC(=O)NCCN1C2=CC=C(C=C2N=C1C1=CN=CN=C1)C(N)=O,Preparation,,,,1,,,,,1,60,,,Reflux,,,,,Experimental part,,,,,,,,sodium hydrogensulfite,,methanol,"Article; Kim, Mi Kyoung; Shin, Heerim; Park, Kwang-Su; Kim, Hyungmi; Park, Jiseon; Kim, Kangjeon; Nam, Joonwoo; Choo, Hyunah; Chong, Youhoon; Journal of Medicinal Chemistry; vol. 58; 18; (2015); p. 7596 - 7602;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=67161148&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
43497853,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=43497853&database=RX&origin=ReaxysOutput&ln=,(129 of 327),1,67,full reaction; has preparation,isobutylamine; pyrimidine-5-carbaldehyde,C9H13N3,152038,CC(C)CN.O=CC1=CN=CN=C1>>CC(C)CN=CC1=CN=CN=C1,Preparation,,,,1,,,,,4,25,,,,,,,,Experimental part,,,,,,,,acetic acid,,methanol,"Article; Floyd, David M.; Stein, Philip; Wang, Zheng; Liu, Jian; Castro, Steve; Clark, Julie A.; Connelly, Michele; Zhu, Fangyi; Holbrook, Gloria; Matheny, Amy; Sigal, Martina S.; Min, Jaeki; Dhinakaran, Rajkumar; Krishnan, Senthil; Bashyum, Sridevi; Knapp, Spencer; Guy, R. Kiplin; Journal of Medicinal Chemistry; vol. 59; 17; (2016); p. 7950 - 7962;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=69594455&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
43836367,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=43836367&database=RX&origin=ReaxysOutput&ln=,(130 of 327),1,67,full reaction; has preparation,phenylmagnesium chloride; pyrimidine-5-carbaldehyde,C11H9ClN2,291477,Cl[Mg]C1=CC=CC=C1.O=CC1=CN=CN=C1>>ClC(C1=CC=CC=C1)C1=CN=CN=C1,Preparation,,,,1,,,2,,1; 2,20,,,,,,,,Scheme or table,,,,,,,phenylmagnesium chloride; pyrimidine-5-carbaldehyde,thionyl chloride,,tetrahydrofuran; dichloromethane,"Article; Labeeuw, Olivier; Levoin, Nicolas; Billot, Xavier; Danvy, Denis; Calmels, Thierry; Krief, Stephane; Ligneau, Xavier; Berrebi-Bertrand, Isabelle; Robert, Philippe; Lecomte, Jeanne-Marie; Schwartz, Jean-Charles; Capet, Marc; Bioorganic and Medicinal Chemistry Letters; vol. 26; 21; (2016); p. 5263 - 5266;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=69857018&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48070228,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48070228&database=RX&origin=ReaxysOutput&ln=,(131 of 327),1,67,full reaction; has preparation,C20H21F4N3O; pyrimidine-5-carbaldehyde,S(086)J001620-1,228605,FC1=CC(NC(=O)N(CC2=CC=CC=C2)C2CCNCC2)=CC(=C1)C(F)(F)F.O=CC1=CN=CN=C1>>FC1=CC(NC(=O)N(CC2=CC=CC=C2)C2CCN(CC3=CN=CN=C3)CC2)=CC(=C1)C(F)(F)F,Preparation,,,,1,,,,,16,20,,,,,,,,Experimental part,,,,,,,,phenylsilane; dibutyltin chloride,,tetrahydrofuran,"Article; Hammill, Jared T.; Bhasin, Deepak; Scott, Daniel C.; Min, Jaeki; Chen, Yizhe; Lu, Yan; Yang, Lei; Kim, Ho Shin; Connelly, Michele C.; Hammill, Courtney; Holbrook, Gloria; Jeffries, Cynthia; Singh, Bhuvanesh; Schulman, Brenda A.; Guy, R. Kiplin; Journal of Medicinal Chemistry; vol. 61; 7; (2018); p. 2694 - 2706;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73636351&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48106043,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48106043&database=RX&origin=ReaxysOutput&ln=,(132 of 327),1,67,full reaction; has preparation,1H-indazol-5-ylamine; cyclohexanone; pyrimidine-5-carbaldehyde,"7-(pyrimidin-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine",148778,NC1=CC2=C(NN=C2)C=C1.O=C1CCCCC1.O=CC1=CN=CN=C1>>C1CCC2=C(C1)C(=NC1=CC=C3NN=CC3=C21)C1=CN=CN=C1,Preparation,,,,1,,,,,12,,,,Reflux,,,,,Experimental part,supporting information,,"7-(pyrimidin-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine",48 percent,48,,,hydrogenchloride,,ethanol,"Article; Opoku-Temeng, Clement; Dayal, Neetu; Hernandez, Delmis E.; Naganna; Sintim, Herman O.; Chemical Communications; vol. 54; 36; (2018); p. 4521 - 4524;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73760168&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48953969,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48953969&database=RX&origin=ReaxysOutput&ln=,(133 of 327),1,66,full reaction; has preparation,D-Alanine; pyrimidine-5-carbaldehyde,C8H11N3O3; C8H11N3O3,224880; 224880,[H][C@](C)(N)C(O)=O.O=CC1=CN=CN=C1.O=CC1=CN=CN=C1.[H][C@](C)(N)C(O)=O>>C[C@@](N)([C@@H](O)C1=CN=CN=C1)C(O)=O.CC(N)(C(O)C1=CN=CN=C1)C(O)=O,Preparation,,,,1,,,,,24,30,,8,Enzymatic reaction,,,,,Scheme or table,,diastereoselective reaction,,,,> 99.5 percent ee,,pyridoxal 5'-phosphate; D-threonine aldolase from pseudomonas sp,,aq. phosphate buffer,"Article; Blesl, Julia; Trobe, Melanie; Anderl, Felix; Breinbauer, Rolf; Strohmeier, Gernot A.; Fesko, Kateryna; ChemCatChem; vol. 10; 16; (2018); p. 3453 - 3458;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74459461&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
48953971,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=48953971&database=RX&origin=ReaxysOutput&ln=,(134 of 327),1,66,full reaction; has preparation,D-Alanine; pyrimidine-5-carbaldehyde,C8H11N3O3; C8H11N3O3,224880; 224880,[H][C@](C)(N)C(O)=O.O=CC1=CN=CN=C1.O=CC1=CN=CN=C1.[H][C@](C)(N)C(O)=O>>C[C@](N)([C@H](O)C1=CN=CN=C1)C(O)=O.CC(N)(C(O)C1=CN=CN=C1)C(O)=O,Preparation,,,,1,,,,,24,30,,8,Enzymatic reaction,,,,,Scheme or table,,diastereoselective reaction,,,,> 99.5 percent ee,,pyridoxal 5'-phosphate; L-threonine aldolase from aeromonas jandaei,,aq. phosphate buffer,"Article; Blesl, Julia; Trobe, Melanie; Anderl, Felix; Breinbauer, Rolf; Strohmeier, Gernot A.; Fesko, Kateryna; ChemCatChem; vol. 10; 16; (2018); p. 3453 - 3458;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74459461&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8826439,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8826439&database=RX&origin=ReaxysOutput&ln=,(135 of 327),1,65,full reaction; has preparation,N-methoxylamine hydrochloride; pyrimidine-5-carbaldehyde,(Z)-pyrimidine-5-carbaldehyde O-methyloxime; (E)-pyrimidine-5-carbaldehyde O-methyloxime,152561; 152561,Cl[H].CON.O=CC1=CN=CN=C1.O=CC1=CN=CN=C1.Cl[H].CON>>CO\N=C/C1=CN=CN=C1.CO\N=C\C1=CN=CN=C1,Preparation,,,,1,,,,,2,,,,Heating,,,,,,,,(E)-pyrimidine-5-carbaldehyde O-methyloxime,62 percent,62,,,,,benzene,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13096458,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13096458&database=RX&origin=ReaxysOutput&ln=,(136 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,2-pyrimidin-5-ylmethyl-1-aza-bicyclo[2.2.2]octan-3-one,25144,O=CC1=CN=CN=C1>>O=C1C2CCN(CC2)C1CC1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:13096458-Steps:9866976;9847771,1: KOH; 2: H2 / Pd/C,,,,,,,,,,,,,,,,,,,,potassium hydroxide; hydrogen,palladium on activated charcoal,,"Article; Mazurov, Anatoly; Klucik, Jozef; Miao, Lan; Phillips, Teresa Y.; Seamans, Angela; Schmitt, Jeffrey D.; Hauser, Terry A.; Johnson Jr., Raymond T.; Miller, Craig; Bioorganic and Medicinal Chemistry Letters; vol. 15; 8; (2005); p. 2073 - 2077;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6499431&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13096459,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13096459&database=RX&origin=ReaxysOutput&ln=,(137 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(2S,3R)-2-Pyrimidin-5-ylmethyl-1-aza-bicyclo[2.2.2]octan-3-ol",25144,O=CC1=CN=CN=C1>>O[C@@H]1C2CCN(CC2)[C@H]1CC1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:13096459-Steps:9866976;9847771;9847287,1: KOH; 2: H2 / Pd/C; 3: Al(O-i-Pr)3,,,,,,,,,,,,,,,,,,,,potassium hydroxide; hydrogen; aluminum isopropoxide,palladium on activated charcoal,,"Article; Mazurov, Anatoly; Klucik, Jozef; Miao, Lan; Phillips, Teresa Y.; Seamans, Angela; Schmitt, Jeffrey D.; Hauser, Terry A.; Johnson Jr., Raymond T.; Miller, Craig; Bioorganic and Medicinal Chemistry Letters; vol. 15; 8; (2005); p. 2073 - 2077;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6499431&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13096460,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13096460&database=RX&origin=ReaxysOutput&ln=,(138 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(2S,3S)-2-Pyrimidin-5-ylmethyl-1-aza-bicyclo[2.2.2]octan-3-ol",25144,O=CC1=CN=CN=C1>>O[C@H]1C2CCN(CC2)[C@H]1CC1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:13096460-Steps:9866976;9847771;9847287,1: KOH; 2: H2 / Pd/C; 3: Al(O-i-Pr)3,,,,,,,,,,,,,,,,,,,,potassium hydroxide; hydrogen; aluminum isopropoxide,palladium on activated charcoal,,"Article; Mazurov, Anatoly; Klucik, Jozef; Miao, Lan; Phillips, Teresa Y.; Seamans, Angela; Schmitt, Jeffrey D.; Hauser, Terry A.; Johnson Jr., Raymond T.; Miller, Craig; Bioorganic and Medicinal Chemistry Letters; vol. 15; 8; (2005); p. 2073 - 2077;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6499431&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13096461,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13096461&database=RX&origin=ReaxysOutput&ln=,(139 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(4-Bromo-phenyl)-carbamic acid (2R,3R)-2-pyrimidin-5-ylmethyl-1-aza-bicyclo[2.2.2]oct-3-yl ester",27768,O=CC1=CN=CN=C1>>BrC1=CC=C(NC(=O)O[C@@H]2C3CCN(CC3)[C@@H]2CC2=CN=CN=C2)C=C1,Multi-step reaction,,,,4,Reaction-ID:13096461-Steps:9866976;9847771;9847287;9889769,1: KOH; 2: H2 / Pd/C; 3: Al(O-i-Pr)3,,,,,,,,,,,,,,,,,,,,potassium hydroxide; hydrogen; aluminum isopropoxide,palladium on activated charcoal,,"Article; Mazurov, Anatoly; Klucik, Jozef; Miao, Lan; Phillips, Teresa Y.; Seamans, Angela; Schmitt, Jeffrey D.; Hauser, Terry A.; Johnson Jr., Raymond T.; Miller, Craig; Bioorganic and Medicinal Chemistry Letters; vol. 15; 8; (2005); p. 2073 - 2077;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6499431&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345974,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345974&database=RX&origin=ReaxysOutput&ln=,(140 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,2,2-trifluoro-N-[3-(hydroxymethyl)phenyl]-N-(pyrimidin-5-ylmethyl)ethane-sulfonamide",224483,O=CC1=CN=CN=C1>>OCC1=CC=CC(=C1)N(CC1=CN=CN=C1)S(=O)(=O)CC(F)(F)F,Multi-step reaction,,,,3,Reaction-ID:13345974-Steps:9733334;9721380;9753618,"1: pyridine / 1,2-dichloro-ethane; 2: TBAF; acetic acid",,,,,,,,,,,,,,,,,,,,pyridine; tetrabutyl ammonium fluoride; acetic acid,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345975,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345975&database=RX&origin=ReaxysOutput&ln=,(141 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"N-(3-benzylphenyl)-2,2,2-trifluoro-N-(pyrimidin-5-ylmethyl)ethane-sulfonamide",224483,O=CC1=CN=CN=C1>>FC(F)(F)CS(=O)(=O)N(CC1=CN=CN=C1)C1=CC(CC2=CC=CC=C2)=CC=C1,Multi-step reaction,,,,2,Reaction-ID:13345975-Steps:9733330;9721373,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345976,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345976&database=RX&origin=ReaxysOutput&ln=,(142 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,2,2-trifluoro-N-(3-phenoxyphenyl)-N-(pyrimidin-5-ylmethyl)ethane-sulfonamide",224483,O=CC1=CN=CN=C1>>FC(F)(F)CS(=O)(=O)N(CC1=CN=CN=C1)C1=CC(OC2=CC=CC=C2)=CC=C1,Multi-step reaction,,,,2,Reaction-ID:13345976-Steps:9733337;9721370,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345977,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345977&database=RX&origin=ReaxysOutput&ln=,(143 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,2,2-trifluoro-N-(4-phenoxyphenyl)-N-(pyrimidin-5-ylmethyl)ethanesulfonamide",224483,O=CC1=CN=CN=C1>>FC(F)(F)CS(=O)(=O)N(CC1=CN=CN=C1)C1=CC=C(OC2=CC=CC=C2)C=C1,Multi-step reaction,,,,2,Reaction-ID:13345977-Steps:9733336;9721371,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345978,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345978&database=RX&origin=ReaxysOutput&ln=,(144 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,2,2-trifluoro-N-[3-(1-methylbutoxy)phenyl]-N-(pyrimidin-5-ylmethyl)ethanesulfonamide",,O=CC1=CN=CN=C1>>CCCC(C)OC1=CC=CC(=C1)N(CC1=CN=CN=C1)S(=O)(=O)CC(F)(F)F,Multi-step reaction,,,,2,Reaction-ID:13345978-Steps:9733328;9721372,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345979,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345979&database=RX&origin=ReaxysOutput&ln=,(145 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,2,2-trifluoro-N-[3-(2-methylphenoxy)phenyl]-N-(pyrimidin-5-ylmethyl)ethane-sulfonamide",224483,O=CC1=CN=CN=C1>>CC1=CC=CC=C1OC1=CC=CC(=C1)N(CC1=CN=CN=C1)S(=O)(=O)CC(F)(F)F,Multi-step reaction,,,,2,Reaction-ID:13345979-Steps:9733331;9721377,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345980,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345980&database=RX&origin=ReaxysOutput&ln=,(146 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,2,2-trifluoro-N-[3-(phenoxymethyl)phenyl]-N-(pyrimidin-5-ylmethyl)ethane-sulfonamide",224483,O=CC1=CN=CN=C1>>FC(F)(F)CS(=O)(=O)N(CC1=CN=CN=C1)C1=CC(COC2=CC=CC=C2)=CC=C1,Multi-step reaction,,,,2,Reaction-ID:13345980-Steps:9733329;9721376,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345981,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345981&database=RX&origin=ReaxysOutput&ln=,(147 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,2,2-trifluoro-N-[3-(2-methoxyphenoxy)phenyl]-N-(pyrimidin-5-ylmethyl)ethanesulfonamide",224483,O=CC1=CN=CN=C1>>COC1=CC=CC=C1OC1=CC=CC(=C1)N(CC1=CN=CN=C1)S(=O)(=O)CC(F)(F)F,Multi-step reaction,,,,2,Reaction-ID:13345981-Steps:9733332;9721375,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345982,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345982&database=RX&origin=ReaxysOutput&ln=,(148 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"N-[3-(cyclopentyloxy)phenyl]-2,2,2-trifluoro-N-(pyrimidin-5-ylmethyl)ethanesulfonamide",,O=CC1=CN=CN=C1>>FC(F)(F)CS(=O)(=O)N(CC1=CN=CN=C1)C1=CC(OC2CCCC2)=CC=C1,Multi-step reaction,,,,2,Reaction-ID:13345982-Steps:9733333;9721374,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345983,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345983&database=RX&origin=ReaxysOutput&ln=,(149 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,2,2-trifluoro-N-[3-(2-fluorophenoxy)phenyl]-N-(pyrimidin-5-ylmethyl)ethane-sulfonamide",224483,O=CC1=CN=CN=C1>>FC1=CC=CC=C1OC1=CC=CC(=C1)N(CC1=CN=CN=C1)S(=O)(=O)CC(F)(F)F,Multi-step reaction,,,,2,Reaction-ID:13345983-Steps:9733338;9721378,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345984,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345984&database=RX&origin=ReaxysOutput&ln=,(150 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"N-[3-(2-bromophenoxy)phenyl]-2,2,2-trifluoro-N-(pyrimidin-5-ylmethyl)ethanesulfonamide",224483,O=CC1=CN=CN=C1>>FC(F)(F)CS(=O)(=O)N(CC1=CN=CN=C1)C1=CC(OC2=CC=CC=C2Br)=CC=C1,Multi-step reaction,,,,2,Reaction-ID:13345984-Steps:9733339;9721379,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345985,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345985&database=RX&origin=ReaxysOutput&ln=,(151 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-{(pyrimidin-5-ylmethyl)[(2,2,2-trifluoroethyl)sulfonyl]amino}benzyl benzoate",224483,O=CC1=CN=CN=C1>>FC(F)(F)CS(=O)(=O)N(CC1=CN=CN=C1)C1=CC(COC(=O)C2=CC=CC=C2)=CC=C1,Multi-step reaction,,,,4,Reaction-ID:13345985-Steps:9733334;9721380;9753618;9730929,"1: pyridine / 1,2-dichloro-ethane; 2: TBAF; acetic acid",,,,,,,,,,,,,,,,,,,,pyridine; tetrabutyl ammonium fluoride; acetic acid,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345986,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345986&database=RX&origin=ReaxysOutput&ln=,(152 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"N-[3-({[tert-butyl(dimethyl)silyl]oxy}-methyl)phenyl]-2,2,2-trifluoro-N-(pyrimidin-5-ylmethyl)ethanesulfonamide",224483,O=CC1=CN=CN=C1>>CC(C)(C)[Si](C)(C)OCC1=CC=CC(=C1)N(CC1=CN=CN=C1)S(=O)(=O)CC(F)(F)F,Multi-step reaction,,,,2,Reaction-ID:13345986-Steps:9733334;9721380,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
13345987,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=13345987&database=RX&origin=ReaxysOutput&ln=,(153 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"2,2,2-trifluoro-N-(pyrimidin-5-ylmethyl)-N-{3-[2-(trifluoromethyl)benzyl]phenyl}ethanesulfonamide",224483,O=CC1=CN=CN=C1>>FC(F)(F)CS(=O)(=O)N(CC1=CN=CN=C1)C1=CC(CC2=CC=CC=C2C(F)(F)F)=CC=C1,Multi-step reaction,,,,2,Reaction-ID:13345987-Steps:9733340;9721381,"1: pyridine / 1,2-dichloro-ethane",,,,,,,,,,,,,,,,,,,,pyridine,,"1,2-dichloro-ethane","Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306588,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306588&database=RX&origin=ReaxysOutput&ln=,(154 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-chloro-[1,2,5]thiadiazol-3-yl)pyrimidine; isobutyl halide",272219,O=CC1=CN=CN=C1>>ClC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:14306588-Steps:8570487;8583586;8583609,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306589,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306589&database=RX&origin=ReaxysOutput&ln=,(155 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-methylsulfanyl-[1,2,5]thiadiazol-3-yl)-pyrimidine",272375,O=CC1=CN=CN=C1>>CSC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:14306589-Steps:8570487;8583586;8583609;9376616,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 47 percent / K2CO3 / dimethylformamide / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306590,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306590&database=RX&origin=ReaxysOutput&ln=,(156 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-ethylsulfanyl-[1,2,5]thiadiazol-3-yl)-pyrimidine",272375,O=CC1=CN=CN=C1>>CCSC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:14306590-Steps:8570487;8583586;8583609;9376367,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 71 percent / K2CO3 / dimethylformamide / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306591,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306591&database=RX&origin=ReaxysOutput&ln=,(157 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-allylsulfanyl-[1,2,5]thiadiazol-3-yl)-pyrimidine",272375,O=CC1=CN=CN=C1>>C=CCSC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:14306591-Steps:8570487;8583586;8583609;9375954,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 64 percent / K2CO3 / dimethylformamide / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306592,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306592&database=RX&origin=ReaxysOutput&ln=,(158 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-isobutylsulfanyl-[1,2,5]thiadiazol-3-yl)-pyrimidine",272375,O=CC1=CN=CN=C1>>CC(C)CSC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:14306592-Steps:8570487;8583586;8583609;9376507,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 79 percent / K2CO3 / dimethylformamide / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306593,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306593&database=RX&origin=ReaxysOutput&ln=,(159 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-prop-2-ynylsulfanyl-[1,2,5]thiadiazol-3-yl)-pyrimidine",272375,O=CC1=CN=CN=C1>>C#CCSC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:14306593-Steps:8570487;8583586;8583609;9376942,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 73 percent / K2CO3 / dimethylformamide / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306594,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306594&database=RX&origin=ReaxysOutput&ln=,(160 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-pentylsulfanyl-[1,2,5]thiadiazol-3-yl)-pyrimidine",272375,O=CC1=CN=CN=C1>>CCCCCSC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:14306594-Steps:8570487;8583586;8583609;9376718,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 73 percent / K2CO3 / dimethylformamide / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306595,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306595&database=RX&origin=ReaxysOutput&ln=,(161 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-benzylsulfanyl-[1,2,5]thiadiazol-3-yl)-pyrimidine",272375,O=CC1=CN=CN=C1>>C(SC1=NSN=C1C1=CN=CN=C1)C1=CC=CC=C1,Multi-step reaction,,,,4,Reaction-ID:14306595-Steps:8570487;8583586;8583609;9376001,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 53 percent / K2CO3 / dimethylformamide / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306596,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306596&database=RX&origin=ReaxysOutput&ln=,(162 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-[4-(4-methyl-benzylsulfanyl)-[1,2,5]thiadiazol-3-yl]-pyrimidine",272375,O=CC1=CN=CN=C1>>CC1=CC=C(CSC2=NSN=C2C2=CN=CN=C2)C=C1,Multi-step reaction,,,,4,Reaction-ID:14306596-Steps:8570487;8583586;8583609;9326646,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 72 percent / K2CO3 / dimethylformamide / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306597,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306597&database=RX&origin=ReaxysOutput&ln=,(163 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-[4-(4-chloro-benzylsulfanyl)-[1,2,5]thiadiazol-3-yl]-pyrimidine",272375,O=CC1=CN=CN=C1>>ClC1=CC=C(CSC2=NSN=C2C2=CN=CN=C2)C=C1,Multi-step reaction,,,,4,Reaction-ID:14306597-Steps:8570487;8583586;8583609;9326606,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 72 percent / K2CO3 / dimethylformamide / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306598,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306598&database=RX&origin=ReaxysOutput&ln=,(164 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-methyl-5-(4-methylsulfanyl-[1,2,5]thiadiazol-3-yl)-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].CSC1=NSN=C1C1=CN=C[N+](C)=C1,Multi-step reaction,,,,5,Reaction-ID:14306598-Steps:8570487;8583586;8583609;9376616;9374470,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 47 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306599,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306599&database=RX&origin=ReaxysOutput&ln=,(165 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-5-(4-methylsulfanyl-[1,2,5]thiadiazol-3-yl)-1,2,3,4-tetrahydro-pyrimidine; compound with oxalic acid",87484,O=CC1=CN=CN=C1>>OC(=O)C(O)=O.CSC1=NSN=C1C1=CNCN(C)C1,Multi-step reaction,,,,6,Reaction-ID:14306599-Steps:8570487;8583586;8583609;9376616;9374470;9319804,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 47 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating; 6.1: NaBH4 / methanol / 0 - 30 C; 6.2: methanol / 1 h / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium hydrogensulfide; ammonium chloride,,"methanol; water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306600,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306600&database=RX&origin=ReaxysOutput&ln=,(166 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-ethylsulfanyl-[1,2,5]thiadiazol-3-yl)-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].CCSC1=NSN=C1C1=CN=C[N+](C)=C1,Multi-step reaction,,,,5,Reaction-ID:14306600-Steps:8570487;8583586;8583609;9376367;9374488,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 71 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306601,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306601&database=RX&origin=ReaxysOutput&ln=,(167 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-isobutylsulfanyl-[1,2,5]thiadiazol-3-yl)-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].CC(C)CSC1=NSN=C1C1=CN=C[N+](C)=C1,Multi-step reaction,,,,5,Reaction-ID:14306601-Steps:8570487;8583586;8583609;9376507;9374513,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 79 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306602,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306602&database=RX&origin=ReaxysOutput&ln=,(168 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-ethylsulfanyl-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydro-pyrimidine; compound with oxalic acid",87484,O=CC1=CN=CN=C1>>OC(=O)C(O)=O.CCSC1=NSN=C1C1=CNCN(C)C1,Multi-step reaction,,,,6,Reaction-ID:14306602-Steps:8570487;8583586;8583609;9376367;9374488;9319805,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 71 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating; 6.1: NaBH4 / methanol / 0 - 30 C; 6.2: methanol / 1 h / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium hydrogensulfide; ammonium chloride,,"methanol; water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306603,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306603&database=RX&origin=ReaxysOutput&ln=,(169 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-allylsulfanyl-[1,2,5]thiadiazol-3-yl)-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].C[N+]1=CC(=CN=C1)C1=NSN=C1SCC=C,Multi-step reaction,,,,5,Reaction-ID:14306603-Steps:8570487;8583586;8583609;9375954;9374506,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 64 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306604,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306604&database=RX&origin=ReaxysOutput&ln=,(170 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-allylsulfanyl-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydro-pyrimidine; compound with oxalic acid",87484,O=CC1=CN=CN=C1>>OC(=O)C(O)=O.CN1CNC=C(C1)C1=NSN=C1SCC=C,Multi-step reaction,,,,6,Reaction-ID:14306604-Steps:8570487;8583586;8583609;9375954;9374506;9319807,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 64 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating; 6.1: NaBH4 / methanol / 0 - 30 C; 6.2: methanol / 1 h / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium hydrogensulfide; ammonium chloride,,"methanol; water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306605,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306605&database=RX&origin=ReaxysOutput&ln=,(171 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-isobutylsulfanyl-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydro-pyrimidine; compound with oxalic acid",87484,O=CC1=CN=CN=C1>>OC(=O)C(O)=O.CC(C)CSC1=NSN=C1C1=CNCN(C)C1,Multi-step reaction,,,,6,Reaction-ID:14306605-Steps:8570487;8583586;8583609;9376507;9374513;9319806,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 79 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating; 6.1: NaBH4 / methanol / 0 - 30 C; 6.2: methanol / 1 h / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium hydrogensulfide; ammonium chloride,,"methanol; water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306606,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306606&database=RX&origin=ReaxysOutput&ln=,(172 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-methyl-5-(4-prop-2-ynylsulfanyl-[1,2,5]thiadiazol-3-yl)-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].C[N+]1=CC(=CN=C1)C1=NSN=C1SCC#C,Multi-step reaction,,,,5,Reaction-ID:14306606-Steps:8570487;8583586;8583609;9376942;9374519,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 73 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306607,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306607&database=RX&origin=ReaxysOutput&ln=,(173 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-5-(4-prop-2-ynylsulfanyl-[1,2,5]thiadiazol-3-yl)-1,2,3,4-tetrahydro-pyrimidine; compound with oxalic acid",87484,O=CC1=CN=CN=C1>>OC(=O)C(O)=O.CN1CNC=C(C1)C1=NSN=C1SCC#C,Multi-step reaction,,,,6,Reaction-ID:14306607-Steps:8570487;8583586;8583609;9376942;9374519;9319808,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 73 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating; 6.1: NaBH4 / methanol / 0 - 30 C; 6.2: methanol / 1 h / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium hydrogensulfide; ammonium chloride,,"methanol; water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306608,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306608&database=RX&origin=ReaxysOutput&ln=,(174 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-benzylsulfanyl-[1,2,5]thiadiazol-3-yl)-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].C[N+]1=CC(=CN=C1)C1=NSN=C1SCC1=CC=CC=C1,Multi-step reaction,,,,5,Reaction-ID:14306608-Steps:8570487;8583586;8583609;9376001;9374555,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 53 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306609,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306609&database=RX&origin=ReaxysOutput&ln=,(175 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-methyl-5-(4-pentylsulfanyl-[1,2,5]thiadiazol-3-yl)-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].CCCCCSC1=NSN=C1C1=CN=C[N+](C)=C1,Multi-step reaction,,,,5,Reaction-ID:14306609-Steps:8570487;8583586;8583609;9376718;9374552,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 73 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306610,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306610&database=RX&origin=ReaxysOutput&ln=,(176 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-benzylsulfanyl-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydro-pyrimidine; compound with oxalic acid",87484,O=CC1=CN=CN=C1>>OC(=O)C(O)=O.CN1CNC=C(C1)C1=NSN=C1SCC1=CC=CC=C1,Multi-step reaction,,,,6,Reaction-ID:14306610-Steps:8570487;8583586;8583609;9376001;9374555;9319809,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 53 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating; 6.1: NaBH4 / methanol / 0 - 30 C; 6.2: methanol / 1 h / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium hydrogensulfide; ammonium chloride,,"methanol; water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306611,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306611&database=RX&origin=ReaxysOutput&ln=,(177 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-5-(4-pentylsulfanyl-[1,2,5]thiadiazol-3-yl)-1,2,3,4-tetrahydro-pyrimidine; compound with oxalic acid",87484,O=CC1=CN=CN=C1>>OC(=O)C(O)=O.CCCCCSC1=NSN=C1C1=CNCN(C)C1,Multi-step reaction,,,,6,Reaction-ID:14306611-Steps:8570487;8583586;8583609;9376718;9374552;9319810,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 73 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating; 6.1: NaBH4 / methanol / 0 - 30 C; 6.2: methanol / 1 h / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium hydrogensulfide; ammonium chloride,,"methanol; water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306612,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306612&database=RX&origin=ReaxysOutput&ln=,(178 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-methyl-5-[4-(4-methyl-benzylsulfanyl)-[1,2,5]thiadiazol-3-yl]-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].CC1=CC=C(CSC2=NSN=C2C2=CN=C[N+](C)=C2)C=C1,Multi-step reaction,,,,5,Reaction-ID:14306612-Steps:8570487;8583586;8583609;9326646;9374599,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 72 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306613,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306613&database=RX&origin=ReaxysOutput&ln=,(179 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-[4-(4-chloro-benzylsulfanyl)-[1,2,5]thiadiazol-3-yl]-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].C[N+]1=CC(=CN=C1)C1=NSN=C1SCC1=CC=C(Cl)C=C1,Multi-step reaction,,,,5,Reaction-ID:14306613-Steps:8570487;8583586;8583609;9326606;9374600,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 72 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydrogensulfide; ammonium chloride,,"water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306614,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306614&database=RX&origin=ReaxysOutput&ln=,(180 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-5-[4-(4-methyl-benzylsulfanyl)-[1,2,5]thiadiazol-3-yl]-1,2,3,4-tetrahydro-pyrimidine; compound with oxalic acid",87484,O=CC1=CN=CN=C1>>OC(=O)C(O)=O.CN1CNC=C(C1)C1=NSN=C1SCC1=CC=C(C)C=C1,Multi-step reaction,,,,6,Reaction-ID:14306614-Steps:8570487;8583586;8583609;9326646;9374599;9319811,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 72 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating; 6.1: NaBH4 / methanol / 0 - 30 C; 6.2: methanol / 1 h / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium hydrogensulfide; ammonium chloride,,"methanol; water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
14306615,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=14306615&database=RX&origin=ReaxysOutput&ln=,(181 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-[4-(4-chloro-benzylsulfanyl)-[1,2,5]thiadiazol-3-yl]-3-methyl-1,2,3,4-tetrahydro-pyrimidine; compound with oxalic acid",87484,O=CC1=CN=CN=C1>>OC(=O)C(O)=O.CN1CNC=C(C1)C1=NSN=C1SCC1=CC=C(Cl)C=C1,Multi-step reaction,,,,6,Reaction-ID:14306615-Steps:8570487;8583586;8583609;9326606;9374600;9319812,1.1: H2O / 5 - 10 C; 1.2: 67 percent / acetic acid / H2O / 2 h / 20 C; 2.1: 39 percent / NH4Cl; NH4OH / acetonitrile / 3 h / Heating; 3.1: 73 percent / S2Cl2 / dimethylformamide / 2 h / 80 C; 4.1: sodium hydrosulfide hydrate / dimethylformamide / 24 h / 100 C; 4.2: 72 percent / K2CO3 / dimethylformamide / 20 C; 5.1: acetone / 48 h / Heating; 6.1: NaBH4 / methanol / 0 - 30 C; 6.2: methanol / 1 h / 20 C,,,,,,,,,,,,,,2.1: Strecker reaction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium hydrogensulfide; ammonium chloride,,"methanol; water; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Jung, Myung Hee; Park, Jewn-Giew; Park, Woo-Kyu; Archiv der Pharmazie; vol. 336; 4-5; (2003); p. 230 - 235;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6395363&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391751,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391751&database=RX&origin=ReaxysOutput&ln=,(182 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,1-(pyrimidin-5-yl)ethan-1-one,304431,O=CC1=CN=CN=C1>>CC(=O)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:15391751-Steps:8826438;2531617,1: 67 percent / diethyl ether / 1 h / 20 C; 2: 67 percent / molecular sieves 4 Angstroem; pyridinium dichromate; HOAc / CH2Cl2 / 0.33 h / 20 C,,,,,,,,,,,,,,1: Grignard reaction,,,,,,dipyridinium dichromate; 4 A molecular sieve; acetic acid,,diethyl ether; dichloromethane,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391752,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391752&database=RX&origin=ReaxysOutput&ln=,(183 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,(Z)-1-(pyrimidin-5-yl)-ethanone O-methyloxime,272379,O=CC1=CN=CN=C1>>CO\N=C(\C)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:15391752-Steps:8826438;2531617;8826639,1.1: 67 percent / diethyl ether / 1 h / 20 C; 2.1: 67 percent / molecular sieves 4 Angstroem; pyridinium dichromate; HOAc / CH2Cl2 / 0.33 h / 20 C; 3.1: NaHCO3 / methanol / 0.5 h / 20 C; 3.2: methanol / 1 h / 20 C,,,,,,,,,,,,,,1.1: Grignard reaction,,,,,,dipyridinium dichromate; 4 A molecular sieve; sodium hydrogencarbonate; acetic acid,,methanol; diethyl ether; dichloromethane,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391753,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391753&database=RX&origin=ReaxysOutput&ln=,(184 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,(E)-1-(pyrimidin-5-yl)-ethanone O-methyloxime,272379,O=CC1=CN=CN=C1>>CO\N=C(/C)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:15391753-Steps:8826438;2531617;8826639,1.1: 67 percent / diethyl ether / 1 h / 20 C; 2.1: 67 percent / molecular sieves 4 Angstroem; pyridinium dichromate; HOAc / CH2Cl2 / 0.33 h / 20 C; 3.1: NaHCO3 / methanol / 0.5 h / 20 C; 3.2: 63 percent / methanol / 1 h / 20 C,,,,,,,,,,,,,,1.1: Grignard reaction,,,,,,dipyridinium dichromate; 4 A molecular sieve; sodium hydrogencarbonate; acetic acid,,methanol; diethyl ether; dichloromethane,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391754,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391754&database=RX&origin=ReaxysOutput&ln=,(185 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,pyrimidine-5-carbaldehyde O-allyl-oxime,,O=CC1=CN=CN=C1>>C=CCO\N=C\C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:15391754-Steps:8826440;8860396,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 70 percent / K2CO3 / acetonitrile / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391755,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391755&database=RX&origin=ReaxysOutput&ln=,(186 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,pyrimidine-5-carbaldehyde O-prop-2-ynyl-oxime,,O=CC1=CN=CN=C1>>C#CCO\N=C\C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:15391755-Steps:8826440;8860670,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 83 percent / K2CO3 / acetonitrile / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391756,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391756&database=RX&origin=ReaxysOutput&ln=,(187 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-1,2,3,4-tetrahydro-pyrimidine-5-carbaldehyde O-methyl-oxime",87484,O=CC1=CN=CN=C1>>CO\N=C\C1=CNCN(C)C1,Multi-step reaction,,,,3,Reaction-ID:15391756-Steps:8826439;8859095;8850070,1: 62 percent / benzene / 2 h / Heating; 2: acetone / Heating; 3: NaBH4 / methanol / -30 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate,,methanol; acetone; benzene,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391757,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391757&database=RX&origin=ReaxysOutput&ln=,(188 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-(3-methyl-1,2,3,4-tetrahydro-pyrimidin-5-yl)-ethanone O-methyl-oxime",87484,O=CC1=CN=CN=C1>>CO\N=C(C)\C1=CNCN(C)C1,Multi-step reaction,,,,5,Reaction-ID:15391757-Steps:8826438;2531617;8826639;8859098;8850598,1.1: 67 percent / diethyl ether / 1 h / 20 C; 2.1: 67 percent / molecular sieves 4 Angstroem; pyridinium dichromate; HOAc / CH2Cl2 / 0.33 h / 20 C; 3.1: NaHCO3 / methanol / 0.5 h / 20 C; 3.2: 63 percent / methanol / 1 h / 20 C; 4.1: acetone / Heating; 5.1: NaBH4 / methanol / -30 - 20 C,,,,,,,,,,,,,,1.1: Grignard reaction,,,,,,sodium tetrahydroborate; dipyridinium dichromate; 4 A molecular sieve; sodium hydrogencarbonate; acetic acid,,methanol; diethyl ether; dichloromethane; acetone,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391758,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391758&database=RX&origin=ReaxysOutput&ln=,(189 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,pyrimidine-5-carbaldehyde O-benzyl-oxime,272864,O=CC1=CN=CN=C1>>C(O\N=C\C1=CN=CN=C1)C1=CC=CC=C1,Multi-step reaction,,,,2,Reaction-ID:15391758-Steps:8826440;8861003,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 60 percent / K2CO3 / acetonitrile / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391759,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391759&database=RX&origin=ReaxysOutput&ln=,(190 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,pyrimidine-5-carbaldehyde O-pentyl-oxime,,O=CC1=CN=CN=C1>>CCCCCO\N=C\C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:15391759-Steps:8826440;8860375,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 85 percent / K2CO3 / acetonitrile / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391760,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391760&database=RX&origin=ReaxysOutput&ln=,(191 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-1,2,3,4-tetrahydro-pyrimidine-5-carbaldehyde O-allyl-oxime",87484,O=CC1=CN=CN=C1>>CN1CNC=C(C1)\C=N\OCC=C,Multi-step reaction,,,,4,Reaction-ID:15391760-Steps:8826440;8860396;8859099;8851508,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 70 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating; 4: NaBH4 / methanol / -30 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; hydroxylamine hydrochloride; potassium carbonate,,methanol; acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391761,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391761&database=RX&origin=ReaxysOutput&ln=,(192 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,pyrimidine-5-carbaldehyde O-(4-methyl-benzyl)-oxime,272864,O=CC1=CN=CN=C1>>CC1=CC=C(CO\N=C\C2=CN=CN=C2)C=C1,Multi-step reaction,,,,2,Reaction-ID:15391761-Steps:8826440;8860938,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 69 percent / K2CO3 / acetonitrile / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391762,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391762&database=RX&origin=ReaxysOutput&ln=,(193 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-1,2,3,4-tetrahydro-pyrimidine-5-carbaldehyde O-prop-2-ynyl-oxime",87484,O=CC1=CN=CN=C1>>CN1CNC=C(C1)\C=N\OCC#C,Multi-step reaction,,,,4,Reaction-ID:15391762-Steps:8826440;8860670;8859103;8851908,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 83 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating; 4: NaBH4 / methanol / -30 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; hydroxylamine hydrochloride; potassium carbonate,,methanol; acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391763,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391763&database=RX&origin=ReaxysOutput&ln=,(194 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,pyrimidine-5-carbaldehyde O-(4-chloro-benzyl)-oxime,272864,O=CC1=CN=CN=C1>>ClC1=CC=C(CO\N=C\C2=CN=CN=C2)C=C1,Multi-step reaction,,,,2,Reaction-ID:15391763-Steps:8826440;8860942,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 75 percent / K2CO3 / acetonitrile / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391764,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391764&database=RX&origin=ReaxysOutput&ln=,(195 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-1,2,3,4-tetrahydro-pyrimidine-5-carbaldehyde O-pentyl-oxime",87484,O=CC1=CN=CN=C1>>CCCCCO\N=C\C1=CNCN(C)C1,Multi-step reaction,,,,4,Reaction-ID:15391764-Steps:8826440;8860375;8859128;8852693,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 85 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating; 4: NaBH4 / methanol / -30 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; hydroxylamine hydrochloride; potassium carbonate,,methanol; acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391765,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391765&database=RX&origin=ReaxysOutput&ln=,(196 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-1,2,3,4-tetrahydro-pyrimidine-5-carbaldehyde O-benzyl-oxime",87484,O=CC1=CN=CN=C1>>CN1CNC=C(C1)\C=N\OCC1=CC=CC=C1,Multi-step reaction,,,,4,Reaction-ID:15391765-Steps:8826440;8861003;8859125;8852319,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 60 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating; 4: NaBH4 / methanol / -30 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; hydroxylamine hydrochloride; potassium carbonate,,methanol; acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391766,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391766&database=RX&origin=ReaxysOutput&ln=,(197 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-1,2,3,4-tetrahydro-pyrimidine-5-carbaldehyde O-(4-chloro-benzyl)-oxime",87484,O=CC1=CN=CN=C1>>CN1CNC=C(C1)\C=N\OCC1=CC=C(Cl)C=C1,Multi-step reaction,,,,4,Reaction-ID:15391766-Steps:8826440;8860942;8859167;8853034,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 75 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating; 4: NaBH4 / methanol / -30 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; hydroxylamine hydrochloride; potassium carbonate,,methanol; acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391767,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391767&database=RX&origin=ReaxysOutput&ln=,(198 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-1,2,3,4-tetrahydro-pyrimidine-5-carbaldehyde O-(4-methyl-benzyl)-oxime",87484,O=CC1=CN=CN=C1>>CN1CNC=C(C1)\C=N\OCC1=CC=C(C)C=C1,Multi-step reaction,,,,4,Reaction-ID:15391767-Steps:8826440;8860938;8859145;8853019,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 69 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating; 4: NaBH4 / methanol / -30 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; hydroxylamine hydrochloride; potassium carbonate,,methanol; acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391769,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391769&database=RX&origin=ReaxysOutput&ln=,(199 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-{1-[(E)-Methoxyimino]-ethyl}-1-methyl-pyrimidin-1-ium; iodide,103419,O=CC1=CN=CN=C1>>[I-].CO\N=C(/C)C1=C[N+](C)=CN=C1,Multi-step reaction,,,,4,Reaction-ID:15391769-Steps:8826438;2531617;8826639;8859098,1.1: 67 percent / diethyl ether / 1 h / 20 C; 2.1: 67 percent / molecular sieves 4 Angstroem; pyridinium dichromate; HOAc / CH2Cl2 / 0.33 h / 20 C; 3.1: NaHCO3 / methanol / 0.5 h / 20 C; 3.2: 63 percent / methanol / 1 h / 20 C; 4.1: acetone / Heating,,,,,,,,,,,,,,1.1: Grignard reaction,,,,,,dipyridinium dichromate; 4 A molecular sieve; sodium hydrogencarbonate; acetic acid,,methanol; diethyl ether; dichloromethane; acetone,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391770,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391770&database=RX&origin=ReaxysOutput&ln=,(200 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-(allyloxyimino-methyl)-1-methyl-pyrimidin-1-ium; iodide,103419,O=CC1=CN=CN=C1>>[I-].C[N+]1=CN=CC(=C1)\C=N\OCC=C,Multi-step reaction,,,,3,Reaction-ID:15391770-Steps:8826440;8860396;8859099,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 70 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391771,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391771&database=RX&origin=ReaxysOutput&ln=,(201 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,1-methyl-5-(prop-2-ynyloxyimino-methyl)-pyrimidin-1-ium; iodide,103419,O=CC1=CN=CN=C1>>[I-].C[N+]1=CN=CC(\C=N\OCC#C)=C1,Multi-step reaction,,,,3,Reaction-ID:15391771-Steps:8826440;8860670;8859103,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 83 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391772,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391772&database=RX&origin=ReaxysOutput&ln=,(202 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-(benzyloxyimino-methyl)-1-methyl-pyrimidin-1-ium; iodide,103419,O=CC1=CN=CN=C1.O=CC1=CN=CN=C1>>[I-].C[N+]1=CN=CC(\C=N\OCC2=CC=CC=C2)=C1,Multi-step reaction,,,,3,Reaction-ID:15391772-Steps:8826440;8861003;8859125,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 60 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391773,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391773&database=RX&origin=ReaxysOutput&ln=,(203 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,1-methyl-5-(pentyloxyimino-methyl)-pyrimidin-1-ium; iodide,103419,O=CC1=CN=CN=C1>>[I-].CCCCCO\N=C\C1=C[N+](C)=CN=C1,Multi-step reaction,,,,3,Reaction-ID:15391773-Steps:8826440;8860375;8859128,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 85 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391774,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391774&database=RX&origin=ReaxysOutput&ln=,(204 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,1-methyl-5-[(4-methyl-benzyloxyimino)-methyl]-pyrimidin-1-ium; iodide,103419,O=CC1=CN=CN=C1>>[I-].CC1=CC=C(CO\N=C\C2=C[N+](C)=CN=C2)C=C1,Multi-step reaction,,,,3,Reaction-ID:15391774-Steps:8826440;8860938;8859145,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 69 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391775,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391775&database=RX&origin=ReaxysOutput&ln=,(205 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-[(4-chloro-benzyloxyimino)-methyl]-1-methyl-pyrimidin-1-ium; iodide,103419,O=CC1=CN=CN=C1.O=CC1=CN=CN=C1>>[I-].C[N+]1=CN=CC(\C=N\OCC2=CC=C(Cl)C=C2)=C1,Multi-step reaction,,,,3,Reaction-ID:15391775-Steps:8826440;8860942;8859167,1: 40 percent / HONH2*HCl / toluene / 1 h / Heating; 2: 75 percent / K2CO3 / acetonitrile / Heating; 3: acetone / Heating,,,,,,,,,,,,,,,,,,,,hydroxylamine hydrochloride; potassium carbonate,,acetone; toluene; acetonitrile,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922512,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922512&database=RX&origin=ReaxysOutput&ln=,(206 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-chloro-[1,2,5]thiadiazol-3-yl)pyrimidine",272219,O=CC1=CN=CN=C1>>ClC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:15922512-Steps:8570487;8583586;8583609,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation,,,,,,disulfur dichloride; ammonium hydroxide; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922513,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922513&database=RX&origin=ReaxysOutput&ln=,(207 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-methoxy-[1,2,5]thiadiazol-3-yl)-pyrimidine",,O=CC1=CN=CN=C1>>COC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:15922513-Steps:8570487;8583586;8583609;8545427,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 96 percent / Na / 1 h / 50 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922514,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922514&database=RX&origin=ReaxysOutput&ln=,(208 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-ethoxy-[1,2,5]thiadiazol-3-yl)-pyrimidine",,O=CC1=CN=CN=C1>>CCOC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:15922514-Steps:8570487;8583586;8583609;8552159,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 93 percent / Na / 1 h / 50 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922515,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922515&database=RX&origin=ReaxysOutput&ln=,(209 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-isobutoxy-[1,2,5]thiadiazol-3-yl)-pyrimidine",55840,O=CC1=CN=CN=C1>>CC(C)COC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:15922515-Steps:8570487;8583586;8583609;8552799,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 92 percent / Na / 1 h / 50 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922516,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922516&database=RX&origin=ReaxysOutput&ln=,(210 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-methoxy-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydro-pyrimidine",87484,O=CC1=CN=CN=C1>>COC1=NSN=C1C1=CNCN(C)C1,Multi-step reaction,,,,6,Reaction-ID:15922516-Steps:8570487;8583586;8583609;8545427;8605610;8597135,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 96 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating; 6: NaBH4 / methanol / -30 - 0 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation / 6: Reduction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium; ammonium chloride,,"methanol; water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922517,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922517&database=RX&origin=ReaxysOutput&ln=,(211 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-allyloxy-[1,2,5]thiadiazol-3-yl)-pyrimidine",,O=CC1=CN=CN=C1>>C=CCOC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:15922517-Steps:8570487;8583586;8583609;8572820,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 93 percent / Na / 1 h / 50 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922518,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922518&database=RX&origin=ReaxysOutput&ln=,(212 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-prop-2-ynyloxy-[1,2,5]thiadiazol-3-yl)-pyrimidine",,O=CC1=CN=CN=C1>>C#CCOC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:15922518-Steps:8570487;8583586;8583609;8569143,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 48 percent / Na / 1 h / 50 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922519,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922519&database=RX&origin=ReaxysOutput&ln=,(213 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-ethoxy-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydro-pyrimidine",87484,O=CC1=CN=CN=C1>>CCOC1=NSN=C1C1=CNCN(C)C1,Multi-step reaction,,,,6,Reaction-ID:15922519-Steps:8570487;8583586;8583609;8552159;8605619;8597568,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 93 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating; 6: NaBH4 / methanol / -30 - 0 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation / 6: Reduction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium; ammonium chloride,,"methanol; water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922520,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922520&database=RX&origin=ReaxysOutput&ln=,(214 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-pentyloxy-[1,2,5]thiadiazol-3-yl)-pyrimidine",,O=CC1=CN=CN=C1>>CCCCCOC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:15922520-Steps:8570487;8583586;8583609;8552836,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 89 percent / Na / 1 h / 50 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922521,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922521&database=RX&origin=ReaxysOutput&ln=,(215 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-benzyloxy-[1,2,5]thiadiazol-3-yl)-pyrimidine",,O=CC1=CN=CN=C1>>C(OC1=NSN=C1C1=CN=CN=C1)C1=CC=CC=C1,Multi-step reaction,,,,4,Reaction-ID:15922521-Steps:8570487;8583586;8583609;8604218,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 90 percent / Na / 1 h / 50 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922522,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922522&database=RX&origin=ReaxysOutput&ln=,(216 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-allyloxy-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydro-pyrimidine",87484,O=CC1=CN=CN=C1>>CN1CNC=C(C1)C1=NSN=C1OCC=C,Multi-step reaction,,,,6,Reaction-ID:15922522-Steps:8570487;8583586;8583609;8572820;8605646;8597989,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 93 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating; 6: NaBH4 / methanol / -30 - 0 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation / 6: Reduction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium; ammonium chloride,,"methanol; water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922523,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922523&database=RX&origin=ReaxysOutput&ln=,(217 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-isobutoxy-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydro-pyrimidine",87484,O=CC1=CN=CN=C1>>CC(C)COC1=NSN=C1C1=CNCN(C)C1,Multi-step reaction,,,,6,Reaction-ID:15922523-Steps:8570487;8583586;8583609;8552799;8605636;8597978,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 92 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating; 6: NaBH4 / methanol / -30 - 0 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation / 6: Reduction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium; ammonium chloride,,"methanol; water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922524,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922524&database=RX&origin=ReaxysOutput&ln=,(218 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-5-(4-prop-2-ynyloxy-[1,2,5]thiadiazol-3-yl)-1,2,3,4-tetrahydro-pyrimidine",87484,O=CC1=CN=CN=C1>>CN1CNC=C(C1)C1=NSN=C1OCC#C,Multi-step reaction,,,,6,Reaction-ID:15922524-Steps:8570487;8583586;8583609;8569143;8605647;8598403,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 48 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating; 6: NaBH4 / methanol / -30 - 0 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation / 6: Reduction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium; ammonium chloride,,"methanol; water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922525,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922525&database=RX&origin=ReaxysOutput&ln=,(219 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-hexyloxy-[1,2,5]thiadiazol-3-yl)-pyrimidine",,O=CC1=CN=CN=C1>>CCCCCCOC1=NSN=C1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:15922525-Steps:8570487;8583586;8583609;8606084,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 73 percent / Na / 1 h / 50 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922526,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922526&database=RX&origin=ReaxysOutput&ln=,(220 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-[4-(4-chloro-benzyloxy)-[1,2,5]thiadiazol-3-yl]-pyrimidine",,,Multi-step reaction,,,,4,Reaction-ID:15922526-Steps:8570487;8583586;8583609;8577283,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 79 percent,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution,,,,,,disulfur dichloride; ammonium hydroxide; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922527,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922527&database=RX&origin=ReaxysOutput&ln=,(221 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-[4-(4-methyl-benzyloxy)-[1,2,5]thiadiazol-3-yl]-pyrimidine",,O=CC1=CN=CN=C1>>CC1=CC=C(COC2=NSN=C2C2=CN=CN=C2)C=C1,Multi-step reaction,,,,4,Reaction-ID:15922527-Steps:8570487;8583586;8583609;8554811,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 69 percent / NaH / tetrahydrofuran,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydride; ammonium chloride,,"tetrahydrofuran; water; acetic acid; N,N-dimethyl-formamide; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922528,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922528&database=RX&origin=ReaxysOutput&ln=,(222 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-benzyloxy-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydro-pyrimidine",87484,O=CC1=CN=CN=C1>>CN1CNC=C(C1)C1=NSN=C1OCC1=CC=CC=C1,Multi-step reaction,,,,6,Reaction-ID:15922528-Steps:8570487;8583586;8583609;8604218;8605672;8599030,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 90 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating; 6: NaBH4 / methanol / -30 - 0 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation / 6: Reduction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium; ammonium chloride,,"methanol; water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922529,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922529&database=RX&origin=ReaxysOutput&ln=,(223 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-5-(4-pentyloxy-[1,2,5]thiadiazol-3-yl)-1,2,3,4-tetrahydro-pyrimidine",87484,O=CC1=CN=CN=C1>>CCCCCOC1=NSN=C1C1=CNCN(C)C1,Multi-step reaction,,,,6,Reaction-ID:15922529-Steps:8570487;8583586;8583609;8552836;8605668;8599047,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 89 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating; 6: NaBH4 / methanol / -30 - 0 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation / 6: Reduction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium; ammonium chloride,,"methanol; water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922530,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922530&database=RX&origin=ReaxysOutput&ln=,(224 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-hexyloxy-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydro-pyrimidine",87484,O=CC1=CN=CN=C1>>CCCCCCOC1=NSN=C1C1=CNCN(C)C1,Multi-step reaction,,,,6,Reaction-ID:15922530-Steps:8570487;8583586;8583609;8606084;8605689;8599312,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 73 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating; 6: NaBH4 / methanol / -30 - 0 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation / 6: Reduction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium; ammonium chloride,,"methanol; water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922531,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922531&database=RX&origin=ReaxysOutput&ln=,(225 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-methyl-5-[4-(4-methyl-benzyloxy)-[1,2,5]thiadiazol-3-yl]-1,2,3,4-tetrahydro-pyrimidine",87484,O=CC1=CN=CN=C1>>CN1CNC=C(C1)C1=NSN=C1OCC1=CC=C(C)C=C1,Multi-step reaction,,,,6,Reaction-ID:15922531-Steps:8570487;8583586;8583609;8554811;8605695;8599654,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 69 percent / NaH / tetrahydrofuran; 5: acetone / 48 h / Heating; 6: NaBH4 / methanol / -30 - 0 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation / 6: Reduction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; sodium hydride; ammonium chloride,,"tetrahydrofuran; methanol; water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922532,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922532&database=RX&origin=ReaxysOutput&ln=,(226 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-[4-(4-chloro-benzyloxy)-[1,2,5]thiadiazol-3-yl]-3-methyl-1,2,3,4-tetrahydro-pyrimidine",87484,O=CC1=CN=CN=C1>>CN1CNC=C(C1)C1=NSN=C1OCC1=CC=C(Cl)C=C1,Multi-step reaction,,,,6,Reaction-ID:15922532-Steps:8570487;8583586;8583609;8577283;8605690;8599651,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 79 percent; 5: acetone / 48 h / Heating; 6: NaBH4 / methanol / -30 - 0 C,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation / 6: Reduction,,,,,,disulfur dichloride; ammonium hydroxide; sodium tetrahydroborate; ammonium chloride,,"methanol; water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922533,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922533&database=RX&origin=ReaxysOutput&ln=,(227 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-methoxy-[1,2,5]thiadiazol-3-yl)-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].COC1=NSN=C1C1=C[N+](C)=CN=C1,Multi-step reaction,,,,5,Reaction-ID:15922533-Steps:8570487;8583586;8583609;8545427;8605610,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 96 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922534,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922534&database=RX&origin=ReaxysOutput&ln=,(228 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-ethoxy-[1,2,5]thiadiazol-3-yl)-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].CCOC1=NSN=C1C1=C[N+](C)=CN=C1,Multi-step reaction,,,,5,Reaction-ID:15922534-Steps:8570487;8583586;8583609;8552159;8605619,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 93 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922535,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922535&database=RX&origin=ReaxysOutput&ln=,(229 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-isobutoxy-[1,2,5]thiadiazol-3-yl)-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].CC(C)COC1=NSN=C1C1=C[N+](C)=CN=C1,Multi-step reaction,,,,5,Reaction-ID:15922535-Steps:8570487;8583586;8583609;8552799;8605636,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 92 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922536,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922536&database=RX&origin=ReaxysOutput&ln=,(230 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-allyloxy-[1,2,5]thiadiazol-3-yl)-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].C[N+]1=CN=CC(=C1)C1=NSN=C1OCC=C,Multi-step reaction,,,,5,Reaction-ID:15922536-Steps:8570487;8583586;8583609;8572820;8605646,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 93 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922537,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922537&database=RX&origin=ReaxysOutput&ln=,(231 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-methyl-5-(4-prop-2-ynyloxy-[1,2,5]thiadiazol-3-yl)-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].C[N+]1=CN=CC(=C1)C1=NSN=C1OCC#C,Multi-step reaction,,,,5,Reaction-ID:15922537-Steps:8570487;8583586;8583609;8569143;8605647,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 48 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922538,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922538&database=RX&origin=ReaxysOutput&ln=,(232 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-benzyloxy-[1,2,5]thiadiazol-3-yl)-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].C[N+]1=CN=CC(=C1)C1=NSN=C1OCC1=CC=CC=C1,Multi-step reaction,,,,5,Reaction-ID:15922538-Steps:8570487;8583586;8583609;8604218;8605672,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 90 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922539,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922539&database=RX&origin=ReaxysOutput&ln=,(233 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-methyl-5-(4-pentyloxy-[1,2,5]thiadiazol-3-yl)-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].CCCCCOC1=NSN=C1C1=C[N+](C)=CN=C1,Multi-step reaction,,,,5,Reaction-ID:15922539-Steps:8570487;8583586;8583609;8552836;8605668,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 89 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922540,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922540&database=RX&origin=ReaxysOutput&ln=,(234 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-(4-hexyloxy-[1,2,5]thiadiazol-3-yl)-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].CCCCCCOC1=NSN=C1C1=C[N+](C)=CN=C1,Multi-step reaction,,,,5,Reaction-ID:15922540-Steps:8570487;8583586;8583609;8606084;8605689,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 73 percent / Na / 1 h / 50 C; 5: acetone / 48 h / Heating,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation,,,,,,disulfur dichloride; ammonium hydroxide; sodium; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922541,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922541&database=RX&origin=ReaxysOutput&ln=,(235 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"5-[4-(4-chloro-benzyloxy)-[1,2,5]thiadiazol-3-yl]-1-methyl-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].C[N+]1=CN=CC(=C1)C1=NSN=C1OCC1=CC=C(Cl)C=C1,Multi-step reaction,,,,5,Reaction-ID:15922541-Steps:8570487;8583586;8583609;8577283;8605690,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 79 percent; 5: acetone / 48 h / Heating,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation,,,,,,disulfur dichloride; ammonium hydroxide; ammonium chloride,,"water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15922542,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15922542&database=RX&origin=ReaxysOutput&ln=,(236 of 327),1,65,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-methyl-5-[4-(4-methyl-benzyloxy)-[1,2,5]thiadiazol-3-yl]-pyrimidin-1-ium; iodide",103419,O=CC1=CN=CN=C1>>[I-].CC1=CC=C(COC2=NSN=C2C2=C[N+](C)=CN=C2)C=C1,Multi-step reaction,,,,5,Reaction-ID:15922542-Steps:8570487;8583586;8583609;8554811;8605695,1: 67 percent / H2O; acetic acid / 5 - 20 C; 2: 39 percent / NH4Cl; aq. NH4OH / acetonitrile / 3 h / Heating; 3: 73 percent / S2Cl2 / dimethylformamide / 3 - 80 C; 4: 69 percent / NaH / tetrahydrofuran; 5: acetone / 48 h / Heating,,,,,,,,,,,,,,1: Addition / 2: Substitution / 3: cyclocondensation / 4: Substitution / 5: Methylation,,,,,,disulfur dichloride; ammonium hydroxide; sodium hydride; ammonium chloride,,"tetrahydrofuran; water; acetic acid; N,N-dimethyl-formamide; acetone; acetonitrile","Article; Park, Jewn-Giew; Lee, Mi-Jeoung; Kong, Jae Yang; Jung, Myung Hee; Archiv der Pharmazie; vol. 333; 5; (2000); p. 113 - 117;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6235585&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
44519603,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=44519603&database=RX&origin=ReaxysOutput&ln=,(237 of 327),1,65,full reaction; has preparation,pyrimidine-5-carbaldehyde; Cyclopentamine,N-[(pyrimidin-5-yl)methyl]cyclopentanamine,228701,O=CC1=CN=CN=C1.NC1CCCC1>>C(NC1CCCC1)C1=CN=CN=C1,Preparation,,,,1,,,2,,,,,,Molecular sieve; Molecular sieve,,,,,Experimental part,supporting information,,N-[(pyrimidin-5-yl)methyl]cyclopentanamine,24 percent,24,,pyrimidine-5-carbaldehyde; Cyclopentamine,sodium tris(acetoxy)borohydride,,dichloromethane; dichloromethane,"Article; Giroud, Maude; Ivkovic, Jakov; Martignoni, Mara; Fleuti, Marianne; Trapp, Nils; Haap, Wolfgang; Kuglstatter, Andreas; Benz, Joerg; Kuhn, Bernd; Schirmeister, Tanja; Diederich, Francois; ChemMedChem; vol. 12; 3; (2017); p. 257 - 270;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=70586329&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
52324588,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=52324588&database=RX&origin=ReaxysOutput&ln=,(238 of 327),1,65,full reaction; has multi-step,4-Chlorobenzenesulfonamide; pyrimidine-5-carbaldehyde,4-chloro-N-(pyrimidin-5-ylmethyl)benzenesulfonamide,224495,NS(=O)(=O)C1=CC=C(Cl)C=C1.O=CC1=CN=CN=C1>>ClC1=CC=C(C=C1)S(=O)(=O)NCC1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:52324588-Steps:29455574;52324555,1: iodine; [bis(acetoxy)iodo]benzene / chloroform / 24 h / 50 C / Inert atmosphere; 2: sodium tetrahydroborate / methanol; dichloromethane / 0.75 h / 0 - 20 C,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; [bis(acetoxy)iodo]benzene; iodine,,methanol; dichloromethane; chloroform,"Article; Hopkins, Megan D.; Abebe, Felagot A.; Scott, Kristina A.; Ozmer, Garett L.; Sheir, Alec A.; Schroeder, Lucas J.; Sheaff, Robert J.; Lamar, Angus A.; Organic and Biomolecular Chemistry; vol. 17; 36; (2019); p. 8391 - 8402;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=77773467&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15597092,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15597092&database=RX&origin=ReaxysOutput&ln=,(239 of 327),1,64,full reaction; has multi-step,pyrimidine-5-carbaldehyde,2-(pyrimidin-5-yl)benzo[d]oxazole,193439,O=CC1=CN=CN=C1>>O1C2=CC=CC=C2N=C1C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:15597092-Steps:8695843;8711675,1: ethanol / 1 h / 20 C; 2: iodobenzene diacetate / ethanol / 0.5 h,,,,,,,,,,,,,,1: Condensation / 2: Cyclization,,,,,,[bis(acetoxy)iodo]benzene,,ethanol,Article; Myung Hee Jung; Choi; Cho; Journal of Heterocyclic Chemistry; vol. 37; 4; (2000); p. 969 - 974;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6266579&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15597093,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15597093&database=RX&origin=ReaxysOutput&ln=,(240 of 327),1,64,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-chloro-2-pyrimidin-5-ylbenzoxazole,193439,O=CC1=CN=CN=C1>>ClC1=CC2=C(OC(=N2)C2=CN=CN=C2)C=C1,Multi-step reaction,,,,2,Reaction-ID:15597093-Steps:8695845;8712697,1: ethanol / 1 h / 20 C; 2: iodobenzene diacetate / ethanol / 0.5 h,,,,,,,,,,,,,,1: Condensation / 2: Cyclization,,,,,,[bis(acetoxy)iodo]benzene,,ethanol,Article; Myung Hee Jung; Choi; Cho; Journal of Heterocyclic Chemistry; vol. 37; 4; (2000); p. 969 - 974;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6266579&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15597094,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15597094&database=RX&origin=ReaxysOutput&ln=,(241 of 327),1,64,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-methyl-2-pyrimidin-5-ylbenzoxazole,193439,O=CC1=CN=CN=C1>>CC1=CC2=C(OC(=N2)C2=CN=CN=C2)C=C1,Multi-step reaction,,,,2,Reaction-ID:15597094-Steps:8695844;8712741,1: ethanol / 1 h / 20 C; 2: iodobenzene diacetate / ethanol / 0.5 h,,,,,,,,,,,,,,1: Condensation / 2: Cyclization,,,,,,[bis(acetoxy)iodo]benzene,,ethanol,Article; Myung Hee Jung; Choi; Cho; Journal of Heterocyclic Chemistry; vol. 37; 4; (2000); p. 969 - 974;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6266579&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15597095,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15597095&database=RX&origin=ReaxysOutput&ln=,(242 of 327),1,64,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-methoxy-2-pyrimidin-5-ylbenzoxazole,193439,O=CC1=CN=CN=C1>>COC1=CC2=C(OC(=N2)C2=CN=CN=C2)C=C1,Multi-step reaction,,,,2,Reaction-ID:15597095-Steps:8695842;8713064,1: ethanol / 1 h / 20 C; 2: iodobenzene diacetate / ethanol / 0.5 h,,,,,,,,,,,,,,1: Condensation / 2: Cyclization,,,,,,[bis(acetoxy)iodo]benzene,,ethanol,Article; Myung Hee Jung; Choi; Cho; Journal of Heterocyclic Chemistry; vol. 37; 4; (2000); p. 969 - 974;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6266579&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
29178177,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=29178177&database=RX&origin=ReaxysOutput&ln=,(243 of 327),1,64,full reaction; has preparation,3-Quinuclidinone; pyrimidine-5-carbaldehyde,C12H13N3O,163467,O=C1CN2CCC1CC2.O=CC1=CN=CN=C1>>O=C1C2CCN(CC2)C1=CC1=CN=CN=C1,Preparation,,,,1,,,,,,,,,,,,,,,scheme or table,,,,,,,potassium hydroxide,,methanol,"Article; Breining, Scott R.; Bencherif, Merouane; Grady, Sharon R.; Whiteaker, Paul; Marks, Michael J.; Wageman, Charles R.; Lester, Henry A.; Yohannes, Daniel; Bioorganic and Medicinal Chemistry Letters; vol. 19; 15; (2009); p. 4359 - 4363;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8847159&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
38543126,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=38543126&database=RX&origin=ReaxysOutput&ln=,(244 of 327),1,64,full reaction; has multi-step,tert-butylisonitrile; pyrimidine-5-carbaldehyde; benzoic acid,1-benzoyl-N-(tert-butyl)-2-(pyrimidin-5-yl)pyrrolidine-2-carboxamide,,CC(C)(C)N=[C].O=CC1=CN=CN=C1.OC(=O)C1=CC=CC=C1>>CC(C)(C)NC(=O)C1(CCCN1C(=O)C1=CC=CC=C1)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:38543126-Steps:38543104;38543079,1.1: indium(III) chloride / methanol / 2 h / 50 C / Microwave irradiation; 2.1: potassium tert-butylate / tetrahydrofuran / 1 h / 25 C / Inert atmosphere; 2.2: 12 h / Inert atmosphere; Reflux,,,,,,,,,,,,,,1.1: |Ugi Condensation,,,,,,indium(III) chloride; potassium tert-butylate,,tetrahydrofuran; methanol,"Article; Polindara-Garcia, Luis A.; Vazquez, Alfredo; Organic and Biomolecular Chemistry; vol. 12; 36; (2014); p. 7068 - 7082;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=64129322&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
52133461,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=52133461&database=RX&origin=ReaxysOutput&ln=,(245 of 327),2,64,full reaction; has multi-step,pyrimidine-5-carbaldehyde,(2-pyridylamino)pyrimidin-5-ylmethanesulfonic acid,225423,O=CC1=CN=CN=C1>>OS(=O)(=O)C(NC1=NC=CC=C1)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:52133461-Steps:52133462;52133459,1: sodium hydrogensulfite / methanol; water / 2 h / 60 C; 2: hydrogenchloride / water / 1 h / 10 - 15 C / pH 4,,,,,,,,,,,,,,,,,,,,hydrogenchloride; sodium hydrogensulfite,,methanol; water,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; DUMAS, Donald J.; HONG, Junbae; (65 pag.)WO2019/173173; (2019); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=77794972&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
52133461,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=52133461&database=RX&origin=ReaxysOutput&ln=,(245 of 327),2,64,full reaction; has multi-step,pyrimidine-5-carbaldehyde,(2-pyridylamino)pyrimidin-5-ylmethanesulfonic acid,225423,O=CC1=CN=CN=C1>>OS(=O)(=O)C(NC1=NC=CC=C1)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:52133461-Steps:52133460;52133457;52133459,1: sodium hydrogensulfite / methanol; water / 0.5 h / 18 - 28 C; 2: water / 5 h / 60 C; 3: hydrogenchloride / water / 1 h / 10 - 15 C / pH 4,,,,,,,,,,,,,,,,,,,,hydrogenchloride; sodium hydrogensulfite,,methanol; water,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; DUMAS, Donald J.; HONG, Junbae; (65 pag.)WO2019/173173; (2019); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=77794972&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
52230098,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=52230098&database=RX&origin=ReaxysOutput&ln=,(246 of 327),1,64,full reaction; has preparation,formamide; pyrimidine-5-carbaldehyde,N-(pyrimidine-5-ylmethyl)formamide,228693,NC=O.O=CC1=CN=CN=C1>>O=CNCC1=CN=CN=C1,Preparation,,,,1,,,,,0.5,180,,,,,,,,Experimental part,,,N-(pyrimidine-5-ylmethyl)formamide,10 percent,10,,,formic acid,,,"Article; Reckzeh, Elena S.; Karageorgis, George; Schwalfenberg, Melanie; Ceballos, Javier; Nowacki, Jessica; Stroet, Marcus C.M.; Binici, Aylin; Knauer, Lena; Brand, Silke; Choidas, Axel; Strohmann, Carsten; Ziegler, Slava; Waldmann, Herbert; Cell Chemical Biology; vol. 26; 9; (2019); p. 1214 - 25,1228;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=77736856&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695842,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695842&database=RX&origin=ReaxysOutput&ln=,(247 of 327),1,63,full reaction; has preparation,pyrimidine-5-carbaldehyde; 2-amino-4-methoxyphenol,4-Methoxy-2-{[1-pyrimidin-5-yl-meth-(E)-ylidene]-amino}-phenol,152561,O=CC1=CN=CN=C1.COC1=CC(N)=C(O)C=C1>>COC1=CC(\N=C\C2=CN=CN=C2)=C(O)C=C1,Preparation,,,,1,,,,,1,20,,,,Condensation,,,,,,,,,,,,,,ethanol,Article; Myung Hee Jung; Choi; Cho; Journal of Heterocyclic Chemistry; vol. 37; 4; (2000); p. 969 - 974;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6266579&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695843,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695843&database=RX&origin=ReaxysOutput&ln=,(248 of 327),1,63,full reaction; has preparation,pyrimidine-5-carbaldehyde; 2-amino-phenol,2-{[1-Pyrimidin-5-yl-meth-(E)-ylidene]-amino}-phenol,152561,O=CC1=CN=CN=C1.NC1=CC=CC=C1O>>OC1=C(C=CC=C1)\N=C\C1=CN=CN=C1,Preparation,,,,1,,,,,1,20,,,,Condensation,,,,,,,,,,,,,,ethanol,Article; Myung Hee Jung; Choi; Cho; Journal of Heterocyclic Chemistry; vol. 37; 4; (2000); p. 969 - 974;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6266579&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695844,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695844&database=RX&origin=ReaxysOutput&ln=,(249 of 327),1,63,full reaction; has preparation,pyrimidine-5-carbaldehyde; 3-amino-4-hydroxytoluene,4-Methyl-2-{[1-pyrimidin-5-yl-meth-(E)-ylidene]-amino}-phenol,152561,O=CC1=CN=CN=C1.CC1=CC(N)=C(O)C=C1>>CC1=CC(\N=C\C2=CN=CN=C2)=C(O)C=C1,Preparation,,,,1,,,,,1,20,,,,Condensation,,,,,,,,,,,,,,ethanol,Article; Myung Hee Jung; Choi; Cho; Journal of Heterocyclic Chemistry; vol. 37; 4; (2000); p. 969 - 974;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6266579&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8695845,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8695845&database=RX&origin=ReaxysOutput&ln=,(250 of 327),1,63,full reaction; has preparation,pyrimidine-5-carbaldehyde; 2-hydroxy-5-chloro-aniline,4-Chloro-2-{[1-pyrimidin-5-yl-meth-(E)-ylidene]-amino}-phenol,152561,O=CC1=CN=CN=C1.NC1=C(O)C=CC(Cl)=C1>>OC1=C(C=C(Cl)C=C1)\N=C\C1=CN=CN=C1,Preparation,,,,1,,,,,1,20,,,,Condensation,,,,,,,,,,,,,,ethanol,Article; Myung Hee Jung; Choi; Cho; Journal of Heterocyclic Chemistry; vol. 37; 4; (2000); p. 969 - 974;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6266579&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
33563180,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=33563180&database=RX&origin=ReaxysOutput&ln=,(251 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3-(4'-cyano-5,2'-dimethyl[1,1'-biphenyl]-3-yl)-2-hydroxy-4-oxo-1-(5-pyrimidinylmethyl)-4H-pyrido[1,2-a]pyrimidinium inner salt",203152,O=CC1=CN=CN=C1>>CC1=CC(=CC(=C1)C1=C(C)C=C(C=C1)C#N)C1=C([O-])[N+](CC2=CN=CN=C2)=C2C=CC=CN2C1=O,Multi-step reaction,,,,3,Reaction-ID:33563180-Steps:33563182;33563201;33563194,1: chloroform / 0.25 h / 20 C; 2: sodium tetrahydroborate; methanol / tetrahydrofuran; 3: 4-methylisopropylbenzene; tetralin / 1.5 h / 178 C,,,,,,,,,,,,,,,,,,,,methanol; sodium tetrahydroborate,,tetrahydrofuran; tetralin; chloroform; 4-methylisopropylbenzene,"Patent; E. I. DU PONT DE NEMOURS AND COMPANY; PAHUTSKI, Thomas, Francis., Jr.; WO2012/92115; (2012); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20156312&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36181136,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36181136&database=RX&origin=ReaxysOutput&ln=,(252 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"N-[(4-morpholinosulfonylphenyl)methyl]-1,3-dihydropyrrolo[3,4-c]pyridine-2-carboxamide",198006,O=CC1=CN=CN=C1>>O=C(NCC1=CC=C(C=C1)S(=O)(=O)N1CCOCC1)N1CC2=CC=NC=C2C1,Multi-step reaction,,,,6,Reaction-ID:36181136-Steps:8695846;36181142;36181135;36181150;36181153;36041022,"1: methanol; sodium tetrahydroborate / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: potassium hydroxide; N-benzyl-N,N,N-triethylammonium chloride / toluene / 20 C / Inert atmosphere; 4: 5,5-dimethyl-1,3-cyclohexadiene / 48 h / 150 C / Inert atmosphere; 5: water; barium hydroxide / 120 C; 6: ethanol / 1 h / 90 C",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; thionyl chloride; barium hydroxide; N-benzyl-N,N,N-triethylammonium chloride; water; potassium hydroxide",,"5,5-dimethyl-1,3-cyclohexadiene; ethanol; dichloromethane; toluene","Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; BUCKMELTER, Alexandre J.; CLODFELTER, Karl H.; DRAGOVICH, Peter; GOSSELIN, Francis; GUNZNER-TOSTE, Janet; HAN, Bingsong; LIN, Jian; LIU, Xiongcai; REYNOLDS, Dominic J.; SMITH, Chase C.; WANG, Zhongguo; ZAK, Mark; ZHANG, Yamin; ZHAO, Guiling; ZHENG, Xiaozhang; YUEN, Po-Wai; WO2013/127266; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727359&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
36183444,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=36183444&database=RX&origin=ReaxysOutput&ln=,(253 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1,3-dihydropyrrolo[3,4-c]pyridin-2-carboxylic acid [5-(3-trifluoromethylbenzenesulfonyl)pyridin-2-ylmethyl]amide",198006,O=CC1=CN=CN=C1>>FC(F)(F)C1=CC=CC(=C1)S(=O)(=O)C1=CN=C(CNC(=O)N2CC3=C(C2)C=NC=C3)C=C1,Multi-step reaction,,,,6,Reaction-ID:36183444-Steps:8695846;36181142;36181135;36181150;36181153;36183449,"1: sodium tetrahydroborate; methanol / 0.5 h / 0 - 10 C; 2: thionyl chloride / dichloromethane / 2 h / 20 C; 3: N-benzyl-N,N,N-triethylammonium chloride; potassium hydroxide / toluene / 20 C / Inert atmosphere; 4: 5,5-dimethyl-1,3-cyclohexadiene / 48 h / 150 C / Inert atmosphere; 5: barium hydroxide; water / 120 C; 6: ethanol / 2 h / 20 C",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; thionyl chloride; barium hydroxide; N-benzyl-N,N,N-triethylammonium chloride; water; potassium hydroxide",,"5,5-dimethyl-1,3-cyclohexadiene; ethanol; dichloromethane; toluene","Patent; GENENTECH, INC.; FORMA TM, LLC; BAIR, Kenneth W.; BAUMEISTER, Timm R.; DRAGOVICH, Peter; GOSSELIN, Francis; YUEN, Po-Wai; ZAK, Mark; ZHENG, Xiaozhang; WO2013/127267; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=48727360&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
37024668,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=37024668&database=RX&origin=ReaxysOutput&ln=,(254 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(1RS,2RS,3RS)-ethyl 2-phenyl-3-(pyrimidin-5-yl)cyclopropanecarboxylate",,O=CC1=CN=CN=C1>>CCOC(=O)[C@H]1[C@H]([C@@H]1C1=CN=CN=C1)C1=CC=CC=C1,Multi-step reaction,,,,2,Reaction-ID:37024668-Steps:37024670;37024936,"1.1: sodium hydride / tetrahydrofuran / 1 h / 0 C / Inert atmosphere; 1.2: 17 h / 20 C / Inert atmosphere; 2.1: (1,4,7,10-tetraoxacyclododecane); lithium hexamethyldisilazane / dichloromethane / 2 h / -78 - 20 C / Inert atmosphere",,,,,,,,,,,,,,,,,,,,"(1,4,7,10-tetraoxacyclododecane); sodium hydride; lithium hexamethyldisilazane",,tetrahydrofuran; dichloromethane,"Article; Buerli, Roland W.; Luckhurst, Christopher A.; Aziz, Omar; Matthews, Kim L.; Yates, Dawn; Lyons, Kathy. A.; Beconi, Maria; McAllister, George; Breccia, Perla; Stott, Andrew J.; Penrose, Stephen D.; Wall, Michael; Lamers, Marieke; Leonard, Philip; Mueller, Ilka; Richardson, Christine M.; Jarvis, Rebecca; Stones, Liz; Hughes, Samantha; Wishart, Grant; Haughan, Alan F.; O'Connell, Catherine; Mead, Tania; McNeil, Hannah; Vann, Julie; Mangette, John; Maillard, Michel; Beaumont, Vahri; Munoz-Sanjuan, Ignacio; Dominguez, Celia; Journal of Medicinal Chemistry; vol. 56; 24; (2013); p. 9934 - 9954;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=62375602&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
37024669,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=37024669&database=RX&origin=ReaxysOutput&ln=,(255 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(1RS,2RS,3RS)-N-hydroxy-2-phenyl-3-(pyrimidin-5-yl)-cyclopropanecarboxamide",,O=CC1=CN=CN=C1>>ONC(=O)[C@H]1[C@H]([C@@H]1C1=CN=CN=C1)C1=CC=CC=C1,Multi-step reaction,,,,3,Reaction-ID:37024669-Steps:37024670;37024936;37024643,"1.1: sodium hydride / tetrahydrofuran / 1 h / 0 C / Inert atmosphere; 1.2: 17 h / 20 C / Inert atmosphere; 2.1: (1,4,7,10-tetraoxacyclododecane); lithium hexamethyldisilazane / dichloromethane / 2 h / -78 - 20 C / Inert atmosphere; 3.1: hydroxylamine; potassium hydroxide / tetrahydrofuran; water; methanol / 20 C / Inert atmosphere",,,,,,,,,,,,,,,,,,,,"(1,4,7,10-tetraoxacyclododecane); hydroxylamine; sodium hydride; potassium hydroxide; lithium hexamethyldisilazane",,tetrahydrofuran; methanol; dichloromethane; water,"Article; Buerli, Roland W.; Luckhurst, Christopher A.; Aziz, Omar; Matthews, Kim L.; Yates, Dawn; Lyons, Kathy. A.; Beconi, Maria; McAllister, George; Breccia, Perla; Stott, Andrew J.; Penrose, Stephen D.; Wall, Michael; Lamers, Marieke; Leonard, Philip; Mueller, Ilka; Richardson, Christine M.; Jarvis, Rebecca; Stones, Liz; Hughes, Samantha; Wishart, Grant; Haughan, Alan F.; O'Connell, Catherine; Mead, Tania; McNeil, Hannah; Vann, Julie; Mangette, John; Maillard, Michel; Beaumont, Vahri; Munoz-Sanjuan, Ignacio; Dominguez, Celia; Journal of Medicinal Chemistry; vol. 56; 24; (2013); p. 9934 - 9954;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=62375602&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
37497816,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=37497816&database=RX&origin=ReaxysOutput&ln=,(256 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,2-(2-(difluoromethyl)pyrimidin-5-yl)-2-morpholinoacetonitrile,197699,O=CC1=CN=CN=C1>>FC(F)C1=NC=C(C=N1)C(C#N)N1CCOCC1,Multi-step reaction,,,,2,Reaction-ID:37497816-Steps:37592281;37592286,1: sodium acetate / acetic acid / 20 C; 2: trifluoroacetic acid; tert.-butylhydroperoxide / dichloromethane; water / 20 C,,,,,,,,,,,,,,,,,,,,tert.-butylhydroperoxide; sodium acetate; trifluoroacetic acid,,dichloromethane; water; acetic acid,"Patent; H. Lundbeck A/S; Kilburn, John Paul; Rasmussen, Lars Kyhn; Jessing, Mikkel; Eldemenky, Eman Mohammed; Chen, Bin; Jiang, Yu; US2014/107335; (2014); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=63369829&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
37497817,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=37497817&database=RX&origin=ReaxysOutput&ln=,(257 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,2-(2-(difluoromethyl)pyrimidin-5-yl)-2-morpholinoethanamine,197699,O=CC1=CN=CN=C1>>NCC(N1CCOCC1)C1=CN=C(N=C1)C(F)F,Multi-step reaction,,,,3,Reaction-ID:37497817-Steps:37592281;37592286;37497833,1: sodium acetate / acetic acid / 20 C; 2: trifluoroacetic acid; tert.-butylhydroperoxide / dichloromethane; water / 20 C; 3: ammonium hydroxide; hydrogen / methanol / 3 h / 20 C / 2585.81 Torr / Inert atmosphere,,,,,,,,,,,,,,,,,,,,tert.-butylhydroperoxide; ammonium hydroxide; hydrogen; sodium acetate; trifluoroacetic acid,,methanol; dichloromethane; water; acetic acid,"Patent; H. Lundbeck A/S; Kilburn, John Paul; Rasmussen, Lars Kyhn; Jessing, Mikkel; Eldemenky, Eman Mohammed; Chen, Bin; Jiang, Yu; US2014/107335; (2014); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=63369829&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
40045743,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=40045743&database=RX&origin=ReaxysOutput&ln=,(258 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(+/-)-4-(2,4-dimethoxybenzyl)-3-(pyrimidin-5-yl)-4H-1'-azaspiro[[1,2,4]oxadiazole-5,3'-bicyclo[2.2.2]octane]",55751,O=CC1=CN=CN=C1>>COC1=CC(OC)=C(CN2C(=NOC22CN3CCC2CC3)C2=CN=CN=C2)C=C1,Multi-step reaction,,,,2,Reaction-ID:40045743-Steps:40045742;40045752,1: hydroxylamine hydrochloride; sodium hydroxide / ethanol / 20 C; 2: sodium hypochlorite / water; dichloromethane / 4 h / 0 - 20 C,,,,,,,,,,,,,,,,,,,,sodium hypochlorite; hydroxylamine hydrochloride; sodium hydroxide,,ethanol; dichloromethane; water,"Patent; FORUM PHARMACEUTICALS, INC.; BURNETT, Duane, A.; BURSAVICH, Matthew, Gregory; MCRINER, Andrew, J.; WO2015/66371; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=66155944&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
40045744,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=40045744&database=RX&origin=ReaxysOutput&ln=,(259 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(R)-4-(2,4-dimethoxybenzyl)-3-(pyrimidin-5-yl)-4H-1'-azaspiro[[1,2,4]oxadiazole-5,3'-bicyclo[2.2.2]octane]",55751,O=CC1=CN=CN=C1>>COC1=CC(OC)=C(CN2C(=NO[C@]22CN3CCC2CC3)C2=CN=CN=C2)C=C1,Multi-step reaction,,,,3,Reaction-ID:40045744-Steps:40045742;40045752;40047177,1: hydroxylamine hydrochloride; sodium hydroxide / ethanol / 20 C; 2: sodium hypochlorite / water; dichloromethane / 4 h / 0 - 20 C; 3: ammonium hydroxide / methanol; ethanol / Resolution of racemate,,,,,,,,,,,,,,,,,,,,ammonium hydroxide; sodium hypochlorite; hydroxylamine hydrochloride; sodium hydroxide,,methanol; ethanol; dichloromethane; water,"Patent; FORUM PHARMACEUTICALS, INC.; BURNETT, Duane, A.; BURSAVICH, Matthew, Gregory; MCRINER, Andrew, J.; WO2015/66371; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=66155944&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
40045745,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=40045745&database=RX&origin=ReaxysOutput&ln=,(260 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(S)-4-(2,4-dimethoxybenzyl)-3-(pyrimidin-5-yl)-4H-1'-azaspiro[[1,2,4]oxadiazole-5,3'-bicyclo[2.2.2]octane]",55751,O=CC1=CN=CN=C1>>COC1=CC(OC)=C(CN2C(=NO[C@@]22CN3CCC2CC3)C2=CN=CN=C2)C=C1,Multi-step reaction,,,,3,Reaction-ID:40045745-Steps:40045742;40045752;40047177,1: hydroxylamine hydrochloride; sodium hydroxide / ethanol / 20 C; 2: sodium hypochlorite / water; dichloromethane / 4 h / 0 - 20 C; 3: ammonium hydroxide / methanol; ethanol / Resolution of racemate,,,,,,,,,,,,,,,,,,,,ammonium hydroxide; sodium hypochlorite; hydroxylamine hydrochloride; sodium hydroxide,,methanol; ethanol; dichloromethane; water,"Patent; FORUM PHARMACEUTICALS, INC.; BURNETT, Duane, A.; BURSAVICH, Matthew, Gregory; MCRINER, Andrew, J.; WO2015/66371; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=66155944&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
40045746,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=40045746&database=RX&origin=ReaxysOutput&ln=,(261 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(R)-3-(pyrimidin-5-yl)-4H-1'-azaspiro[[1,2,4]oxadiazole-5,3'-bicyclo[2.2.2]octane] hydrochloride",55751,O=CC1=CN=CN=C1>>Cl.C1CN2CCC1[C@@]1(C2)NC(=NO1)C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:40045746-Steps:40045742;40045752;40047177;40047180,1: hydroxylamine hydrochloride; sodium hydroxide / ethanol / 20 C; 2: sodium hypochlorite / water; dichloromethane / 4 h / 0 - 20 C; 3: ammonium hydroxide / methanol; ethanol / Resolution of racemate; 4: trifluoroacetic acid / dichloromethane / 3 h / 0 C,,,,,,,,,,,,,,,,,,,,ammonium hydroxide; sodium hypochlorite; hydroxylamine hydrochloride; trifluoroacetic acid; sodium hydroxide,,methanol; ethanol; dichloromethane; water,"Patent; FORUM PHARMACEUTICALS, INC.; BURNETT, Duane, A.; BURSAVICH, Matthew, Gregory; MCRINER, Andrew, J.; WO2015/66371; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=66155944&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
40045747,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=40045747&database=RX&origin=ReaxysOutput&ln=,(262 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(S)-3-(pyrimidin-5-yl)-4H-1'-azaspiro[[1,2,4]oxadiazole-5,3'-bicyclo[2.2.2]octane] hydrochloride",55751,O=CC1=CN=CN=C1>>Cl.C1CN2CCC1[C@]1(C2)NC(=NO1)C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:40045747-Steps:40045742;40045752;40047177;40047181,1: hydroxylamine hydrochloride; sodium hydroxide / ethanol / 20 C; 2: sodium hypochlorite / water; dichloromethane / 4 h / 0 - 20 C; 3: ammonium hydroxide / methanol; ethanol / Resolution of racemate; 4: trifluoroacetic acid / dichloromethane / 3 h / 0 C,,,,,,,,,,,,,,,,,,,,ammonium hydroxide; sodium hypochlorite; hydroxylamine hydrochloride; trifluoroacetic acid; sodium hydroxide,,methanol; ethanol; dichloromethane; water,"Patent; FORUM PHARMACEUTICALS, INC.; BURNETT, Duane, A.; BURSAVICH, Matthew, Gregory; MCRINER, Andrew, J.; WO2015/66371; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=66155944&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
41064876,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=41064876&database=RX&origin=ReaxysOutput&ln=,(263 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,tert-butyl (1-hydroxy-3-(pyrimidin-5-yl)propan-2-yl)carbamate,,O=CC1=CN=CN=C1>>CC(C)(C)OC(=O)NC(CO)CC1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:41064876-Steps:41064879;41064885;41064886,1.1: potassium tert-butylate / tetrahydrofuran; dichloromethane / 0.25 h / -30 C / Inert atmosphere; 1.2: 4.16 h / -30 - 0 C; 2.1: hydrogen; 5%-palladium/activated carbon / methanol / 16 h / 20 C / 5171.62 Torr; 3.1: sodium tetrahydroborate; methanol / 16 h / 0 - 20 C,,,,,,,,,,,,,,,,,,,,methanol; sodium tetrahydroborate; 5%-palladium/activated carbon; potassium tert-butylate; hydrogen,,tetrahydrofuran; methanol; dichloromethane,"Patent; INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION; ASSEMBLY BIOSCIENCES, INC.; TURNER, William W.; ARNOLD, Lee Daniel; MAAG, Hans; ZLOTNICK, Adam; WO2015/138895; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=67157386&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
41064877,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=41064877&database=RX&origin=ReaxysOutput&ln=,(264 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,tert-butyl (1-methoxy-3-(pyrimidin-5-yl)propan-2-yl)carbamate,,O=CC1=CN=CN=C1>>COCC(CC1=CN=CN=C1)NC(=O)OC(C)(C)C,Multi-step reaction,,,,4,Reaction-ID:41064877-Steps:41064879;41064885;41064886;41064113,"1.1: potassium tert-butylate / tetrahydrofuran; dichloromethane / 0.25 h / -30 C / Inert atmosphere; 1.2: 4.16 h / -30 - 0 C; 2.1: hydrogen; 5%-palladium/activated carbon / methanol / 16 h / 20 C / 5171.62 Torr; 3.1: sodium tetrahydroborate; methanol / 16 h / 0 - 20 C; 4.1: sodium hydroxide; N-benzyl-N,N,N-triethylammonium chloride / water; tetrahydrofuran / 24 h / 0 - 20 C",,,,,,,,,,,,,,,,,,,,"methanol; sodium tetrahydroborate; 5%-palladium/activated carbon; potassium tert-butylate; N-benzyl-N,N,N-triethylammonium chloride; hydrogen; sodium hydroxide",,tetrahydrofuran; methanol; dichloromethane; water,"Patent; INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION; ASSEMBLY BIOSCIENCES, INC.; TURNER, William W.; ARNOLD, Lee Daniel; MAAG, Hans; ZLOTNICK, Adam; WO2015/138895; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=67157386&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
41064878,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=41064878&database=RX&origin=ReaxysOutput&ln=,(265 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,methyl 2-((tert-butoxycarbonyl)amino)-3-(pyrimidin-5-yl)propanoate,,O=CC1=CN=CN=C1>>COC(=O)C(CC1=CN=CN=C1)NC(=O)OC(C)(C)C,Multi-step reaction,,,,2,Reaction-ID:41064878-Steps:41064879;41064885,1.1: potassium tert-butylate / tetrahydrofuran; dichloromethane / 0.25 h / -30 C / Inert atmosphere; 1.2: 4.16 h / -30 - 0 C; 2.1: hydrogen; 5%-palladium/activated carbon / methanol / 16 h / 20 C / 5171.62 Torr,,,,,,,,,,,,,,,,,,,,5%-palladium/activated carbon; potassium tert-butylate; hydrogen,,tetrahydrofuran; methanol; dichloromethane,"Patent; INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION; ASSEMBLY BIOSCIENCES, INC.; TURNER, William W.; ARNOLD, Lee Daniel; MAAG, Hans; ZLOTNICK, Adam; WO2015/138895; (2015); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=67157386&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
43497851,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=43497851&database=RX&origin=ReaxysOutput&ln=,(266 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,C18H19N3O3,23551,O=CC1=CN=CN=C1>>CC(C)CN1[C@H]([C@H](C(O)=O)C2=C(C=CC=C2)C1=O)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:43497851-Steps:43497853;43497517,1: acetic acid / methanol / 4 h / 25 C; 2: acetic acid / 16 h / Reflux,,,,,,,,,,,,,,,,,,,,acetic acid,,methanol,"Article; Floyd, David M.; Stein, Philip; Wang, Zheng; Liu, Jian; Castro, Steve; Clark, Julie A.; Connelly, Michele; Zhu, Fangyi; Holbrook, Gloria; Matheny, Amy; Sigal, Martina S.; Min, Jaeki; Dhinakaran, Rajkumar; Krishnan, Senthil; Bashyum, Sridevi; Knapp, Spencer; Guy, R. Kiplin; Journal of Medicinal Chemistry; vol. 59; 17; (2016); p. 7950 - 7962;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=69594455&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
43497852,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=43497852&database=RX&origin=ReaxysOutput&ln=,(267 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"N-(3-cyano-4-fluorophenyl)-2-isobutyl-1-oxo-3-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",222929,O=CC1=CN=CN=C1>>CC(C)CN1[C@H]([C@H](C(=O)NC2=CC(C#N)=C(F)C=C2)C2=C(C=CC=C2)C1=O)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:43497852-Steps:43497853;43497517;43497281,"1: acetic acid / methanol / 4 h / 25 C; 2: acetic acid / 16 h / Reflux; 3: triethylamine; 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide / dichloromethane; ethyl acetate / 16 h / 0 - 20 C",,,,,,,,,,,,,,,,,,,,"acetic acid; 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; triethylamine",,methanol; dichloromethane; ethyl acetate,"Article; Floyd, David M.; Stein, Philip; Wang, Zheng; Liu, Jian; Castro, Steve; Clark, Julie A.; Connelly, Michele; Zhu, Fangyi; Holbrook, Gloria; Matheny, Amy; Sigal, Martina S.; Min, Jaeki; Dhinakaran, Rajkumar; Krishnan, Senthil; Bashyum, Sridevi; Knapp, Spencer; Guy, R. Kiplin; Journal of Medicinal Chemistry; vol. 59; 17; (2016); p. 7950 - 7962;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=69594455&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
44296147,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=44296147&database=RX&origin=ReaxysOutput&ln=,(268 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"methyl malonate (R)-1-(pyrimidin-5-yl)-7-(5,6,7,8-tetrahydro-[1,8]-naphthyridin-2-yl)-(E)-hept-1-en-3-ol",304179,O=CC1=CN=CN=C1>>COC(=O)CC(=O)O[C@H](CCCCC1=NC2=C(CCCN2)C=C1)\C=C\C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:44296147-Steps:44296148;44296383;44296150,"1.1: lithium chloride / acetonitrile / 0.25 h; 1.2: 0.5 h / Sonication; 1.3: 2.25 h; 2.1: 1,1-bi-2,2?-naphthol-lithium aluminum hydride complex / tetrahydrofuran; dichloromethane; toluene / 1.42 h / -75 - -69 C / Inert atmosphere; 3.1: hydrogenchloride / dichloromethane; Isopropyl acetate / 5 - 20 C",,,,,,,,,,,,,,,,,,,,"hydrogenchloride; 1,1-bi-2,2?-naphthol-lithium aluminum hydride complex; lithium chloride",,tetrahydrofuran; dichloromethane; Isopropyl acetate; toluene; acetonitrile,"Patent; MERCK SHARP &amp; DOHME CORP.; COX, Jason, M.; MA, Lijun; ZHOU, Xiaoyan; HAIMBACH, Robin, E.; COLEMAN, Paul, J.; ZHOU, Haihong; KELLEY, David, E.; STOCH, Selwyn Aubrey; DUONG, Le, T.; HOEK, Maarten; (68 pag.)WO2016/154369; (2016); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=69699432&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
44519601,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=44519601&database=RX&origin=ReaxysOutput&ln=,(269 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"4-{cyclopentyl[(pyrimidin-5-yl)methyl]amino}-6-(morpholin-4-yl)-1,3,5-triazine-2-carbonitrile",226599,O=CC1=CN=CN=C1>>N#CC1=NC(=NC(=N1)N1CCOCC1)N(CC1=CN=CN=C1)C1CCCC1,Multi-step reaction,,,,3,Reaction-ID:44519601-Steps:44519603;44519710;44519578,"1.1: dichloromethane / Molecular sieve; 1.2: Molecular sieve; 2.1: N-ethyl-N,N-diisopropylamine / dichloromethane / 0 C; 3.1: 1,4-diaza-bicyclo[2.2.2]octane / dimethyl sulfoxide; water / 80 C / Sealed tube",,,,,,,,,,,,,,,,,,,,"1,4-diaza-bicyclo[2.2.2]octane; N-ethyl-N,N-diisopropylamine",,dichloromethane; water; dimethyl sulfoxide,"Article; Giroud, Maude; Ivkovic, Jakov; Martignoni, Mara; Fleuti, Marianne; Trapp, Nils; Haap, Wolfgang; Kuglstatter, Andreas; Benz, Joerg; Kuhn, Bernd; Schirmeister, Tanja; Diederich, Francois; ChemMedChem; vol. 12; 3; (2017); p. 257 - 270;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=70586329&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
44519602,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=44519602&database=RX&origin=ReaxysOutput&ln=,(270 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"4-chloro-N-cyclopentyl-6-(morpholin-4-yl)-N-[(pyrimidin-5-yl)methyl]-1,3,5-triazin-2-amine",215828,O=CC1=CN=CN=C1>>ClC1=NC(=NC(=N1)N(CC1=CN=CN=C1)C1CCCC1)N1CCOCC1,Multi-step reaction,,,,2,Reaction-ID:44519602-Steps:44519603;44519710,"1.1: dichloromethane / Molecular sieve; 1.2: Molecular sieve; 2.1: N-ethyl-N,N-diisopropylamine / dichloromethane / 0 C",,,,,,,,,,,,,,,,,,,,"N-ethyl-N,N-diisopropylamine",,dichloromethane,"Article; Giroud, Maude; Ivkovic, Jakov; Martignoni, Mara; Fleuti, Marianne; Trapp, Nils; Haap, Wolfgang; Kuglstatter, Andreas; Benz, Joerg; Kuhn, Bernd; Schirmeister, Tanja; Diederich, Francois; ChemMedChem; vol. 12; 3; (2017); p. 257 - 270;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=70586329&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
46782310,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=46782310&database=RX&origin=ReaxysOutput&ln=,(271 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,N-[methoxy(5-pyrimidinyl)methyl]-2-pyridinamine,196361,O=CC1=CN=CN=C1>>COC(NC1=NC=CC=C1)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:46782310-Steps:33563182;46782305,1: toluene-4-sulfonic acid / toluene / 3.75 h / 112 - 114 C / 760.05 Torr / Inert atmosphere; Dean-Stark; 2: 16 - 24 C,,,,,,,,,,,,,,,,,,,,toluene-4-sulfonic acid,,toluene,"Patent; E I DU PONT DE NEMOURS AND COMPANY; DUMAS, Donald J.; TRAN, Loc Thanh; (24 pag.)WO2017/189339; (2017); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=72745592&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
47816300,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=47816300&database=RX&origin=ReaxysOutput&ln=,(272 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,(2E)-1-[2-(2-hydroxyethoxy)-4-phenylquinolin-3-yl]-3-(pyrimidin-5-yl)prop-2-en-1-one,252596,O=CC1=CN=CN=C1>>OCCOC1=NC2=CC=CC=C2C(C2=CC=CC=C2)=C1C(=O)\C=C\C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:47816300-Steps:47816296;47816208;47816233,"1: water; barium(II) hydroxide / methanol / 0.67 h / 20 C; 2: potassium carbonate / N,N-dimethyl-formamide / 46 h / 20 - 60 C; 3: hydrogenchloride / methanol / 0.5 h / 20 C",,,,,,,,,,,,,,,,,,,,hydrogenchloride; water; potassium carbonate; barium(II) hydroxide,,"methanol; N,N-dimethyl-formamide","Patent; PADLOCK THERAPEUTICS, INC.; DEVRAJ, Rajesh; KUMARAVEL, Gnanasambandam; LECCI, Cristina; LOKE, Pui; MENICONI, Mirco; MONCK, Nat; NORTH, Carl; RIDGILL, Mark; TYE, Heather; (205 pag.)WO2018/49296; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73439980&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
47816301,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=47816301&database=RX&origin=ReaxysOutput&ln=,(273 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,(2E)-1-[4-phenyl-2-(prop-2-en-1-yloxy)quinolin-3-yl]-3-(pyrimidin-5-yl)prop-2-en-1-one,252596,O=CC1=CN=CN=C1>>C=CCOC1=NC2=CC=CC=C2C(C2=CC=CC=C2)=C1C(=O)\C=C\C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:47816301-Steps:47816296;47816211,1: water; barium(II) hydroxide / methanol / 0.67 h / 20 C; 2: potassium carbonate; copper(l) iodide; L-proline / dimethyl sulfoxide / 6.5 h / 90 C / Inert atmosphere,,,,,,,,,,,,,,,,,,,,copper(l) iodide; water; potassium carbonate; L-proline; barium(II) hydroxide,,methanol; dimethyl sulfoxide,"Patent; PADLOCK THERAPEUTICS, INC.; DEVRAJ, Rajesh; KUMARAVEL, Gnanasambandam; LECCI, Cristina; LOKE, Pui; MENICONI, Mirco; MONCK, Nat; NORTH, Carl; RIDGILL, Mark; TYE, Heather; (205 pag.)WO2018/49296; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73439980&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
47816303,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=47816303&database=RX&origin=ReaxysOutput&ln=,(274 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-{2-[(tert-butyldimethylsilyl)oxy]ethyl}-4-phenyl-3-[(2E)-3-(pyrimidin-5-yl)prop-2-enoyl]-1,2-dihydroquinolin-2-one",32729,O=CC1=CN=CN=C1>>CC(C)(C)[Si](C)(C)OCCN1C(=O)C(C(=O)\C=C\C2=CN=CN=C2)=C(C2=CC=CC=C2)C2=C1C=CC=C2,Multi-step reaction,,,,2,Reaction-ID:47816303-Steps:47816296;47816208,"1: water; barium(II) hydroxide / methanol / 0.67 h / 20 C; 2: potassium carbonate / N,N-dimethyl-formamide / 46 h / 20 - 60 C",,,,,,,,,,,,,,,,,,,,water; potassium carbonate; barium(II) hydroxide,,"methanol; N,N-dimethyl-formamide","Patent; PADLOCK THERAPEUTICS, INC.; DEVRAJ, Rajesh; KUMARAVEL, Gnanasambandam; LECCI, Cristina; LOKE, Pui; MENICONI, Mirco; MONCK, Nat; NORTH, Carl; RIDGILL, Mark; TYE, Heather; (205 pag.)WO2018/49296; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73439980&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
47816304,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=47816304&database=RX&origin=ReaxysOutput&ln=,(275 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,(2E)-1-(2-{2-[(tert-butyldimethylsilyl)oxy]ethoxy}-4-phenylquinolin-3-yl)-3-(pyrimidin-5-yl)prop-2-en-1-one,252596,O=CC1=CN=CN=C1>>CC(C)(C)[Si](C)(C)OCCOC1=NC2=CC=CC=C2C(C2=CC=CC=C2)=C1C(=O)\C=C\C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:47816304-Steps:47816296;47816208,"1: water; barium(II) hydroxide / methanol / 0.67 h / 20 C; 2: potassium carbonate / N,N-dimethyl-formamide / 46 h / 20 - 60 C",,,,,,,,,,,,,,,,,,,,water; potassium carbonate; barium(II) hydroxide,,"methanol; N,N-dimethyl-formamide","Patent; PADLOCK THERAPEUTICS, INC.; DEVRAJ, Rajesh; KUMARAVEL, Gnanasambandam; LECCI, Cristina; LOKE, Pui; MENICONI, Mirco; MONCK, Nat; NORTH, Carl; RIDGILL, Mark; TYE, Heather; (205 pag.)WO2018/49296; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73439980&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
47816305,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=47816305&database=RX&origin=ReaxysOutput&ln=,(276 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-(2-hydroxyethyl)-4-phenyl-3-[(2E)-3-(pyrimidin-5-yl)prop-2-enoyl]-1,2-dihydroquinolin-2-one",249520,O=CC1=CN=CN=C1>>OCCN1C(=O)C(C(=O)\C=C\C2=CN=CN=C2)=C(C2=CC=CC=C2)C2=C1C=CC=C2,Multi-step reaction,,,,3,Reaction-ID:47816305-Steps:47816296;47816208;47816232,"1: water; barium(II) hydroxide / methanol / 0.67 h / 20 C; 2: potassium carbonate / N,N-dimethyl-formamide / 46 h / 20 - 60 C; 3: hydrogenchloride / methanol / 0.5 h / 20 C",,,,,,,,,,,,,,,,,,,,hydrogenchloride; water; potassium carbonate; barium(II) hydroxide,,"methanol; N,N-dimethyl-formamide","Patent; PADLOCK THERAPEUTICS, INC.; DEVRAJ, Rajesh; KUMARAVEL, Gnanasambandam; LECCI, Cristina; LOKE, Pui; MENICONI, Mirco; MONCK, Nat; NORTH, Carl; RIDGILL, Mark; TYE, Heather; (205 pag.)WO2018/49296; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73439980&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
47816306,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=47816306&database=RX&origin=ReaxysOutput&ln=,(277 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-cyclopropyl-4-phenyl-3-[(2E)-3-(pyrimidin-5-yl)prop-2-enoyl]-1,2-dihydroquinolin-2-one",249413,O=CC1=CN=CN=C1>>O=C(\C=C\C1=CN=CN=C1)C1=C(C2=CC=CC=C2)C2=C(C=CC=C2)N(C2CC2)C1=O,Multi-step reaction,,,,2,Reaction-ID:47816306-Steps:47816296;47816210,"1: water; barium(II) hydroxide / methanol / 0.67 h / 20 C; 2: copper diacetate; sodium carbonate; [2,2]bipyridinyl / 1,2-dichloro-ethane / 4.5 h / 80 C",,,,,,,,,,,,,,,,,,,,"[2,2]bipyridinyl; water; copper diacetate; sodium carbonate; barium(II) hydroxide",,"methanol; 1,2-dichloro-ethane","Patent; PADLOCK THERAPEUTICS, INC.; DEVRAJ, Rajesh; KUMARAVEL, Gnanasambandam; LECCI, Cristina; LOKE, Pui; MENICONI, Mirco; MONCK, Nat; NORTH, Carl; RIDGILL, Mark; TYE, Heather; (205 pag.)WO2018/49296; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73439980&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49213616,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49213616&database=RX&origin=ReaxysOutput&ln=,(278 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,amino(pyrimidin-5-yl)acetamide,,O=CC1=CN=CN=C1>>NC(C(N)=O)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:49213616-Steps:14306587;24727791,1: ammonium chloride / methanol; water; 2: sodium carbonate / hydrogenchloride,,,,,,,,,,,,,,,,,,,,ammonium chloride; sodium carbonate,,hydrogenchloride; methanol; water,Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49213617,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49213617&database=RX&origin=ReaxysOutput&ln=,(279 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-Methyl-1,2,3,6-tetrahydro-5-(1,3-dioxolan-2-yl)pyrimidine Hydrochloride",87167,O=CC1=CN=CN=C1>>Cl.CN1CNC=C(C1)C1OCCO1,Multi-step reaction,,,,3,Reaction-ID:49213617-Steps:24714931;24716193;24727785,1: sodium carbonate / methanol; chloroform; ethylene glycol; benzene; 2: acetonitrile; 3: sodium tetrahydroborate / methanol; water,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; sodium carbonate,,methanol; chloroform; water; ethylene glycol; acetonitrile; benzene,Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49213618,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49213618&database=RX&origin=ReaxysOutput&ln=,(280 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-Methyl-1,2,3,6-tetrahydro-5-(1,3-oxathiolan-2-yl)pyrimidine Hydrochloride",86113,O=CC1=CN=CN=C1>>Cl.CN1CNC=C(C1)C1OCCS1,Multi-step reaction,,,,3,Reaction-ID:49213618-Steps:24714931;24716193;24727786,1: sodium carbonate / methanol; chloroform; ethylene glycol; benzene; 2: acetonitrile; 3: sodium tetrahydroborate / methanol; water,,,,,,,,,,,,,,,,,,,,sodium tetrahydroborate; sodium carbonate,,methanol; chloroform; water; ethylene glycol; acetonitrile; benzene,Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49213621,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49213621&database=RX&origin=ReaxysOutput&ln=,(281 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-Methyl-5-(1,3-dioxolan-2-yl)pyrimidinium iodide",90090,O=CC1=CN=CN=C1>>[I-].C[N+]1=CN=CC(=C1)C1OCCO1,Multi-step reaction,,,,2,Reaction-ID:49213621-Steps:24714931;24716193,1: sodium carbonate / methanol; chloroform; ethylene glycol; benzene; 2: acetonitrile,,,,,,,,,,,,,,,,,,,,sodium carbonate,,methanol; chloroform; ethylene glycol; acetonitrile; benzene,Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49213622,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49213622&database=RX&origin=ReaxysOutput&ln=,(282 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"1-Methyl-5-(1,3-oxathiolan-2-yl)pyrimidinium Iodide",86507,O=CC1=CN=CN=C1>>[I-].C[N+]1=CN=CC(=C1)C1OCCS1,Multi-step reaction,,,,2,Reaction-ID:49213622-Steps:24717674;24716194,1: sodium carbonate; toluene-4-sulfonic acid / toluene; 2: acetonitrile,,,,,,,,,,,,,,,,,,,,sodium carbonate; toluene-4-sulfonic acid,,toluene; acetonitrile,Patent; The University of Toledo; US5175166; (1992); A;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=169138&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49365116,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49365116&database=RX&origin=ReaxysOutput&ln=,(283 of 327),1,63,full reaction; has preparation,C13H17BO3; pyrimidine-5-carbaldehyde,2-phenyl-1-(pyrimidin-5-yl)-3-(tetrahydro-4H-pyran-4-ylidene)propan-1-ol,113425,OB(O)C1(CCOCC1)C=CC1=CC=CC=C1.O=CC1=CN=CN=C1>>O[C@@H]([C@H](\C=C1/CCOCC1)C1=CC=CC=C1)C1=CN=CN=C1,Preparation,,,,1,,,,,,20,,,Flow reactor; Irradiation; Inert atmosphere,,,,,Experimental part,supporting information,diastereoselective reaction,2-phenyl-1-(pyrimidin-5-yl)-3-(tetrahydro-4H-pyran-4-ylidene)propan-1-ol,27 mg,,92.308 percent de,,,,,"Article; Chen, Yiding; Blakemore, David C.; Pasau, Patrick; Ley, Steven V.; Organic Letters; vol. 20; 20; (2018); p. 6569 - 6572;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=75114310&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49504011,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49504011&database=RX&origin=ReaxysOutput&ln=,(284 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(+/-)-1,1-dimethylethyl 4-[2-amino-2-oxo-1-(5-pyrimidinyl)ethyl]-1-piperazinecarboxylate",,O=CC1=CN=CN=C1>>CC(C)(C)OC(=O)N1CCN(CC1)C(C(N)=O)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:49504011-Steps:28135446;28135560,"1.1: titanium(IV) isopropylate / 1,1-dichloroethane / 20 C; 1.2: 4 h / 20 C; 2.1: methanol; sodium hydroxide; water; dihydrogen peroxide / dimethyl sulfoxide / 20 C",,,,,,,,,,,,,,,,,,,,titanium(IV) isopropylate; methanol; sodium hydroxide; water; dihydrogen peroxide,,"1,1-dichloroethane; dimethyl sulfoxide",Patent; GLAXO GROUP LIMITED; WO2008/148853; (2008); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8669005&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49504012,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49504012&database=RX&origin=ReaxysOutput&ln=,(285 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(+/-)-N'-[3,5-bis(trifluoromethyl)phenyl]-2-(1-piperazinyl)-2-(5-pyrimidinyl)-acetohydrazide",,O=CC1=CN=CN=C1>>FC(F)(F)C1=CC(=CC(NNC(=O)C(N2CCNCC2)C2=CN=CN=C2)=C1)C(F)(F)F,Multi-step reaction,,,,4,Reaction-ID:49504012-Steps:28135446;28135560;28135498;28135561,"1.1: titanium(IV) isopropylate / 1,1-dichloroethane / 20 C; 1.2: 4 h / 20 C; 2.1: methanol; sodium hydroxide; water; dihydrogen peroxide / dimethyl sulfoxide / 20 C; 3.1: dmap; di-tert-butyl dicarbonate / dichloromethane / 20 C; 3.2: 2 h / 20 C; 4.1: trifluoroacetic acid / dichloromethane / 20 C",,,,,,,,,,,,,,,,,,,,titanium(IV) isopropylate; methanol; dmap; sodium hydroxide; di-tert-butyl dicarbonate; water; dihydrogen peroxide; trifluoroacetic acid,,"1,1-dichloroethane; dichloromethane; dimethyl sulfoxide",Patent; GLAXO GROUP LIMITED; WO2008/148853; (2008); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8669005&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49504013,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49504013&database=RX&origin=ReaxysOutput&ln=,(286 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(+/-)-N'-[3,5-bis(trifluoromethyl)phenyl]-2-(4-methyl-1-piperazinyl)-2-(5-pyrimidinyl)acetohydrazide",,O=CC1=CN=CN=C1>>CN1CCN(CC1)C(C(=O)NNC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=CN=C1,Multi-step reaction,,,,5,Reaction-ID:49504013-Steps:28135446;28135560;28135498;28135561;28135472,"1.1: titanium(IV) isopropylate / 1,1-dichloroethane / 20 C; 1.2: 4 h / 20 C; 2.1: methanol; sodium hydroxide; water; dihydrogen peroxide / dimethyl sulfoxide / 20 C; 3.1: dmap; di-tert-butyl dicarbonate / dichloromethane / 20 C; 3.2: 2 h / 20 C; 4.1: trifluoroacetic acid / dichloromethane / 20 C; 5.1: water; acetonitrile / 1 h / 20 C; 5.2: 3 h",,,,,,,,,,,,,,,,,,,,titanium(IV) isopropylate; methanol; dmap; sodium hydroxide; di-tert-butyl dicarbonate; water; dihydrogen peroxide; trifluoroacetic acid,,"1,1-dichloroethane; dichloromethane; water; dimethyl sulfoxide; acetonitrile",Patent; GLAXO GROUP LIMITED; WO2008/148853; (2008); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8669005&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49504015,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49504015&database=RX&origin=ReaxysOutput&ln=,(287 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(+/-)-1,1-dimethylethyl 4-[2-{2-[3,5-bis(trifluoromethyl)phenyl]hydrazino}-2-oxo-1-(5-pyrimidinyl)ethyl]-1-piperazinecarboxylate",,O=CC1=CN=CN=C1>>CC(C)(C)OC(=O)N1CCN(CC1)C(C(=O)NNC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:49504015-Steps:28135446;28135560;28135498,"1.1: titanium(IV) isopropylate / 1,1-dichloroethane / 20 C; 1.2: 4 h / 20 C; 2.1: methanol; sodium hydroxide; water; dihydrogen peroxide / dimethyl sulfoxide / 20 C; 3.1: dmap; di-tert-butyl dicarbonate / dichloromethane / 20 C; 3.2: 2 h / 20 C",,,,,,,,,,,,,,,,,,,,titanium(IV) isopropylate; methanol; dmap; sodium hydroxide; di-tert-butyl dicarbonate; water; dihydrogen peroxide,,"1,1-dichloroethane; dichloromethane; dimethyl sulfoxide",Patent; GLAXO GROUP LIMITED; WO2008/148853; (2008); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8669005&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49674461,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49674461&database=RX&origin=ReaxysOutput&ln=,(288 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(rel S)-5-(4-chIorophenylsulfonyl)-4-(pyrirnidin-5-yl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridine",226336,O=CC1=CN=CN=C1>>ClC1=CC=C(C=C1)S(=O)(=O)N1CCC2=C(C=NN2)[C@@H]1C1=CN=CN=C1,Multi-step reaction,,,,4,Reaction-ID:49674461-Steps:10753386;10753387;10753388;10753389,1: 4 A molecular sieves; MP-TsOH / toluene / 18 h / Heating / reflux; 2: tetrahydrofuran / 36 h / Heating / reflux; 3: 4 h / 70 C; 4: hydrazine / methanol; acetic acid / 18 h / 20 C,,,,,,,,,,,,,,,,,,,,hydrazine,,tetrahydrofuran; methanol; acetic acid; toluene,"Patent; ELAN PHARMACEUTICALS, INC.; WO2007/64914; (2007); A2;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8938376&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49674462,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49674462&database=RX&origin=ReaxysOutput&ln=,(289 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,1-(4-chlorophenylsulfonyl)-2-(pyrimidin-5-yl)piperidin-4-one,2388,O=CC1=CN=CN=C1>>ClC1=CC=C(C=C1)S(=O)(=O)N1CCC(=O)CC1C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:49674462-Steps:10753386;10753387,1: 4 A molecular sieves; MP-TsOH / toluene / 18 h / Heating / reflux; 2: tetrahydrofuran / 36 h / Heating / reflux,,,,,,,,,,,,,,,,,,,,4 A molecular sieves; MP-TsOH,,tetrahydrofuran; toluene,"Patent; ELAN PHARMACEUTICALS, INC.; WO2007/64914; (2007); A2;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8938376&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49797058,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49797058&database=RX&origin=ReaxysOutput&ln=,(290 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,C26H26N4O4,198012,O=CC1=CN=CN=C1>>COC1=CC(NC(C(=O)C2=CN(C(=O)OC(C)(C)C)C3=C2C=CC=C3)C2=CN=CN=C2)=CC=C1,Multi-step reaction,,,,2,Reaction-ID:49797058-Steps:35518817;49796983,"1: ethanol / 6 h / 60 C; 2: 3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; triethylamine / ethanol / 70 C",,,,,,,,,,,,,,,,,,,,"3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; triethylamine",,ethanol,"Article; Bardiot, Dorothee; Koukni, Mohamed; Smets, Wim; Carlens, Gunter; McNaughton, Michael; Kaptein, Suzanne; Dallmeier, Kai; Chaltin, Patrick; Neyts, Johan; Marchand, Arnaud; Journal of Medicinal Chemistry; vol. 61; 18; (2018); p. 8390 - 8401;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74910400&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49797059,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49797059&database=RX&origin=ReaxysOutput&ln=,(291 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,1-(1H-indol-3-yl)-2-((3-methoxyphenyl)amino)-2-(pyrimidin-5-yl)ethanone,90960,O=CC1=CN=CN=C1>>COC1=CC(NC(C(=O)C2=CNC3=CC=CC=C23)C2=CN=CN=C2)=CC=C1,Multi-step reaction,,,,3,Reaction-ID:49797059-Steps:35518817;49796983;49797087,"1: ethanol / 6 h / 60 C; 2: 3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; triethylamine / ethanol / 70 C; 3: ethanol / 0.07 h / 160 C / Microwave irradiation",,,,,,,,,,,,,,,,,,,,"3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; triethylamine",,ethanol,"Article; Bardiot, Dorothee; Koukni, Mohamed; Smets, Wim; Carlens, Gunter; McNaughton, Michael; Kaptein, Suzanne; Dallmeier, Kai; Chaltin, Patrick; Neyts, Johan; Marchand, Arnaud; Journal of Medicinal Chemistry; vol. 61; 18; (2018); p. 8390 - 8401;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=74910400&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
50248449,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=50248449&database=RX&origin=ReaxysOutput&ln=,(292 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,pyrimidin-5-yl(thiophen-3-yl)methanone,304165,O=CC1=CN=CN=C1>>O=C(C1=CSC=C1)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:50248449-Steps:50248450;50248448,"1.1: N,N,N,N,-tetramethylethylenediamine; n-butyllithium / tetrahydrofuran; hexane / 0.5 h / -78 C; 1.2: 2 h / -78 - -40 C; 2.1: 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; potassium bromide; tetra(n-butyl)ammonium hydrogensulfate; sodium hypochlorite / dichloromethane; water / 1.5 h / 0 C",,,,,,,,,,,,,,,,,,,,"sodium hypochlorite; n-butyllithium; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; N,N,N,N,-tetramethylethylenediamine; tetra(n-butyl)ammonium hydrogensulfate; potassium bromide",,tetrahydrofuran; hexane; dichloromethane; water,"Patent; ARCTIC PHARMA AS; GOLDING, Louise; KLAVENESS, Jo; SIENG, Bora; LUNDVALL, Steffi; BØEN, Claudia Alejandra; HNIDA, Kathrin; (128 pag.)WO2018/211277; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=75535132&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
52747002,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=52747002&database=RX&origin=ReaxysOutput&ln=,(293 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,(pyrimidin?5?yl)methanamine,228752,O=CC1=CN=CN=C1>>NCC1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:52747002-Steps:8695846;36181142;52747010,1: sodium tetrahydroborate / methanol / 4 h / 0 - 20 C; 2: thionyl chloride / tetrahydrofuran / 4 h / 0 - 20 C; 3: ammonium hydroxide / tetrahydrofuran / 0.5 h / 20 C,,,,,,,,,,,,,,,,,,,,ammonium hydroxide; sodium tetrahydroborate; thionyl chloride,,tetrahydrofuran; methanol,"Patent; REMEDY PLAN, INC.; CRIMMINS, Gregory, Thomas; DE JESUS DIAZ, Dennise, Alexandra; BHURRUTH-ALCOR, Yushma; (483 pag.)WO2019/213570; (2019); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78332759&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100022,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100022&database=RX&origin=ReaxysOutput&ln=,(294 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(E)?N?[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]?1?(6?methylpyridin?2?yl)methanimine",272232,O=CC1=CN=CN=C1>>CC1=CC=CC(\C=N\C2=NC(=CC(=N2)C2=CNC3=CC=CC=C23)C2=CN=CN=C2)=N1,Multi-step reaction,,,,3,Reaction-ID:53100022-Steps:53100033;53100013;53100014,1.1: sodium hydroxide / ethanol; water / 3 h / Reflux; 2.1: sodium / isopropyl alcohol / 3 h / Reflux; 2.2: 8 h / Reflux; 3.1: acetic acid / ethanol / 18 h / Reflux,,,,,,,,,,,,,,,,,,,,sodium; acetic acid; sodium hydroxide,,ethanol; water; isopropyl alcohol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100023,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100023&database=RX&origin=ReaxysOutput&ln=,(295 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(E)?N?[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]?1?(3?methylpyridin?2?yl)methanimine",272232,O=CC1=CN=CN=C1>>CC1=CC=CN=C1\C=N\C1=NC(=CC(=N1)C1=CNC2=CC=CC=C12)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:53100023-Steps:53100033;53100013;53100015,1.1: sodium hydroxide / ethanol; water / 3 h / Reflux; 2.1: sodium / isopropyl alcohol / 3 h / Reflux; 2.2: 8 h / Reflux; 3.1: acetic acid / ethanol / 18 h / Reflux,,,,,,,,,,,,,,,,,,,,sodium; acetic acid; sodium hydroxide,,ethanol; water; isopropyl alcohol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100024,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100024&database=RX&origin=ReaxysOutput&ln=,(296 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(E)?N?[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]?1?(6?methylpyridin?3?yl)methanimine",272232,O=CC1=CN=CN=C1>>CC1=NC=C(\C=N\C2=NC(=CC(=N2)C2=CNC3=CC=CC=C23)C2=CN=CN=C2)C=C1,Multi-step reaction,,,,3,Reaction-ID:53100024-Steps:53100033;53100013;53100016,1.1: sodium hydroxide / ethanol; water / 3 h / Reflux; 2.1: sodium / isopropyl alcohol / 3 h / Reflux; 2.2: 8 h / Reflux; 3.1: acetic acid / ethanol / 18 h / Reflux,,,,,,,,,,,,,,,,,,,,sodium; acetic acid; sodium hydroxide,,ethanol; water; isopropyl alcohol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100025,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100025&database=RX&origin=ReaxysOutput&ln=,(297 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(E)?1?(4?ethylpyridin?3?yl)?N?[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]methanimine",272232,O=CC1=CN=CN=C1>>CCC1=CC(\C=N\C2=NC(=CC(=N2)C2=CNC3=CC=CC=C23)C2=CN=CN=C2)=NC=C1,Multi-step reaction,,,,3,Reaction-ID:53100025-Steps:53100033;53100013;53100017,1.1: sodium hydroxide / ethanol; water / 3 h / Reflux; 2.1: sodium / isopropyl alcohol / 3 h / Reflux; 2.2: 8 h / Reflux; 3.1: acetic acid / ethanol / 18 h / Reflux,,,,,,,,,,,,,,,,,,,,sodium; acetic acid; sodium hydroxide,,ethanol; water; isopropyl alcohol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100026,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100026&database=RX&origin=ReaxysOutput&ln=,(298 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(E)?N?[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]?1?(5?methylpyridin?2?yl)methanimine",272232,O=CC1=CN=CN=C1>>CC1=CN=C(\C=N\C2=NC(=CC(=N2)C2=CNC3=CC=CC=C23)C2=CN=CN=C2)C=C1,Multi-step reaction,,,,3,Reaction-ID:53100026-Steps:53100033;53100013;53100018,1.1: sodium hydroxide / ethanol; water / 3 h / Reflux; 2.1: sodium / isopropyl alcohol / 3 h / Reflux; 2.2: 8 h / Reflux; 3.1: acetic acid / ethanol / 18 h / Reflux,,,,,,,,,,,,,,,,,,,,sodium; acetic acid; sodium hydroxide,,ethanol; water; isopropyl alcohol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100027,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100027&database=RX&origin=ReaxysOutput&ln=,(299 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(E)?1?(2,6?dimethoxypyridin?3?yl)?N?[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]methanimine",21545,O=CC1=CN=CN=C1>>COC1=CC=C(\C=N\C2=NC(=CC(=N2)C2=CNC3=CC=CC=C23)C2=CN=CN=C2)C(OC)=N1,Multi-step reaction,,,,3,Reaction-ID:53100027-Steps:53100033;53100013;53100019,1.1: sodium hydroxide / ethanol; water / 3 h / Reflux; 2.1: sodium / isopropyl alcohol / 3 h / Reflux; 2.2: 8 h / Reflux; 3.1: acetic acid / ethanol / 18 h / Reflux,,,,,,,,,,,,,,,,,,,,sodium; acetic acid; sodium hydroxide,,ethanol; water; isopropyl alcohol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100028,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100028&database=RX&origin=ReaxysOutput&ln=,(300 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(E)?N?[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]?1?(2?methylpyridin?3?yl)methanimine",272232,O=CC1=CN=CN=C1>>CC1=NC=CC=C1\C=N\C1=NC(=CC(=N1)C1=CNC2=CC=CC=C12)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:53100028-Steps:53100033;53100013;53100020,1.1: sodium hydroxide / ethanol; water / 3 h / Reflux; 2.1: sodium / isopropyl alcohol / 3 h / Reflux; 2.2: 8 h / Reflux; 3.1: acetic acid / ethanol / 18 h / Reflux,,,,,,,,,,,,,,,,,,,,sodium; acetic acid; sodium hydroxide,,ethanol; water; isopropyl alcohol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100029,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100029&database=RX&origin=ReaxysOutput&ln=,(301 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(E)?N?[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]?1?(4?methylpyridin?2?yl)methanimine",272232,O=CC1=CN=CN=C1>>CC1=CC=NC(\C=N\C2=NC(=CC(=N2)C2=CNC3=CC=CC=C23)C2=CN=CN=C2)=C1,Multi-step reaction,,,,3,Reaction-ID:53100029-Steps:53100033;53100013;53100021,1.1: sodium hydroxide / ethanol; water / 3 h / Reflux; 2.1: sodium / isopropyl alcohol / 3 h / Reflux; 2.2: 8 h / Reflux; 3.1: acetic acid / ethanol / 18 h / Reflux,,,,,,,,,,,,,,,,,,,,sodium; acetic acid; sodium hydroxide,,ethanol; water; isopropyl alcohol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100030,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100030&database=RX&origin=ReaxysOutput&ln=,(302 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"6?(1H?indol?3?yl)?4,5??bipyrimidine?2?amine",272232,O=CC1=CN=CN=C1>>NC1=NC(=CC(=N1)C1=CNC2=CC=CC=C12)C1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:53100030-Steps:53100033;53100013,1.1: sodium hydroxide / ethanol; water / 3 h / Reflux; 2.1: sodium / isopropyl alcohol / 3 h / Reflux; 2.2: 8 h / Reflux,,,,,,,,,,,,,,,,,,,,sodium; sodium hydroxide,,ethanol; water; isopropyl alcohol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100031,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100031&database=RX&origin=ReaxysOutput&ln=,(303 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"3?[(E)?{[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]imino}methyl]pyridin?4?amine",272232,O=CC1=CN=CN=C1>>NC1=CC=NC=C1\C=N\C1=NC(=CC(=N1)C1=CNC2=CC=CC=C12)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:53100031-Steps:53100033;53100013;53100003,1.1: sodium hydroxide / ethanol; water / 3 h / Reflux; 2.1: sodium / isopropyl alcohol / 3 h / Reflux; 2.2: 8 h / Reflux; 3.1: acetic acid / ethanol / 18 h / Reflux,,,,,,,,,,,,,,,,,,,,sodium; acetic acid; sodium hydroxide,,ethanol; water; isopropyl alcohol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
53100032,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=53100032&database=RX&origin=ReaxysOutput&ln=,(304 of 327),1,63,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(E)?N?[6?(1H?indol?3?yl)?4,5??bipyrimidine?2?yl]?1?(pyrimidine?5?yl)methanimine",272418,O=CC1=CN=CN=C1>>N1C=C(C2=CC=CC=C12)C1=NC(\N=C\C2=CN=CN=C2)=NC(=C1)C1=CN=CN=C1,Multi-step reaction,,,,3,Reaction-ID:53100032-Steps:53100033;53100013;53100034,1.1: sodium hydroxide / ethanol; water / 3 h / Reflux; 2.1: sodium / isopropyl alcohol / 3 h / Reflux; 2.2: 8 h / Reflux; 3.1: acetic acid / ethanol / 18 h / Reflux,,,,,,,,,,,,,,,,,,,,sodium; acetic acid; sodium hydroxide,,ethanol; water; isopropyl alcohol,"Article; Arshad, Mohammad; Journal of the Iranian Chemical Society; vol. 17; 6; (2020); p. 1305 - 1315;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=78832347&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
31968174,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=31968174&database=RX&origin=ReaxysOutput&ln=,(305 of 327),1,62,full reaction; has preparation,(anilino-pyridin-2-yl-methyl)-phosphonic acid diphenyl ester; pyrimidine-5-carbaldehyde,C17H14N4,169114,O=P(OC1=CC=CC=C1)(OC1=CC=CC=C1)C(NC1=CC=CC=C1)C1=NC=CC=C1.O=CC1=CN=CN=C1>>N(C(=CC1=CN=CN=C1)C1=CC=CC=N1)C1=CC=CC=C1,Preparation,,,,1,,,,,,,,,,Horner-Emmons condensation,,,,,scheme or table,,,,,,,caesium carbonate,,tetrahydrofuran; isopropyl alcohol,"Article; Roberts, R. Lee; Bradley, A. Paul; Bunnage, E. Mark; England, S. Katherine; Fobian, M. Yvette; Fox, N.A. David; Gymer, Geoff E.; Heasley, Steven E.; Molette, Jerome; Smith, Graham L.; Fairman, David; Schmidt, Michelle A.; Tones, Michael A.; Dack, Kevin N.; Bioorganic and Medicinal Chemistry Letters; vol. 21; 21; (2011); p. 6515 - 6518;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=20042238&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
35518818,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=35518818&database=RX&origin=ReaxysOutput&ln=,(306 of 327),1,62,full reaction; has multi-step,m-Anisidine; pyrimidine-5-carbaldehyde,1-(1H-indol-3-yl)-2-((3-methoxyphenyl)amino)-2-(pyrimidin-5-yl)ethanone,90956,COC1=CC(N)=CC=C1.O=CC1=CN=CN=C1>>COC1=CC(NC(C(=O)C2=CNC3=CC=CC=C23)C2=CN=CN=C2)=CC=C1,Multi-step reaction,,,,2,Reaction-ID:35518818-Steps:35518817;35519029,"1: 6 h / 60 C / Sealed tube; 2: triethylamine; 3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride / ethanol / 24 h / 70 - 160 C / Sealed tube; Microwave irradiation",,,,,,,,,,,,,,,,,,,,"3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride; triethylamine",,ethanol,"Patent; KATHOLIEKE UNIVERSITEIT LEUVEN; BARDIOT, Dorothee; CARLENS, Gunter; DALLMEIER, Kai; KAPTEIN, Suzanne; McNAUGHTON, Michael; MARCHAND, Arnaud; NEYTS, Johan; SMETS, Wim; WO2013/45516; (2013); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=35472108&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
47680949,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=47680949&database=RX&origin=ReaxysOutput&ln=,(307 of 327),1,62,full reaction; has multi-step,pyrimidine-5-carbaldehyde; 4-(diethoxyphosphoryl)-but-2-enoic acid ethyl ester,C11H14N2O2,169921,O=CC1=CN=CN=C1.CCOC(=O)C=CCP(=O)(OCC)OCC>>CCOC(=O)C\C=C/CC1=CN=CN=C1,Multi-step reaction,,,,2,Reaction-ID:47680949-Steps:47680952;47681061,"1.1: lithium diisopropyl amide / tetrahydrofuran / 1 h / -78 C / Inert atmosphere; 1.2: 3 h / -78 - 20 C / Inert atmosphere; 2.1: triphenylphosphine; chloro(1,5-cyclooctadiene)rhodium(I) dimer; formic acid; triethylamine / acetonitrile / 35 C / Inert atmosphere; Sealed tube",,,,,,,,,,,,,,1.1: |Horner-Wadsworth-Emmons Olefination / 1.2: |Horner-Wadsworth-Emmons Olefination,,,,,,"chloro(1,5-cyclooctadiene)rhodium(I) dimer; formic acid; triethylamine; triphenylphosphine; lithium diisopropyl amide",,tetrahydrofuran; acetonitrile,"Article; Dada, Raphael; Wei, Zhongyu; Gui, Ruohua; Lundgren, Rylan J.; Angewandte Chemie - International Edition; vol. 57; 15; (2018); p. 3981 - 3984; Angew. Chem.; vol. 130; (2018); p. 4045 - 4048,4;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73370059&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
47816302,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=47816302&database=RX&origin=ReaxysOutput&ln=,(308 of 327),1,62,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(2E)-1-[2-(2-methoxyethoxy)-4-phenylquinolin-3-yl]-3-(pyrimidin-5-yl)prop-2-en-1-one; 1-(2-methoxyethyl)-4-phenyl-3-[(2E)-3-(pyrimidin-5-yl)prop-2-enoyl]-1,2-dihydroquinolin-2-one",252596; 249520,O=CC1=CN=CN=C1>>COCCOC1=NC2=CC=CC=C2C(C2=CC=CC=C2)=C1C(=O)\C=C\C1=CN=CN=C1.COCCN1C(=O)C(C(=O)\C=C\C2=CN=CN=C2)=C(C2=CC=CC=C2)C2=C1C=CC=C2,Multi-step reaction,,,,2,Reaction-ID:47816302-Steps:47816296;47816209,"1: water; barium(II) hydroxide / methanol / 0.67 h / 20 C; 2: sodium hydride / N,N-dimethyl-formamide / 23 h / 20 C",,,,,,,,,,,,,,,,,,,,water; sodium hydride; barium(II) hydroxide,,"methanol; N,N-dimethyl-formamide","Patent; PADLOCK THERAPEUTICS, INC.; DEVRAJ, Rajesh; KUMARAVEL, Gnanasambandam; LECCI, Cristina; LOKE, Pui; MENICONI, Mirco; MONCK, Nat; NORTH, Carl; RIDGILL, Mark; TYE, Heather; (205 pag.)WO2018/49296; (2018); A1;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=73439980&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49504014,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49504014&database=RX&origin=ReaxysOutput&ln=,(309 of 327),1,62,full reaction; has multi-step,pyrimidine-5-carbaldehyde,"(S)-N'-[3,5-bis(trifluoromethyl)phenyl]-2-(4-methyl-1-piperazinyl)-2-(5-pyrimidinyl)acetohydrazide; (R)-N'-[3,5-bis(trifluoromethyl)phenyl]-2-(4-methyl-1-piperazinyl)-2-(5-pyrimidinyl)acetohydrazide",,O=CC1=CN=CN=C1>>CN1CCN(CC1)[C@H](C(=O)NNC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=CN=C1.CN1CCN(CC1)[C@@H](C(=O)NNC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=CN=C1,Multi-step reaction,,,,6,Reaction-ID:49504014-Steps:28135446;28135560;28135498;28135561;28135472;28135562,"1.1: titanium(IV) isopropylate / 1,1-dichloroethane / 20 C; 1.2: 4 h / 20 C; 2.1: methanol; sodium hydroxide; water; dihydrogen peroxide / dimethyl sulfoxide / 20 C; 3.1: dmap; di-tert-butyl dicarbonate / dichloromethane / 20 C; 3.2: 2 h / 20 C; 4.1: trifluoroacetic acid / dichloromethane / 20 C; 5.1: water; acetonitrile / 1 h / 20 C; 5.2: 3 h; 6.1: Resolution of racemate",,,,,,,,,,,,,,,,,,,,titanium(IV) isopropylate; methanol; dmap; sodium hydroxide; di-tert-butyl dicarbonate; water; dihydrogen peroxide; trifluoroacetic acid,,"1,1-dichloroethane; dichloromethane; water; dimethyl sulfoxide; acetonitrile",Patent; GLAXO GROUP LIMITED; WO2008/148853; (2008); A1;,https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8669005&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49674463,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49674463&database=RX&origin=ReaxysOutput&ln=,(310 of 327),1,62,full reaction; has multi-step,pyrimidine-5-carbaldehyde,1-(4-chlorophenylsulfonyl)-3-((dimethylamino)methylene)-2-(pyrimidin-5-yl)piperidin-4-one; 1-(4-chlorophenylsulfonyl)-5-((dimethylamino)methylene)-2-(pyrimidin-5-yl)piperidin-4-one,198238; 198264,O=CC1=CN=CN=C1>>CN(C)\C=C1\C(N(CCC1=O)S(=O)(=O)C1=CC=C(Cl)C=C1)C1=CN=CN=C1.CN(C)\C=C1\CN(C(CC1=O)C1=CN=CN=C1)S(=O)(=O)C1=CC=C(Cl)C=C1,Multi-step reaction,,,,3,Reaction-ID:49674463-Steps:10753386;10753387;10753388,1: 4 A molecular sieves; MP-TsOH / toluene / 18 h / Heating / reflux; 2: tetrahydrofuran / 36 h / Heating / reflux; 3: 4 h / 70 C,,,,,,,,,,,,,,,,,,,,4 A molecular sieves; MP-TsOH,,tetrahydrofuran; toluene,"Patent; ELAN PHARMACEUTICALS, INC.; WO2007/64914; (2007); A2;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=8938376&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
49946074,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=49946074&database=RX&origin=ReaxysOutput&ln=,(311 of 327),1,62,full reaction; has preparation,"rac-(3R,5S)-[5-(hydrazinylmethyl)piperidine-3-carboxylic acid] dihydrochloride; pyrimidine-5-carbaldehyde",C12H17N5O2,152561,Cl.NNC[C@H]1CNC[C@H](C1)C(O)=O.O=CC1=CN=CN=C1>>OC(=O)[C@H]1CNC[C@@H](CNN=CC2=CN=CN=C2)C1,Preparation,,,,1,,,,,,,,7.1,,,,,,Experimental part,,,,,,,,sodium L-ascorbate; sodium hydroxide,,aq. phosphate buffer; dimethyl sulfoxide,"Article; Hauke, Tobias J.; Wein, Thomas; Hoefner, Georg; Wanner, Klaus T.; Journal of Medicinal Chemistry; vol. 61; 22; (2018); p. 10310 - 10332;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=75388650&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
15391768,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=15391768&database=RX&origin=ReaxysOutput&ln=,(312 of 327),1,60,full reaction; has multi-step,pyrimidine-5-carbaldehyde,5-(methoxyimino-methyl)-1-methyl-pyrimidin-1-ium; iodide,103419,O=CC1=CN=CN=C1>>[I-].CO\N=C\C1=C[N+](C)=CN=C1,Multi-step reaction,,,,2,Reaction-ID:15391768-Steps:8826439;8859095,1: 62 percent / benzene / 2 h / Heating; 2: acetone / Heating,,,,,,,,,,,,,,,,,,,,,,acetone; benzene,"Article; Jung, Myung Hee; Park, Jewn-Giew; Yang, Kong Jae; Lee, Mi-Jeoung; Archiv der Pharmazie; vol. 334; 3; (2001); p. 79 - 85;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6289719&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9866976,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9866976&database=RX&origin=ReaxysOutput&ln=,(313 of 327),1,59,full reaction; has preparation,3-Quinuclidinone; pyrimidine-5-carbaldehyde,2-[1-Pyrimidin-5-yl-meth-(Z)-ylidene]-1-aza-bicyclo[2.2.2]octan-3-one,163467,O=C1CN2CCC1CC2.O=CC1=CN=CN=C1>>O=C1C2CCN(CC2)\C1=C/C1=CN=CN=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,potassium hydroxide,,,"Article; Mazurov, Anatoly; Klucik, Jozef; Miao, Lan; Phillips, Teresa Y.; Seamans, Angela; Schmitt, Jeffrey D.; Hauser, Terry A.; Johnson Jr., Raymond T.; Miller, Craig; Bioorganic and Medicinal Chemistry Letters; vol. 15; 8; (2005); p. 2073 - 2077;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6499431&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733328,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733328&database=RX&origin=ReaxysOutput&ln=,(314 of 327),1,54,full reaction; has preparation,[3-(1-methylbutoxy)phenyl]amine; pyrimidine-5-carbaldehyde,[3-(1-methyl-butoxy)-phenyl]-pyrimidin-5-ylmethyl-amine,224501,CCCC(C)OC1=CC=CC(N)=C1.O=CC1=CN=CN=C1>>CCCC(C)OC1=CC=CC(NCC2=CN=CN=C2)=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733329,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733329&database=RX&origin=ReaxysOutput&ln=,(315 of 327),1,54,full reaction; has preparation,3-(phenoxymethyl)aniline; pyrimidine-5-carbaldehyde,(3-phenoxymethyl-phenyl)-pyrimidin-5-ylmethyl-amine,224501,NC1=CC=CC(COC2=CC=CC=C2)=C1.O=CC1=CN=CN=C1>>C(NC1=CC(COC2=CC=CC=C2)=CC=C1)C1=CN=CN=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733330,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733330&database=RX&origin=ReaxysOutput&ln=,(316 of 327),1,54,full reaction; has preparation,3-benzylaniline; pyrimidine-5-carbaldehyde,(3-benzylphenyl)(pyrimidin-5-ylmethyl)amine,224501,NC1=CC=CC(CC2=CC=CC=C2)=C1.O=CC1=CN=CN=C1>>C(NC1=CC(CC2=CC=CC=C2)=CC=C1)C1=CN=CN=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733331,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733331&database=RX&origin=ReaxysOutput&ln=,(317 of 327),1,54,full reaction; has preparation,3-(o-tolyloxy)aniline; pyrimidine-5-carbaldehyde,pyrimidin-5-ylmethyl-(3-o-tolyloxy-phenyl)-amine,224501,CC1=C(OC2=CC=CC(N)=C2)C=CC=C1.O=CC1=CN=CN=C1>>CC1=CC=CC=C1OC1=CC(NCC2=CN=CN=C2)=CC=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733334,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733334&database=RX&origin=ReaxysOutput&ln=,(318 of 327),1,54,full reaction; has preparation,pyrimidine-5-carbaldehyde; 3-[[tert-butyl(dimethyl)silyl]-oxymethyl]aniline,[3-(tert-butyl-dimethyl-silanyloxymethyl)-phenyl]-pyrimidin-5-ylmethyl-amine,224501,O=CC1=CN=CN=C1.CC(C)(C)[Si](C)(C)OCC1=CC=CC(N)=C1>>CC(C)(C)[Si](C)(C)OCC1=CC=CC(NCC2=CN=CN=C2)=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733335,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733335&database=RX&origin=ReaxysOutput&ln=,(319 of 327),1,54,full reaction; has preparation,pyrimidine-5-carbaldehyde; m-trifluoromethoxyaniline,N-(pyrimidin-5-ylmethyl)-3-(trifluoromethoxy)aniline,224501,O=CC1=CN=CN=C1.NC1=CC(OC(F)(F)F)=CC=C1>>FC(F)(F)OC1=CC=CC(NCC2=CN=CN=C2)=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733336,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733336&database=RX&origin=ReaxysOutput&ln=,(320 of 327),1,54,full reaction; has preparation,pyrimidine-5-carbaldehyde; 4-phenoxyanilin,(4-phenoxy-phenyl)-pyrimidin-5-ylmethyl-amine,224501,O=CC1=CN=CN=C1.NC1=CC=C(OC2=CC=CC=C2)C=C1>>C(NC1=CC=C(OC2=CC=CC=C2)C=C1)C1=CN=CN=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733337,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733337&database=RX&origin=ReaxysOutput&ln=,(321 of 327),1,54,full reaction; has preparation,pyrimidine-5-carbaldehyde; 3-phenoxyaniline,(3-phenoxy-phenyl)-pyrimidin-5-ylmethyl-amine,224501,O=CC1=CN=CN=C1.NC1=CC(OC2=CC=CC=C2)=CC=C1>>C(NC1=CC=CC(OC2=CC=CC=C2)=C1)C1=CN=CN=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733338,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733338&database=RX&origin=ReaxysOutput&ln=,(322 of 327),1,54,full reaction; has preparation,pyrimidine-5-carbaldehyde; 3-(2-fluoro-phenoxy)-phenylamine,[3-(2-fluoro-phenoxy)-phenyl]-pyrimidin-5-ylmethyl-amine,224501,O=CC1=CN=CN=C1.NC1=CC=CC(OC2=CC=CC=C2F)=C1>>FC1=CC=CC=C1OC1=CC(NCC2=CN=CN=C2)=CC=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733339,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733339&database=RX&origin=ReaxysOutput&ln=,(323 of 327),1,54,full reaction; has preparation,pyrimidine-5-carbaldehyde; 3-(2-bromo-phenoxy)-phenylamine,[3-(2-bromo-phenoxy)-phenyl]-pyrimidin-5-ylmethyl-amine,224501,O=CC1=CN=CN=C1.NC1=CC=CC(OC2=CC=CC=C2Br)=C1>>BrC1=CC=CC=C1OC1=CC(NCC2=CN=CN=C2)=CC=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
9733340,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=9733340&database=RX&origin=ReaxysOutput&ln=,(324 of 327),1,54,full reaction; has preparation,pyrimidine-5-carbaldehyde; 3-[2-(trifluoromethyl)benzyl]aniline,N-(pyrimidin-5-ylmethyl)-3-[2-(trifluoromethyl)-benzyl]aniline,224501,O=CC1=CN=CN=C1.NC1=CC=CC(CC2=CC=CC=C2C(F)(F)F)=C1>>FC(F)(F)C1=CC=CC=C1CC1=CC(NCC2=CN=CN=C2)=CC=C1,Preparation,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Hu, Essa; Chua, Peter C.; Tehrani, Lida; Nagasawa, Johnny Y.; Pinkerton, Anthony B.; Rowe, Blake A.; Vernier, Jean-Michel; Hutchinson, John H.; Cosford, Nicholas D.P.; Bioorganic and Medicinal Chemistry Letters; vol. 14; 20; (2004); p. 5071 - 5074;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6472131&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
5855014,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=5855014&database=RX&origin=ReaxysOutput&ln=,(325 of 327),2,22,half reaction; has preparation,,pyrimidine-5-carbaldehyde,,>>O=CC1=CN=CN=C1,Preparation (half reaction),,,,1,,,,,,,,,,,,,,,,,,,,,,,,,"Article; Bredereck,H. et al.; Justus Liebigs Annalen der Chemie; vol. 766; (1972); p. 73 - 88;; ; Article; Bredereck et al.; Angewandte Chemie; vol. 78; (1966); p. 717;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=79705;2668033&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
5855014,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=5855014&database=RX&origin=ReaxysOutput&ln=,(325 of 327),2,22,half reaction; has preparation,,pyrimidine-5-carbaldehyde,,>>O=CC1=CN=CN=C1,Preparation (half reaction),108.1,[Step 1],[Step 1] Synthesis of 5-pyrimidine ethanol Pyrimidine-5-carboxyaldehyde (400 mg) prepared by the procedure described in Syn. Commun. 24:,1,,,,,,,,,,,,,,,,,,,,,,,,,"Patent; Mochida Pharmaceutical Co., Ltd.; US6018046; (2000); A;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=142531&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
8498563,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=8498563&database=RX&origin=ReaxysOutput&ln=,(326 of 327),1,12,half reaction,diisopropyl zinc; pyrimidine-5-carbaldehyde; (S)-2-methyl-1-(5-pyrimidyl)-1-propanol,,,CC(C)[Zn]C(C)C.O=CC1=CN=CN=C1.CC(C)[C@H](O)C1=CN=CN=C1>>,Chemical behaviour,,,,1,,,,,66,0,,,other substituted pyrimidine-5-carbaldehyde; automultiplication,,,,,,,,,,,,,,,toluene,"Article; Shibata, Takanori; Morioka, Hiroshi; Hayase, Tadakatsu; Choji, Kaori; Soai, Kenso; Journal of the American Chemical Society; vol. 118; 2; (1996); p. 471 - 472;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=6014533&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
5754602,https://www.reaxys.com/reaxys/secured/hopinto.do?context=R&query=RX.ID=5754602&database=RX&origin=ReaxysOutput&ln=,(327 of 327),1,-4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4; -4,half reaction,pyrimidine-5-carbaldehyde,,,O=CC1=CN=CN=C1>>,Chemical behaviour,,,,1,,,,,,,,,,,,,,,,"Rk. mit Na-phenylacetat, Acetanhydrid",,,,,,,,,"Article; Perkampus; Bluhm; Tetrahedron; vol. 28; (1972); p. 2099,2104;",https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&amp;query=CNR.CNR=2718437&amp;database=RX&amp;origin=ReaxysOutput&amp;ln=
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Copyright © 2020 Elsevier Life Sciences IP Limited except certain content provided by third parties. Reaxys is a trademark of Elsevier Life Sciences IP Limited.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,